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Enhancers are cis-regulatory sequences which promote the expression of target genes in a 
spatial and temporal fashion.  They can be located within genes or between them and can act 
at distances of over 1 Mb.  There are several different mechanisms by which enhancers 
regulate gene expression.  Some, such as those regulating the Hox genes, are located close to 
each other in the genome in a structure referred to as a regulatory archipelago.  These come 
together and act in combination to regulate gene expression, with different enhancer 
combinations resulting in different patterns of expression.  On the other hand, enhancers can 
act individually, with designated enhancers responsible for regulating the expression of the 
same gene in different tissues or at different stages of development.  Indeed, this is the case 
for the Sonic Hedgehog gene (Shh) where several different enhancers located within a gene 
sparse region referred to as a gene desert, act separately leading to Shh expression in areas 
such as the brain, the lungs, the notochord and neural tube and the limbs. 
Within the developing mouse embryo, Shh is expressed over roughly a two day period from 
E10 to E12 in a posterior distal region referred to as the Zone of Polarising Activity (ZPA).  
Ectopic expression in anterior regions has been observed in some common congenital diseases 
which affect the limbs, sometimes resulting in the formation of extra digits.  The reason for 
this mis-expression is largely due to defects in the Shh limb enhancer commonly referred to as 
the Zone of Polarising Activity Regulatory Sequence (ZRS). Mutations within this highly 
conserved sequence create additional protein binding sites thus activating the enhancer in the 
wrong locations.  The associated diseases are known collectively as the ZRS associated 
syndromes and can range from the less severe phenotype of preaxial polydactyly type II 
(characterised by an extra digit near the thumb) to the more severe Werner Mesomelic 
Syndrome (WMS), where patients present with a clear displacement of their tibia. 
The mechanism by which the ZRS functions is yet to be fully elucidated, with current studies 
producing conflicting data.  What is known, is that the region encapsulating the Shh gene is 
highly compact, with both the gene and its enhancers located in a highly conserved Toplogical 
Associated Domain (TAD) as proven by Hi-C experiments.  The boundaries of this domain 
are likely created by the binding of the protein CTCF to specified binding sites located at the 
either end of the locus.  This restricts the ability of the enhancers to regulate the expression of 
genes outside the TAD. 
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To study the exact mechanism by which the ZRS is activated and regulates Shh expression, 
the Hill laboratory has used cultured cell lines derived from the posterior regions of an E11.5 
limb bud.  Gene expression in these cells is highly reflective of the posterior limb bud, with 
the key exception being Shh, which is not expressed.  However, using different drug treatments 
or biological manipulations Shh can be activated thereby making this the perfect system to 
analyse the mechanisms leading to Shh activation. 
In this investigation the cell lines were used to determine how the position of the ZRS changes 
upon activation.  Using techniques such as Fluorescent in situ hybridisation (FISH) with either 
fosmid probes or directly labelled probes called MYtags, it was confirmed that the Shh locus 
is indeed highly compact in both Shh expressing and non-expressing cells. However, no 
differences were observed in terms of the distance between the ZRS and Shh between these 
two conditions in our cell lines.  Next, both carbon copy chromosome conformation capture 
(5C) and circular chromosome conformation capture (4C) were used to look at changes to the 
Shh locus in different conditions.  This confirmed Hi-C experiments and other recent 
publications suggesting that Shh is located within a TAD, the position of which is highly 
conserved between different conditions and cell lines.  Furthermore, treatments activating the 
Shh gene resulted in significant deviations to the chromatin interactions within the locus 
suggesting a repositioning of structures when the gene is active. 
It is believed that the use of Shh inducible limb derived cell lines will prove extremely useful 
in future scientific endeavours to study the mechanisms of mammalian limb development.  
These provide a quick and easy means of accessing large numbers of Shh expressing cells, a 
feature which is increasingly important in an era where large cell numbers are needed for 










During embryonic development genes are controlled by sequences called enhancers which are 
able to turn genes on and off at very specific times.  This is extremely important in the process 
of limb development as the specific times when enhancers are active determine the precise 
number of fingers and toes in fully formed mammals.  One of the main genes orchestrating 
limb development is named after the popular fictional computer character Sonic Hedgehog 
and is expressed at the base of the developing limb in healthy embryos.  However, DNA 
mutations can lead to expression in other locations within the limb resulting in congenital 
malformations.  Most commonly extra digits are observed - a condition referred to as 
polydactyly or the fusion of digits, referred to as syndactlyl.  This condition occurs not just in 
humans but also in other mammals such as mice, chickens and cats.  Indeed, Ernest 
Hemmingway was well known for owning a polydactylous cat with 6 digits, descendants of 
which are now referred to as Hemingway’s cats. 
Understanding the mechanisms by which enhancers operate to produce a fully developed limb 
is a major focus of scientific research today.  Indeed, members of the Hill laboratory focus 
particularly on the enhancer which regulates Sonic Hedgehog.  They study the effect of 
mutations, its sequence composition and its relationship with the Sonic Hedgehog gene when 
it is being expressed and when it is not.  The focus of this investigation was to determine how 
the position of the Sonic Hedgehog enhancer changes when the Sonic Hedgehog gene is turned 
off and when it is turned on.  To do this, cells taken from an embryonic limb bud were grown 
and used to perform various laboratory based techniques.  Consequently, it was found that the 
Sonic Hedgehog enhancer maintains a very close relationship with the gene in all conditions 
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1.1 Hedgehog Signalling  
 
1.1.1 The Hedgehog Protein; Discovery of the Hedgehog Protein and 
its Processing in the Nucleus 
 
The Hedgehog group proteins are currently regarded as one of the most important classes of 
signalling molecules present in both vertebrates and invertebrates.  Although significant leaps 
in understanding of both their mechanism of action and role during development have been 
made, our knowledge of this group still remains in its relative infancy.  The hedgehog mutation 
was first observed in the Nobel Prize winning experiment conducted in 1980 by Nüsslein-
Volhard and Wieschaus (Nüsslein-Volhard and Wieschaus, 1980) where a large scale 
mutagenesis screen was conducted in an attempt to identify the genes responsible for 
regulating the segmental pattern of the Drosophila embryo.  One of the resulting mutants 
displayed dentricle structures across the entirety of each independent body segment, thereby 
giving it a prickly appearance which the author’s believed resembled that of a hedgehog’s 
spikes and hence led to the identifying name hedgehog.  Several other mutants such as 
gooseberry and patch were also identified, with a common feature being the deletion of a 
posterior region of each segment and its replacement with the mirror image duplication of the 
anterior portion of the segment.  Together these were referred to as the segment polarity 
mutants.  Two other classes of mutants were also characterised from this screen: the pair-rule 
mutants such as even-skipped and runt, where only alternate segments were affected; and, the 
Gap mutants such as Krüppel and knirps where substantial numbers of segments were 
simultaneously affected.  Together these mutants defined a class of genes that would later be 
recognised as instrumental in patterning both the vertebrate and invertebrate embryo. 
 
However, after its initial discovery in the Drosophila, it was over a decade before variants 
were discovered in mammals.  In 1993 three papers (Krauss et al., 1993, Riddle et al., 1993, 
Echelard et al., 1993) were published in the same volume of the journal Cell detailing the 
discovery of three mammalian genes homologous to the hedgehog gene from Drosophila: 
Sonic hedgehog (Shh); Indian Hedgehog (Ihh); and, Desert Hedgehog (Dhh).  In addition, 
zebrafish also have the additional hedgehog genes tiggywinkle, echidna and qiqhar hedgehog.   
Of these, Shh became the most studied probably due to its importance in regulating key 
developmental processes at specifically defined times during development of the vertebrate 
embryo.   Some of the most important developmental roles of Shh are discussed in the 
following sections.   
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Over subsequent years the structure, function and mechanism of the hedgehog proteins were 
studied in greater detail at both a molecular and cellular levels.  It is now known that 
Drosophila hedgehog protein exists initially as a 45 kDa pro-protein which undergoes an auto-
cleavage reaction (Lee et al., 1994) using the Hog domain at the carboxyl terminal to produce 
both an amino-terminal (HH-N) and carboxyl terminal (HH-C) polypeptide, with only the HH-
N polypeptide involved in the further signalling processes.  This occurs through the production 
of a thioester intermediate which subsequently undergoes nucleophilic attack on the thioester 
carbonyl group by cholesterol.  The resulting HH-N species formed is therefore a cholesterol 
adduct (Porter et al., 1996).  Using ESI-MS and HPLC, Pepinsky et al. (Pepinsky et al., 1998) 
later showed that human SHH - expressed in both insect and mammalian cell lines - was 
palmitoylated on the α-amino group on Cys-24 of the HH-N polypeptide, in addition to 
cholesterol.  However, this did not occur on every peptide, with the authors concluding that 
both cholesterol only (HH-N) and cholesterol with palmitoyl (HH-Np) polypeptides exist.  The 
identity of the protein responsible for this palmitoyl addition was published concomitantly by 
several different research groups and can therefore be identified by the numerous synonyms: 
skinny hedgehog (ski) (Chamoun et al., 2001); sightless (Lee and Treisman, 2001); central 
missing (Amanai and Jiang, 2001); or, rasp (Micchelli et al., 2002).  In humans this 
palmitoyltransferase, which catalyses the addition of a palmitate group to SHH, is known as 
Hedgehog acyltransferase (HHAT).  These proteins belong to a class of enzymes collectively 
referred to as the membrane-bound O-acyl transferases (MBOAT).  Buglino and Mesh 
(Buglino and Resh, 2008) showed that a palmitate group, most likely provided by a palmitoyl-
CoA substrate, was added to the N-terminus of SHH through an amide linkage and that the 
addition of this group was independent of the previous auto-cleavage reactions and the 
cholesterol addition. They also performed immunofluorescence experiments to show that the 
HHAT protein was localised in both the endoplasmic reticulum (ER) and golgi apparatus 
suggesting that the palmitoylation of SHH occurs in the secretory pathway. 
 
The exit of this cholesterol modified form of hedgehog from the cell is orchestrated by the 12 
pass transmembrane protein Dispatched (Disp) which shares a large amount of sequence 
homology to the hedgehog target protein Patched (Ptc).  In studies of the wing imaginal disc 
(Burke et al., 1999), disp-\- cells retain the cholesterol adduct within the cell and are unable to 
release it for long range signalling processes.  This contrasts with wild type cells which can 
effectively spread the hedgehog signal to their neighbouring cells.  Burke et al. (Burke et al., 
1999) highlighted that the presence of cholesterol is critical to the release of this auto-
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processed, post-translationally modified protein.  When cholesterol was swapped with an 
alternative lipid anchor Disp was unable to remove this protein from the cell. 
 
The addition of cholesterol to hedgehog proteins seems to have a key role in regulating the 
location of hedgehog signalling.  Gallet et al. (Gallet et al., 2006) showed that the cholesterol 
addition in Drosophila cells was essential in targeting the modified hedgehog protein to the 
plasma membrane.  After release from the cell cholesterol addition was also needed for the 
formation of large hedgehog multimers necessary for the transport of hedgehog as large 
punctuate structures (LPSs) to long range targets.  For example long-range hedgehog 
signalling was shown in Drosophila in both the ventral ectoderm and embryonic dorsal 
epidermis (Gallet et al., 2006).  Without cholesterol, hedgehog cannot form dimers and shows 
no long range activity.   
 
The hedgehog cholesterol addition and the protein Dispatched were shown to play a key role 
in localising Hh-Np to the apical membrane (Gallet et al., 2003) in cells of the Drosophila 
ectoderm.  Without cholesterol, hedgehog is unable to form LPSs within the cell and is located 
only at the basolateral surface.  Likewise, in disp mutants LPSs were not formed and Hh-Np 
was only present at the basolateral surface in small quantities. 
 
Research continues into the removal of hedgehog and its subsequent transport to other cells 
situated both close by and at longer distances.  What has become clear is that lipoproteins in 
both invertebrates and vertebrates are necessary for long range Hh/Shh signalling processes 
(Palm et al., 2013).  In Drosophila the lipoprotein lipophorin is necessary for long range Hh 
signalling in imaginal discs (Panáková et al., 2005) and this is mediated by the binding of 
lipophorin to glypicans such as Dally and Dally-like through both GPI anchors and herapan 
sulfate moieties (Eugster et al., 2007).  A similar process occurs in vertebrate SHH signalling.  
However, this is only one of a variety of mechanisms leading to the eviction of HH from the 
cell, with evidence for HH exiting as multimers and through the recently discovered shedding 
mechanism (Ohlig et al., 2011).  Also, HH can leave in vesicles specifically referred to as 
NVPs (Nodal Vesicular Parcels).  In this case, SHH and retinoic acid (RA) are transported 
within NVPs in the nodal flow and, therefore, contribute to left-right asymmetry in the 
developing vertebrate embryo (Tanaka et al., 2005).  In vertebrates, the protein SCUBE2, an 
ortholog of the zebrafish protein you has been shown to assist in the secretion of SHH from 
the cell.  SCUBE2 binds to the cholesterol on SHH thereby maintaining it in a soluble state 
enabling easy release into the extracellular matrix (Tukachinsky et al., 2012, Creanga et al., 
 5 
2012).  It is hypothesised that SHH is passed from Dispatched to SCUBE2 and then released 
from the cell where it then forms multimers for long range transport. 
 
1.1.2 The Hedgehog Signalling Pathway 
 
SHH signalling has been tightly conserved throughout evolution utilising very similar 
mechanisms from Drosophila to mammals.  The main difference however, is that all SHH 
signalling is conducted in the primary cilium in mammals whereas this structure is not needed 
for HH signalling in Drosophila.  In mammals SHH binds to the patched receptor (PTCH1) 
which is in complex with associated co-receptors GAS1, CDO and BOC thereby nullifying its 
inhibition of smoothened (SMO). Entry into the cilium is facilitated by the binding of 
phosphorylated SMO to β-arrestin and KIF3A.  Release of SMO inhibition results in the 
anterograde movement of KIF7 from the base to the tip of the cilium, which may act to release 
GLI3 from SUFU allowing GLI3-A to enter the nucleus.  Loss of SHH signalling maintains 
SMO in an inhibitory state which maintains inhibition of GLI3 by SUFU.  KIF7 remains at 
the base of the cilia in complex with GLI proteins where, after phosphorylation and β-TRCP 
recognition, they are partially degraded into their repressor form (GLI3-R) (Anderson et al., 
2012, Briscoe and Thérond, 2013).  Cos2, the Drosophila homolog of KIF7, has lost its kinesin 
motor activity thereby relinquishing the need for primary cilia in Hedgehog signalling.  The 































Figure 1.1 – The SHH signalling pathway in mammals in (A) non-expressing and (B) 
expressing cells.  (A) In non-expressing cells patched represses smoothened.  KIF7 remains 
at the base of cilia, leaving GLI3 to be degraded into its repressor form.  (B)  In Shh 
expressing cells patched loses its inhibitory effect on smoothed and moves into the cilia via 
β-arrestin and KIF3A.  KIF7 travels up the cilia allowing the release of GLI3 from SUFU which 





1.2 Signalling in the limb bud 
 
The developing mouse embryonic limb bud is an ideal model system to study the mechanisms 
by which morphogens act.  The limb is patterned along three separate axes: the proximal-distal 
axis; the anterior-posterior axis; and, the dorsal-ventral axis.  This results in three separate 
limb sections; the most proximal of which is referred to as the stylopod and (when referring to 
the mouse forelimb) contains the humerus. The zeugopod follows - containing the radius and 
ulna - and finally, the autopod contains the carpals, metacarpals and phalanges (Figure 1.3(A)).  
The length of time active, the distance travelled within the limb bud and the amounts of 
signalling molecules present are all equally important factors in the formation of a fully 
functional limb.  In addition, an intricate cross talk is necessary between different signalling 
molecules involved in patterning the three limb axes.  This section will discuss some of the 
key signalling processes which occur within the embryonic mouse limb bud with a special 
focus on the secreted morphogen SHH which plays a key role in establishment of the anterior-
posterior limb axis. 
 
1.2.1 Stages of Limb Development  
 
The majority of mouse limb formation occurs over five days from E9.5 to E14.5 (Figure 
1.2(A)).  During this period a small limb bud emerges from the side of the body trunk and 
grows outwards; the proximal skeletal elements developing first followed by the more distal 
elements at later stages.  The process of forelimb and hindlimb formation is very similar with 
hindlimb development trailing that of the forelimb by roughly half a day (Martin, 1990). 
 
The forelimb bud is first visible at E9.5 occurring adjacent to somites 7-13 with the hindlimb 
apparent at E10 beside somites 27-31.  However, it is not until E11.5 that the beginning of 
cartilaginous structures can be detected in the most proximal regions of the forelimb.  A day 
later the humerus, radius and ulna are all visible along with digits 3, 4 and 5.  The apical 
ectodermal ridge (AER) - a structure important in regulating the signalling processes within 
the limb bud (Chapter 1.2.3) found at the growing tip - is also fully visible by E11.5, with a 
small thickening of ectodermal cells visible a day earlier.  An invasion of myogenic cells from 
the dermomoyotme, which will later develop into muscle, migrate towards the base of the limb 
bud at E10.5 with muscle formation evident the following day.  Around that time, nerve cells 
infiltrate the limb and begin to spread distally.  By E14 all digits are clearly visible and cells 
are beginning to die in the mesenchyme separating these structures.  The nerves have spread 
to the fingers and toes and the tendons can be seen.  Finally, by E14.5 the interdigital 
 8 
mesenchyme has disappeared leaving a full complement of digits and toes (although these still 
lack the most distal phalangeal structures) (Martin, 1990). 
 
1.2.2 Initiation of the Limb Bud 
 
The limb bud initially forms as outgrowth of the lateral plate mesoderm (LPM) in mice and in 
chicks.  Development of the three limb axes is dependent on the production of Fgf10, a 
signalling molecule needed to initiate the Fgf-Shh feedback loop which defines limb growth 
(Chapter 1.2.4).  The expression of Fgf10 is driven by retinoic acid (RA) expressed in both the 
paraxial and lateral plate mesoderm.  The process is initiated by an as yet unknown molecule 
originating in the paraxial mesoderm activating RA and leading to Tbx5 (Tbx4 in the hind 
limb) (Figure 1.2(B)) expression in the LPM of the forelimb (Nishimoto et al., 2015).  In chick 
limb buds, a foil barrier placed between the paraxial mesoderm and the LPM between stages 
12 and 13 resulted in a loss of Fgf10 expression in the LPM but Tbx5 levels either side of the 
barrier were unaffected.  Expression of Fgf10 was rescued when a RA soaked bead was placed 
on the distal side of the barrier.  The conclusions from these experiments were that RA from 
the LPM was initially needed to activate Tbx5/4 (in accordance with the Hox and -
catenin/LEF/TCF genes) in a  process referred to as limb induction.  At later stages, Tbx5/4 
then acts in tandem with RA to activate Fgf10 in a process referred to as limb initiation 
(Nishimoto et al., 2015).  
 
The positions at which limb buds develop along the body axis are also tightly controlled.  The 
T-box transcription factors mark these areas with Tbx5 expressed in the forelimb LPM and 
Tbx4, Pitx1 and Islet1 marking the hindlimb.  Their expression is controlled through the 
collinear activation of Hox genes in a progressively rostral to caudal orientation.  Hox 
paralogous groups (PG) 4 and 5 expressed in the forelimb LPM activate Tbx5 while Hoxc8, 9 
and 10 expressed in more caudal regions repress Tbx5.  In contrast, Hoxc9 is a positive 










Figure 1.2 – The major stages of limb development occur over 5 days from E9.5 to E14.5 
during which a series of complex interconnecting signalling pathways are established 
leading to the growth of the limb along three axes.  (A) The forelimb bud is visible at E9.5 
and has substantially increased in size a day later.  At this point, myogenic progenitor cells 
begin to invade the limb bud to initiate muscle formation.  Nerves can been seen invading 
the forelimb at E11.5 - a process referred to as innervation (nerves shown as red lines) - 
and grow in a proximal to distal direction.  By E12.5 the beginnings of digits II, III and IV are 
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visible while digits I and V appear a day later.  Interdigital mesenchyme is removed by 
apoptosis at E13.5 leaving fully formed digits at E14.5.  The formation of the cartaliginous 
structures of the forelimb are shown along the bottom of this diagram.  (B) The key 
signalling processes involved in both limb induction and limb initiation.  Limb induction 
occurs first resulting with the production of TBX5.  Together with RA this acts to induce 
Fgf10 which is subsequently involved in a self regulating feedback loop with Fgf8 resulting 
in limb outgrowth.  (C)  The signalling pathways involving the Fgfs produced in the AER and 










































1.2.3 Formation of the Proximal-Distal Axis 
 
The proximal-distal limb axis of the developing limb bud runs from the shoulder to the tips of 
the fingers.  Elongation of the limb bud along this axis is driven by the apical ectodermal ridge 
(AER), a thickening of ectoderm at the tip of the growing limb bud.  Various models have 
been proposed to explain the mechanism by which the limb is specified along this axis leading 
to the formation of the three limb sections.  Initially the “progress zone” model was favoured 
in which the AER maintains a small group of cells in an undifferentiated state at the tip of the 
developing limb - the so-called progress zone.  As the limb grows and cells divide, some cells 
are displaced from this region allowing them to develop into a particular structure.  Cells which 
leave at an early stage develop into more proximal structures while those which are maintained 
within the progress zone for a longer time period form the distal features.  Experiments in 
support of this theory were largely based on the effect of removing the AER on limb 
development.  For example, when the AER of chick limb buds was removed at an early stage 
only proximal structures were formed with a complete lack of distal features.  On the other 
hand, when the AER was removed at later stages distal structures had also developed 
(Summerbell, 1974, Summerbell et al., 1973).  It was proposed that a signal from the AER 
was responsible for maintaining the progress zone but had no role in specification of the 
tissues.  Instead, the time at which cells were evicted from the progress zone was critical in 
determining the anatomical feature which developed.  Evidence for this hypothesis came from 
experiments where the AERs from different chick limbs at different developmental stages 
were removed, switched and re-grafted (Rubin and Saunders, 1972).  For the most part, these 
grafts had little influence on the specification of tissues along the proximo-distal axis.  This 
result contrasts another model where different signals emitted from the AER pattern the limb 
at progressive developmental stages.  It was nearly 20 years after the “progress zone” model 
was hypothesised before signalling molecules capable of replicating the function of the AER 
were identified.  In two separate studies FGF-4 and FGF-2 were both shown to drive normal 
proximo-distal limb outgrowth in chick limbs when implanted at the distal edge of the limb 
after removal of the AER (Niswander et al., 1993, Fallon et al., 1994). 
 
In the following years the importance of AER-FGFs to proximo-distal limb architecture was 
confirmed (Mariani et al., 2008).  Whilst, the “progress zone” model - which argued that cells 
were specified after they leave the progress zone – continued to be investigated, increasing 
evidence suggested that limb cells were specified at a very early stage after which the three 
limb sections expand sequentially in a proximal to distal direction, the “early specification” 
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model (Dudley et al., 2002).  The “two-signal” model (Zeller et al., 2009) incorporates the 
opposing functions of retinoic acid (RA) produced in the proximal regions and the FGFs 
produced in the progress zone.  RA activates Meis1 and Meis2 thereby defining the proximal 
portions of the developing limb.  These signals are inhibited by FGFs within the progress zone.  
As the limb grows the influence of RA decreases distally eventually being completely 
inhibited by AER-FGFs.  At this point the zeugopod becomes specified (Mercader et al., 
2000).  The “two-signal” model supports the hypothesis that the limb bud cells may be 
specified early as the initial limb bud is immediately exposed to both RA and FGFs which 
influence its development.   
 
The “differentiation front” model incorporates aspects of both the “two-signal” and “progress 
zone” models to interpret proximodistal patterning (Tabin and Wolpert, 2007).  In this theory, 
the AER-FGFs in the distal limb produce an area of undifferentiated cells - the undifferentiated 
zone - with its border referred to as the differentiation front.  As the cells cross the 
differentiation front, the influence of the AER-FGFs is lost and they become committed to 
differentiation.  The most proximal cells of the developing limb will pass through the 
differentiation front first, followed by progressively more distal cells and hence the limb is 
patterned in a proximal to distal fashion.  However, this model differs from the “progress zone” 
model as the cells in the undifferentiated zone do not rely on an internal clock within this 
region to relay positional information.  Instead, this information is attained by dynamic gene 
expression patterns that arise as the limb expands.  Like the “two-signal model”, the AER-
FGFs and RA induced Meis gene expression form overlapping regions which eventually 
separate as the limb expands and leave a middle region unaffected by both signals.  Hoxa11 
begins to dominate the distal limb and forms a boundary to the Meis expressing regions as 
both genes are probably inhibitory of each other.  Hoxa13 then becomes expressed in the distal 
most cells and begins to dominate the region as Hoxa11 cells progress through the 
differentiation front.  Now the zeugopod is identified exclusively through Hoxa11 expression 
in comparison to the autopod expressing Hoxa13, while the posterior stylopod is characterised 













Figure 1.3 – (A) The limb is patterned along three separate axes; the proximo-distal axis 
running from the shoulder to the tips of the digits, the anterior-posterior axis which runs 
from the thumb to the little finger and the dorso-ventral axis which runs from the back of 
the hand to the palm.   The bones from the resulting fully grown limb are partitioned into 
three discrete sections.  For the forelimb, the stylopod contains the humerus, the zeugopod 
contains the radius and ulna and the autopod contains all the bones of the hand plate as 
well as the phalanges making up the digits.   A similar pattern is observed for the hindlimb.  
This diagram only highlights the various features of the forelimb.  (B)  The common lab 
mouse and fruit bat are both descended from a common ancestor in existence roughly 100 
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million years ago.  Both have evolved very different limb structures which can partly be 
explained through the divergence of enhancer sequences from this common ancestor.  
Enhancers for the Prx1 gene are an example of this evolutionary process.  When the Prx1 


































1.2.4 Formation of the Anterior-Posterior Axis 
 
Prior to Shh expression the limb is initially pre-patterned based on the antagonistic relationship 
between the two transcription factors GLI3-R and dHAND along the anterior-posterior axis.  
GLI3-R inhibits dHAND expression in the anterior portion of the limb bud while promoting 
the expression of other factors such as Alx4 that define the anterior identity.  In contrast, 
dHAND inhibits the expression of Gli3-R and other anteriorly expressed genes from spreading 
to posterior regions and contributes to the expression of posteriorly expressed genes such as 
Shh (te Welscher et al., 2002).  Expression of Shh within posterior regions thereby establishes 
a new signalling centre referred to as the Zone of Polarising Activity (ZPA).  The ZPA was 
initially identified through grafting experiments using chick limb buds where the posterior 
portion of the limb bud from one animal was fused to the anterior portion of another resulting 
in mirror image duplications of the digits.  SHH was confirmed as the molecule driving this 
polarizing activity within the ZPA; that is when SHH expressing cells were implanted into the 
anterior regions of chick limb buds, phenotypes similar to the ZPA grafts were produced 
(Riddle et al., 1993).  The conclusion from these experiments was that SHH was essential - 
not only for specifying the number of digits produced but also the positional identity of these 
digits.  However, what remained unknown was the mechanism by which SHH acted within 
the limb bud to achieve proper digit formation. 
 
It was immediately hypothesised that SHH may act as a morphogen within the limb bud.  
Morphogens are small signalling molecules capable of regulating the positional identity of 
cells within tissues based on the quantity of signal exposed to each cell (Crick, 1970, Wolpert, 
1969).  Defined signal levels within a morphogen gradient will specify cell fates, with for 
example, a higher concentration of morphogen eliciting a different effect than that of a lower 
concentration. 
 
In this case SHH produced within the ZPA would diffuse throughout the limb bud in a 
posterior to anterior direction and the identity of each digit would be defined by the 
concentration of SHH at that particular location.  The highest concentration of SHH would 
lead to the formation of the little finger (digit 5 in mice) and the lowest concentration to the 
thumb (digit 1 in mice).  Experiments using irradiated ZPA grafts prior to the discovery of 
SHH, had suggested that a diffusible morphogen specifies the digits.  For example, Smith et 
al. (Smith et al., 1978) showed that when chick ZPA cells were subjected to an increasing 
dosage of radiation and then grafted onto the anterior of another limb bud, the ability to form 
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digits 4 to 2 was inversely proportional to the amount of radiation.  The conclusion from these 
experiments was that increasing the radiation directly affected the quantity of a potential signal 
from the grafted cells thereby reducing its ability to form digits needing high signal levels.  
Further experiments  using irradiated ZPA grafts (Smith, 1980) confirmed that the time at 
which duplicated digits develop agrees with a morphogen model for limb patterning. 
 
However, this morphogenic model of anterior-posterior patterning within the limb bud was 
revised in a report by Harfe et al. (Harfe et al., 2004) that proposed that digit formation was 
dependent on both a spatial and temporal gradient of SHH.  This study highlighted the 
observation that digits 3 to 5 are descended from SHH expressing cells while digit 2 is not - 
although it is still dependent on SHH to form.  The authors suggested that as cells in the 
posterior region expand, some move away from the SHH expressing domain of the ZPA.  This 
is a sequential process, where the length of time cells are exposed to SHH defines whether 
they will develop into digits 3, 4 or 5.  Digit 2 is dependent on the diffusion of the SHH 
morphogen anteriorly, as the cells which produce this digit have never been part of the ZPA. 
 
In contrast to the spread of SHH in a posterior to anterior direction, GATA6 is shown to have 
a higher concentration in the anterior hindlimb which decreases posteriorly.  Deletion of 
GATA6 resulted in the spread of Shh expression anteriorly, while increased GATA6 resulted 
in a drop in Shh expression.  In subsequent experiments, the Shh limb enhancer, the ZRS 
(Chapter 1.3.8), was shown to possess binding sites for GATA6.  When a ZRS-lacZ construct 
was used in transgenic experiments a combination of GATA6 and FOG2 reduced its activity.  
The conclusions from this study were therefore that GATA6 binding at the ZRS inhibited Shh 
expression thereby restricting it from spreading ectopically (Kozhemyakina et al., 2014). 
 
1.2.5 Communication Between the ZPA and the AER is Essential for 
Limb Development 
 
Although development along the three limb axes are usually analysed individually, it is 
important to be aware of a complex cross-talk between the individual components of each 
pathway.  For example, an interconnecting relationship between the AER-FGFs and SHH 
produced in the ZPA is important in both anterior-posterior and proximo-distal axis 
development.  Early studies showed that a combination of FGF4 and RA induces Shh 
expression.  SHH and FGF4 then enter into a positive feedback loop, each maintaining the 
expression of the other without the need for RA (Niswander et al., 1994).  Induction of Fgf4 
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expression by SHH was later shown to be mediated through the BMP antagonist gremlin 
(Figure 1.2(C)).  BMP is an inhibitor of Fgf4 expression but inhibition of BMP by gremlin 
subsequently allows Fgf4 expression within the AER (Zúñiga et al., 1999).  In the chick limb 
bud this feedback loop is turned off by E6.  At this stage, SHH producing cells and their 
descendants no longer produce gremlin.  At first this is not a problem as the SHH protein is 
able to diffuse through cells and activate gremlin in the more anterior responsive cells.  
However, as the pool of gremlin non-expressing cells increases, the SHH protein has further 
to travel and eventually is unable to reach the responsive tissue.  As a result, FGF4 is no longer 
produced and the SHH-FGF4 feedback loop breaks down (Scherz et al., 2004).  In 2008 this 
model was updated to incorporate the inhibitory function of Fgf8 on gremlin (Verheyden and 
Sun, 2008).  Here, Shh induced gremlin expression leads to the induction of Fgfs 4, 8, 9 and 
17.  At this stage the SHH-FGF4 feedback loop is functional and induction of both genes 
occurs.  However, FGF8 is able to inhibit gremlin and as time progresses levels of FGF8 
increase.  As a result, gremlin expression is inhibited thus allowing the BMPs to inhibit the 
AER-Fgfs.  Loss of the Fgf4 expression thereby leads to a drop in Shh expression and the 
termination of the self-regulating feedback loop.  In addition, both TBX2 (Farin et al., 2013) 
and TWIST2 (Wade et al., 2012) have been shown to inhibit gremlin; hence both assist to 
terminate the SHH-FGF4 feedback loop. 
 
The integration of the Hox (HoxA;D) genes at different developmental stages into the SHH-
FGF feedback loop provides an additional layer of complexity to this system.  At early stages 
these can promote the expression of Fgf10 which subsequently induces Fgf8.  Also, the 
HoxA;D genes initiate gremlin expression independent of Shh.  Later on (around E11.5 in 
mice), these genes promote the spread of gremlin to anterior positions of the limb bud and the 
maintenance of Shh expression.  Expression of Hox genes at key developmental stages is 
therefore essential in regulating the development of both the anterior-posterior and proximo-













1.2.6 Formation of the Dorso-Ventral Axis 
 
The dorso-ventral limb axis runs from the back of the hand to the palm and, like the other two 
axes, requires signals emanating from the AER for proper formation.  Among these are the 
Wnt family of signalling molecules.  Wnt7a is expressed in the dorsal ectoderm and is 
responsible for regulating the spatiotemporal expression of Lmx1 in the dorsal mesenchyme.  
Misexpression of Lmx1 ventrally causes a “Double Dorsal” limb pattern (Riddle et al., 1995).  
Interestingly, Wnt7a signals through a -catenin independent pathway in contrast to Wnt3a 
which functions in both establishing the AER as well as regulating the expression of key genes 
such as Bmp2, Fgf4 and Fgf8 (Kengaku et al., 1998).  However, there is an interconnection 
between this Wnt7a signalling pathway and the previously discussed SHH-FGF4 feedback 
loop (Chapter 1.2.4).  Removal of the dorsal ectoderm and therefore WNT7A results in a loss 
of Shh signalling and the formation of some proximal skeletal elements which can be rescued 
by the addition of Shh expressing cells to the posterior distal region of the limb (Yang and 
Niswander, 1995).   This restriction of Wnt7a to the dorsal ectoderm is mediated by En-1 
expression which is expressed in both the ventral ectoderm and mesenchyme and represses the 
spread of Wnt7a to these regions.  Ectopic En-1 in the dorsal ectoderm results in a loss of 
Wnt7a expression and the malformation of the AER.  This impacts the SHH-FGF4 feedback 
loop which leads to a reduction in Shh expression and defects in the developing  proximodistal 
skeleton (Logan et al., 1997).  A further study looking at the role of BMP signalling in dorso-
ventral patterning showed that a conditional knock out of the Bmpr gene responsible for the 
type I BMP receptor (BMPR-IA) resulted in a loss of ventral structures.  This correlated with 
a reduction in En-1 and an increase in Wnt7a and Lmx1b.  Expression of BMPs such as Bmp7 
occur in ventral regions near the AER at early limb bud development stages.  It seems, 
therefore, that BMPs are responsible for activating En-1 in the ventral ectoderm which is 
subsequently needed to pattern the ventral limb (Ahn et al., 2001). The order in which BMPR-
IA and -catenin are utilised in the signalling cascade leading to AER formation remains to 
be fully elucidated and has been debated in two conflicting reports (Soshnikova et al., 2003, 
Barrow et al., 2003).  However, BMPR-IA is undoubtedly involved in regulating Fgf8 
expression, as continued stimulation of the receptor results in Fgf8 expression ectopically.  
 
The transcription factors SP6 and SP8 are also a vital component of the signalling cascade 
resulting in correct dorso-ventral limb patterning.  Both factors act in a redundant manner; 
however, SP8 is the more important of the two due to its higher expression within the 
developing limb.  SP6/SP8 act downstream of -catenin to regulate the Fgf8 expression needed 
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in AER formation and, loss of both SP6/SP8 therefore results in a loss of Fgf8 expression.  As 
Fgf10 is in a self-regulating feedback loop with Fgf8, Fgf10 is initially expressed but quickly 
lost leading to the disappearance of the limb bud at E11.5.  SP6/SP8 are also responsible for 
regulating the correct expression of En-1, with mutants displaying Wnt7a in ventral regions.  
BMP signalling in the absence of SP6/SP8 cannot maintain the correct level of En-1 (Haro et 
al., 2014). 
 
Dorso-ventral patterning of the limb is therefore reliant on signals within the AER.  However, 
there is some evidence that the early limb is patterned prior to the emergence of this structure.  
In experiments using quail-chick chimeras, both the mesoderm and ectoderm within and 
surrounding the presumptive wing were examined.  The ectoderm within this region was 
shown to give rise only to the AER.  Dorsal limb ectoderm derived from the ectoderm covering 
the paraxial and intermediate mesoderm, while ventral limb ectoderm derived from lateral 
somatopleural ectoderm.  Further experiments also suggested that a signal emitted from the 
somites functions to pattern the dorsal limb, while a signal emitted from the lateral 
somatopleure patterns the ventral limb.  In this way, dorso-ventral patterning is established 
prior to the formation of the AER (Michaud et al., 1997).  One hypothesis is that patterning of 
the limb bud is initiated by the signals from both the somites and lateral somatopleure but, 
once the AER is operational it takes over the role of polarising the limb. 
 
1.2.7 Evolution of the Tetrapod Limb  
 
The purpose of this section is to provide a basic compendium of some of the key evolutionary 
processes leading to the formation of a human limb, with a focus on certain genetic changes 
that have occurred at different phylogenetic branch points.  These events have been chosen as 
they relate to differences in both anterior-posterior and proximal-distal limb patterning 
(Chapter 1.2.2-1.2.4) as well as changes in enhancer activity (Chapter 1.2). 
As mentioned previously, the mouse limb is composed of the three different sections; the 
stylopod, zeugopod and autopod (Chapter 1.2).  In fact, the same basic limb structure can be 
applied to all vertebrates of the superclass Tetrapoda.  However, the same structure cannot be 
applied to describe the limbs of all living animals.  For instance, within actinopterygii, teleost 
fish show a clear absence of autopod structures.  Instead, these fish have proximal endoskeletal 
elements referred to as radials which are followed by long fin rays more distally (Wagner and 
Chiu, 2001). Within sarcopterygians, components of both the stylopod and zeugopod can be 
distinguished and begin to resemble the human form in correlation with how closely they are 
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related (Schneider and Shubin, 2013).  Striking structural similarities are obvious when 
comparing to fossils such as those of the Acanthostega which display these features in addition 
to distal bones.  It therefore seems reasonable that the evolutionary fin to limb transition 
occurred through a loss of fin rays and an expansion of endoskeletal structures (Schneider and 
Shubin, 2013). 
Within tetrapods, the structure of mammalian limbs is highly diverse. This is best highlighted 
by the contrasting structure of both the fruit bat (Carollia perspicillata) and mouse (Mus 
musculus) limbs where both animals share a common ancestor from roughly 80-100 million 
years ago.  Bat limbs have become adapted for flight with the forelimb containing digits of 
increased length separated by wing membrane which is also attached to the hindlimb (Cretekos 
et al., 2001).  The reasons for these differences are hypothesized to be the result of diversified 
patterning mechanisms between both animals.  Indeed, this has been shown in one study where 
the enhancers responsible for expressing the Prx1 gene in mice were replaced with the Prx1 
enhancers from bats (Figure 1.3(B)).  The resulting mice showed increased digit length of the 
forelimbs caused by increased Prx1 expression in the forelimb bones at E17.5 (Cretekos et al., 
2008). 
The idea that differences in enhancer activity affect gene expression thereby resulting in 
evolutionary changes to morphological features, is of particular interest.  In addition to 
changes in the activity of enhancers, the emergence of new enhancers and the removal of 
existing ones is likely to have evolutionary consequences.  Indeed, a study looking at changes 
in the number and location of enhancers in humans, rhesus macaque and mouse limbs at 
different time points during development identified 2,915 limb specific enhancers unique to 
humans.  The genes associated with these new enhancers were related to processes such as 
bone morphogenesis and growth suggesting that the presence of these features directed the 






1.3 Sonic Hedgehog    
 
“...the one gene that my students remember is Sonic hedgehog” 
Lewis Wolpert (Ingham and Vicente, 2014) 
 
1.3.1 Shh related limb abnormalities     
  
Analyses of SHH related limb phenotypes have typically been undertaken with mice and 
chickens - two model systems which provide a quick and decipherable tool to analyse 
patterning mechanisms within the developing embryonic limb bud.  In mice, Shh expression 
is first detected in the limb bud at embryonic day E9.75 and is completely absent by E12.  As 
mentioned previously, control of Shh expression within the ZPA of the limb is maintained 
through the ZRS, a highly conserved 780 bp sequence.  This is situated 800 kb in mice, and 1 
Mb in humans, away from the Shh gene in intron 5 of the Lmbr1 gene (previously called 
C7orf2 in humans).    Many different mutations have been identified within the ZRS leading 
to a number of limb phenotypes.  These are collectively referred to as the “ZRS associated 
syndromes” (Wieczorek et al., 2010).  Several of these mutations give rise to ectopic Shh 
expression with other mutations believed to have a similar effect.  In mice, ectopic expression 
in anterior regions of the limb bud results in the production of extra digits at this location - a 
condition referred to as pre-axial polydactyly.  This trait contrasts with other enhancer 
associated point mutations which usually lead to a reduction in gene expression.  In humans, 
a spectrum of limb phenotypes has been observed which depends upon the type of ZRS 
mutation with point mutations, microduplications, inversions and deletions within the Shh 
locus having been identified.  As such, the “ZRS associated syndromes” can be categorised 
into three main categories.  Isolated point mutations causing preaxial polydactyly type 2 
(PPD2; MIM #174500) are referred to as Type1a syndromes while Type 1b syndromes refer 
solely to point mutations at position 404 within the ZRS causing Werner Mesomelic Syndrome 
(WMS) (tibial hypoplasia-polysyndactyly-triphalangeal thumb, THPSTPT; MIM# 188770).  
Typically these mutations have presented as a G > A or G > C but recently a G > T was also 
identified (Girisha et al., 2014).  Intriguingly, a 402C > T mutation has been identified where 
heterozygotes have TP and PPD, but homozygotes have WMS (VanderMeer et al., 2014).  In 
addition a 406A > G mutation has also been linked to WMS (Norbnop et al., 2014).  Type II 
syndromes do not involve point mutations but include the duplications which result in 
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conditions such as Hass-type polysyndactly (HTS) among others (Wieczorek et al., 2010).  
Duplications of small regions can have particularly serious effects causing diseases such as 
Laurin-Sandrow syndrome (LSS)  (Lohan et al., 2014). 
 
By 2012, 15 single point mutations had been identified within the human ZRS with each one 
contributing specifically to limb defects (Anderson et al., 2012).  In addition, mutations have 
been identified in other species such as the so-called “Hemingways’ cats” which display 
supernumerary digits (Lettice et al., 2008).   It was proposed that some of these mutations may 
alter transcription factor binding sites within the ZRS; either by producing new sites for 
transcription factors which enhance Shh expression, or, by removing sites to which repressor 
proteins bind.   Indeed, this was observed for the ETS transcription factor binding sites within 
the ZRS.  The correct balance of ETS factors binding to the ZRS is important for maintaining 
Shh expression in posterior regions of the limb bud.   ETS1 and GABPα are positive regulators 
of Shh expression and have 5 known binding sites within the ZRS while ETV4 and ETV5 
repress Shh expression and have 2 known ZRS binding sites (Figure 1.4).  The so-called 
“AUS” mutation transforms an ETV4/5 binding site into an ETS/GABPα site thereby resulting 
in Shh expression ectopically (Lettice et al., 2012). 
 
The deletions identified relating to Shh limb phenotypes do not incorporate the ZRS itself.  
However, this does not rule out the possibility that their absence affects the mechanism by 
which the ZRS enhances Shh expression.  One of these deletions upstream of the ZRS results 
in Acheiropodia, a condition defined by the absence of both hands and feet (Ianakiev et al., 
2001).  Another affects a putative silencer located 240 kb upstream of the gene, the absence 
of which results in PPD-hypertrichosis (Petit et al., 2016).  The authors suggest that this region 
could be involved in the interactions with other cis-regulatory elements and the Shh promoter, 
with the removal of the silencer possibly affecting the looping structures bringing these regions 
together.  However, this sequence is more likely to act as a silencer as it contains GATA 
binding sites which is significant as GATA6 has been shown to repress Shh activity in the 
















Figure 1.4 – ETS factors control the location of Shh expression within the E11.5 limb bud.  
(A) The ZRS is 780 bp in length and contains five ETS1/GABPα binding sites and two 
ETV4/ETV5 binding sites.  ETS1 and GABPα are positive regulators of Shh expression while 
ETV4 and ETV5 are negative regulators.  A greater ratio of ETS1/GABPα: ETV4/ETV5 
transcription factors in the posterior region of the limb bud coincides with the expression 
of Shh in this region.  In contrast reduced levels of ETS1/GABPα in the anterior regions 














1.3.2 Shh signalling in the Neural Tube 
 
SHH produced in the notochord induces the floor plate of the neural tube to also produce SHH.  
A gradient of SHH is established with highest concentration at the ventral side of the neural 
tube and lowest concentration at the dorsal side.  As a result, a high concentration of GLIA 
builds up ventrally and decreases distally, while a high concentration of GLIR builds up 
distally and decreases ventrally. The ratio of GLIA:GLIR is responsible for determining cell 
fates along the dorso-ventral axis (Cohen et al., 2013).  Cells receiving the highest dose of 
SHH and therefore GLIA develop floor plate cells, with lower concentrations inducing motor 
neurons.  Cells receiving the lowest concentration of SHH and therefore highest concentrations 
of GLIR at the ventral neural tube become ventral neurons (Choudhry et al., 2014). 
 
1.3.3 Shh signalling in Craniofacial Development  
  
SHH plays a key role in orchestrating various aspects of craniofacial development.  In humans, 
Shh mutations can cause holoprosencephaly (HPE) characterised by a failure of the two cranial 
hemispheres to split.  Patients can have a range of different phenotypes depending on the 
severity of the disease, which can range from cyclopia in extreme cases to microcephaly and 
ocular hypotelorism in more moderate cases (Nanni et al., 1999).  In situ hybridisation 
experiments have identified Shh expression in craniofacial features as early as E8.5 where it 
is maintained in the pharyngeal endoderm and diencephalon (Paiva et al., 2010).  Its role in 
pharyngeal arch development was confirmed through the use of Shh mutants.  In these mice 
development of the first pharyngeal arch is stunted and becomes fused by E9.5 - possibly as a 
result of abnormal neural crest cell migration (Yamagishi et al., 2006).  From E12 - E13.5 
there is evidence for the involvement of Shh in the development of the teeth and oral 
epithelium (Paiva et al., 2010). 
At later developmental stages (E16.5 onwards) Shh is involved in the formation of sutures 
within the skull.  Expression occurs predominantly in the midline suture mesenchyme with a 
possible involvement in coronal suture development.  Through the induction of Msx2, Shh is 
involved in the process of mesenchyme proliferation.  This contrasts with the role of Ihh which 
has a proven function in osteoblastogenesis eventually resulting in the fusion of sutures (Pan 
et al., 2013). 
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1.3.4 Shh signalling in the Lungs 
 
In mice, lung organogenesis can be divided into four phases with Shh signalling evident at 
each of these stages: Pseudoglandular stage (E12.5 - E16.6); canalicular stage (E16.5 - E17.5); 
saccular stage (E17.5 - P0); and, alveolar stage (P0 - P14).  SHH is first observed at E10.5 and 
is clearly localised at the distal end of branchial tubules at E13.5, thereby highlighting its role 
in orchestrating lung bud branching (Miller et al., 2001, Kugler et al., 2015).  This was 
confirmed by the Shh null mouse which showed a complete loss of branching and developed 
lungs consisting of only a very basic sac structure (Kugler et al., 2015).  By the canalicular 
stage, SHH is detected only in discrete locations such as the respiratory epithelium. 
 
1.3.5 Shh signalling in the Gut 
 
The gastrointestinal (GI) tract or alimentary canal is heavily reliant on Shh signalling for 
proper development.  Indeed, SHH expression is observed at various locations and times 
within the embryonic gut.  In mice, in situ hybridisations experiments have identified an 
uneven distribution of SHH between the forestomach and hindstomach epitheliums at E11.5, 
with the forestomach showing much higher expression.  This patterning persists until E14.5 
(Bitgood and McMahon, 1995).  As shown by Shh-/- mutants, Shh expression is important in 
the formation of the tracheoesophageal septum as mutants present with a fusion of the trachea 
and oesophagus; two tubes which are normally morphologically distinct by E10.5 (Litingtung 
et al., 1998). Restriction of SHH from the pancreatic epithelium is equally important as 
experiments in chicks suggest that SHH inhibits the formation of the pancreatic buds (Hebrok, 
2003).  By E18.5, SHH is present in the epithelium of the stomach, small intestine and colon 
(Ramalho-Santos et al., 2000). 
 
1.3.6 Other regions involving Shh signalling 
 
Shh signalling is also involved in several other features in mammals including whiskers, hair 
and the urogenital system (Bitgood and McMahon, 1995). 
 
1.3.7 The Shh Regulatory Domain 
 
As previously mentioned, the enhancer responsible for regulating Shh expression in the limb 
is known as the Zone of Polarising Activity Regulatory Sequence (ZRS).  It is located 1 Mb 
upstream of Shh within intron 5 of the Lmbr1 gene (Figure 1.5).  The region between Shh and 
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Lmbr1 contains only a single gene (Rnf32) and is referred to as a gene desert.  This contains 
several other enhancers which regulate Shh expression in different tissues:  MACS1, MFCS4 
and MRCS1 are each responsible for different aspects of epithelial Shh expression (Sagai et 
al., 2009), SFPE1 and SFPE2 regulate floor plate expression in the spinal cord and hindbrain 
(Jeong et al., 2006), SBE1 ensures ventral midbrain and diencephalon expression; and SBE2 
– SBE4 control forebrain expression. 
 
The development of the Local Hopping Enhancer Detection (LHED) System has proved useful 
in studying the mechanisms of enhancer function within a locus (Kokubu et al., 2009).  This 
technique involves inserting a transposon connected to a lacZ reporter gene into a 
chromosome.  The sleeping beauty transposase enzyme is expressed allowing the transposon 
to “hop” to a different location within the locus.  In this way the activity of different enhancers 
can be studied by analysis of the lacZ expression profiles in different tissues. 
 
Anderson et al. (Anderson et al., 2014) have recently utilised this system to study the 
mechanism of enhancers within the Shh locus.  They created a range of lacZ insertions with 
four of these mapping to the gene desert between Shh and Rnf32.  When limb bud development 
was analysed, lacZ expression was higher for inserts located close to the ZRS and Shh with a 
decrease in expression in the intervening locations.  Interestingly, Rnf32 - which is not 
regulated by any of the known Shh enhancers - contained an insert in intron 6 which replicated 
Shh expression in the CNS, brain, gut and limb.  The authors suggest that regions within this 
gene are susceptible to the action of the Shh enhancers but activation of the Rnf32 gene itself 
is prevented - possibly through some protective mechanism within its promoter. 
 
1.3.8 The Mechanism of the ZRS 
 
Research into the mechanism by which the ZRS interacts with Shh remains in its infancy.    
Amano et al. (Amano et al., 2009) analysed E10.5 embryos containing a ZRS knockdown.  
Genes within this region maintained a normal expression pattern while SHH expression was 
diminished.  This highlighted the specificity at which the ZRS controls Shh expression.  3D-
FISH was also conducted using cells taken from three different regions along the anterior-
posterior axis of an E10.5 limb bud.  One of these regions contained cells exclusively from the 
ZPA.  A probe specific for the ZRS and another for Shh were used to analyse the interaction 
between both sequences within the three regions.  In the ZPA cells, 18 % of probes co-localised 
compared to the 4 % recorded for cells derived from the middle of the limb bud.  However, in 
anterior cells 11 % of probes co-localised, which was much higher than expected.  In the same 
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investigation Amano et al. (Amano et al., 2009) used chromosome conformation capture (3C) 
to confirm the interaction between the ZRS and Shh.  They found that in E10.5 embryos there 
was a specific interaction between the ZRS and Shh which was later diminished by E12.5.  
From this research, a model was proposed suggesting that cells within the ZPA can exist within 
three different chromosome conformation states.  In cells from the middle of the limb bud, the 
ZRS is situated far from Shh.  In both anterior and posterior cells, the ZRS and Shh are in close 
proximity.  However, the Shh locus from ZPA cells loops out of the chromosome territory 
(CT) leading to Shh expression.  This is not observed for anterior cells, which contain the ZPA 























Figure 1.5 - (A) In mice, the distance between the Shh gene and the ZRS is roughly 850 kb.  
The intervening region contains a plethora of different enhancers which regulate Shh 
expression in different spatial and temporal patterns.  The ZRS (yellow oval) regulates SHH 
in the developing limb bud, while other subgroups of enhancers regulate Shh expression 
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throughout the CNS (orange and purple ovals) and in the epithelia of the lungs, gut and 
pharynx (pink ovals).  Genes are depicted as blue boxes, with Rnf32 the only gene 
separating Lmbr1 and Shh.  Dpp6 is on the other side of Shh from the ZRS at a roughly 
equidistant position.  (B)  An E10.5 embryo with Shh expression highlighted in blue.  The 
enhancers responsible for Shh expression at these locations are indicated.  (C)(D) The two 
most studied locations of Shh expression are the developing limb bud and the notochord 
and neural tube.  In the limb bud (C) Shh is expressed in the ZPA located in the posterior 
distal region, while ectopic expression can sometimes be observed in anterior regions 
leading to a diverse range of phenotypes.  Shh expression from both the notochord and 
floor plate of the neural neural tube (D) creates a gradient of Shh along the neural tube, 
highest at the ventral end and lowest at the dorsal end.  The concentration of Shh at each 
position along the neural tube regulates the cellular identity of cells along the dorso-vental 







































“I think one of the maybe disappointing things in the sequencing of the human genome was 
that actually, we didn’t have very many more genes than a worm has and I guess we felt 
affronted by that. We thought we were a bit more complicated. So, the realisation since that 
time has actually been, it’s not how many genes you’ve got, but what you do with them, how 
you control them.” 
Professor Wendy Bickmore, Director of the MRC Human Genetics Unit, the University 
of Edinburgh – in an interview from the Naked Scientists, 2013.  Available from: 
http://www.thenakedscientists.com/HTML/interviews/interview/1000180/ 
 
1.4.1 Regulatory Locus Composition 
 
Prior to sequencing the human genome in 2001, scientists believed that the added complexity 
of humans over other animals was due to a greater number of protein coding genes.  Indeed 
some predicted that the total number of human genes could exceed 100,000 (Pennisi, 2003).  
However, by 2014, studies predicted that protein coding genes within humans could total as 
little as 20,000 or less.  It was therefore clear that additional information within the genome 
must be contributing to human complexity.   In the intervening period, the importance of a 
class of non-coding sequences - referred to as enhancers – was gaining increasing attention.  
Enhancers are cis regulatory sequences which can bind to transcription factors and enhance 
gene transcription (Douglas and Hill, 2014).  They can operate over large genomic distances 
with some (such as the ZRS regulating Shh limb bud expression) located up to 1 Mb from the 
target gene.  Enhancers can regulate gene expression in several different ways.  Some operate 
individually and regulate the expression of a particular gene at a particular developmental 
stage.  In contrast other enhancers come together in groups with different combinations 
yielding different expression profiles.   
 
One of the most well studied examples of enhancers acting in combination are the HoxD 
enhancers which form a “regulatory archipelago” (Montavon et al., 2011).  This consists of a 
plethora of individual enhancer sequences spread out over a large area which come together 
at defined times to regulate transcription of target genes.  Enhancers regulating the HoxD genes 
are located across two different topological associated domains (TADs) (Chapter 1.5.1).  Early 
expressed genes are regulated by enhancers within the telomeric TAD which eventually 
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become inactivated over time.  This coincides with an increase in activity of enhancers within 
the centromeric TAD which activate genes expressed at later stages.  In this way the expression 
of the HoxD genes is tightly controlled (Andrey et al., 2013). 
 
Enhancers regulating the expression of Fgf8 also act in combination and have been referred to 
as holo-enhancer.  These enhancers are located throughout the Fgf8 locus, each with individual 
enhancer activities, which combine to produce a defined Fgf8 expression profile which does 
not necessarily reflect their independent activities (Marinić et al., 2013).  In contrast to the 
HoxD regulatory archipelago and the Fgf8 holo-enhancer the Shh gene is regulated by 

























1.4.2 Super Enhancers and Stretch Enhancers 
 
In recent years, the term “super enhancer” has been used to describe a subset of highly active 
enhancers.  In the initial study (Whyte et al., 2013), enhancers were identified based on their 
ability to bind Oct4, Sox2 and Nanog simultaneously.  For analytical purposes, closely spaced 
enhancers (within 12.5 kb) were combined and considered as a single unit.  Enhancers were 
then ranked based on the extent of MED1 ChIP-seq binding from lowest to highest, the values 
scaled from 0 to 1 and plotted on x axis of a graph with the scaled values again plotted on the 
y axis.  This produced a line which an obvious deviation in incline at a defined x coordinate.  
This region where the tangent of the curve is equal to 1.0 is the division point separating 
normal enhancers from super enhancers. Only those with an x coordinate corresponding to a 
tangent > 1.0 were considered as super enhancers.     
 
Therefore, by definition the main difference between super enhancers and normal enhancers 
is the ability to bind high levels of MED1 above a defined threshold.  However, the MED1 
cut-off value used to separate enhancer categories is not derived from an experimental finding, 
but is merely an analytical tool to process the data.  Therefore, questions still remain over 
whether super enhancers are a discrete class of non-coding elements functioning differently 
from normal enhancers or are simply a more powerful enhancer.   Whatever the case, super 
enhancers seem to play a key role in maintaining the identity of a cell, such as in ESCs where 
they regulate the expression of factors promoting pluripotency such as Oct4, Sox2 and Nanog.  
Super enhancers in these cells are also enriched in binding sites for KLF4 and ESRRB (Whyte 
et al., 2013) as well as NRFA2, PRDM14, TCFCP2L1, SMAD3, STAT3, and TCF3 (Hnisz et 
al., 2013) which all play a role in maintaining the identity of the cell.  It seems therefore that 
super enhancers are involved in an auto-regulatory feedback loop, where the gene products 
they activate bind back to the super enhancer thus promoting their own expression. 
 
Super enhancers can play a role in regulating certain diseases.  When placed next to an 
oncogene, they can accelerate gene expression resulting in cancers such as multiple myeloma 
(MM).  In one study (Lovén et al., 2013), super enhancers were identified based on the binding 
of both MED1 and BRD4 in MM1.S tumor cells.  Treatment with the drug JQ1 inhibits BRD4 
which disrupts the super enhancers and limits the expression of oncogenes.  The positioning 
of super enhancers close to oncogenes can occur through chromosome rearrangements.  This 
has been shown for the MYC locus which is brought into the vicinity of super enhancers 
resulting in increased gene expression (Affer et al., 2014) . The methylation status of super 
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enhancers can also result in aberrant expression of gene targets with both hypomethylation 
and hypermethylation of these sequences capable of causing tumours (Heyn et al., 2016). 
 
“Stretch enhancers” have also been described as large enhancers greater than 3 kb in length 
(Parker et al., 2013).  Like super enhancers, stretch enhancers are important in regulating genes 
responsible for maintaining a particular cellular identity.  Diseases associated with a particular 
cell type also showed an enrichment of disease causing SNPs in stretch enhancers compared 
to normal enhancers.   
 
Analysis of the transition of pluripotent naive mESCs to epiblast stem cells (mEpiSCs) 
identified a subset of enhancers displaying the active histone marks H3K4me1 and H3K27ac 
(Chapter 1.2.10) that were unused in the mESCs but were later used in mEpiSCs to regulate 
pluripotency genes that were commonly expressed in both cell types (Factor et al., 2014).  
These enhancers were referred to as “seed enhancers” while the enhancers originally 
regulating gene expression in the mESCs that become inactive are referred to as the naive-
dominant enhancers.  The reason why these genes change the enhancers that regulate them 
(i.e. the switch from using naive-dominant to seed enhancers) during the progression of 
mESCs to mEpiSCs has not yet been fully deciphered.  However, it is clear that seed enhancers 
do play an important role in later processes with many involved as components of super 
enhancers or stretch enhancers in adult tissue. 
 
1.4.3 Evolution of Enhancers 
 
1.4.3.1 Highly Conserved and Ultra-Conserved Enhancer 
Sequences 
 
The primary method of identifying novel enhancers is through sequence comparison of 
different genomes.  Identification of conserved non-coding sequence is a primary indication 
that a regulatory element may be conserved between species and is therefore of functional 
significance.  However not all enhancers have maintained tight sequence conservation between 
different organisms throughout evolution.  Indeed, enhancers with similar functional 
properties that lack strict sequence conservation have been identified.  On the other hand, the 
so called “ultra-enhancers” which contain 100 % sequence conservation for at least 200 bp 
(Bejerano et al., 2004) suggest that precise sequence information is important for these 
elements to function.  Therefore, why do some enhancers require precise, uncompromising 
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sequence information to function whilst others can operate efficiently without such stringent 
requirements?  
 
The association between conserved enhancer sequences and developmental genes was again 
highlighted by Plessy et al. (Plessy et al., 2005) who attempted to identify common elements 
in zebrafish from a test sample of 104 murine enhancers by sequence comparison methods.  
Only 10.5 % of the test set showed conserved function, all of which acted upon developmental 
genes such as dlx2, pax6, dlx5, pax2, hoxc8, hoxd4 and nkx2.5.  It seems therefore that this 
tendency for highly conserved non-coding regions to regulate developmental genes is not 
unique to ultra-conserved enhancers, a point which was further emphasised by Visel et al. 
(Visel et al., 2008).  In this study, transgenic assays were conducted using both ultra-conserved 
enhancers and other highly conserved enhancers that lacked ultra-conservation.  No significant 
difference was found in their functionality with both subsets predictably acting upon 
developmental genes.  Pennacchio et al. (Pennacchio et al., 2006) used high sequence 
conservation between human and pufferfish and ultra-conservation between humans and 
rodents as a method of identifying potential enhancers.  Of the 167 sequences tested in 
transgenic reporter assays, the majority of identified enhancers were involved in nervous 
system development at E11.5.  In an interesting side note, the authors compared their data to 
that provided by an additional ChIP-on-ChIP study (Lee et al., 2006).  This showed that 4 
enhancers active at E11.5 also function as gene silencers in embryonic stem cells.  Having this 
important dual role in development may explain the need for such high sequence conservation 
throughout evolution of these sequences. 
These studies therefore suggest a critical role for ultra-conserved sequences in regulating gene 
expression.  Removal of an ultra-conserved enhancer region would therefore be expected to 
cause massive phenotypic effects.  However, in a study where four ultra-conserved regions 
were knocked out in mice (Ahituv et al., 2007) no significant phenotype was observed.   These 
ultra-conserved regions were specifically chosen because they mimicked the expression of 
nearby genes in in vivo reporter assays and were therefore believed to be acting as enhancers.  
The question therefore arises - why are such highly conserved sequences, which seem to act 
as enhancers, present in an organism when their removal seems to have no detrimental effect?  
Also, why is such high sequence conservation maintained?  The authors suggest that these 
knock out mice may still exhibit mild phenotypic effects which show no obvious phenotype 
in a laboratory environment.  Also, the deleted elements may exhibit a level of redundancy 
with other enhances able to take over their functional roles. 
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1.4.3.2 Conservation of Function without Conservation of 
Sequence 
 
Although sequence comparison techniques remain the primary method of enhancer 
identification, these methods alone do not reveal all of the functional non-coding regulatory 
elements acting within the genome.  Some enhancers show relatively poor sequence 
conservation between species yet remain mechanistically functional.  For example, the even-
skipped (eve) enhancers in Drosophila and sepsids share poor sequence similarity but, when 
non-coding information from sepsid species are introduced into Drosophila, the eve expression 
patterns remain similar (Hare et al., 2008b, Hare et al., 2008a).  Only small sequence blocks 
of roughly 20 - 30 bp remain highly conserved between the different species.  These 
correspond to overlapping and adjacent pairs of transcription factor binding sites. 
Similar experiments (Fisher et al., 2006) were conducted in which human conserved non-
coding sequences regulating the RET gene were introduced into zebrafish via a transposon 
based assay.  These human sequences recapitulated the zebrafish RET expression patterns 
despite lacking sequence conservation.  The authors suggest two possible reasons for this.  
Firstly, the non-coding sequences from both organisms have evolved to function in a similar 
fashion despite lacking orthology.  Alternatively, these sequences are orthologous but have 
undergone substantial rearrangement of transcription factor binding motifs while maintaining 
a similar function. 
Sparkling (spa), an enhancer responsible for regulating dPax2 expression in Drosophila cone 
cells, shows significant sequence differences between species with a rearrangement of specific 
transcription factor binding sites, while remaining functionally conserved (Swanson et al., 
2011).  When chimeric enhancers were created containing opposing halves from both D. 
melanogaster (mel) and D. pseeudoobscura (pse) spa, the mel5’ + pse3’ construct was inactive 
highlighting that the pse3’ could not substitute for the mel3’.  Therefore, substantial binding site 
rearrangement has occurred over a relatively quick evolutionary timescale.  This study went 
on to identify novel binding site motifs within both mel spa and pse spa which differ in both 
number and location within these enhancers.  As the function of these regions is identical, the 
distribution of factors binding to these motifs must be variable between both regions.  
However, although binding site location was interchangeable between species, distances 
between some motifs were conserved, perhaps highlighting why enhancer function could be 
maintained despite differences in transcription factor distribution. 
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1.4.3.3 Conservation of Sequence vs Conservation of Function 
 
It seems that two very different types of enhancers are present within metazoans.  Some require 
precise sequence information to function, with this sequence highly conserved throughout 
evolution.  Others share a less stringently conserved sequence between species but maintain 
small pockets of short, highly conserved nucleotides. 
 
The “enhanceosome” and “billboard” models have been proposed as a paradigm of enhancer 
function and their viability reviewed extensively (Arnosti and Kulkarni, 2005, Rubinstein and 
de Souza, 2013).  In the enhanceosome model, transcription factors bind collectively to 
binding sites within the enhancer to form a large nucleoprotein complex.  Consequently, minor 
nucleotide alterations within the enhancer can disrupt protein binding suggesting that high 
sequence conservation within this region is important.  Alternatively, in the billboard model 
transcription factor binding sites do not have such strict positional restraints.  Separate 
nucleoprotein complexes form and act independently to ensure the correct enhancer activity.  
Several biological examples of both models have been identified. 
Ifnβ represents a well-studied example of a gene regulated by an enhanceosome (Thanos and 
Maniatis, 1995).  Its enhancer is made up of 4 positive regulatory domains (PRDs) responsible 
for binding three transcription factors; NF-κB, IRF-1 (later found to be IRF-3 and IRF-7 [20]) 
and ATF-2/c-Jun.  In PRD swap experiments, virus stimulated IFNβ expression was reduced 
and was less specific, while other transcription factors such as TNFα were able to influence 
expression.  The authors concluded that the precise organisation of PRDs was required for 
wild type expression and specificity.  When a half helical turn of random DNA was inserted 
between these PRDs gene expression was greatly reduced.  However, when the half helical 
turn was replaced by a full turn, higher gene expression levels resumed.   Various combinations 
of DNA insertions were tested between PRDs leading to the conclusion that the precise 
orientation of PRDs was necessary to allow the combinational binding of transcription factors 
to maintain wild type gene expression levels.  Therefore, IFNβ expression relies on the 
formation of a large nucleoprotein enhanceosome complex created by specific transcription 





1.4.3.4 Mechanisms of Ultra-Conservation 
 
As discussed previously, various hypotheses have been suggested to explain the mechanism 
of ultra-conservation.  Purifying (negative) selection at CNEs or decreased mutational rates 
are two opposing theories which have been put forward.   However, recent studies (Drake et 
al., 2006, Katzman et al., 2007) argue that purifying selection is the dominant driving force 
behind these highly conserved regions and they are not mutational cold spots.  A common 
theme in both studies is the analysis of derived allele frequencies (DAFs) to investigate the 
differences between conserved and nonconserved regions.  Drake et al. (Drake et al., 2006) 
analysed DAFs within CNEs in three separate human populations.  An excess of rare derived 
alleles of SNPs (< 10 %) within these populations compared to nonconserved regions suggests 
that CNEs undergo purifying selection.  Katzman et al. (Katzman et al., 2007) looked at DAFs 
specifically within ultra-conserved elements in humans and compared these to nonsynomous 
sites.  They concluded that the purifying selection is three times stronger at ultra-conserved 
regions compared to nonsynomous sites. 
In 2006, Derti et al. (Derti et al., 2006) investigated whether ultra-conserved elements were 
maintained within segmental duplications (SDs) and copy number variants (CNVs).   They 
compared several sets of ultra-conserved elements with both data sets comprising SDs and 
CNVs from various sources.  Ultra-conserved elements were shown to be severely reduced in 
both SDs and CNVs with three separate models proposed to explain these findings.  Firstly, 
ultra-conserved elements may oppose DNA reorganisation.  Secondly, these ultra-conserved 
regions are mutated or removed after duplication events.  Finally, inclusion of ultra-conserved 
elements within a duplicated region produces a lethal phenotype or decreases fitness levels of 
an organism.  The authors suggest that ultra-conserved elements may be dosage sensitive and 
both maternal and paternal copies pair together through some mechanism to maintain the 
correct copy number.  If this mechanism is disrupted, by perhaps the presence of additional 
copies of the ultra-conserved element, then the fitness of the organism is detrimentally 
affected.  Therefore, precise sequence information is needed to maintain this pairing, with 
deviations resulting in the eventual removal of the sequence from the population.   
 
1.4.3.5 Evolution of Enhancers 
 
Carter and Wagner (Carter and Wagner, 2002) suggest that enhancer evolution is simply 
dependent upon population size.  They present a model whereby enhancer sequence variation 
is created by two deleterious mutations which together maintain enhancer function.  In smaller 
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populations evolution rate is lower leading to tighter sequence conservation.  Large 
populations have a faster evolution rate leading to increased sequence turnover.  This may 
explain why invertebrate species with large population sizes and fast generation times have 
significantly greater sequence variability in enhancer regions compared to vertebrates. 
Glassford and Rebeiz (Glassford and Rebeiz, 2013) analysed the sequence changes of the 
Neprilysin-1 (Nep1) enhancer from the Drospholia yakuba/Drosophila santomea ancestor to 
the modern day Drosophila santomea.  4 mutations within this enhancer have evolved over 
400,000 years.   By creating all possible combinations of the 4 mutations leading to this current 
sequence and analysing the effects of these mutations iteratively by in vivo reporter assays, 
the authors were able to determine likely pathways for evolution of this enhancer.  This study 
highlighted differing factors which affect enhancer evolution.  For example, the addition of 
some mutations had no effect on their own in some pathways unless they were combined with 
an additional mutation.  This shows that epistasis plays a critical role in enhancer evolution.  
The authors suggest that this enhancer displays aspects of an enhanceosome mechanism as 
protein-protein binding is necessary for optimum function.  Conversely as no mutation causes 
significant detrimental effects the Nep1 enhancer also shows characteristics of a Billboard 
model. 
Non-coding human accelerating regions (ncHARs) have become of increasing interest to 
identify human specific enhancer sequences.  These are non-coding regions which show high 
sequence comparison between mammals yet exhibit various alterations between humans and 
chimpanzees.  These specific changes may regulate human specific gene expression profiles, 
unique from other mammals.  In one study (Capra et al., 2013) a large sample of ncHARs were 
identified and subjected to several biological and computational based analysis methods 
leading to the conclusion that many of these regions serve as developmental enhancers.  Of 
these, a subset of enhancers exhibited different expression profiles from chimpanzee reference 
sites, suggesting that these ncHARs displayed enhancer activity unique to humans. 
1.4.3.6 Enhancer Mutations and Disease 
 
Mutations in promoters and the coding regions of developmental genes have long been shown 
to cause a reduction in gene expression and an associated phenotype.  Indeed, complete 
deletions of such regions have proven to be the cause of many congenital abnormalities.  In 
the same way, mutations within enhancer sequences are gaining increasing recognition as an 
alternative culprit for a reduction in gene activity leading to disease.  Such mutations in 
enhancers are responsible for deregulating the normal spatiotemporal expression of Pax6 and 
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Sox9.  Pax6 is a key developmental regulator which displays a central role in eye formation 
and one of the main consequences of human PAX6 misexpression is the disease aniridia.  One 
of these mutations, a G > T transversion within the SIMO enhancer downstream of PAX6, was 
shown to affect the binding of PAX6 protein to the enhancer; thereby prohibiting 
autoregulation (Bhatia et al., 2013).  In addition, a 681 kb deletion downstream of PAX6 which 
deletes the 3’ regulatory enhancers plus five other genes, has been linked to the disease ocular 
coloboma (Guo et al., 2013). 
 
Campolmelic Dysplasia (CD, MIM114290) defined by skeletal defects and male sex reversal 
is caused by mutations within SOX9.  This gene is situated within a gene desert which contains 
a number of enhancers (Bien-Willner et al., 2007).  Many of these identified as Sox9 enhancers 
in chromosome translocations which alter the position of the enhancers within the locus 
thereby affecting their interaction with the gene promoter resulting in an associated 
abnormality. Alterations of regions close to the gene  have a more damaging effect compared 
to changes 375 kb to 932 kb upstream, suggesting that the former region contains enhancers 
with more critical functions (Yao et al., 2015). However microduplications within the more 
distant region can cause 46, XX SRY-negative DSD (Hyon et al., 2015, Xiao et al., 2013).  
Pierre Robin Sequence (PRS, OMIM 261800) is caused by translocations occurring within a 
160 kb region in the gene desert between KCNJ2 and SOX9.   In the same study, deletions both 
5’ and 3’ of the SOX9 gene were implicated in causing PRS as well as a T to C point mutation 
within a highly conserved non-coding element. (Benko et al., 2009).  Interestingly, 
duplications within this gene desert do not cause PRS or CD, but result in brachydactyly-
anonychia (Kurth et al., 2009). 
1.4.4 Enhancer Identification 
 
As mentioned previously, sequence comparison methods were used extensively to identify 
enhancers.  However, this is not always an effective approach, with many enhancers showing 
significant sequence deviations between different species throughout evolution.  Therefore, 
using sequence comparison approaches exclusively to identify enhancers may result in an 
incomplete analysis.  Other additional, complementary techniques must also be applied to 




 Chromosome Conformation Capture (3C) Techniques 
 
Chromosome Conformation Capture (3C) has traditionally been used to study chromosome 
interactions (Hagège et al., 2007, Dekker et al., 2002, Miele et al., 2006).  In this technique 
cross-linked chromatin is digested with a restriction enzyme after which closely located DNA 
is ligated together followed by the reversal of cross-linking.  Primers designed to both of the 
digested fragments are used in PCR reactions to determine which DNA sites interact (Dekker 
et al., 2002).  However, this procedure relies on prior knowledge or a hypothesis of interacting 
partners and is known as a “one-to-one” method.  In 2006, two papers were published (Zhao 
et al., 2006, Simonis et al., 2006) describing a procedure (referred to as circular chromosome 
conformation capture (4C)) which built upon the original 3C protocol.  This technique differed 
by the incorporation of a second digestion and ligation step to create small DNA circles where 
a known DNA sequence is ligated to an unknown sequence with which it interacts in vivo.  
Inverse PCR using primers designed within the known sequence were used to create a 4C 
library which was subsequently analyzed using microarrays.  The advantage of this procedure 
was that the entire set of interactions of a sole DNA sequence could be examined, a so called 
“one-to-all” application. 
 
Since then, a number of different protocols diversifying from the core 3C and 4C principles 
have been developed to analyse chromatin interactions (de Wit and de Laat, 2012, Duan et al., 
2012, Simonis et al., 2009, Sexton et al., 2012).  One of these was published in 2013 
(Stadhouders et al., 2013) and described a variant of chromosome conformation capture 
referred to as multiplexed 3C-seq.  This protocol is similar to 4C - involving two rounds of 
digestion and ligation – but, in contrast to traditional 4C technology, the amplified libraries 
are sequenced at the end of the procedure instead of using microarrays.  Multiplexed 3C-seq 
allows the analysis of the interaction between a single “bait” sequence and the rest of the 
genome; i.e. a “many-to-all” strategy.  This provides a distinct advantage over 3C-qPCR and 
4C as several bait sequences can be analysed in a single experiment.  Multiplexed 3C-seq also 
provides genome wide coverage and can thus provide information on trans contacts as well as 
those in cis. 
 
Chromatin Confirmation Capture Carbon Copy (5C) has been used to look at all the genomic 
interactions occurring within a locus (Dostie et al., 2006).  In this technique, 3C libraries are 
made as first described in the original 3C protocols but following ligation sequences designed 
to anneal to the ends of each restriction fragment are added.  After a short annealing period, 
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Taq DNA ligase is added which ligates the annealed primers together.  Amplification of these 
primers by PCR followed by high throughput sequencing and bioinformatic analysis, allows 
the construction of a detailed interaction map for every restriction fragment. 
 
Traditional 3C provided a means of confirming suspected sequences are acting as enhancers.  
If a test sequence shows an interaction with a promoter, then it is likely that it may act as an 
enhancer in vivo.  4C and 5C are more exploratory measures which can identify all the 
sequences interacting with a tested gene.  In this way, new enhancers can be identified. 
 
Variations of the original 3C technique are summarised in Figure 1.6. 
 
 
 Fluorescent in situ hybridisation (FISH) 
 
Fluorescent in situ hybridization (FISH) is a technique which can be used to confirm 
observations obtained from chromatin conformation capture experiments (although this is not 
always the case (Williamson et al., 2014)).  There are many variations but a basic protocol 
involves labelling specific DNA probes with molecules such as biotin or digoxigenin (dig).  
These are then re-suspended in hybridization mix and denatured at a high temperature.  At the 
same time, formaldehyde fixed cells are treated with RNase and then denatured at a high 
temperature.  The two are then combined allowing the tagged probes to hybridize to their 
corresponding sequences within the cells.  The following day the cells are exposed to a series 
of fluorescently labelled antibodies which bind to either biotin or the dig and can be visualized 
using a fluorescent light microscope (Levsky and Singer, 2003, Price, 1993). 
 
FISH experiments have proved useful in identifying or confirming enhancer promoter 
interactions.  By fluorescently labelling an enhancer with one fluorophore and a promoter with 
another, the distance between both regions can be determined.  If differing experimental 
conditions or cell types lead to changes in distances between enhancers and promoters, 
assumptions can be made about the activity of an enhancer in each case.  For example; if a 
drug treatment results in a decreased distance between an enhancer and promoter, one may 
assume that the enhancer has actively moved to the promoter - a process which may drive 
transcription. 
 
To date, many variations of FISH are utilised depending on the biological question.  Basic 2D- 
FISH allows measurements in only the x and y planes while 3D-FISH allows additional 
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measurements through the z plane.  Three colour FISH typically involves labelling the nuclei 
with DAPI and the DNA probes with two other fluorophores, while four colour FISH allows 
the use of three fluorophores in addition to DAPI.  RNA FISH can also be conducted where 
RNA probes are utilised instead of DNA. 
 
 DNAse1-seq, MNase-seq, FAIRE-seq and ATAC-seq 
 
Interphase chromatin forms a highly compact structure allowing the roughly two metres of 
DNA present in each human cell to be condensed within the nucleus.  At the very basic level, 
this compaction is maintained by repeating units of histone complexes with DNA wrapped 
around them – referred to as nucleosomes.   Within the genome, nucleosomes are a ubiquitous 
feature yet there are portions where these structures are depleted.  These regions coincide with 
areas of active enhancers and expressing genes, where transcription factors and other proteins 
bind.  Various techniques are used to identify such areas of open chromatin. 
DNAse1-seq (Song and Crawford, 2010) utilizes the enzyme DNAse1 to cut between 
nucleosome compact regions releasing the active chromatin - the so-called DNase 
hypersensitive (HS) sites.  After further processing and the ligation of adaptors, these short 
pieces of DNA can be sequenced using next generation technologies.  The output from such 
an experiment is a list of sequences which can be aligned to a reference genome thus providing 
a visual map of open chromatin.  In contrast to DNAse1-seq, MNase-seq (Cui and Zhao, 2012) 
can be used to identify precise nucleosome positions.  This uses MNase to digest the open 
chromatin leaving only the nucleosome bound DNA behind.  This can then be isolated, 
amplified and sequenced with the analysis conducted in a similar manner to before.  The 
mapped sequences should thus contrast directly with the results from DNase1-seq as they are 
highlighting areas of nucleosome occupancy.  An alternative method of identifying open 
chromatin is FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements).  This 
involves the cross linking of DNA to chromatin which is then sheared, isolated and sequenced.  
The information gained from such an experiment is similar to that from DNase1-seq and often 
the two are often used in combination.  One advantage of FAIRE is that formaldehyde fixation 
captures the chromatin state immediately prior to cell death whereas in DNAse1-seq several 
steps are needed to permeabilize the cell which may cause the build-up of artifacts (Giresi et 
al., 2007). 
 
Finally, ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) is the 
most recent method designed to analyse open chromatin.  This uses the Tn5 transposase to 
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integrate sequencing adaptors into open chromatin.  One of the main advantages of this 
technique is that between 500 and 5,000 cells can be used as a starting point in contrast to the 
millions of starting cell numbers required in the previously described techniques.  In this way 
tissue samples can be tested easily instead of growing cells in culture, a process which may 
affect their epigenomic state and thus the positioning of their nucleosomes (Buenrostro et al., 
2013). 
 
 Reporter Assays, STARR-seq and Enhancer Trap 
 
The presence of open chromatin, although a strong indicator of active DNA, does not provide 
a quantitative measure of the strength of an enhancer.   Traditionally, this has been measured 
using transgenic reporter assays.  One simple approach may be to place a suspected enhancer 
sequence upstream of a minimal promoter and a reporter gene such as lacZ.  If the enhancer is 
functional, the lacZ gene will be expressed and the level and location of this expression can 
be visualized by in situ hybridization experiments (or by staining for β-galactosidase which is 
the product of the lacZ gene).  However, the use of such experiments becomes increasingly 
more time consuming when large numbers of suspected enhancers need to be tested.  Indeed, 
such an approach is practically impossible when large libraries of sequences are to be tested.  
One potential genome-wide approach that has been developed for such a purpose is STARR-
seq (Self-Transcribing Active Regulatory Region Sequencing).  Here, libraries of suspected 
enhancer sequences are placed downstream of a minimal promoter and cloned using a given 
cell line.  An active enhancer will act on the promoter increasing transcription of itself.  The 
RNA from these cells is isolated, reverse transcribed and sequenced.  When this is mapped to 
reference genome, only the active enhancers from the initial library are identified (Arnold et 
al., 2013).  This technique therefore avoids a labor intensive means of screening multitudes of 
sequences for enhancer activity. 
 
The enhancer trap technique utilises tranposase enzymes to integrate promoter bound reporter 
genes randomly into the genome. It was first utilised in Drosophila (O'Kane and Gehring, 
1987) before later adaptations allowed its use in vertebrates (Balciunas et al., 2004). Only 
promoters in close proximity to an enhancer will allow reporter gene expression.  The reporter 
expression data can be used in coordination with gene expression data to identify the 







In recent years, ChIP-seq has proved an excellent tool not only to identify enhancers but to 
also provide an indication of their activity.  The basis of this technique lies in the fact that 
defined protein complexes are known to bind at enhancers which subsequently play a role in 
activating transcription at promoters.  Probing for these complexes thus identifies a region 
containing an enhancer.  One of the most common proteins tested is the acetyltransferase, 
P300.  Using a P300 antibody, ChIP-seq has identified tissue specific enhancers in several 
studies with their activity confirmed in transgenic assays (Visel et al., 2009, Blow et al., 2010).  
This has identified enhancers that display poor sequence correlation between species and were 
not directly apparent. 
 
In addition, the histones surrounding enhancers display intricate epigenetic patterns which 
correlate with the activity of the enhancer they surround. For example, in human ES cells 
(hESCs) active enhancers were associated with both H3K4me1 and H3K27ac and designated 
Class I, while Class II enhancers replaced H3K27ac with H3K27me3 and were termed 
“poised”.  Higher levels of RNA pol II were associated with the active enhancers thereby 
inferring transcription while SUZ12 - a component of the polycomb PCR2 complex - was 
associated with the poised enhancers suggesting a more repressive state (Rada-Iglesias et al., 
2011).  In a later study in mouse ES cells (mESCs), three classes of enhancer were described 
with further subdivisions within each class.  Similar to hESCs, active enhancers were classified 
based on high levels of both H3K4me1 and H3K27ac, while poised enhancers had both 
H3K4me1 and H3K27me3.  Intriguingly the third class - termed intermediate enhancers - were 
identified purely by the presence of H3K4me1 without H3K27ac or H3K27me3.  The activity 
of the genes nearest these enhancers was highest when near those classified as active, followed 
by intermediate and lastly by the poised enhancers.  Additionally, other histone marks such as 
H3K36me3 provide an alternative classifier of active enhancers while H3K9me3 marks poised 
enhancers (Zentner et al., 2011).  When ChIP is conducted using antibodies for these types of 
histone marks, the location and activity status of such enhancers can be determined.  These 
types of experiments are particularly informative when analysing multiple tissue types 
simultaneously.  For example, if studying the differentiation of ESCs to a particular cell type, 
the epigenetic status of enhancers could be compared across both cell lines.  If, for instance, a 
particular enhancer changes from a poised to active state between the ESCs and differentiated 






Figure 1.6 – Summary of the keys stages of the commonly used chromosome conformation 
capture techniques; 3C, 4C, 5C, Hi-C and ChIA-PET.  A multitude of other 3C style techniques 
are available but are not analysed in this figure.   Both 4C and 5C involve the construction 
of a 3C library before further steps are conducted.  Hi-C and ChIA-PET only follow the 
original 3C protocol until the first restriction enzyme digestion after which both protocols 
diverge.  In all protocols the finished libraries are sequenced using next generation 
technologies. 
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1.5 Chromatin Structure 
 
1.5.1 Topological Associated Domains (TADs) 
 
“The DNA can be imagined as a long thread that is subdivided by walls into various sections 
or TADs.  All elements within a section – genes, regulators, transcription factors, polymerases 
and many others – can interact freely. The walls separate the sections and shield them from 
neighbouring activity”. 
Professor Stefan Mudlos, Genetic diseases shift boundaries within the genome, 
Available from: https://www.mpg.de/9229203/dna-tads 
 
The advent and subsequent development of the “C” technologies provided a novel way of 
looking at chromatin structure and folding at a genome wide level.  Hi-C in particular allowed 
scientists to view the multitude of interactions a gene can make both in cis and in trans and 
the boundaries along the DNA preventing further interactions from occurring.  From these 
experiments the term “Topological Associated Domain (TAD)” was derived to describe 
regions of DNA, typically around 1 Mb in length, in which the interactions within the region 
are maintained.  Chromatin from all cells is divided into such regions with the same TAD 
boundaries  consistent across different species and cell types, but also showing diverse intra-
TAD interaction profiles dependent on the activity of genes within the TAD (Dixon et al., 
2012).  The reason DNA is divided into such regions and the exact time at which this occurs 
in development is an active area of research.  At present, increasing evidence has implicated 
CCCTC-binding factor (CTCF) in marking the boundaries of TADs.  For some time CTCF 
was thought to behave solely as an insulating protein shielding genes from the activating effect 
of enhancers (Bell et al., 1999).  However, recent reports suggest an architectural role where 
CTCF can bring distant acting regions into close proximity.  Indeed, 3C has shown that CTCF 
is necessary for creating loops between two distant regions, with its removal resulting in the 
destabilisation of these structures (Splinter et al., 2006).  The assumption is, therefore, that by 
bringing two regions together in a loop, CTCF can mediate the interaction between an 
enhancer and promoter leading to gene activation.  However, other enhancers excluded from 
the loop are physically unable to interact with genes within the loop.  In this way, CTCF is 
acting as an insulator.  The loops created by the binding of CTCF are the TADs observed from 
Hi-C.  This basic model of CTCF facilitating DNA loops, which bring distant sites together, 
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becomes more complicated when other architectural proteins are also considered.  ChIP-seq 
experiments showed that CTCF shares binding sites with both cohesin and mediator, two 
proteins known to interact with a predicted involvement in DNA looping (Kagey et al., 2010, 
Ramalho-Santos et al., 2000).  The size of the DNA loops created by these proteins is 
dependent on the combination of proteins present.  For example, in one study using multipotent 
neural progenitor cells (NPCs) and mouse ES cells, the largest loop structures were formed 
when CTCF and SMC-1 combine (> 1 Mb) while the smallest loops formed when MED12 
and SMC-1 were present (<100 kb).  Loops ranging from 600 - 1 Mb occur when MED12 
binds on its own while a combination of the three factors produces loops of < 300 kb (Phillips-
Cremins et al., 2013).  The combination of architectural proteins present is therefore necessary 
in determining the size of DNA loops which are manifested as TADs or the small sub-domains 
within TADs referred to as sub-TADs. 
 
Recent studies suggest that the orientations of CTCF binding sites (CBS) along the genome 
are involved in the construction of TADs.  CBSs in the forward orientation are likely to interact 
with those in the opposite orientation leading to the formation of a loop.  TAD boundaries 
form when a reverse CBS is placed alongside a forward site.  Indeed, CRISPR/Cas 9 
experiments where CBSs have been re-orientated in the human β-globin locus show that novel 
interactions are possible when reverse-forward CBSs have been transformed into forward-
forward, with the new forward CBS interacting with a reverse CBS previously inaccessible 
(Guo et al., 2015). 
 
This system of correctly orientated CBSs along the genome creating TADs seems to be 
conserved across species suggesting a universal method of packaging DNA.  Indeed, highly 
conserved CBSs are located at TAD boundaries, while CBSs with weaker sequence 
conservation tend to be species specific and are more likely to fall within TADs.  These unique 
sites are probably involved in novel interactions leading to gene expression profiles which 









1.5.2 Identifying Mechanisms of Loop Formation through Polymer 
based Modelling 
 
Using Hi-C and ChIP-seq for chromatin architectural proteins, various studies investigated the 
mechanism by which TAD loops are initially formed.  One of the most promising models is 
known as the “Chromatin Extrusion” model.  In this scenario, loop extruding factors (LEFs) 
bind to the DNA, probably as a dimer, with one unit moving along the genome in a forward 
direction and the other in reverse.  In this way, DNA is looped through the LEFs without 
producing a knot.  The loop will continue to grow in size until it reaches a boundary element.  
The most likely candidates for LEFs are cohesin while the boundary elements may be the 
CBSs (Fudenberg et al., 2016).  The means by which cohesin and CTCF coordinate to loop 
out DNA have not yet been elucidated.  It can be imagined that a cohesin dimer binds and 
moves along the DNA until it reaches CTCF already bound to two separate correctly orientated 
CBSs thereby stopping the cohesin unit in its path.  Alternatively, cohesin and CTCF may bind 
to DNA together and the combined structure is stopped upon reaching the CBSs (Sanborn et 
al., 2015, Yardımcı and Noble, 2015). In contrast, the cohesin complex may not bind within 
the TAD, but two separate complexes may bind at the TAD boundaries along with RNA pol 
II.  As the DNA is transcribed, it is looped through both complexes, only stopping when they 
meet (Razin et al., 2016). 
 
Recently, the location of both CTCF binding and DNase1 hypersensitivity sites (DHSs) have 
been used to create models of chromatin structure.  In these examples, chromatin is modelled 
as a polymer consisting of multiple beads, with protein bridges able to form between individual 
CTCF binding sites or DHSs.  The accuracy of these conformations are established by 
comparisons with experimental chromatin conformation capture data.  These models were 
applied to both the α- and β-globin loci, producing structures with interaction profiles 
correlating highly with Capture-C data.  The authors suggest that removing CTCF bridges 
from the models may provide an in-silico approach to analyse the effect of CTCF binding site 
deletions.  In this way systemically removing aspects of the model may provide an insight into 
their biological significance (Brackley et al., 2016). 
 
The aforementioned studies have all used a defined set of parameters to create simple 
chromatin models where the contact frequencies within a defined region can be compared to 
heat maps from experimental 3C type data.  An alternative approach is to use these heat maps 
directly to induce chromatin structure. 
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1.5.3 Mutations at TAD boundaries cause disease 
 
As previously raised, TADs play an important role in restricting the accessibility of a defined 
set of genes to a selection of enhancers which dictate the spatiotemporal expression of these 
genes within an organism.  The protection role TADs provide is established through the 
boundary regions which prohibit enhancers in other TADs from acting.  Over the last several 
years there has been increasing interest in the effect of disrupting TAD boundaries and the 
correlation of this with disease (Figure 1.7). 
 
In a recent study, defects at human TAD boundaries were shown to result in limb abnormalities 
(Lupiáñez et al., 2015).  The region containing three TADs was examined with the genes 
WNT6 and IHH contained in the first and most centromeric TAD; EPHA4 in the second TAD; 
and, PAX3 in the third most telomeric TAD.  Genomic deletions incorporating the boundary 
between the EPHA4 containing TAD and the PAX3 containing TAD resulted in the phenotype 
Brachydactyly, while inversions and duplications at the boundary between the WNT6-IHH 
TAD and the EPHA4 TAD resulted in F-sydrome.  These mutations were replicated in mouse 
models using the CRISPR/Cas9 system and the interaction profiles of the genes within the 
TADs analysed by 4C.  Interestingly, novel interactions were observed for the WNT6 and IHH 
genes with regions in the adjacent TAD when the boundary region was altered.  New 
interactions were also detected for the PAX3 gene with the EPHA4 TAD when the TAD 
boundary separating the two was removed.  A cluster of common interactions was observed 
for all these mutant 4C profiles to a region of 150 kb within the EPHA4 TAD; a site containing 
several EPHA4 enhancers.   The disruption of the EPHA4 TAD boundaries therefore allows 
the genes in adjacent TADs such as WNT6, IHH and PAX3 to adopt enhancers to which they 
have previously been insulated, resulting in aberrant gene expression profiles and mutant 
phenotypes.  Deletions at TAD boundaries have also been linked to other diseases such as 
autosomal dominant leukodystrophy (ADLD) where a   ̴660 kb deletion removes a boundary 
element of the LMNB1 containing TAD.   This allows enhancers from the adjacent TAD to 
make previously inhibited interactions with LMNB1 resulting in increased Lamin B1 
expression in the brain (Giorgio et al., 2015).  In one study, Mesomelic dysplasia Savarirayan 
type was shown to be caused by large deletions across three TAD boundaries.  This is believed 
to bring a number of enhancers into the vicinity of ID4, altering its expression thereby 
producing the associated skeletal abnormalities (Flöttmann et al., 2015).  This mechanism, 
where enhancers - previously shielded from a gene by a boundary element - come into contact 
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with the gene when the boundary is removed and alters its expression levels, has been termed 
“enhancer adoption”. 
 
The method of using the CRISPR/Cas9 system to re-position TAD boundaries by deleting 
CBSs has been used in several other studies to determine if ectopic interactions that result from 
these mutations alter gene expression.  For example, one such investigation focussed on the 
role CBSs had in demarcating TADs during the retinoic acid induced differentiation of ES 
cells (ESCs) to motor neurons (MNs).  In WT MNs, a CBS situated between Hoxa5-6 separates 
two adjacent TADs, with Hoxa1-5 fully expressed in one TAD and Hox7-13 repressed in the 
other.  Deletion of the CBS shifts the TAD boundary caudally to the next CBS resulting in 
increased Hoxa7 and Hoxa9 expression (Narendra et al., 2015). 
 
Recently the effect of shifting TAD boundaries has also been shown as a cause of cancer 
(Valton and Dekker, 2016).  For example, gain-of-function IDH mutant gliomas show 
increased DNA methylation which, when present at CBSs, reduces the binding of CTCF.  
Among the many loci affected, the reduction in CTCF binding between the adjacent TADs 
containing FIP1L1 and PDGFRA allows the interaction of FIP1L1 enhancers with PDGFRA 
thereby leading to increased expression of this oncogene (Flavahan et al., 2016).  Several other 
examples have been identified where the removal of a CBS increases expression of a proto-
oncogene (Hnisz et al., 2016) or structural genomic rearrangements such as duplications and 
deletions have re-positioned enhancers in close proximity to an oncogene resulting in cancer 











Figure 1.7 – (A, top) The output from most 3C type experiments is an interaction frequency 
map which depicts how frequently different portions of the genome interact with each 
other.  When presented graphically, these frequently present as triangles as only certain 
regions of the genome are capable of interacting with each other.  These regions are 
referred to as Topological Associated Domains (TADs) and are separated by boundary 
elements.  The cause of these boundaries is an area of ongoing research but the increasing 
evidence suggests that the binding of the protein CTCF to its binding sites (orange 
diamonds) is sufficient to stop interactions between TADs.  (A, bottom) In reality, TADs 
probably appear as loops of DNA, where all sequences within the loop are capable of 
interacting with each other.  (B, top) Using the CRISPR/Cas9 system, some laboratories 
have systematically removed CTCF binding sites and studied the effect on the associated 
TADs.  In some cases, this has resulted in the merging of two adjacent TADs allowing 
enhancers previously inaccessible in one TAD to interact with genes in the other TAD 
thereby resulting in an aberrant gene expression.  In interaction frequency maps this is 
shown by the merging of two triangles.  The removal of TAD boundaries has been identified 
as a source of several diseases due to enhancers from foreign TADs activating genes at 
inappropriate times.  (B, bottom) Removal of such a boundary is likely to affect the looping 


















1.5.4 Lamin Associated Domains (LADs)  
 
In eukaryotic cells, the nuclear envelope separates the cytoplasm from the nucleoplasm and is 
composed of two separate membranes: the inner nuclear membrane (INM); and, the outer 
nuclear membrane (ONM).  The surface of the INM pointing into the nucleoplasm is 
surrounded by a mesh of intermediate filaments referred to as the lamin proteins (Wilson and 
Foisner, 2010).  This is known as the nuclear lamina.  In mammals, the three genes LMNA, 
LMNB1 and LMNB2 are responsible for regulating a series of different lamin isoforms 
(Dittmer and Misteli, 2011). The most common are Lamin A, Lamin B1, Lamin B2 and Lamin 
C.  The roles of these lamin proteins in regulating gene expression is an area of ongoing 
biological research. 
 
In 2008, a study was conducted to identify all genomic sequences interacting with the nuclear 
lamina in human fibroblasts.  DNA adenine methyltransferase identification (DamID), using 
a chimera of DNA adenine methyltransferase (Dam) and human lamin B1, identified 1300 
regions binding to the nuclear lamina.  These sequences - referred to as Lamin Associated 
Domains (LADs) - ranged in size from 0.1 - 10 Mb and were associated with areas of low 
transcription based on the decreased levels of RNA polymerase II and the activating histone 
mark H3K4me2 at gene promoters.  The presence of CTCF and active gene promoters acting 
away from the LADs, near the LAD boundaries was hypothesised to prevent the spread of 
euchromatin into the LAD and the spread of heterochromatin out of the LAD (Guelen et al., 
2008). 
 
This study was quickly followed by another looking at the change in LADs accompanying the 
transition of mouse embryonic stem cells (mESCs) to neural precursor cells (NPCs) and then 
to astrocytes (ACs).  Overall the position of LADs was highly maintained with a conservation 
of between 73 - 87 % between cell types.  However, there were some important differences.  
Genes involved in maintaining the pluripotency of the ESCs such as Nanog and Klf4 were 
repositioned towards the nuclear lamina during the differentiation process which correlated 
with a decrease in their expression.  However, a reduced gene expression accompanying an 
association with the nuclear lamina was evident only in certain cases.  When ESC to NPC 
differentiation was examined, nuclear lamina repositioning occasionally had little effect on 
gene expression.  However, these “silent” genes which either moved towards or away from 
the nuclear lamina and had no effect on gene expression during the transition from ESCs to 
NPCs, did show expression differences during the subsequent transition of NPCs to ACs.  The 
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authors suggested this first movement primes the genes to be activated at later stages (Peric-
Hupkes et al., 2010). 
At this stage it was known that LADs were associated with a repressed chromatin state, with 
genes located in these areas showing a reduction in gene expression compared to genes located 
away from the nuclear lamina into the nucleoplasm.  However, the mechanism promoting this 
relationship between LADs and gene expression was not understood.  Were poorly expressed 
genes simply repositioned to the nuclear lamina or was there an active process that shuttles 
specific genes to the nuclear lamina where gene expression is subsequently reduced?  In a 
series of experiments using constructs containing either LAD or non-LAD DNA, Zullo et al. 
showed that the expression of a gene could be reduced when relocated to the nuclear lamina.  
The specific sequences in LADs responsible for this were enriched for the sequence motif 
GAGA and referred to as lamina associating sequences (LASs).  The protein CKROX along 
with HDAC3 and LAP2 were shown to bind to LASs with knockdown of CKROX reducing 
the ability of LADs to position at the nuclear lamina (Zullo et al., 2012).   In addition, studies 
using Drosophila had previously shown the Lamin LamDm0 mutants had increased expression 
in testis specific gene clusters in the regions 60D1 and 22A1.  Removal of LamDm0 by RNAi 
also resulted in the movement of these genes from the lamina into the nucleoplasm (Shevelyov 
et al., 2009). Using TALENs, Therizols et al. showed that transcriptional activation of the 
genes Ptn, Sox6 and Nrp1 in ESCs was sufficient to drive repositioning of chromatin towards 
the nuclear centre.  However, by introducing an acidic peptide at these genes which causes 
chromatin decondensation with the absence of gene transcription, there was still a movement 
of chromatin away from the nuclear periphery. This suggests that chromatin decondensation 
alone is sufficient to relocate chromatin from the nuclear lamina to the nucleoplasm (Therizols 
et al., 2014). 
Interestingly, in mESCs the presence of lamin proteins was not essential for the formation of 
LADs.  This was proven by replacing Lamin B1 with Emerin (EMD) for DamID experiments.  
Emerin is also bound at the nuclear lamina and produces near identical DamID profiles to 
those produced with Lamin B1.  Knock out of both Lamin B1 and B2 in mESCs produced 
almost identical Dam-EMD profiles to those obtained from wild type cells.  The expression of 
genes within LADs was also unaffected suggesting that these proteins were not essential for 
the repressive nature observed at LADs.  To eliminate the possibility that Lamin A and C were 
compensating for the removal of Lamin B1 and B2 in LAD formation, these were knocked 
down by RNAi.  Again Dam-EMD profiles were near identical to the wild type profiles.  
Therefore, this study suggests that an alternative mechanism is responsible for the repression 
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of genes at LADs in mESCs which does not utilize lamin proteins to clamp genes to the nuclear 
lamina.  This is in contrast to differentiated cells and human fibroblasts where the presence of 
lamin proteins at LADs is essential for gene repression at the nuclear lamina (Amendola and 
van Steensel, 2015). 
1.5.5 Laminopathies  
 
In many cell types, the presence of lamin proteins at the nuclear lamina plays an essential role 
in regulating gene expression (Chapter 1.3.5).  Disruption of these proteins therefore seems a 
likely source of gene expression irregularities possibility resulting in disease.  Indeed, many 
diseases have been identified with defective lamin proteins being the root cause.  Collectively, 
these diseases are termed “laminopathies”. 
 
Many laminopathies have been identified and extensively reviewed (Worman and Bonne, 
2007) with the source of many of these diseases routed to defects in either Lamin A or Lamin 
B proteins.  Emery-Dreifuss muscular dystrophy (EDMD) is one of these diseases 
characterised by abnormalities in both skeletal and cardiac muscle.  A study using C.elegans 
looked at the effect of a Y59C mutation in LMN-1, a mutation which has been observed in 
human EDMD patients.  This prevented the release of chromatin linked to muscle specific 
genes at the nuclear periphery thereby reducing their expression.  The same circumstances 
may be occurring in humans (Mattout et al., 2011).  Another well studied laminopathy is 
Hutchinson-Gilford progeria syndrome (HGPS), a premature aging disease resulting in 
average life span of 13 years (Merideth et al., 2008). The source of HGPS is an irregular form 
of Lamin A caused by a C > T mutation in exon 11 at residue 1824.  This mutant is known as 
progerin and - unlike the Lamin A protein - it maintains the farnesyl group post translational 
modification. (Cao et al., 2007).  This affects progerin by anchoring it to the nuclear membrane 
and preventing its release.  Treatment with farnesyltransferase inhibitors (FTIs) can remedy 
some of the cellular effects seen in HGPS by allowing release of progerin from the nuclear 
membrane (Capell et al., 2005).  In one study, progerin was shown to interact with a unique 
subset of genes from lamin A causing abnormal gene expression changes which may 
contribute to the phenotypes observed in HGPS patients (Kubben et al., 2012). 
 
1.5.6 Radial Positioning in the Nucleus and Chromosome Territories  
 
After mitosis chromosomes undergo a process of decompaction and present as less ordered 
chromatin within the nucleus.  For a long time, it was not known whether chromatin originating 
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from different chromosomes was allowed to intermingle or whether it was restricted to a series 
of distinct domains.  Over the last several decades the latter option has been proved with 
interphase chromosomes occupying the so-called chromosome territories (CTs).  In one of the 
key experiments leading to this conclusion, conducted by Zorn and colleagues, cells were 
irradiated with a UV laser and then monitored for DNA damage.  Only certain chromosomes 
showed damage at any one time thus demonstrating how unlikely it was that chromosome 
regions are intertwined.  If this were the case, multiple sites of damage on many different 
chromosomes would have been observed (Zorn et al., 1979). 
 
Later research highlighted that the organization of CTs within the nucleus was also structured.  
In general, a correlation exists between the density of genes within a chromosome and its 
location within the nucleus.  FISH experiments using chromosome paints in both human 
lymphoblast and fibroblast cell lines showed that the more gene rich chromosomes such as 
HSA1, -16, -17, -19 and -22 were located much closer towards the centre of the nucleus than 
the gene poor chromosomes such as HSA2, -4, -13 and -18 which are located much closer to 
the nuclear periphery (Boyle et al., 2001) (Figure 1.8). This pattern seems applicable to most 
cell lines as a study looking at the nuclear position of the gene poor chromosome 18 and the 
gene dense chromosome 19 showed that the CT of chromosome 19 was situated closer towards 
the nuclear interior in a variety of different cell types (Cremer et al., 2003). 
 
So, how does this concept of chromatin territories feed into what is already known about 
transcriptional regulation?  In 2004, Chambeyron and Bickmore conducted a study looking at 
the regulation of the HoxB gene cluster during differentiation of ES cells.  Retinoic acid (RA) 
induced expression of the Hoxb genes in a co-linear fashion beginning with the expression of 
Hoxb1 after 4 days and ending with the expression of Hoxb9 after 10 days.  Interestingly, 
activating histone marks were evident across the entire gene cluster 4 days after RA addition 
and a global decompaction of the region was evident after 2 days.  The authors concluded that 
both of these events served to poise the genes for activation without activating them, as some 
genes containing activating histone marks 4 days after RA addition were not expressed.  
Instead, the looping out of poised genes from the CT resulted in the subsequent gene 
expression.  Genes along the HoxB cluster are looped out in order from Hoxb1 to Hoxb9 
thereby reflecting the order in which they are expressed (Chambeyron and Bickmore, 2004).  
The result of this looping out of genes from their CT may be to allow their interaction with 
transcription factories (Chapter 1.3.5). 
 
 57 
Interestingly in a follow up study, this time looking at the HoxD gene cluster instead of the 
HoxB cluster it was found that the process of decondensation did not always correlate with 
dissociation of genes from their CT.  Indeed, the order of events seems to depend on the 
anatomical position in which the genes are expressed.  For example, the mouse tail bud showed 
both decondensation and looping out of genes while the limb bud showed decondensation 
while maintaining genes within the CT (Morey et al., 2007). 
 
1.5.7 Transcription Factories   
 
In an experiment conducted in 1996 transcription in HeLa cells was shown to be localised to 
a set of roughly 2,100 discrete “transcription factories” within the nucleus each with a diameter 
of around 71 nm (Iborra et al., 1996).  The authors of this study suggested that contrary to 
previous thought suggesting RNA polymerases were believed to move along DNA regulating 
transcription, the RNA polymerases may occupy fixed positions within transcription factories 
and instead it is the DNA template which moves over the enzyme.  Since then there has been 
a stream of publications concerning transcription factories.  In 2004, Osborne and colleagues 
showed that multiple genes situated at different locations along a chromosome could come 
together at the same transcription factory.  Using both RNA FISH, DNA FISH and RNA 
immuno-FISH, Hbb-1 and Eraf (two genes expressed in erythrocyte cells) showed an 
increased interaction at the same RNA polymerase II site for transcriptionally active alleles.  
Alleles that were transcriptionally inactive were located outside these regions.  As 
transcription is known to be a discontinuous process, the authors concluded that the repeated 
movement of genes into and out of a transcription factory is likely to result in these pulses of 
transcription (Osborne et al., 2004).  Interestingly a complete loss of transcription does not 
alter the number of transcription factories within the nucleus suggesting that they are distinct 
non-transient structures (Mitchell and Fraser, 2008). 
 
The next question addressed was whether all transcription factories are equivalent or are 
different factories responsible for the transcription of different types of genes?  This was 
answered recently when Xu and Cook showed that promoters specific for RNA polymerases 
type I, II and III are localised to different transcription factories.  Genes with introns also re-
located to transcription factories different to those occupied by genes without introns (Xu and 
Cook, 2008).  Accordingly, transcription factories are specialised compartments which are 






Figure 1.8 – Recent evidence has shown that the nucleus of eukaryotic cells is not as 
disorganised as previously thought but has a distinct structure.  After mitosis the 
chromosomes of interphase nuclei decondense and occupy discrete chromosome 
territories (CTs).  In general, gene rich CTs such as the human HSA 16 CT (shown in green) 
are located closer to the nuclear interior while gene poor CTs such as HSA2 (shown in blue) 
are located closer to the periphery.  At the periphery, chromatin in contact with the lamina 
referred to as LADs (lamina associated domains) generally has inactivated genes which can 
become activated by withdrawing from this region.  Sometimes, genes within CTs have 
been shown to loop out from their CT and make contact with transcription factories (purple 







1.5.8 10 nm Fibre (beads-on-a-string) and 30 nm Fibre Chromatin 
Structures 
 
In humans, the nucleus of each cell holds the genomic DNA which (when extended) is roughly 
two metres in length.  To fit into such a small compartment, DNA must be tightly packaged - 
a process hypothesised to occur through multiple processes.  At the basic level, DNA is 
wrapped around histone proteins which - due to their positive charge - negate the repulsive 
forces of long negatively charged DNA chains.  Histone octamers, consisting of an H3-H4 
tetramer bound to two H2A-H2B dimers, wrap around 147 bp of DNA (Ausió, 2015).  
Evidence of chains of histones entangled by DNA and separated by linking DNA is 
widespread, with the “beads-on-a-string” like structure (Olins and Olins, 1974) referred to as 
the 10 nm fibre.  The discovery of a more compact 30 nm fibre in vitro suggested that the 10 
nm fibre may integrate into this structure to aid compaction.  However, scientific 
understanding of the 30 nm fibre remains in its infancy with debate ongoing as to whether 
such a structure actually exists in vivo.  The way in which the 30 nm fibre folds is also contested 
with a one start helix solenoid model and a two start helix zigzag model the most likely 
scenarios (Maeshima et al., 2014).  The crystal structure of a tetranucleosome favours the latter 
model (Schalch et al., 2005).  However, increasing evidence suggests that an important 
structural feature is the interaction between acidic amino acids on H2A with the H4 N-terminal 
tail; disruption of which results in destabilisation of the entire 30 nm fibre (Tremethick, 2007).  
A number of extrinsic factors may influence the structure of the fibre during the isolation 
process and it is possible that both structures may exist depending on the conditions.  The lack 
of in vivo evidence for the 30 nm fibre remains a worry with some researchers even suggesting 
that it is merely an artefact caused by low salt concentrations which are dissimilar to the 
physiological conditions (Maeshima et al., 2014).  
Evidence for the existence of the 30 nm fibre in mitotic chromosomes has centred on results 
obtained from small-angle X-ray scattering (SAXS) which has detected peaks believed to 
represent the 30 nm fibre (Langmore and Paulson, 1983).  However, the results were a direct 
contradiction of those obtained from cryo-EM studies which showed the absence of such 
structures.   Further analysis of the SAXS data highlighted that the 30 nm fibre peak was 
actually caused by contaminating ribosomes and when these were removed the peak was no 
longer detected.  However, a peak is still detected in chicken erythrocyte nuclei which do not 
have ribosomes suggesting that this structure may be present in erythrocytes.  The authors of 
this study suggested that mitotic chromosomes therefore, are not composed of 30 nm fibres 
but are assembled based on the irregular cooperation of 10 nm fibres (Nishino et al., 2012). 
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1.5.9 Higher Order Chromatin Structure  
Whilst it seems that the basic packaging unit of chromosomes are irregularly orientated 10 nm 
fibres (Chapter 1.3.5) with the potential involvement of 30 nm fibres, what are the additional 
higher order packaging structures which allow the chromatin to be so highly condensed?  In 
1978 Sedat and Manuelidis proposed what would later become known as the hierarchical 
helical folding model (Sedat and Manuelidis, 1978) where the 30 nm fibre folds into a 100 nm 
fibre which subsequently folds into a 500 nm fibre, with the process continuing until the largest 
chromatin fibres are formed.  A year later, the radial loop model was also hypothesized 
(Marsden and Laemmli, 1979) which suggested that chromatin is first organized into loops 
where the base of each loop is brought together to form a central core.  However, both of these 
models were based on the idea that the 30 nm fibre is present in vivo.  The current model 
referred to as the polymer melt model, suggests that - in low chromatin concentrations - intra-
molecular interactions are favoured allowing the formation of a 30 nm fibre.  However, as the 
chromatin concentration is increased the number of inter-molecular interactions also increases 
and the irregularly folded chromatin 10 nm fibres interdigitate (Maeshima et al., 2010).  This 
gives chromatin a liquid like property as it can adopt certain conformations depending on the 
conditions (Maeshima et al., 2016).  This model may apply to both mitotic and interphase 
chromatin.  Accumulation of clumps of interdigitated irregularly packaged chromatin may 
come together to form “chromatin liquid drops” - clumps of chromatin where transcription can 
only occur on the outside of the drop while the inner regions are shielded (Maeshima et al., 
2014).  These structures may correlate with the previously discussed TADs and form the basis 











1.6 Project Aims 
 
The aim of this investigation was to gain an increased understanding of the mechanism by 
which the ZRS activates the Shh gene.  To do this chromosome conformation capture and 
fluorescent in situ hybridisation (FISH) techniques were both employed using Shh inducible 
cell lines (14fp cells) which were derived from mouse E11.5 limb buds.  These cell lines 
allowed the study of the ZRS in a controlled environment where the Shh gene could be 
activated by the addition of the chemical trichostatin A (TSA) or by other means such as the 
addition of the protein GABPα or knock down of the protein PEA3.  The addition of TSA to 
the 14fp cells results in increased H3K27ac, an activating histone mark (Creyghton et al., 
2010), at the ZRS.  This does not occur when either ES cells or control cells from the 
mandibular region (MD cells) of the E11.5 mouse are treated with TSA.  This suggests that 
TSA is activating the Shh gene directly through the ZRS. 
By studying both Shh expressing and non-expressing cells the following questions could be 
tested: 
 How compact is the Shh locus compared to other regions of similar size? 
 Is compaction of the locus altered when Shh is expressed? 
 Is there an increased co-localisation between the ZRS and Shh gene in Shh expressing 
cells? 
 Does the ZRS make different contacts within the Shh regulatory region upon Shh 
expression? 
 
However, before attempting to answer such questions the use of these Shh inducible cell lines 
as a model system to study the limb bud was to be further examined.  In particular RNA 
sequencing experiments needed to be conducted to ensure genes expressed within the cell lines 
were similar to those expressed within the E11.5 limb bud.  Using RNA obtained from both 
TSA treated and untreated (Shh expressing and non-expressing) cell lines and proximal and 
distal (containing the ZPA where Shh is expressed) limb sections the following questions could 
be tested: 
 Do the untreated cell lines express similar genes to the limb sections? 
 Do the TSA treated cell lines express similar genes to the distal limb bud? 































2.1 Materials  
  
Chemicals and Reagents  
 Trizol Reagent (Life Technologies, 
cat no. 15596026) 
 Glycogen (Roche, cat no. 
10901393001) 
 Lightcycler 480 SYBR Green I 
Master Mix (Roche, cat no. 
0488735200) 
 DMEM (Life Technologies, cat no. 
41966029) 
 Paraformaldehyde (Sigma Aldrich, 
cat no. P6418) 
 Triton X-100 (Sigma Aldrich, cat 
no. 9002-93-1) 
 Chloramphenicol (Sigma Aldrich, 
cat no. C0378) 
 Phenol/chloroform/isomayl alcohol 
(25:24:1 (vol/vol/vol); pH 8; Sigma- 
Aldrich, cat. no. 77617) 
 Chloroform/isoamyl alcohol (24:1 
(vol/vol); Sigma-Aldrich, cat. no. 
C0549) 
 RNaseA (Roche, cat no.10 109 169 
001) 
 Glucose (AnalR, cat no. 101174Y) 
 Tris(hydroxymethyl)aminomethane 
(AnalR, cat. No 103156X) 
 Potassium Acetate (Fisher 
Scientific, cat. no. 127-09-3) 
 Glacial Acetic Acid (Sigma Aldrich, 
cat no.33209) 
 Magnesium Sulfate (Mg2SO4) 
(Sigma Aldrich, cat no. 10034-99-8) 
 Dithiothreitol (DTT) 
 Formamide (Sigma Aldrich, cat. no. 
F7503) 
 Cot I (Fisher Scientific, cat. no.  
18440016) 
 Sonicated Salmon Sperm (Sigma 
Aldrich, cat. no. 68938-01-2) 
 Dextan Sulfate (Sigma Aldrich, cat. 
no. 42867) 
 Tween 20 (Sigma Aldrich, cat. no. 
P1379) 
 Marvel Dried Skimmed Milk 
 DAPI (Sigma Aldrich, cat. no. 
D8417) 
 Formaldehyde solution 37 % 
(vol/vol) (Merck, cat. no 
1039992500) 
 Glycine (Fisher Scientific, cat. no. 
G/0800/60) 
 Hind III (Roche, cat. no. R0104M, 
NEB, cat. no. R3104S) 
 T4 DNA ligase (NEB, cat. no. 
M0202M) 
 T4 DNA ligase buffer (NEB, cat. no. 
B0202S) 
 Sodium Acetate (Fisher Scientific, 
cat. no. S/2080/60) 
 Igepal CA-630 (Sigma Aldrich, cat. 
no. I8896) 
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 Complete EDTA free protease 
inhibitor tablets (Roche, cat. no. 
11873580001) 
 MluCI (NEB, cat. no. R0538L) 
 Salmon testis DNA (STD) (Sigma 
Aldrich, cat. no. D7656) 
 Taq ligase (NEB, cat. no. M0208L) 
 10 × Taq ligase buffer (NEB, cat. no. 
B0208S) 
 Proteinase K (Roche, cat. no. 
03115836001) 
 Trisodium Citrate (Fisher Scientific, 
cat. no. S/3320/60) 
 Methanol (Fisher Scientific, cat. no. 
M/4000/17) 
 Potassium Chloride (Sigma Aldrich, 
cat. no.31248) 
 Colcemid (KaryoMAX, cat. no. 
15210-040) 
 Trichostatin A (TSA) (Cayman 
Chemical Company, cat. no. 89730) 
 Dimethyl sulfoxide (DMSO) 
(Sigma Aldrich, cat. no. D2650) 
 dNTPs (Fisher Scientific, cat. no. 
10297018) 
 Propan-2-ol (Fisher Scientific, 
P/7500/15) 
 Ethanol (Fisher, E/0650DF/15) 
 Bovine Serum Albumin (BSA) 
(Sigma Aldrich, cat. no. A3294) 
 Taq DNA polymerase (NEB, cat. 
no. M0273S) 
 Vectashield (Vector Laboratories, 
cat. no. H-1200) 
 Hi-Pure low EEO Agraose 
(Biogene, cat. no. 300-300) 
 Dnase1 (Roche, cat. no. 
10104159001) 





 QuantiTect Reverse Transcription 
Kit (Qiagen, cat no. 205313) 
 MinElute PCR purification kit 
(Qiagen, cat no. 28004) 
 Lonza-Mycoalert Mycoplasma 
Detection Kit (Lonza, cat no. LT07-
318) 
 QIA quick PCR Purification Kit 
(Qiagen, cat no. 28106) 
 Expand Long Template PCR 




 22 × 22 mm coverslip (Fisher 
Scientific, cat. no. 12-541B) 
 22 × 40 mm coverslip (Fisher 
Scientific, cat. no. 12-543A) 
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 22 × 50 mm coverslip (Fisher 
Scientific, cat. no. 12-543C) 
 40 µM cell strainer (BD Falcon, cat. 
no. 352340) 
 quadriPERM 16 × 12 chamber (REF 
946077308) 
 Quick Spin Columns for 
Radiolabelled Purification (Roche, 
cat. no. 11273965001) 
 Sorvall Legend X1R centrifuge 
 Eppendorf®Safe-Lock 
microcentrifuge tubes (Sigma 
Aldrich, cat. no. T9661) 
 Thermo Scientific Heraeus Fresco 
21 Centrifuge 
 DNA Engine Tetrad 2 Peltier 
Thermal Cycler 
 Grant Instruments Grant 26 Ltr 
Expert Unstirred Water Bath 
Stainless Steel 
 Thermo Scientific Savant DNA 120 
Speedvac Concentrator 
 Peq Power 300V Peqlab Power 
supply 
 Mettler PM4600 DeltaRange 
Balance 
 Spectrolinker™ XL-1000 Series UV 
Crosslinker 




 SHH Antibody [RM0128-4A37] 
(AB86462) (Abcam) 
 Alexa Fluor® 488 (Thermo 
Scientific, cat no.  A-11094) 
 FITC Anti-Digoxigenin (Sigma 
Aldrich, cat no. 11207741910) 
 FITC Anti-Sheep 
 Biotinylated Anti-Avidin (Vector 
Laboratories, cat no. BA-0300) 
 Avidin Texas Red (Vector 
Laboratories, cat no. A-2016) 
 Rhodamine Anti-Digoxigenin 
 Texas Red Anti-Sheep (Vector 
Laboratories, cat no. TI-6000) 
 Avidin FITC (Vector Laboratories, 
cat no. A-2011)
 66 
2.2 General Laboratory Solutions 
 
The following solutions were made by the Human Genetics Unit Technical Services 
department and used throughout this investigation: 
 20 × SSC:  For a 1 L solution -  175.3 g Sodium Chloride, 88.2 g Sodium Citrate, 
made up in distilled water 
 50 X TAE: For a 1 L solution – 242 g Tris Base, 57.1 ml Glacial Acetic Acid, 100 ml 
0.5 M EDTA (pH 8.0), made up in distilled water 
 0.5 M EDTA:  For a 1 L solution – 186.1 g EDTA, ~20 g Sodium Hydroxide, made 
up in distilled water 
 5 M NaOH:  For a 1 L solution – 200 g Sodium Hydroxide, made up in distilled water 
 5 M NaCl:  For a 1 L solution – 292.2 g Sodium Chloride, made up in distilled water 
 Trypsin:  For a 1 L solution –  2g trypsin 1:250, 5 ml Phenol Red, 0.06 g Penicillin, 
0.13 g Streptomycin, made up in PBS, pH to 7.8 with sodium hydrogen carbonate 
 Versene:  For a 1 L solution – 10 Dulbecco tablets, 0.4 g Sodium EDTA, 5 ml 0.2 % 
Phenol Red, made up in distilled water  
 PBS:  For a 1 L solution – 10 Dulbecco tablets, 0.1 g Sodium Azide, 20 g Bovine 
Serum Albumin, made up in distilled water  
 L-Glutamine:  For a 1 L solution – 30 g L-Glutamine, made up in distilled water  
 Penicillin/Streptomycin:  For a 1 L solution - 7.0 g (10 x 108 U) Penicillin, 13 g 
Streptomycin, made up in distilled water 
 L-Broth:  For a 1 L solution – 10 g Tryptone, 5 g Yeast Extract, 10 g Sodium Chloride, 









2.3 General Laboratory Procedures 
 
2.3.1 Isolation of RNA 
 
RNA was isolated from cells with trizol reagent using the protocol provided by life 
technologies.  This procedure could be carried out on cells immediately or alternatively cells 
could be isolated and stored in the appropriate volume of trizol at -20 °C until needed.  In 
chromosome conformation capture experiments (4C and 5C) and in FISH experiments, 1 × 
106 cells were isolated from the rest of the cells needed to conduct the experiment and stored 
in 500 µl of trizol reagent.  RNA could therefore be isolated when required allowing the 
subsequent production of cDNA which could be used for quantitative real time PCR 
experiments.   
In brief, for a 500 µl trizol sample, the protocol involved leaving the solution at room 
temperature for 5 min followed by the addition of 100 µl of chloroform.  After thorough 
mixing and a further short incubation at room temperature, samples were centrifuged at 12,000 
g for 15 min at 4 °C thereby producing a solution with three separate layers: a lower organic 
phase; an interphase; and an aqueous phase on top which contained the isolated RNA.  This 
aqueous phase was removed and added to 10 µg of glycogen (20 mg/ml) and 250 µl of propan-
2-ol and then centrifuged for a further 10 min at 12,000 g (4 °C).  Subsequently the supernatant 
was removed and the sample was washed in 75 % ethanol, centrifuged for 5 min (7500 g, 4 
°C) and then left for 10 min at room temperature.  Finally, the remaining RNA pellet was re-
suspended in 50 µl of RNase free water and heated at 55 °C for 15 min.  At this point the RNA 
solution was either stored at – 80 °C or placed on ice and used immediately to make CDNA. 
2.3.2 Assessment of RNA purity, quantity and integrity 
 
To assess the integrity of RNA samples, 1 µl of a 50 µl sample was run on an ethidium bromide 
stained 1 % agarose gel.  RNA was noted to be of an acceptable quality if two dominant bands 
were observed representing 28S (larger molecular weight) and 18S (lower molecular weight) 
cytoplasmic rRNA, where the intensity of the 28S band was roughly double that of the 18S 
band. 
The purity and quantity of RNA was determined using a NanoDrop ND-1000 
spectrophotometer.  Acceptable RNA samples displayed an A260/280 ratio of ~ 2.0 and 
A260/230 ratio of ~ 2.0-2.2.  Sometimes noticeable absorbance peaks were observed around 
230 nm which may be the presence of contaminating trizol within the sample which had not 
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been removed from a previous stage.  In these cases a further ethanol precipitation was 
conducted where 3 µl of sodium acetate pH 5.2 and 1 µl of 20 mg/ml glycogen were added to 
the 50 µl RNA sample in addition to 2.5 volumes of 100 % ethanol and left overnight at -20 
°C.  The following day the samples were centrifuged at 12,000 g for 10 min, the supernatant 
removed and the sample re-suspended again in 20 µl - 50 µl RNase free water. Samples were 
subsequently analysed on the NanoDrop spectrophotometer. 
2.3.3 Reverse Transcription Reaction  
 
Reverse transcription was conducted using either the QuantiTect Reverse Transcription Kit 
(Qiagen) or the first strand cDNA synthesis kit (Roche) which is no longer available.  Using 
the Qiagen kit consists of two separate reactions: a Genomic DNA Elimination Reaction and 
a Reverse-transcription reaction.  The Genomic DNA Elimination Reaction involves 
incubating up to 1 µg RNA in 7 × gDNA Wipeout Buffer and Rnase free water in a 14 µl 
reaction at 42 °C for 2 min.  This mixture is then added to a reverse transcription master mix 
consisting of the following components: Quantiscript Reverse Transcriptase; 5 × Quantiscript 
RT Buffer; and RT primer mix.  Tubes were then incubated at 42 °C for 15 min followed by 
a further incubation at 95 °C for 3 min.  30 µl of RNase free water was added to each reaction 
to give a total of 50 µl of cDNA which could then be used for quantitative real-time PCR 
(qPCR).   
When preparing samples for qPCR, replicate reverse transcription reactions were conducted 
without the addition of the reverse transcription enzyme.  These served to identify any 
contaminating genomic DNA in the samples tested. 
2.3.4 Quantitative Real-Time PCR (qPCR) 
 
Quantitative real-time PCR (qPCR) was conducted using the Lightcycler 480 SYBR Green I 
Master protocol (Roche).  In brief a master mix was made up for each series of primers used 
in the qPCR.  18 µl of master mix were added to the appropriate positions in a 96 multiwell 
plate, followed by 2 µl of sample cDNA.  The master mix components for a single 20 µl 
reaction are given in Table 2.1.  The programme for the Lightcycler 480 Instrument is given 
in Table 2.2.  A melt curve was performed for each qPCR experiment to ensure unwanted 
material, such as primer dimers, were not analysed.  GAPDH was used as the standard 
housekeeping gene in all relative qPCR experiments.  Lightcycler 480 software v 1.5 was used 
to analyse qPCR results.  The advanced relative quantification setting was selected which uses 
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the ∆∆CT method to calculate relative fold gene expression (assuming efficiency (E)=2).  The 
primers used in qPCR reactions are detailed in Table 2.3. 
 
Component Reaction Volume (µl) 
LightCycler® 480 SYBR Green I Master 10 
5 µM Primer Mix 1.2 
RNase free water 6.8 
Total 18 
 
Table 2.1 – Volume of each component needed for a 1 × reaction master mix.  18 µl of 
master mix are added per well in 96 multiwell plate in addition to 2 µl of cDNA. 
 
Stage Process Temperature (ºC) Time (min:sec) No. Cycles 
1 Pre-incubation 95 10:00 1 
2 Amplification 95 00:10 50 
 Melting  Primer Dependent 00:30  
 Annealing 72 00:30  
3 Melt Curve Primer Dependent 00:15 1 
  95 Continuous  
 















Table 2.3 – Primer sequences used for qPCR experiments 
 
2.3.5 Phenol Chloroform Extractions 
 
Isolation of DNA was conducted by phenol/chloroform extractions followed by ethanol 
precipitations.  In brief, an identical volume of phenol/chloroform/isomayl alcohol (25:24:1) 
(Sigma) was added to the experimental sample in a 1.5 ml tube, shaken vigorously for 15 s 
and centrifuged at 13,000 rpm for 5 min.  The solution separates into 2 layers with the aqueous 
phase forming the top layer and the organic phase the lower layer.  DNA maintained within 
this top aqueous layer was carefully removed and placed in a fresh tube.  The organic phase 
was discarded in designated phenol waste containers.   
2.3.6 DNA Ethanol Precipitations 
 
The aqueous phase from Chapter 2.3.5 was used to perform ethanol precipitations.  To 100 µl 
aqueous solution the following components were added: 1 µl glycogen (20 mg/ml); 10 µl 3 M 
Sodium Acetate pH 5.2; and 250 µl ethanol.  This solution was mixed thoroughly and left on 
dry ice for 15 min before centrifuging at 13000 rpm for 30 min (4 °C).  Next, the supernatant 
was removed leaving a DNA pellet which was washed in 70 % ethanol and centrifuged at 
13000 rpm for 2 min (4 °C).  This process was repeated, removing the supernatant and washing 
the pellet again in 70 % ethanol.  After centrifugation and removal of the supernatant the DNA 
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pellet was left to dry for 5 min after which it was re-suspended in MilliQ water and used as 
appropriate. (Typically DNA was analysed by agarose gel electrophoresis.) 
 
2.3.7 Agarose Gel Electrophoresis 
 
0.6 % - 2.5 % agarose gels (w/v) were prepared in Tris-Acetate-EDTA (TAE) buffer.  10 
mg/ml ethidium bromide was added to visualise DNA bands under UV light.  Samples were 
added in loading buffer prepared in-house consisting of 15 % Ficol (Fisher) and Orange G 
(Sigma).  Gels were run at 100 V for 1 hr.   
 
2.3.8 Generation and Statistical Analysis of RNA-seq data 
 
RNA was prepared on-site and tested for purity and integrity as described in section 3.3.1.  
Next generation sequencing was conducted by GATC Biotech AG.  Analysis of RNA-seq data 














2.4  Fluorescent in situ hybridisation (FISH) 
 
2.4.1 Cell Culture and Cell Fixation  
 
Cells were first grown to confluency in a T75 flask in complete DMEM media containing 10 
% FCS; 1 % Pen/Strep; 1 % L-Glutamine; and 0.1 % Interferon Gamma.  Cells were 
subsequently washed in 5 ml PBS and trypsinised for 15 min at 33 °C.  10 × complete DMEM 
media was subsequently added to neutralise the effects of the trypsin and the cells centrifuged 
at 1200 rpm for 5 min.  1 ml of complete DMEM media was added to the cell pellet and an 
appropriate volume of cell suspension added to a superfrost slide in a quadriPERM 16 × 12 
chamber.  5 ml of complete DMEM media were added to each slide and the cells were allowed 
to adhere to the surface of the slide and grow overnight.  The following day, the media for 
each slide was replaced with 5 ml of fresh DMEM media containing the appropriate 
concentration of TSA or DMSO.  Cells were then incubated for the appropriate time at 33 °C 
as dictated by the experimental protocol. 
 
Before fixation, cells were washed for three min in PBS three times.  Slides were then 
transferred to 4 % paraformaldehyde (PFA) solution and left for 10 min.  PFA was removed 
and the slides washed again in PBS three times for three min each.  After the washes the slides 
were transferred to a 0.5 % Triton X-100/PBS solution and left for 10 min.  Finally, slides 
were washed in PBS in the same manner as previously mentioned and left to dry.  After 10 
min, slides were washed briefly in MilliQ water and left to dry at room temperature.  Slides 
containing fixed cells could either be used immediately or stored at -80 °C until needed. 
2.4.2 Purification of Fosmid DNA 
 
An overnight culture was set up for each fosmid glycerol stock.  Each culture consisted of 5 
ml L-Broth containing 12.5 ng/µl chloramphenicol.  Cultures were left overnight at 37 °C.  For 
each fosmid being tested, 1.5 ml of culture media was extracted and spun at maximum speed 
in a 4 °C table-top centrifuge for 30 seconds.  The supernatant was removed and replaced with 
200 µl GTE Buffer containing lysozyme.  The pellet was re-suspended in the GTE Buffer, 
vortexed and left at room temperature for 5 min.  400 µl of lysis buffer was subsequently added 
to this solution and mixed by inversion.  At this point the solution should go clear.  This was 
left on ice for a further 5 min.  300 µl of acetate buffer was subsequently added producing 
masses of white flocculent.  This was left on ice for 5 min followed by centrifugation at 
maximum speed in a table-top centrifuge at 4 °C for 5 min.  The supernatant was removed and 
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added to an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1, pH 8.0).  The 
solution was mixed thoroughly and spun at maximum speed in a table-top centrifuge at 4 °C 
for 4 min.  The aqueous upper layer was removed and placed in a new Eppendorf tube along 
with an equal volume of chloroform:isoamyl alcohol (24:1).  The solution was mixed and 
centrifuged as described for the above phenol:chloroform:isoamyl alcohol extraction.  The top 
aqueous layer was extracted and placed in a new tube with an equal volume of iso-propanol.  
This was stored at -20 °C for 1 hr and then centrifuged at 4 °C for 15 min at maximum speed.  
After the supernatant was removed the pellet was washed in 70 % ethanol, briefly centrifuged 
at maximum speed at 4 °C and left to dry for 5 min.  This pellet was re-suspended 25 µl TE 
Buffer after which 2 µl 10 mg/ml RNaseA was added and the solution heated for 5 min in a 
37 °C water bath.  The final solution could either be stored at -20 °C or used directly in nick 




GTE Buffer 50 mM Glucose, 25 mM Tris pH 8.0, 10 mM 
EDTA 
Lysis Buffer 0.2 M NaOH, 1 % SDS 
Acetate Buffer 3 M potassium acetate, 11.5 % glacial acetic 
acid 
 
Table 2.4 - List of Buffers used in the purification of fosmid DNA. 
 
2.4.3 Nick Translation Reactions (NTR) 
 
A nick translation reaction was used to introduce either biotin or digoxigenin into each fosmid.  
Each 20 µl reaction contained 0.0625 mM dATP, dCTP and dGTP in addition to either 0.0625 
mM bio-16-dUTP or 0.0375 mM digoxigenin-11-dUTP. (When digoxigenin probes were used 
0.025 mM dTTP was also added).  In addition, 1 µg of purified fosmid DNA (Chapter 2.4.2), 
1 µl 1:10 DNase 1 (Roche), 1 µl DNA polymerase 1 (Invitrogen) and 2 µl nick translation salts 
were added to the reaction mixture.  This was left at 16 °C for 90 min after which 2 µl 20 % 
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SDS and 3 µl 0.5 M EDTA were added.  The solution was then made up to 90 µl in TE buffer 
and purified using Pharmica Quick spin columns according to the manufacturer’s instructions. 
Nick Translation Salts (0.5 M Tris pH 7.5, 0.1 M Mg2SO4, 1 mM DTT, 0.5 mg/ml BSA 
fraction V Sigma). 
2.4.4 3D-FISH 
 
3D-FISH was conducted over two days with denaturing of both slides and probes conducted 
on the first day, an annealing stage overnight and both washing and detection conducted the 
following day.  Fixed slides were removed from -80 °C and washed briefly in 2 × SSC.  The 
slides were then transferred to 2 × SSC containing 100 µg/ml RnaseA and left for 1 hr at 37 
°C.  After incubation, the slides were washed briefly in 2 × SSC and then washed sequentially 
in 70 %, 90 % and 100 % ethanol solutions for 2 min each, after which the slides were left to 
air dry at room temperature.  Once dry, the slides were heated at 70 °C for 5 min in an oven 
then denatured for between 15 – 30 min (experiment dependent) at 80 °C in 70 % formamide, 
pH 7.5.  Subsequently, the slides were placed immediately into ice cold ethanol for 2 min then 
washed in 90 % and 100 % ethanol respectively (2 min per wash) and left to dry at room 
temperature.  All slides and coverslips were warmed on a hot plate set to 37 °C before the 
addition of the probes.  
To prepare the probes, 100 ng of each fosmid was added to 14 µg CotI, 5 µg sonicated salmon 
sperm DNA and 2 volumes of 100 % ethanol in a 1.5 ml Eppendorf tube.  This was repeated 
for each slide being examined.  These tubes were then transferred to a heated vacuum 
centrifuge and spun until no liquid remained.  In the meantime, a hybridisation solution was 
made up consisting of 50 % deionised formamide, 2 × SSC, 20 % dextran sulfate and 1 % 
Tween 20.  30 µl of this hybridisation solution was added to each tube containing the dried 
probe mixture, mixed well and left for 1 hr at room temperature.  To denature the probes these 
tubes were transferred to an 80 °C water bath and left for 5 min.  Subsequently, probes were 
transferred to a 37 °C water bath to pre-anneal for 15 min. 15 µl of pre-annleaed probe solution 
was added to a 22 × 40 mm coverslip and then added to a pre-warmed slide which was then 
sealed with rubber solution and placed in a covered tray in a 37 °C water bath overnight. 
The following day the slides were transferred to 2 × SSC and washed at 45 °C for 3 min.  This 
was repeated 3 more times.  Slides were then transferred to 0.1 × SSC and washed at 60 °C 
for 3 min with this washing procedure also repeated an additional 3 times.  Finally, slides were 
transferred to 4 × SSC, 0.1 % Tween 20 at room temperature and left for several min.  Before 
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antibody solutions were added blocking solution was first added to the slides (4× SSC, 5 % 
marvel) for 5 min on a 22 × 50 mm coverslip.  This was removed, replaced with the first 
antibody solution (Table 2.5) and the slides placed in a moistened chamber and incubated at 
37 °C for 30 min.  After this incubation the coverslips were removed and slides washed three 
times, 2 min each time in 4 × SSC, 0.1 % Tween 20 at 37 °C.  Three more antibody incubations 
were conducted in the order detailed in Table 2.5, with each incubation lasting 30 min and 
conducted in a moistened chamber at 37 °C.  Again slides were washed three times for 2 min 
each time in 4 × SSC, 0.1 % Tween 20 at 37 °C in between antibody incubations.  After the 
final antibody incubation, slides were added to 4 × SSC, 0.1 % Tween 20 containing 50 ng/ml 
DAPI for 5 min.  Slides were then removed and mounted in 25 µl vectashield on a 22 × 50 
mm coverslip and sealed with Pang Rubber Solution.  All FISH slides can be stored for several 
weeks and analysed when required if stored in the dark at 4 °C. 
 
Order Combination 1 Combination 2 
1 1:20 FITC Anti-Digoxigenin 1:20 Rhodamine Anti-
Digoxigenin 
2 1:100 FITC Anti-Sheep + 1:500 
Avidin Texas Red 
1:100 Texas Red Anti-Sheep + 
1:500 Avidin FITC 
3 1:100 Biotinylated Anti-Avidin 1:100 Biotinylated Anti-Avidin 
4 1:500 Avidin Texas Red 1:500 Avidin FITC 
 
Table 2.5 - The order of antibody incubations used in FISH experiments.  
 
2.4.5 Deconvolution Microscopy   
 
All images were acquired using a Zeiss Axioplan 2 system referred to in-house as “Granny” 
containing a Lumen 200 W metal halide light source (Prior Scientific Instruments) and 
Chroma #89014ET single excitation and emission filters (Chroma Technology Corporation).  
The system contains a PIFOC collar (PIFOC model P-721, Physik Instrumente, Karlsruhe, 
Germany) allowing acquisition of fluorescent images at 0.2 µm intervals through the z-plane.  
All FISH images were captured at 100 × magnification with a Hamamatsu Orca AG CCD 
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camera (Hamamatsu Photonics, Welwyn Garden City, UK).  These were acquired using 
Volocity software (PerkinElmer, Waltham, MA, USA) with all images deconvolved using 
Volocity as well (Williamson, 2012).  To do this calculated point spread functions (PSFs) for 
DAPI, FITC and TxRED were used as inputs for Volocity’s iterative restoration procedure.  
To measure the distance between fluorescent spots Volocity’s quantitation module was used.  
This placed each image in the xy plane and allowed users to manually scroll through the z axis 
to identify the position at which the fluorescence of each probe was at its maximum.  A line 
could then be created from the centroid of one probe dissecting the z axis to that of another 
probe and the distance of this line measured.  Over 100 measurements were collected for each 
FISH experiment. 
 
2.4.6 Preparation of cells for metaphase spreads. 
 
Metaphase spreads were made for 14fp, 88fp and MD cell lines.  Cells were grown in complete 
DMEM media until 80 % confluent with a 1:100 dilution (stock 10 µg/ml) of colcemid 
(Karyomax) added 45 min before use.  After removal of the media, trypsin was added for 15 
min and cells incubated at 33 °C.  × 10 volume of complete DMEM media was added and 
cells centrifuged for 5 min at 1200 rpm.  The media was removed and cells washed in PBS 
before being centrifuged again for an additional 5 min at 1200 rpm.  After removal of wash, 
cell pellets were re-suspended in 10 ml lysis buffer (0.5 % trisodium citrate/0.25 % potassium 
chloride) and left for 10 min in a 37 °C water bath.  Following this step, cells were spun down 
as before and fix solution (3:1 methanol:acetic acid) added dropwise to the cell pellet with 
constant vortexing.  Cells were spun down as before and the fix solution removed.  Fresh fix 
solution was added again as described and the process repeated 3 times.  Finally fixed cells 
were dropped onto microscope slides and allowed to dry before use.  The remaining solution 
could be stored at -20 °C until needed.  2D images were obtained using the Zeiss Axioplan 2 
microscope described in Chapter 2.4.5. 
2.4.7 Preparation of cells for 2D-FISH. 
 
MYtag experiments were conducted on 14fp cells using a 2D-FISH protocol.  Preparation of 
cells for these experiments was conducted as described in Chapter 2.4.6 with the omission of 
the first step where colcemid is added.  ES cells were obtained from the Laura Lettice and 
Fiona Kilanowski (Hill laboratory) and were prepared for MYtag experiments as Chapter 2.4.6 




2D-FISH was conducted for MYtag experiments.  In brief, the 3D-FISH protocol was followed 
(Chapter 2.4.4) with several alterations.  Firstly, MYtags were not spun down with CotI and 
sonicated salmon sperm in a vacuum centrifuge.  Instead the hybridisation mix was made as 
previously described, with 1 µl of each MYtag library added to 10 µl of this solution.    Unlike 
the 3D-FISH procedure the hybridisation mix was not left for 1 hr.  Instead after addition of 
the MYtags, the mix was immediately transferred to a 70 °C water bath and denatured for 5 
min. After this step, the mix was placed directly on ice.  Slides were RNase treated and washed 
in ethanol as previously described.  However, denaturation was conducted in 70 % formamide, 
pH 7.5 for only 2 min 15 sec in a 70 °C water bath.  Slides were then washed in 70 %, 90 % 
and 100 % ethanol as before.  12 µl of denatured hybridisaton mix was added to a 22 × 22 mm 
coverslip and incubated overnight on the denatured slides as previously described.  The 
following day slides were washed 5 times in 2 × SSC at 45 °C for 2 min each time.  This was 
followed by five 2 min washes in 0.1 × SSC at 60 °C.  Slides were washed in DAPI and 

















2.5 Chromosome Conformation Capture Techniques 
 
2.5.1 Preparation of 3C libraries  
 
3C libraries were made as detailed in the protocol published by the Stoler laboratory 
(Stadhouders et al., 2013) and were subsequently used in either 4C or 5C experiments (Figure 
2.1).  Between 1 × 106 and 1 × 107 cells were used as a starting point for these experiments.  
For the cell lines, cells were grown in culture and either treated with TSA or DMSO (as a 
control) and left for the length of time dictated by the experiment.  After this, cells were washed 
in 5 ml PBS and trypsinised for 15 min at 33 °C.  10 × complete DMEM media was 
subsequently added to neutralise the effects of the trypsin after which cells were passed 
through a 40 m cell strainer to provide a single cell solution which was then centrifuged at 
1200 rpm for 5 min.  The media was removed leaving the cell pellet which was re-suspended 
in 1 ml 10 % FCS/PBS.  Using a haemocytometer, the number of cells were counted.  At this 
point, a fraction of these cells (usually 1 × 106 cells) were removed, spun down at 1200 rpm 
for 5 min and re-suspended in 500 l trizol solution.  This was stored at -20 °C until needed.  
This aliquot was used to make RNA and then cDNA which was tested by qPCR for Shh 
expression.  In this way the effect of TSA on the cells could be examined in each 4C/5C 
experiment. 
 
The remaining cell suspension was made up to 12 ml in 10 % FCS/PBS after which 649 l 37 
% formaldehyde solution was added (2 % final formaldehyde solution) with the tubes rotated 
gently for 10 min.   After this, glycine solution at a final concentration of 0.125 M (made up 
in PBS) was added to quench the reaction which was then centrifuged at 340 g for 8 min at 4 
°C.  As described in the protocol, the cell pellet was then washed in PBS and centrifuged again 
as detailed above.  In initial experiments, a large number of aggregates were formed at the 
stage of HindIII digestion.  As a result, the length of time cells were exposed to lysis buffer 
was increased and the cells were also dounced.  In total, cells were left in 5 ml lysis buffer 
(Table 2.6) for 15 min after which they were dounced 40 times and then spun down at 650 g 
for 5 min.  After removal of lysis buffer, nuclei were once again washed in PBS, spun down 
at 650 g for 5 min and then frozen in liquid nitrogen before storing at -80 °C. 
 
HindIII digestions were conducted by combining aspects of the protocols provided by the 
Stoler (Stadhouders et al., 2013) and de Laat (van de Werken et al., 2012).  If more than 5 × 
106 cells were used in the experiment, nuclei were made up to 2 ml in 1.2 × HindIII restriction 
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buffer and then divided into 4 separate tubes each containing 500 l of solution.  HindIII 
digestions were performed on each of these tubes which were later combined before the first 
ligation.  SDS was added to each of these tubes to a final concentration of 0.2 %, with the 
tubes then shaken on a thermomixer at 1400 rpm for 1 hr.  This was followed by the addition 
of Triton X-100 to a final concentration of 2 % (vol/vol) and further shaking for 1 hr 
(1400rpm).  Both NEB and Roche HindIII restriction enzymes were used interchangeably in 
this process.  200 U HindIII was first added for 4 hr (37 °C, 1400 rpm), followed by the 
addition of a further 200 U with overnight incubation.  The next day, another 200 U was added 
for 4 hr and then another 200 U for an additional 4 hr.  Thus 800 U HindIII was added overall. 
 
To check the digestion was conducted to completion, 2 x 5 l aliquots were taken from each 
of the tubes prior to digestion (undigested control) and a further 2 taken after digestion 
(digested control).  One of each of the digested and undigested controls were combined with 
90 μl of 10 mM Tris–HCl (pH 7.5) and 2.5 l 20 mg/ml proteinase K and then incubated at 65 
°C for 4 hr followed by a phenol/chloroform extraction and ethanol precipitation.  These were 
referred to as the de-crosslinked digested and undigested controls.  The remaining undigested 
and digested controls were made up to 100 l in 10 mM Tris–HCl (pH 7.5)  and also subjected 
to a phenol/chloroform extraction and ethanol precipitation.  These controls were referred to 
as the crosslinked digested and undigested controls.  All samples were run on a 0.6 % agarose 
gel and compared.  Crosslinked controls were not visible on the gel, while the de-crosslinked 
undigested control appeared as a high molecular weight band appearing at around 12 kb.  The 
de-crosslinked digested controls appeared as a smear running from a high molecular weight to 
a lower molecular weight of around 4 kb.  Providing the control experiments looked as 
expected the protocol was continued.  In the rare occasions were HindIII digestion was 
incomplete additional enzyme was added (typically 400 U) overnight and the digested controls 
analysed again as described. 
To halt HindIII digestion, a final concentration of 1.6 % SDS was added to each of the 500 l 
aliquots for 25 min at 65 °C on a thermomixer (1400 rpm).  At this point, each of the 4 500 l 
aliquots were combined and 24.5 ml of 1.15 × T4 DNA ligase ligation buffer added, followed 
by the addition of Triton X-100 to a final concentration of 1 % (performed in 50 ml tubes.)  
Tubes were incubated in a 37 °C water bath for 1 hr followed by the addition of 26800 CEU 
T4 DNA ligase (NEB) and overnight incubation at 16 °C. At this stage, 100 μl solution was 
removed and 2.5 μl (20 mg/ml) proteinase K added at 65 °C for 4 hr.  DNA was then purified 
by performing a phenol:chloroform extraction followed by an ethanol precipitation.  The final 
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DNA pellet was made up to 20 μl in MilliQ water and run out on a 0.6 % agarose gel.  
Successful 3C libraries appeared as a high molecular weight band while libraries with 
incomplete ligation still appeared as a high molecular weight smear.  In cases where ligation 
was incomplete additional ligase was added together with ATP and the solution left at 16 °C 
again overnight. 
1200 g RNase A was then added to the solution which was left in a 65 °C water bath overnight 
to de-crosslink the DNA.  The following day, the solution was again split into 4 equal aliquots 
of roughly 7 ml to which an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) 
was added.  After vigorous mixing, tubes were centrifuged at 3200 g for 15 min at RT.  After 
careful removal of the phenol layer, the following additions were made to the remaining 
solution in each of the 4 tubes: 7 ml MilliQ Water; 1.5 ml 2M Sodium Acetate (pH 5.6); and 
35 ml 100 % ethanol.  These were mixed thoroughly and left at -80 °C for 3 hr.  Following 
this incubation, the tubes were centrifuged for 45 min at 3200 g (RT), the supernatant removed 
and pellet washed in 70 % ethanol, before being centrifuged again for 15 min at 3200 g (4 °C).  
Upon removing the supernatant from the ethanol wash, the DNA pellets were left to dry for 
20 min after which 37.5 μl of 10 mM Tris-HCI (pH 7.5) was added to each pellet and the tubes 
transferred to a 37 °C water bath allowing the DNA pellets to go back into solution.  Once all 
pellets were re-dissolved, the solutions were combined giving a final volume of 150 l final 
3C library.  When making 3C libraries for further use in 5C, 20 μl TE buffer was added to 
each pellet which were later combined to give 100 μl final 3C library.  1 μl final 3C libraries 
were run on 0.6 % agarose gels as a quality control check.  Final libraries produced a high 
molecular weight band showing that all digested HindIII fragments had been successfully re-
ligated and purified. 
Buffer Component 
Lysis Buffer 10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 0.2 
% (vol/vol) Igepal and 1× EDTA free 
protease inhibitor solution 
Table 2.6 - Components used to make the lysis buffer used in the 3C protocol. 
2.5.2 Preparation of 4C libraries 
Before 3C libraries were digested with a second restriction enzyme, their quantity was assessed 
by gel densitometry.  Increasing concentrations of genomic DNA were run on a 0.6 % gel 
along with 1 μl 3C library.  Using imageJ software (http://imagej.net/Welcome) the intensity 
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of each band was determined and then plotted on a graph of intensity vs DNA concentration.  
The intensity of the 3C library band then allowed an approximate concentration of the 3C 
library to be established.  As described in the Stoler protocol (Stadhouders et al., 2013), around 
25 μg 3C library was digested with the 4-cutter restriction enzyme MluCI (using 1 U per μg 
DNA) overnight at 37 °C where the concentration of 3C library was 100 ng/μl.  After digestion, 
the DNA was purified by a phenol: chloroform extraction and ethanol precipitation.  In brief, 
an identical volume of phenol:chloroform:isoamyl alcohol (25:24:1) solution was added to the 
digestion reaction, mixed vigorously and spun down at RT for 15 min at 15,800 g.  After the 
phenol layer was discarded, the following solutions were added:  40 mg glycogen; 1/10th total 
reaction volume of 2 M Sodium Acetate (pH 5.6); and 850 μl 100 % ethanol.  The solution 
was mixed thoroughly and added to liquid nitrogen for around 5 s.  Upon removal, tubes were 
centrifuged at 4 °C for 20 min at 15,800 g.  Finally, the supernatant was removed and the pellet 
washed in 70 % ethanol.  This also was centrifuged at 4 °C for 5 min at 15,800 g.  Upon 
removing the supernatant, the pellet was dried for 15 min before 100 μl MilliQ water was 
added and the tubes transferred to a 37 °C water bath for an additional 15 min allowing the 
pellets to re-dissolve.  At this point, 5 μl of sample were removed and run on a 1.5 % agarose 
gel to assess the quality of the second restriction digest.  Successful digests appeared as a 
smear between 0.3 – 1 kb.  Secondary ligations were conducted overnight at 16 °C in a total 
reaction volume of 14 ml.  This consisted of the MlucI digested 3C library, 13400 CEU T4 
DNA ligase (NEB) and 1.4 ml 10 × ligase buffer. 
The remainder of the protocol was conducted exactly as described by the Stoler laboratory 
protocol (Stadhouders et al., 2013) to the point of purifying the 4C library.  In brief, this 
involved an additional phenol/chloroform extraction and ethanol precipitation of the ligated 
sample to eventually produce 150 μl 4C library.  DNA purification was conducted using the 
QIA quick PCR purification kit according to the manufacturer’s protocol 
(https://www.qiagen.com/gb/).  The 4C library was divided into 4 aliquots and 4 columns were 
used to purify each of these samples.  Purified libraries were later recombined to give a total 
volume of 300 μl purified 4C library. 
2.5.3 Amplification of 4C libraries. 
 
4C libraries were amplified using the expand long template PCR system according to the 
manufacturer’s protocol (Roche).  The primers used are provided in Table 2.7 and the PCR 
protocol provided in Table 2.8.  Increasing concentrations of 4C library (25, 50, 100, 200 ng) 
were first amplified and analysed on a 1.5 % agarose gel to determine which starting 
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concentration to use in subsequent PCR reactions. (The aim was to find a starting 
concentration of 4C library which, when amplified, showed a range of products while at the 
same time ensuring that these products were not amplified to the point of saturation).  After 
choosing a starting concentration of 4C library, PCRs were repeated 16 times and the resulting 




HindIII Primer GGGGAACTGATCACAAGA 
MluCI Primer  CATCTTTTTCTTGCAGGTGT 
 
Table 2.7 – Primer sequences used for amplification of 4C libraries. 
 
Stage Temperature (°C) Time (min:sec) No. Cycles 
1 94 2:00 1 
2 94 0:15 34 
 58 1:00  
 68 3:00  
3 68 7:00 1 
4 4 forever 1 
 
Table 2.8 - PCR program used for amplification of 4C libraries 
 
2.5.4 Sequencing of 4C libraries 
 
4C libraries were sequenced by the Human Genetics Unit Technical Services department.  
Libraries were first sheared and sequencing adaptors ligated on.  Sequencing was conducted 





2.5.5 Preparation of 5C libraries 
 
2.5.5.1 Titration of amplified 3C libraries  
 
To determine the quantity of 3C library needed to perform 5C reactions, the 3C library was 
serially diluted into 10 separate aliquots and amplified.  In brief, 5 μl 3C library was added to 
5 μl MilliQ water in a 1.5 ml tube and mixed thoroughly.  5 μl of this solution was removed 
and replaced in a second tube already containing 5 μl MilliQ water.  In this way the 3C library 
was first diluted to ½ strength and then to ¼ strength.  This process was repeated until 10 tubes 
containing serially diluted 3C libraries were produced.  4 μl from each tube was removed and 
placed in separate wells of a 96 well plate on ice.  In the meantime, master mix 1 and 2 were 
prepared according to Tables 2.9 and 2.10.  Dilutions of primers and salmon testis DNA (STD) 
were conducted prior to this and left on ice for 10 min before use.  8.2 μl master mix 1 followed 
by 10.8 μl master mix 2 were added to the appropriate position in the plate.  Lastly 2 μl of the 
second primer were added.  PCR was conducted as Table 2.11.  The PCR programme was first 
started and paused at the first step thereby maintaining the block at 94 °C before the plate was 
added.  The program was resumed when the plate was added.   All steps in this procedure were 
conducted on ice with all reagents kept as cold as possible.  This helped reduce the amount of 
primer dimers in reactions containing sufficient amounts of 3C library.  Upon completion of 
the PCR the products were analysed on a 1.5 % agarose gel.  Well-made 3C libraries showed 
a product size of around 150 bp which decreased in intensity as the dilution factor increased.  
This correlated with an increase in primer dimer.  The sequence of primers used in this PCR 
are given in Table 2.12. 
Using ImageJ software (http://imagej.net/Welcome) the relative intensities of the 3C products 
could be determined allowing a graph of intensity vs volume of sample added (μl)  to be 
plotted.  This graph should appear as a straight line showing a direct correlation between 
intensity and volume of sample which curves off at higher sample volumes.  The amount of 






Master Mix 1 Volume (μl) 
10 × HIFI 2.5 
50 mM Mg2SO4 2 
25 mM dNTPs 0.2 
0.1 mg/ml STD 1.5 
5 μM primer 1 2 
Total 8.2 
 
Table 2.9 – Volume of reagents needed for master mix 1 in the titration of amplified 3C 
libraries protocol. 
 
Master Mix 2 Volume (μl) 
MilliQ Water 10.6 
Taq DNA Polymerase (5000 U/ml) 0.2 
Total 10.8 
 












Stage Temperature (°C) Time (min:sec) No. Cycles 
1 94 5:00 1 
2 94 0:30 35 
 65 0:30  
 72 1:00  
3 94 1:00 1 
 65 0:45  
 72 8:00  
4 4 forever 1 
 
Table 2.11 – PCR program used in the titration of amplified 3C libraries protocol. 
 
Primer Sequence 
USP 14 CAGTGTGCCTCCAAACACCAAACTAACAACC 
USP 15 CAAAGAACAAAGCAACCGCTGGACATAGTGG 
 
Table 2.12 – Sequence of primers used to amplify products in the titration of amplified 3C 
libraries protocol. 
 
2.5.5.2 Annealing Reaction  
 
Prior to setting up the annealing reaction 5C primers (at 20 μM starting concentration) stored 
at -20°C were thawed at 4 °C.  In the meantime, 96.4 μl MilliQ water was added to each 
position in five 96 well plates which were kept on ice at all times.  Once thawed, the primer 
tubes were kept on ice, with 3.6 μl of each primer added to separate positions in the 96 well 
plates.  This was repeated until all primers were diluted in individual wells (each primer was 
now at a concentration of 0.73 μM).   
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 Next, 4 μl of each primer dilution was added to a single 1.5 ml tube on ice giving a final 
volume of 1460 μl.  At this stage, each primer has a concentration of 0.002 μM.  2 control 
reactions are typically performed with each 5C sample.  The first control is a “no ligase” 
control where Taq ligase is not added after the annealing step.  The second control is the “no 
template” control where 3C library is not added to the annealing master mix.  The annealing 
master mix was made up as detailed in Table 2.13 with final volumes also incorporating the 
two control reactions.  The annealing reaction was set up as detailed in Table 2.14.  The volume 
of 3C library used in this reaction was decided from the graph of amplified 3C product 
intensity vs volume (Chapter 2.5.4.1).  The starting concentration of STD used in this reaction 
was 1 mg/ml.  For all cell lines and E11.5 limb cells used in this investigation the annealing 
reaction was conducted at 55 °C overnight.  This was conducted on a PCR machine which had 
been set at 55 °C and paused.  The primer plate could therefore be added to the machine and 
the annealing reaction started as quickly as possible.  
A list of the 5C primers primers is provided in Table 2.15. 
 
Annealing Master Mix Volume (μl) 
5C Primers 1.7 
NEB Buffer 4 1 
 
Table 2.13 – Volume of reagents needed for annealing master mix. 
 
 DNA (μl) STD (μl) Annealing 
Master Mix (μl) 
5C reaction 5.86 1.44 2.7 
No ligase Control 5.86 1.44 2.7 
No template control 0.00 1.44 2.7 
 















28319935 28324734 5 Forward AGCATAGAGTGTGTGTAGGTGCTGCCTAAG 
28331586 28333893 8 Forward GGTAAGAGTCCCAAAGAACAGCTTGTTAAG 
28336650 28340960 10 Forward AACACCTCTAGCATGATAGCACTTTGCAAG 
28344676 28347365 12 Forward CAAAACCCTAGAAGCCACAGGGACCAAG 
28355883 28370234 18 Forward GGAGACCCACACTAAGGGCCTCAAG 
28373717 28374948 20 Forward TGTGTTTTAGGGATGAGGGATTCTTTAAAG 
28388373 28403099 27 Forward TTTGATAGTGCTGTTTCCTGTGGCTAGAAG 
28419609 28428926 31 Forward TTCTAAATATAATCCAGAGAGAAGGCTAAG 
28452395 28454456 34 Forward CAATAAAGGTAGAACTTGGGCCCAGTGAAG 
28463308 28463573 38 Forward ATGGGGCCGGATTTAACTCAACAATCAAAG 
28469869 28470959 42 Forward AAAAATAAAAAGGAGGCCTGGATTCTGAAG 
28484053 28486216 45 Forward AAAATCTCCCTGGAGTCAAAGGGTTAAAAG 
28491940 28496579 47 Forward CCACCCCCAGTATCTGCAACCTCAAG 
28506236 28509301 50 Forward GCAAGAGCCCACCAGGGTCAAG 
28511000 28511814 53 Forward GTGATGTCTCCCCTGTGAGCAGGAAG 
28514357 28515715 57 Forward TTCTCATGTCAAGATCCACATAATATCAAG 
28528248 28532168 59 Forward TTACATATCAGCTGCTGTATCCATCACAAG 
28537154 28541461 62 Forward CACAGGGCTCTTTCATAGCCTAAGAACAAG 
28542833 28543234 64 Forward CACAGTCACCCCCTGTACCCCAAAG 
28547549 28547729 68 Forward GGTACTTCTACAGTGGGGGAGGATGTAAAG 
28559901 28566954 73 Forward TCTATGTATAAGCCACACCAAGGAAAGAAG 
28570464 28571000 75 Forward TGGCAAATCAGAAAAACTCTTTGGATTAAG 
28572085 28576299 77 Forward GAGTTCAAGAGCCCCCAAATCCCTCTAAG 
28577016 28580658 79 Forward GGAGGCAGAGCCTCTGAGTCACAAG 
28581219 28585322 81 Forward CTCCAGACTGAGACCTTCCTGAGACCAAAG 
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28593412 28595934 84 Forward GGAAAGGTACTCTGGGGTGCATCACAAAG 
28611343 28619284 90 Forward GACCTGACACCTTTGGGATGAAAGTGTAAG 
28620320 28627997 93 Forward ATTGGCTATGTAGATGAAGATGGTCCCAAG 
28631581 28635856 95 Forward CGTGTTACAGTTAGCTACACCCTCAAAAAG 
28638809 28643392 97 Forward GTAGCGTTCGCGCGCCTCAAG 
28646447 28647705 99 Forward TAGCATAGGGGTTATGGATGGACTCAAAAG 
28650693 28651422 101 Forward TGAGTTTTCAGTAACCACTATAAAAAGAAG 
28652424 28656081 103 Forward GCTGATTCCTTTGCTGACTGGAGTGTGAAG 
28668895 28669869 107 Forward GTCTTCTTATCCCTGGGTAAATTGTTAAAG 
28681874 28682959 111 Forward CAGCATGGCTGTGAGGGAAAGTAGCTAAG 
28685148 28687114 114 Forward CAATTTCAGTGCCAGCCTCTCTCGGTAAG 
28689808 28693301 117 Forward CCTGTTTGCACTGTGTCTTCTCACAGGAAG 
28698429 28705774 119 Forward AAAAGAAAAAGAATCACCATGACTCTTAAG 
28710086 28710865 121 Forward CATGGTAACATCGTGTGTAGATAGAAAAAG 
28715945 28717043 123 Forward AACTTTGTGGCACCTTTCTCCTCCAGAAAG 
28723250 28724961 128 Forward CCTTCTGTGTGATCATCTGACACATAAAAG 
28731809 28735435 130 Forward GTTGCAGACTGAGGGGCTCCAGAAG 
28738818 28743466 132 Forward ATTTTCTTGTGGCATTATTAGGCAGGTAAG 
28748046 28750565 134 Forward CCTGCAGTCAGGGAACCGAGAGAAG 
28763979 28767078 140 Forward ATATTTGGATGTTCTGTCAGTGGCCTGAAG 
28780564 28782634 144 Forward CCAGAGACCCCTCCATCTGCTCAAAG 
28789547 28793709 147 Forward CATCTGATTGGCCAAGCCGCACAAG 
28799299 28801546 152 Forward TAGAAAAGATGCTGGGAACCTCATTCTAAG 
28805808 28806894 155 Forward GTGGAGCCATCATGGAAATTGCATGGAAG 
28837190 28843289 162 Forward AGAACCACAGGATACCCATAAGAGCCAAAG 
28870608 28876511 168 Forward ATATCTACACCAGCTTTCTAAAATGGAAAG 
28878135 28878784 170 Forward CTGTGATCTGAAGGTGTAAGCTGAGATAAG 
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28879305 28880400 173 Forward GGTGTGCAGCCAGTGTGCATATTAGACAAG 
28882358 28883821 176 Forward GGCTGCAAAAGTTGGGTCTCATTTGTGAAG 
28884804 28887360 178 Forward CTTGGGTAAAGCTATACTGGATGCGGCAAG 
28889233 28895175 180 Forward TTACCTAGGTAACTGCTGCCCTTTCAGAAG 
28923745 28923931 191 Forward TTGTTATTCCTGGGAGACTTAATTGGCAAG 
28942022 28945936 197 Forward CCACAACCTGCCCCTACGGTGTAAAG 
28949570 28950647 199 Forward GGTATGGGATATCCTTTGGGGTTCACTAAG 
28951389 28952477 201 Forward CTTCACTCCCTCAGTTACCAAGCCACAAAG 
28954090 28954407 204 Forward CAGGATGCCTTAGGAGACACGAGGAAG 
28997868 29000514 212 Forward CAGGCACCTAAGTGTTAGAGAAGTTGGAAG 
29003766 29004021 214 Forward TACAAGTCTCATCTGAGCCCTCCAAAAAAG 
29005071 29006498 216 Forward GATGGGTCTTTCAGAGTCTGTTCCCTGAAG 
29008670 29011994 218 Forward TGTTCACCAAAATTTATTCTAAAAGGCAAG 
29013867 29014066 220 Forward CAAGATTACCCTGAAGTGCCGGTACAGAAG 
29020058 29022523 222 Forward GCTCTGTGTGTCCTTCAGCTCTCTGAAG 
29028121 29029629 224 Forward AGCAGGCTTCCTCCTAGGATTATAATGAAG 
29032469 29038542 226 Forward CTGAGTCTCAAGCAGCTAGCTTTCAGAAAG 
29048476 29050003 230 Forward CTTCCCAGGCTTTGAAGGGAACACACTAAG 
29051240 29058423 232 Forward GGTCCACTGGCAGCCCAAGAAG 
29060962 29068732 234 Forward AGTGTTTAGGGTTCTAAGGACATGGCAAAG 
29081208 29082327 238 Forward AGTTTCCTTGAAAATCATGGCCCAGCAAAG 
29084039 29096781 241 Forward TCACACACCTGGCAGCTGGACAAG 
29100884 29101246 243 Forward AAGATAAAAACCTTCCATCTTAGAACAAAG 
29109460 29111881 245 Forward TAGGAAAAGGGACTTAATTTGTCATCAAAG 
29113253 29117196 247 Forward CGTATAGACTTAAATGAATTAGAACAAAAG 
29130489 29131877 251 Forward AGAAGGATTGTTTTATTCCTGTCCTTAAAG 
29137043 29154044 254 Forward GTTTTTTTCTGGCACAAGCTACCACTTAAG 
 90 
29155708 29159386 256 Forward TTTATTCTAACACTTATCCCATCCTGCAAG 
29160129 29166826 259 Forward CTATATTTATTTAAAGTACAAAAACCTAAG 
29168467 29173627 261 Forward GCACCGAGACCAGCTTCTGAGATCAAG 
29173866 29174415 263 Forward CATTAAACTGTGTTGAACCTATTTATTAAG 
29179396 29180591 265 Forward TGGCACCTCAAATTGAGACCTTGCTTTAAG 
29184580 29185047 267 Forward AGTGTTTCTATTTTTATGCTGAGTCCCAAG 
29185853 29188276 269 Forward TGAGAACAGTATTTTACTTAATTTGAGAAG 
29191727 29196352 272 Forward TTGAAAGCTGATTTCAAACAATGATTAAAG 
29199537 29203806 275 Forward AGCTATCATTTGGTTAAAAACTGTTAGAAG 
29206157 29209241 278 Forward GGCACATGCTGGGTCCCAGATAAG 
29216469 29220327 280 Forward CATGGGAGGTGTCAAACGGATTGGTGAAG 
29230618 29233018 283 Forward GCCACAGTCTGGAAGCACAGATCCAAG 
29236381 29237108 285 Forward CCAGGGTCATCTATGTGCATGCTCACAAG 
29240128 29243266 288 Forward TGTCATCCCTTGTTCTAGTTTGACTCTAAG 
29246729 29247568 290 Forward GCGTAGTAAACACGGGGGTTATAAGCTAAG 
29250430 29250736 292 Forward GGGAGCAATTCTTAAGAGTGCTTTTCTAAG 
29259187 29262463 296 Forward CTAGGTTTCTTGGGGAGAAGGGCTATGAAG 
29264722 29268159 298 Forward GGAGCAGCCAGTAGCCCCAGAAG 
29268268 29270862 300 Forward TGATGCTATCTCTCTTCAAAGGAGGAGAAG 
29277402 29281527 303 Forward TGGTAAGAAAATGAAATGTAAGGTACGAAG 
29292944 29296257 309 Forward GATGGATCTGGAAGGAGGGACACCAAAAG 
29309648 29310307 314 Forward CCAGCCTGTGATGACAGGTGGTAGAAG 
29310490 29311401 316 Forward ACCTTTCCTCTTCCTAACTGCCATGCAAAG 
29317749 29319160 319 Forward GCCCCTGAAGATATAGCACAGTCTTGCAAG 
29319273 29320195 321 Forward TCAAACCATACAGCTGAATATGGAGAGAAG 
29331158 29332122 325 Forward CACAGCTCCTGCACATCTGGGGAAG 
29347104 29352141 327 Forward CCATTTAAGGCCTGCCCAGCTCAAG 
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29356572 29358986 330 Forward AGATCTGTGCAACTTTCTTCAAGCCACAAG 
29384407 29389154 342 Forward TCACCACATGTTGAACTCTGGATGGGAAAG 
29402955 29404268 346 Forward TTTGGTTTGGTTTTCTGGGTTGAGGGGAAG 
29407972 29411033 350 Forward AGCCTCCAGCTAAATGCCAACAAATGAAAG 
29411528 29412802 353 Forward CAAATACAAAAAATCTGCCAAACAACAAAG 
29413668 29419014 355 Forward CCCTCTTCTCTTTCAAAGATGGAAAGTAAG 
29426352 29436153 361 Forward TTACTTATTTGTGACATGGTATCTAAAAAG 
29457358 29463943 367 Forward GACCACATCCTGTCTAAACCCTGCCAAG 
29471071 29483618 371 Forward CTGGCTGTCCTTTGCCACCAAACAAAG 
29486277 29487932 373 Forward GTTCTTTCAGTGATAGATGAGAAGTGTAAG 
29495457 29497960 376 Forward TCAAGGAAGGCTACAAGAGGAGAGGCAAG 
29514013 29518402 379 Forward GGATATTGTCTCCAATGGTTATGTTAAAAG 
29521325 29521533 383 Forward GTTGGCCTGCTATTAATCTGCTTCTACAAG 
29527531 29527778 386 Forward GTAGGCTTGAGCACTTACCAGCAGTGAAAG 
29530052 29530237 388 Forward CAGCTGAGAAGACCCAGCACAAATCCAAG 
29534954 29536943 391 Forward AGAGCCACAGTGAACAATGTCTCTAGCAAG 
29539102 29543893 394 Forward CTAAAGGTCTTCTTGAGAGGAGCACTGAAG 
29555730 29559300 399 Forward CAGGCTTCTGCCTGCAGAACCAAG 
29560665 29560851 402 Forward GGAGTAAATGCTACATGACTGCCTGGGAAG 
29561929 29563972 404 Forward TAGTTATCCCGTGAGAAAGGTACACTCAAG 
29570405 29571012 408 Forward GACCTGACACTGTTGATGACATTAACAAAG 
29574786 29577091 410 Forward CCTCACAACTTCTTTGTAGCAAGTGATAAG 
29577562 29579620 412 Forward ATTATTTTAATGTAGTTAGTAATTTGAAAG 
29582839 29584474 415 Forward TATATATACTTATGAACATGTTTGTAAAAG 
29585001 29590052 418 Forward AGCAAAAGCATTAAGTGTAGCAGTGGAAAG 
29595576 29595777 421 Forward TACCCTTATCAGAATGAAGTGTGCACAAAG 
29607876 29613408 426 Forward CTATGGATGTTAACCAATAAGCTACAGAAG 
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29626315 29628597 431 Forward ACATCCATAAGATTATTTCCGATGATCAAG 
29632212 29635239 435 Forward TGCTCTACCATGCGTGAAGGTGATATAAAG 
29637006 29638519 437 Forward ATAAATCTAACAAACTAAAAATCAGTCAAG 
29640676 29641133 439 Forward CTCATTTCATTTACCTCACTCCTTTAGAAG 
29642804 29649071 441 Forward CATACAAAAGCCAGTTTTCTCAATGTGAAG 
29656939 29658283 447 Forward TTCACATGTAACAAAGCCAAATTTATGAAG 
29701562 29703903 457 Forward GAGCCACTGCAGGGCTGGAAG 
29705291 29706210 459 Forward ACATTTCTGTTGCAGGGCTATTCATGGAAG 
29709706 29713030 461 Forward GGTAACAAGAATAGCATTGAAAATTCTAAG 
29716182 29720154 464 Forward CACCAGCCACCATCAACTACACAAAGAAG 
29727115 29730837 466 Forward CTGAATTTAGGTGTATGTTTACTCAGTAAG 
29750154 29752052 470 Forward CATAATAAAACTGAAAGGAGATGACCCAAG 
29757662 29764922 474 Forward TAGTACTTTAGCTAATGGCATTCACTGAAG 
29768741 29769326 477 Forward TGAAATGTCCCACAAAGGATTATCAGGAAG 
29770691 29772235 479 Forward GGTGAGCTAGTCAGAGCAGTGCTGAAAAG 
29777534 29781541 482 Forward TGGCCATTTTATATCTACTTAGGAGAAAAG 
29782721 29784642 484 Forward GACCCCAAGGCACCCAACTTCAAG 
29786563 29787575 487 Forward TTCTGAGCTCCTGTTTTCCCTCAGAGTAAG 
29797223 29805362 489 Forward GGTTGGAGAGTTTGGAGGCTGAACACAAG 
29806189 29807449 491 Forward GTTTGTTGTGTAGGGGATGTGATCCAAAAG 
29809880 29815593 493 Forward ATTTGCCACTCAAAATCTGCACTTTCCAAG 
29816517 29820938 495 Forward GGAGGGGGGAGGTGGGAACAAG 
29835164 29835981 497 Forward AAGACTCAGTTATACCAATGGTTCAATAAG 
29836157 29838218 499 Forward GGTGCAGGGAAAGTTGATAAGGGCAAAG 
29845799 29846398 505 Forward TTCAGCTTTGTCTTGGTGTGTGGACTAAAG 
29848888 29849213 507 Forward GTACTGAGCCTAGCAGAGGAAGCTCAAG 
29854912 29855302 511 Forward AGTGACCTAGATCTTCCCCTACACTTTAAG 
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29859545 29863829 513 Forward CATCATCTGTGCCATTTCTTAGCCCCAAAG 
29870040 29874795 517 Forward CTCTGAAACATGCAACCACACAGGCAAAG 
29896489 29896823 521 Forward TTTTTTTTCCCATTAGGCGAAATTTTAAAG 
29897293 29900118 523 Forward TAAAACTTGCAGCAACTTTCCTGTGTTAAG 
29902876 29906098 525 Forward AATATGGTTTCCTTATGATGTAGCTTTAAG 
29907125 29909799 527 Forward TTGTGATCAAATTTACATGTCTAAGCTAAG 
29913291 29913607 530 Forward TTCCTTTAGCTTTATATATTGATGGAGAAG 
29918393 29927218 533 Forward AGATCTCTCTACTTGTTGATTAATAGCAAG 
29938026 29947212 536 Forward AAGTTAATTGAATGAAAATGATCAACTAAG 
29949610 29953599 538 Forward CATGTGTTGTAGAGGCTGGGAACCACAAG 
29958999 29960405 540 Forward CATGTGGGTTAACAGTGAGTTAAGCCCAAG 
29963243 29963692 543 Forward TAGACATGTGAATTTTATTCTTGGAGGAAG 
29967853 29970155 546 Forward GATTTTTTTTTCCTAGGGGTTTATTTCAAG 
29977865 29978715 548 Forward AAGGAAAAAAAAAGAATAAGGTTTCAGAAG 
29979320 29988808 550 Forward TGTACAGTATAAGCACCCCTATAGCCAAAG 
29996460 30001398 554 Forward GCAACTCAGTGAAATTAACCAAAGATGAAG 
60918191 60924238 2 Forward GGGAGGAAGATAAAAAGATGGGGATGGAA
G 
60932406 60937638 5 Forward CTGTCAGTCTCCTGCTGCCACTAACAAG 
60949684 60966226 9 Forward GTGTCAAGGAGGCAGACCTTCAGGAAG 
60970542 60976197 11 Forward AACCCATCTCTAACAATCCCTTTGTAAAAG 
60977797 60977935 14 Forward GCAGGAGTCTAAGCCACCAGGGAAG 
61000572 61003268 17 Forward ACTTTTCCCAAAATCCAAGCTGACTTCAAG 
28317087 28319149 3 Reverse CTTCCAGTATTGGGTTACAGTTAATGGAGT 
28325862 28331585 7 Reverse CTTTCTCTCATCCCTACACTAACCAGGCCT 
28333894 28336649 9 Reverse CTTGACACACCTACCCTCTAAGTAATCAAT 
28340961 28344675 11 Reverse CTTAGGATGTGCCTCTACTGTGGGGG 
28347366 28348911 13 Reverse CTTGCCAGTTTATCTAGGTAGCCTGCCAG 
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28370235 28373716 19 Reverse CTTGGATTGGCGTGGCTCTGAGTCAT 
28385728 28388130 25 Reverse CTTCCTTTCTGGTATCTATTGACCTTCCCT 
28416843 28419608 30 Reverse CTTCTCCTGTAAGATGGCAATTTATTTATT 
28428927 28447705 32 Reverse CTTTGTCATTCCACCATGGTTGTGGTGAAC 
28454457 28458325 35 Reverse CTTGAGCTCACATATGGGACACTCTTGACA 
28469222 28469868 41 Reverse CTTCTCTAGCTAGGCCAGCATAATGTACCG 
28476584 28484052 44 Reverse CTTAGCTCAAAATGTAGGAAATGGCCATTC 
28486217 28491939 46 Reverse CTTGTGAACAGTCCCACCAGGTCACTG 
28504618 28506235 49 Reverse CTTAAGGTGGGGGTGACACAGTCCAAAG 
28509323 28510999 52 Reverse CTTCAGTTTGGGTGACACATGCAGGACAAA 
28511842 28514356 56 Reverse CTTATCCTCTTCTGTGTCTAGTTGAAGTGG 
28515716 28528247 58 Reverse CTTGTTGAGCTCATGTAAATGCCTATGGAT 
28534318 28537153 61 Reverse CTTGAAAAGCACAGATAAAAATGCCATTTG 
28541462 28542832 63 Reverse CTTCCTTGGGCAAGTGGTATCTTCCTTAGC 
28543235 28543365 65 Reverse CTTTGACAAAGTGATGCATCTAAGATCCTA 
28547730 28548357 69 Reverse CTTCTCATATGACTCTGGTTTCTTGGCCCA 
28566955 28570463 74 Reverse CTTAGCATGGGACTCAGAAAACAAAATAGG 
28571001 28572084 76 Reverse CTTGAAATTGAAGTATCTCTCTCAGCACCT 
28576300 28577015 78 Reverse CTTCCAGAAGATCTGCAGCAACTCTCTCTC 
28580659 28581218 80 Reverse CTTGAAGCATGTGTGGACTCCCATTCTTCT 
28585390 28593411 83 Reverse CTTGCGGTTGTAGCTAAGAGTGAATTTGAA 
28604862 28605362 86 Reverse CTTTGGGGTGGGAACAAGGAGACTTCAC 
28619329 28620319 92 Reverse CTTGACAGAGGAGCCTAAAAGGTGACTTAA 
28627998 28631580 94 Reverse CTTTCATTGAGACACTCCCTCAGCCTCAGT 
28635857 28638808 96 Reverse CTTAGCAGTTTCTGTAAAAAATAAAAGTAC 
28643393 28646446 98 Reverse CTTGTGCAGTACTAAATCATAATGCCATAA 
28647706 28650692 100 Reverse CTTTAAAAGGTACAATGATAGAAGAAATAG 
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28651423 28652423 102 Reverse CTTCCTATGGCTGAGAACTGCTTAGATAAT 
28662072 28668894 106 Reverse CTTTTGGTTGTTTCAACCATTTTTCACTTA 
28676542 28681826 109 Reverse CTTCCTCTCTCAGGAAACCAGTCTTCTGAG 
28682960 28684009 112 Reverse CTTCCAACAGTACATTATCCTAAGCGTCTA 
28687115 28688407 115 Reverse CTTACACCAATTAACTTCTTAGAAGTAGAC 
28693302 28698428 118 Reverse CTTAAATCACGAAGTACTGAGGCTTACCAA 
28705775 28710085 120 Reverse CTTATTCACAGGCCATTCTGGTAGGAACAT 
28710866 28715944 122 Reverse CTTATGTGGAGAACTAACACCATCATAAAT 
28717044 28718937 124 Reverse CTTTACCACTGCGGAAGGGGGAAAACA 
28724962 28731808 129 Reverse CTTATACTGGGTGGAGGTCAATTCTGGACT 
28735436 28738817 131 Reverse CTTTAACCTGGCTCTGCTCTCAGAATGAGG 
28743467 28748045 133 Reverse CTTTAATGTTCTGGTTTGTTGTTGTTCTAA 
28759100 28763978 139 Reverse CTTTTATGTGGCTCTGCTTTTGTATTACAA 
28770697 28780563 143 Reverse CTTGTTCCCCGTACCCACATAAAAGGCC 
28782635 28789524 145 Reverse CTTTTCCCTCACCCCATTGAAAGAAGGGAG 
28794058 28797606 149 Reverse CTTACTACCAGTCCTTTGCTCTGTCTAATA 
28798546 28799298 151 Reverse CTTGGCTAACATTGGACAACCCAAGTGTTT 
28805019 28805807 154 Reverse CTTCTGGACACCCAGAAATGTGCGTCTC 
28821671 28827662 158 Reverse CTTCTCCTAAGAACAGCTAGACCTATGCAC 
28843290 28847606 163 Reverse CTTCAAAGCTGCAGTGCTTTGAAGTGTCTG 
28876512 28878134 169 Reverse CTTTATTGCCAGGTCAAATGATTTAAACAT 
28878785 28879286 171 Reverse CTTTGAAGGAGACCCTATTTCCTATGTGGG 
28880401 28880839 174 Reverse CTTTATTCACCTCTGACATGCAAGCCAACA 
28883822 28884803 177 Reverse CTTTGGAAGGCTGGGTGGTCAGC 
28887361 28889232 179 Reverse CTTCCAAAATTCTATTTTGGGAAAAAATGA 
28895176 28899338 181 Reverse CTTCCAGAAACTGTTTACTTCCTTCTGGAG 
28925837 28929215 193 Reverse CTTCCAGGTCACGTTAAAGATATTTCAGTA 
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28945937 28949569 198 Reverse CTTAGAAGGACCCTAGAATGGTCCCCTGAA 
28950648 28951388 200 Reverse CTTTGAATGAGGTCAATAAAAATCTACCTC 
28971638 28978794 207 Reverse CTTTTCAAAAAGCCACATGAAAATCTACTA 
29000515 29003765 213 Reverse CTTATGAGTGCAAGGTCTGCCCAGGTTG 
29004022 29005070 215 Reverse CTTAGTTGTTCCTTCAGTGTCAGTTACTTC 
29006499 29008669 217 Reverse CTTTTATTAAAAGGCCATGGGGCCATGGAG 
29011995 29013866 219 Reverse CTTCTAATGAACCTGCTCCTGACCGCATG 
29014067 29020057 221 Reverse CTTCAGGAGTCTAACTGCAATAATAATGCA 
29022524 29028120 223 Reverse CTTTGCTGTTGGTCAAAGGTAGCAGCTGA 
29029630 29032468 225 Reverse CTTCGGGCCCCGGAGGGAGG 
29038543 29039555 227 Reverse CTTTTGAGAGGTGTGAGACAATCAAAATAA 
29050004 29051239 231 Reverse CTTCAATTTGTGAGCCTCTACAAAACCTCA 
29058424 29060961 233 Reverse CTTCCTTTTCATCTTGAATCAGCCTATAGA 
29078836 29081207 237 Reverse CTTTCTCCCAGTGATGCTGTTAGTTGTTCC 
29082328 29083134 239 Reverse CTTGCAATACTTCCAAGAGAAAGAGAACAC 
29096782 29100883 242 Reverse CTTTCAATTACTGCTCTAGCACAATGCCTG 
29101247 29109459 244 Reverse CTTGAAAAGAGGAATATTCGGGAATGGAGG 
29111882 29113252 246 Reverse CTTAGATCTGGTGGTAGAAGGGATACTGGA 
29117197 29119739 248 Reverse CTTTGCTGTCTGCTCAGAGGAGAACTCTGT 
29131878 29136802 252 Reverse CTTAGGCCATGAAGGAAGATGGCTTTGACA 
29154045 29155707 255 Reverse CTTCCAATGATCCTCTCTGCTCCAATGAAA 
29159409 29160128 258 Reverse CTTGGGGACCATTTAAAATATGTTCTAGAT 
29166827 29168466 260 Reverse CTTGCCATGTAAGATGGGATATCTGGCCAG 
29173628 29173865 262 Reverse CTTATTTATCAAGTACAGTTGCTCAAGTAT 
29174416 29179395 264 Reverse CTTGCAGCTCCAGACATTTACCCATCTCTG 
29180592 29184579 266 Reverse CTTCCTCCTTACCCCGGCTGCTAATC 
29185048 29185852 268 Reverse CTTTGATATTACAGTGATGAATTGATATGT 
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29188338 29191726 271 Reverse CTTAGACTTCCTTTTAGAACATTCTTGGTT 
29198345 29199536 274 Reverse CTTATCAACAACACCTGCATTTTAAAAGAC 
29203807 29203920 276 Reverse CTTCATGCTGGCAGACAAAGTAAATTCGGG 
29209242 29216468 279 Reverse CTTCCTTGTAAATATCTGGAATAGAAAGAG 
29220328 29223230 281 Reverse CTTGGAGATTTCCAGGTCTGCTTCTACATT 
29233019 29236380 284 Reverse CTTCCATCAGATCTGTGTTGTCCAAGAATC 
29237129 29240127 287 Reverse CTTGCTAACACCGTTTGAGGTGGAGATGC 
29243267 29246728 289 Reverse CTTCTCCTGGTCATCATCTGGCCAGTATCA 
29247569 29250429 291 Reverse CTTGGCTACACTGCATTTCCTTGTATTATA 
29253038 29259186 295 Reverse CTTTGAAGATTTCCAAGAGTTCAAACCCAG 
29262464 29264721 297 Reverse CTTGAAAAGTGAAGAGATATCCTACAGAAT 
29268160 29268267 299 Reverse CTTGCTTTGCCATTGGACCCTTGTCAG 
29270863 29272035 301 Reverse CTTTAAAGCAACAATATGATATGCATCATC 
29281528 29287941 304 Reverse CTTCCATCTTTTTTCATTTAGAAGCACCAG 
29305044 29309647 313 Reverse CTTTAAATTCCTGCTTGTAAAAATTGTTTT 
29311402 29315522 317 Reverse CTTGACCTCAGTATTCTGTACTCACTCCCC 
29319161 29319272 320 Reverse CTTGCACGTCTCCATTCATCTTGACTAAAG 
29321894 29331157 324 Reverse CTTAAATCTAATAAGATGAAGGAAAATAAC 
29332123 29347103 326 Reverse CTTCCAACACCAAATGTGGTTCAATTACGC 
29358987 29363174 331 Reverse CTTGGATGCCTTTGATCCCCTTATAACTTA 
29401642 29402954 345 Reverse CTTCTACGTAGTAGATTTTTATATGGAATT 
29406181 29407971 349 Reverse CTTCCCTCCTGGGAATGCTGTGTGG 
29411034 29411488 351 Reverse CTTAGGATAGGAAGGAATTAGTGATACAGT 
29412803 29413667 354 Reverse CTTGGAAACTGCACCATGGAACTCTCACTT 
29425367 29425485 359 Reverse CTTTCTTGAGAAGGAGTTTTCATTCTAGTA 
29436154 29438524 362 Reverse CTTCAGGGGAGTGAAAGAATTAAGATTTCT 
29454397 29457357 366 Reverse CTTGCCCCCACAGGGCAGGC 
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29466664 29471070 370 Reverse CTTTGGTATGAGGTAATAAAAATAATTGAA 
29483619 29486276 372 Reverse CTTCGTGGTTGTATGCCTGTAATTGTGTTT 
29492359 29495456 375 Reverse CTTTCAAGGTTGCAGGTTACAAAATTATTA 
29508039 29514012 378 Reverse CTTTGTGAGGACGTGAGTCCGGCTG 
29519437 29521324 382 Reverse CTTTTGGATGCCATTAGCTAGACCTGAGTT 
29527218 29527530 385 Reverse CTTAACTTACTTCACTAGATTTACTTCTGG 
29527779 29530051 387 Reverse CTTTCTACAAACTGGGAAAACCAGCCTTTG 
29531243 29534953 390 Reverse CTTATGAAGTTTTTCAGTTAAAAGTCACAT 
29537971 29539101 393 Reverse CTTTTACTGGTTTAATATCCTTCCAGGCTT 
29543894 29545876 395 Reverse CTTTACTTTCTGTCACCTTAAAGGTGAAAA 
29559301 29560638 400 Reverse CTTCTCCTAGCACCAACCTTATGATCCTGG 
29560852 29561928 403 Reverse CTTGGTCTTTAATGTAGGCATGATGGGGTA 
29563973 29566252 405 Reverse CTTGGCAGTTTGATTAATGCATGCTTAAGC 
29567141 29570404 407 Reverse CTTGGGTACCAGTTGCATAAGCGTGG 
29571013 29574785 409 Reverse CTTCCCAACCAAGGTGGGTGGG 
29577092 29577561 411 Reverse CTTGCGAACAGAATAAAGGACGCATTTACC 
29582421 29582838 414 Reverse CTTAGCTTCCATTTGTTGGGAAGAGTGGTG 
29584537 29585000 417 Reverse CTTACTTCAGAATTAGGAAAACACAAAGCA 
29590053 29595530 419 Reverse CTTTCCATTCTGAGTCTAGTGACTTAAAGG 
29606038 29607875 425 Reverse CTTGTCACTGCCCATTACCTGACTGTGC 
29622314 29623626 429 Reverse CTTCTTATTGGAAAAATTGAAATTTTTCCT 
29628598 29629851 432 Reverse CTTCATATCTAACATTTGACTCATTGAGAG 
29635240 29637005 436 Reverse CTTAGAACATTAGGAATCATCACTAACTCT 
29638520 29640675 438 Reverse CTTGCTGCCCTCACCTGTGTTGGTAA 
29641134 29642803 440 Reverse CTTGCTTTTGTTGTAGGGATTTTACTTCCT 
29652798 29652907 444 Reverse CTTGCCACAGCCTAGTTTGAGCCTTAGG 
29677935 29691941 453 Reverse CTTGAGTGAGGCTTTATTTTTAGCATTTGG 
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29703904 29705290 458 Reverse CTTCAATAAACAAGTGAGGGCGGGTGCA 
29706211 29709705 460 Reverse CTTAGAATACTTAGTACTTGGTTTACACCT 
29713093 29716181 463 Reverse CTTGGCACTCTTTCAGGAAAGAAAGGACAG 
29720155 29727114 465 Reverse CTTTGGTGTGTAGTACTTTGGAGTGATAAG 
29741658 29748329 468 Reverse CTTTGGGGATCCTCTGTAAGTGGTTGCTC 
29755324 29755456 472 Reverse CTTTCTCAATTGATTCTGAAAGGGAAAATG 
29766525 29768740 476 Reverse CTTCCTCGTTCCAGATGGGGTCTGG 
29769327 29770690 478 Reverse CTTGAGGTTTTCATATCAACAAGGCTCAGT 
29774284 29777533 481 Reverse CTTGTCTTTGAGAGCCCGGTGCCT 
29781542 29782720 483 Reverse CTTTTTCCAAGTCAGGTTAGTAAAAGCAGA 
29787576 29797222 488 Reverse CTTATACCTTTATGACCCATAATGCACAGA 
29805363 29806188 490 Reverse CTTGATTTCTCAAACTACTTATTGATTCGT 
29807450 29809879 492 Reverse CTTTCTAAAAAGGGAGGAAGGAAATCCAAG 
29815594 29816516 494 Reverse CTTCCCTGCTGTAGGGGAGAGCG 
29820939 29835163 496 Reverse CTTGATGAAGATCTTGGCATGGCAATGCAC 
29835982 29836156 498 Reverse CTTCTTTGCGGAATTCCTAGGACGCTAATG 
29838219 29839237 500 Reverse CTTGCCGCCAGGAAGCTAATTCCTC 
29844732 29845798 504 Reverse CTTTCAGAAATGGAAGACTTTTTTAATTCT 
29846399 29848887 506 Reverse CTTGAATGAGGAAACATAGGCTGAGAGGCC 
29849214 29850560 508 Reverse CTTTCTACAGCCATGCCATTTACAGAAGCC 
29851352 29854911 510 Reverse CTTCTACCTGCTAACAAACTTTCTCCTGTC 
29855303 29859544 512 Reverse CTTGCGCCTTTCCAGCAGTCTTGAAACATA 
29863830 29864649 514 Reverse CTTATCCACCATGGCCCCAAGATTATCTTT 
29874796 29884457 518 Reverse CTTAACCAAGTAACACTACCAACTGGAGAC 
29896824 29897292 522 Reverse CTTCATCTGACCTCGTTTGCACGAAGCTC 
29906099 29907124 526 Reverse CTTCCAAGTTTCTGAAGCATCCTCACCAGA 
29911938 29913290 529 Reverse CTTTTGACTAGTGGACTTTATCTGCTCTCA 
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29913932 29918392 532 Reverse CTTCAGTTATACAAAGTTCTTTCATGCCCC 
29931042 29938025 535 Reverse CTTAGGTATAAAAGAAAATCTTTAAATACC 
29947213 29949609 537 Reverse CTTTCTGACCAAAGTTGACAACAGCACTAT 
29953600 29958998 539 Reverse CTTTTGTTTATGGTCTGGAATGTACCCATT 
29960412 29963242 542 Reverse CTTCAGCCCCTTGCCTTGATGCC 
29963693 29963925 544 Reverse CTTTGAAAGACCCATGTCATAGTACGTGTT 
29970156 29977864 547 Reverse CTTAGGCTCAAAGATGACTGCAGAGGAGAG 
29978716 29979319 549 Reverse CTTGCAAGCTAGCTAGCCCAAGGGATAC 
29988809 29991479 551 Reverse CTTTCAATTTTTCCACATCCTGCCCAACAC 
29995277 29996459 553 Reverse CTTTCCAGTATTGCTGGAGCTGTAGTCCGA 
30001399 30005000 555 Reverse CTTTCCAGGCATAAAGCAGAGACAGGCAAA 
60917307 60918190 1 Reverse CTTTGAGACTAGACCGAAGTCTCCAGAATC 
60937639 60942991 6 Reverse CTTGAGGAGACAGCACTGCTGGTAGATAG 
60966227 60970541 10 Reverse CTTACTGTGGGCTACCCATTTGTACTCTTA 
60976198 60977387 12 Reverse CTTTTATTTATAAGAGATCTTAGCTAATGA 
60981479 61000571 16 Reverse CTTTTTTCCAAATAGTAACCCACAGGGCCA 
 
Table 2.15 – List of 5C primers 
 
2.5.5.3 Ligation Reaction 
 
The following day, the ligation buffer master mix was made up as detailed in Table 2.16.  Due 
to the NADH content, the Taq DNA ligase × 10 buffer was kept at -80 °C and thawed at 65 
°C for 10 min prior to use.  The addition of the ligation buffer master mix to the annealing 
reaction was conducted by opening the lid of the PCR machine and adding the solution directly 
to the wells of the PCR plate while still at 55 °C.  Once the solution was added, the lid was 
closed and the ligation reaction left for a further hour.  Finally, after this incubation the plate 




Ligation Buffer Master Mix Volume (μl) 
Taq DNA ligase  0.25 
Taq DNA ligase × 10 buffer 2.5 
MilliQ Water 17.25 
 
Table 2.16 - Volume of reagents needed for ligation buffer master mix 
 
2.5.5.4 5C library amplification 
 
The 5C library was amplified using two separate master mixes as detailed in Tables 2.17 and 
2.18.  Each PCR was performed in a 96 well plate by first adding 5.7 μl master mix 1 followed 
by 16.3 μl master mix 2 and lastly 3 μl 5C library per reaction.  The PCR amplification program 
is detailed in Table 2.19.    PCR was conducted using either 26 or 28 cycles in stage 2 and 
comparing the results.  The resulting products were analysed by agarose gel electrophoresis 
using a 2.5 % gel.  The amplified product appeared as a single band at approximately 120 bp.  
Typically, no bands were present in the “no template” control while sometimes a faint smear 
could be seen in the “no ligase” control appearing below the expected molecular weight of the 
product.  If the 5C library produced a band of the correct size the PCR was conducted an 
additional 3 times and the products combined.  The number of cycles chosen for stage 2 in this 
PCR was chosen by observing the agarose gel from the previous PCR and determining the 
number of cycles which produced the most product while keeping primer dimers and other 
non-specific products to a minimum.  Typically, 26 cycles were chosen; however sometimes 
more were necessary (Chapter 5.3.2).  The A and P1 key primers are the sequencing adaptors 






Master Mix 1  Volume (μl) 
10 × HIFI 2.5 
25 mM dNTPs 0.2 
20 μM A key Primer 0.5 
20 μM P1 key Primer 0.5 
50 mM Mg2SO4 2 
 
Table 2.17 - Master Mix 1 used in the 5C library amplification protocol.  
 
Master Mix 2 Volume (μl) 
Taq polymerase 0.2 
MilliQ Water 16.1 
 
Table 2.18 - Master Mix 2 used in the 5C library amplification protocol. 
 
Stage Temperature (°C) Time (min:sec) No. Cycles 
1 95 5:00 1 
2 95 0:30 26/28 
 60 0:30  
 72 0:30  
3 95 0:30 1 
 60 0:30  
 72 8:00  
4 4 forever 1 
 




A KeyPrimer CTGAGTCGGAGACACGCAGGGATGAGATGG 
P1 Key Primer CCTCTCTATGGGCAGTCGGTGAT 
 
Table 2.20 – The sequence of the Ion Torrent adaptors used for amplification of the 5C 
libraries. 
 
2.5.5.5 Purification, Quantification and Sequencing of Amplified 
5C libraries 
Amplified 5C libraries were purified using the MinElute PCR purification kit as described in 
the manufacturer’s protocol (https://www.qiagen.com).  Libraries were eluted in 15 μl Buffer 
EB (10 mM TrisHCl, pH 8.5) and stored at -20 °C until required.  To determine the quantity 
of 5C product, samples were run on the Agilent Bioanalyser using the DNA 1000 kit.  Samples 
were then diluted in MilliQ water to 2600 pmol/L and sent to the in-house sequencing 
department.  Here, samples were sequenced as described by the Bickmore laboratory 
(Williamson et al., 2016).  In brief, they were diluted to 26 pmol/L and run using an Ion 316TM 
Chip on the Ion PGMTM Sequencer.  
 
2.5.6 Analysis of 4C and 5C data 
 
All 4C experiments were analysed by our collaborators in the Semple laboratory using the 
package r3C-seq.  Normalisation procedures are described in (Thongjuea et al., 2013).  In 
summary reads were normalised using a power-law reference distribution to generate reads 
per million (RPM).  In both 4C and 5C experiments significant cis interactions were 
determined data by calculating a Z-score for each interaction (section 5.3.3).  The associated 
p-values and q-values (incorporating false discovery rate) were used to gauge the significance 






Figure 2.1 – Overview of the 5C protocol and quality control experiments.  (A)  The first 
step of the 5C protocol is to create a 3C library.  Cross-linking agents such as formaldehyde 
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are used to join two regions in close physical proximity.  Samples are then digested with a 
restriction enzyme (typically a 6-cutter such as HindIII) followed by a ligation reaction, 
where the closely spaced regions are ligated together.  After reversing the cross-linking, 
PCR can be used to determine if two regions interact.  (B)  On completion of a 3C library, 
5C primers are annealed to the ends of each restriction fragment.  Primers situated next to 
each other are ligated together using the enzyme Taq DNA ligase.  Finally, PCR is conducted 
using primers which anneal to the ends of each 5C primer.  The PCR primers also contain 
sequencing adaptors for Ion Torrent sequencing thereby allowing the amplified 5C product 
to undergo next generation sequencing.  (C)  To examine the quality of the 3C library and 
determine the quantity needed for 5C experiments, the 3C library is amplified using two 
primers which anneal to two regions known to interact.  Several reactions are performed, 
each using a decreasing starting volume of 3C library.  For high quality 3C samples the 
intensity of amplified product (shown as a single band on an agarose gel) should decrease 
linearly with decreasing volume of initial 3C library.  (D)  The intensity of the bands for each 
5C product can then be plotted on a graph vs the initial starting volume of 3C library used 
in each PCR reaction.   The volume of starting 3C library used in the proceeding 5C 
experiments was selected from the linear portion of this graph.  Figure adapted from 


















2.6 Cell Culture Techniques  
 
2.6.1 Immortalised Cell lines 
 
14fp, 88fp and MD cell lines were already in use by the Hill laboratory prior to this 
investigation.  These are all immortalised cells derived from the offspring of an immortamouse 
(H-2KbtsA58) × CD1 cross.  The immortamouse contains a temperature sensitive large tumor 
antigen (permissive at 33 °C) driven by the H-2Kb promoter which is induced upon addition 
of interferon (Jat et al., 1991).  14fp and 88fp cells are derived from the posterior region of an 
E11.5 limb bud, while MD cells are derived from the mandibular regions.  14fp and 88fp cells 
were obtained by members of the Hill laboratory while MD cells were obtained from the 
Jackson laboratory.  For the 14fp and 88fp cell lines, cells were dissected and left for 20 min 
in trypsin (0.2 g/l)/versene solution after which they were transferred to tissue culture plates 
containing DMEM media with the following additions:  interferon gamma (IFNγ); fetal calf 
serum (FCS); and penicillin-streptomycin (P/S).  These were maintained at 33 °C in tissue 
culture incubators. 
2.6.2 Cell Passaging  
 
All immortalised cells were grown no later than passage 18 as beyond this point they grow 
much more quickly - perhaps becoming transformed.  Cells were grown at 33 °C in 3 % O2 
and 5 % CO2 in tissue culture incubators. The culture media used was DMEM which also 
contained: interferon gamma (IFNγ); fetal calf serum (FCS); penicillin-streptomycin (P/S); 
and L-glutamine (referred to as complete DMEM media).  To split the cells, the media was 
first removed from flasks and the cells washed in PBS.  After removal of the PBS wash, a 
small amount of trypsin (0.2 g/l)/versene solution was applied (usually around 1 ml per T75 
flask) and left covering the cells for 15 min at 33 °C.  Cell flasks were then shaken gently 
allowing the cells to be stripped from the base of the flask and into solution.  Complete DMEM 
media was then added to 10 × the volume of trypsin/versene solution.  The total solution was 
then divided into separate flasks with extra complete DMEM solution added as appropriate. 
 
2.6.3 Drug Treatments 
 
In many experiments immortalised cells were treated with either Trichostatin A (TSA) or 
DMSO as a control.  TSA solution was ordered as a powder and re-suspended in DMSO to 1 
mM upon arrival.  Both TSA and DMSO solutions were stored at -20 °C when not in use.  For 
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1 μM TSA treatments stock TSA solution was diluted 1/1000 in complete DMEM media and 
added to the cells. 
 
2.6.4 Mycoplasma Testing 
 
Immortalised cell lines were tested periodically for mycoplasma by the Human Genetics Unit 
Technical Services department using the Lonza-Mycoalert Mycoplasma Detection Kit (LT07).  


























Immunofluorescence was conducted on cells grown on superfrost slides which had been fixed, 
permeabilized and frozen at -80 °C as described in Chapter 2.4.1.  Frozen slides were thawed 
at room temperature and washed in PBS+ blocking solution (1 % BSA/PBS) for 30 min. For 
detection of SHH expression, 0.75 μl of the C-terminal antibody AB86462 was diluted in 50 
μl PBS+ blocking solution, added to a 22 × 50 mm coverslip and left on the slide at 4 °C 
overnight.  The following day, the coverslip was removed and slides washed four times (2 min 
each) in PBS+ blocking solution.  The secondary antibody Alexa Fluor® 488 was diluted 
1:1500 in PBS+ added to a 22 × 50 mm coverslip and left on the slide for 30 min in the dark.  
Upon removal, slides were washed for 2 min in PBS+ blocking solution an additional 4 times.  
Lastly, slides were stained with a 1/1000 dilution of DAPI (stock 50 μg/ml) in PBS for 3 min 
and mounted in vectashield.  Images were obtained using the in-house Zeiss epifluprescence 















2.8 Mouse Work 
 
2.8.1 Mouse Dissections 
 
All mice embryos at stage E11. 5 were obtained from the Edinburgh Biomedical Research 
Facility (BRF).  All mice used were the species CD1 which were originally obtained from 





























Using Sonic Hedgehog Inducible Cell 











One of the main ambitions of the Hill laboratory is to elucidate the processes leading to 
induction of the Shh gene in the mouse embryonic limb bud.  In particular, there is an interest 
in how the ZRS, the enhancer responsible for activating Shh in the limb bud functions.  Among 
many lines of inquiry, we are interested in: changes in histone marks at the ZRS upon induction 
of the Shh gene; the specificity of the ZRS towards Shh in both Shh expressing and non-
expressing cells; the compaction of the ZRS-Shh region in Shh expressing and non-expressing 
cells; and the transcription factors and other proteins binding to the ZRS in Shh expressing and 
non-expressing cells.  However, the E11.5 mouse embryonic limb bud consists of an extremely 
complex series of interconnecting signalling pathways.  In vivo manipulation of individual 
components from a single pathway can have a knock on effect on several others and therefore 
dissecting the series of events within a single pathway can prove challenging.  Therefore, to 
look at the process of Shh induction by the ZRS in isolation it was decided that a more 
controlled system should be examined.  A Shh inducible system was suggested, where cultured 
cell lines could be used to analyse the ZRS and Shh when the gene was not expressed and then 
how both components were affected upon activation of the gene.  The results from such 
experiments could be then be compared to in vivo experiments using E11.5 limb bud tissue. 
 
In addition, using cultured cell lines to study gene activation can have several advantages.  For 
example, modern techniques used to analyse chromatin structure such as chromosome 
conformation capture (3C) usually require a large number of cells in the range of 106 - 107.  In 
the case of the mouse limb SHH is expressed over a period of only a few days (E9.75 – E12, 
Chapter 1.3.1) and is produced in a small sub-section of the limb referred to as the zone of 
polarising activity (ZPA) which is found in the posterior distal region.  At E11.5, when SHH 
expression is at its maximum, we estimate the limb bud consists of roughly 200,000 – 300,000 
cells with the ZPA occupying only roughly a twentieth of this area.  Therefore, if performing 
mouse dissections to isolate SHH expressing cells, several mouse litters may be required.  
Normal dissections are also inaccurate as it is extremely difficult to separate the ZPA from the 
remainder of the limb bud.  At best the limb can be dissected into different sections i.e. into 
proximal and distal limb sections or anterior and posterior sections, where the ZPA is 
contained in either the distal or posterior portions.  However, using cultured cell lines it is 
relatively easy to harvest large numbers of cells relatively quickly and these types of 
experiments can be conducted over a much smaller time scale. 
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3.1.1 The 14fp cell line 
 
The 14fp cell line are immortalised cells (cells derived from the immortamouse containing the 
temperature sensitive T antigen (Chapter 2.6.1) arising from the posterior region of an E11.5 
limb bud.  These cells are grown in culture at 33 C with 3 % O2 and 5 % CO2 in the presence 
of interferon gamma (IFNγ); fetal calf serum (FCS); penicillin-streptomycin (P/S); and L-
glutamine. They can be grown up to around passage 18 after which clear indications of 
transformation are evident.  PCR has shown that some genes expressed within the E11.5 limb 
bud are also expressed within the 14fp cells (such as Hand2 and Gremlin) suggesting that the 
cells are largely reflective of early embryonic limb bud cells (Figure 3.1(A)).  One key 
exception is that no detectable levels of SHH are evident. 
 
Peluso et al. (manuscript in preparation) have shown that treatment of 14fp cells with 
trichostatin A (TSA) is sufficient to induce a low level expression of Shh.  TSA is a histone 
deacteylase inhibitor capable of inhibiting class I and class II HDACs (HDACs: 1, 3, 4, 6, 10). 
It has also been shown to affect the expression of a number of genes in chick limb buds (Zhao 
et al., 2009).  In 14fp cells, increasing the concentration of TSA up to 1 M increases the 
output of SHH expressed.  Above this concentration, there is an observable increase in cell 
death.  As a result, a concentration of 1 M TSA was chosen for all 14fp treatments.  At this 
concentration, time course experiments have shown Shh expression to increase incrementally 
up to 24 hrs after which expression decreases and returns to basal levels by 36 hr (Figure 
3.1(B)). 
 
Chromatin immunoprecipitation (ChIP) experiments have shown that in these cells the Zone 
of Polarising Activity Regulatory Sequence (ZRS) - the enhancer responsible for SHH 
expression in the limb bud - is in a poised state as indicated by histone H3K4 monomethylation 
(H3K4me1) and the binding of the protein P300 which, in combination are considered 
indicators of an enhancer poised for activation (Creyghton et al., 2010).  On TSA addition, - 
H3K27ac, a marker of active enhancers - is also detected at the ZRS.  At this stage, the 
enhancer histone marks at the ZRS reflect those observed in the distal region of the E11.5 limb 






3.1.2 Additional Cell Lines 
 
The 14fp cell lines are the most well characterized cells used in this investigation as ChIP 
experiments have determined the activity status of the ZRS both before and after TSA 
treatment.  The 88fp cell line, derived from the same region and the same stage as the 14fp 
cells, is also immortalized and can induce Shh upon TSA treatment when grown in similar 
conditions.  These cells have been used in experiments to determine if the properties of the 
14fp cells are unique to this cell line or, alternatively, are shared among immortalized limb 
cells originating from the limb. 
 
The MD cell line are immortalized cells that originate from the mandible of the E11.5 mouse 
embryo.  SHH is not expressed in this region in mouse embryonic tissue and the MD cell line 
does not induce Shh expression upon TSA treatment.  When compared to the 14fp cells, there 
is negligible H3K4me1 and H3K27ac at the ZRS when TSA is either absent or present, 
suggesting that the enhancer is inactive within these cell lines. The MD cell line is therefore a 
good control for this investigation (Silvia Peluso, manuscript in preparation). 
 
3.1.3 Alternatives to TSA 
 
In addition to TSA drug treatment, Silvia Peluso (project supervisor) has shown that either 
knockdown of the transcription factor PEA3 or upregulation GABP is sufficient to induce 
SHH expression in 14fp cells (Figure 3.1(C)(D)).  Immunoprecipitation experiments have 
identified PEA3 as a binding partner of HDAC2 and GABP as a binding partner of P300.  
Both GABP and PEA3 are members of the ETS factor family and have binding sites within 
the ZRS (Chapter 1.3.1).  Within the limb bud GABP is expressed throughout the distal edge 
with a larger expression domain in posterior regions overlapping the ZRS than anterior 
regions.  PEA3 (also known as ETV4) is expressed throughout the distal edge with expression 
distributed equally between anterior and posterior sites.  Both proteins have been shown to 
regulate Shh expression within the limb bud with GABP increasing levels of SHH and ETV4 
reducing SHH.  The balance of both proteins within the limb bud is therefore essential for 
restricting Shh expression to the ZPA.  The importance of maintaining this equilibrium is 
illustrated by ZRS mutants where a ETV4 binding site has been substituted for a GABP site.  
These mutants display ectopic Shh expression in anterior regions. 
 
In this chapter RNA-seq experiments were conducted on both TSA treated and control 14fp 
cells.  ChIP experiments suggest that TSA induces the Shh gene through the ZRS.  As a result, 
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the addition of TSA to 14fp cells has the potential to acts as a good model system for studying 
the mechanism by which the ZRS activates the Shh gene.  RNA-seq experiments were 
conducted on these cells to investigate the effect TSA has on other genes (perhaps activating 
additional developmental enhancers) and to determine if the addition of TSA to the 14fp cell 





























































Figure 3.1 – Project background – data provided by Christine Mordstein and Silvia Peluso. 
(A)  Agarose gel electrophoresis of RT-PCR samples showing that after 24 hr TSA treatment 
Gremlin and Hand2 expression decreases in 14fp cells, while the housekeeping gene Hgprt 
is unaffected.  Alx4 is not detected in TSA treated and control 14fp cells.  (B-D) RT-qPCR 
was used to test the expression of Shh, Gabpα and Pea3 in 14fp cells under different 





















































































































































































conditions.  (B) Shh expression increases upon TSA treatment up to 24 hr and returns to 
base line levels by 36 hr (36 hr time point omitted).  (C)  A GABPα producing, doxycycline 
inducible vector was introduced into 14fp cells.  An increase in Gabpα expression (i) 
coincided with an increase in Shh expression (ii).  (D)  Knock-down of Pea3 levels (i) 













































3.2 Aims  
 
3.2.1 General Aims 
 
The aim of this section was to characterize the 14fp cells further by using RNA-seq to 
determine how closely they resemble an embryonic limb bud at day E11.5.  If the cells 
expressed the same genes as the E11.5 limb bud, they could be used as to the model system to 
investigate limb signaling pathways.  We also looked at different aspects of the 88fp cell lines 
to see how they compare with those of the 14fp cells. 
 
3.2.2 Experimental Aims 
 
The experimental aims of this section are as follows: 
 
 To investigate gene expression differences between TSA treated (Shh expressing) 
and control (Shh non-expressing) 14fp cells. 
 
 To investigate gene expression differences between distal (Shh expressing) and 
proximal (Shh non-expressing) portions of the E11.5 limb bud. 
 
 To investigate gene expression differences between the 14fp cells (control and TSA 
treated) and the distal and proximal E11.5 limb bud sections. 
 
 To investigate the concentrations of TSA needed to regulate the maximum SHH 
expression in 88fp cells. 
 
 To investigate the time point where SHH expression is at its maximum after 
treatment with the optimum concentration of TSA in 88fp cells. 
 











3.3 Experimental Procedures  
 
3.3.1 14fp Cells: Preparation of RNA for sequencing 
 
RNA for both treated and untreated 14fp cells was provided by Silvia Peluso. This involved 
treating 14fp cells with either 1 M TSA or DMSO (acting as a control) for 24 hrs.  At this 
point cells were harvested by scraping and RNA was isolated using a standard trizol extraction 
protocol (Chapter 2.3.1).  The integrity of RNA was tested by agarose gel electrophoresis, and 
analysed using the nanodrop spectrophotometer and by running on an Agilent Technologies 
2100 Bioanalyser.  Only RNA with an OD 260/280 ratio greater than 1.8; an 260/230 ratio 
greater than 1.7 and an RNA integrity number of 8 or above was considered for sequencing.  
This process was repeated on a different day, thereby providing biological replicates of both 
control and TSA treated 14fp cells. 
 
3.3.2 E11.5 Limb Cells: Preparation of RNA for sequencing 
 
RNA for both proximal and distal limb sections was provided by Silvia Peluso.  In summary, 
the limb buds from several CD1 embryos at E11.5 were dissected in PBS and divided into 
both proximal and distal sections.  All proximal sections were collated into the same vial and 
this was repeated for all distal sections.  Both mouse forelimbs and hindlimbs were combined 
for these experiments.  The RNA extraction procedure and RNA quality checks were 
performed as Chapter 3.3.1.  Two biological replicates of distal limb sections and two 
biological replicates of proximal limb sections were sent for sequencing. 
 
3.2.1 RNA-sequencing: Analysis Pipeline 
 
Raw sequencing reads were first checked for sequencing quality using the tool FastQC.  After 
checking, they were changed into a suitable format for use in further processing steps using 
FastQC Groomer.  After trimming poor quality reads (using FastQ quality trimmer tool) and 
the removal of sequencing adaptors (using Clip tool), Tophat was used to align the processed 
reads to the mouse mm9 genome (the Tophat settings are provided in Appendices – Table 1).  
Differential expression was conducted using the Cuffdiff tool with the default settings.  
Finally, CummeRbund was used to visualize the output from Cuffdiff.  This process was 




3.4 Results and Discussion 
 
3.4.1 Processing of RNA sequencing data 
 
RNA was prepared and sequenced by GATC Biotech AG according to Chapter 3.3.1.  The 
Inview Transcriptome Explore package was used where mRNA was selected by poly(A) 
enrichment and then subsequently fragmented.  cDNA was then prepared using random 
hexamer priming.  After adapter ligation, Illumina sequencing was conducted yielding single 
end 50 bp reads.    For the cell line experiments, more than 20 million reads were obtained for 
each sample (Table 3.1) with an alignment rate to the mm9 genome of greater than 80 % (after 
trimming and removal of adapter sequences).  For the limb bud experiments, more than 25 
million reads were obtained for each sample with a mapping rate of greater than 95 %.  In 
terms of read number, the greatest variability between replicates was observed for the control 
14fp samples, with one replicate yielding 88 million reads and the other only 25 million reads. 
 
The output from Cuffdiff gene differential expression testing was filtered in two parts.  Firstly, 
for gene IDs which had passed the Cuffdiff statistical testing procedures and secondly for gene 
IDs with significant changes in FPKM (Fragments per Kilobase of Sequence Mapped) as 
determined by the Cuffdiff statistical testing.  The resulting lists were then ranked in either 
ascending order or descending order of log2fold change in FPKM values.  The top 20 hits were 
extracted and presented in this section.  For cell line experiments a positive change in log2fold 
FPKM relate to a significant upregulation in gene expression from the control 14fp cells to the 
TSA treated cells.  In contrast a negative value relates to a significant reduction in gene 
expression from the control 14fp cells to the TSA treated cells.  A similar rationale can be 
applied to the limb bud experiments where a positive change in log2fold FPKM relates to a 
significant upregulation in gene expression from the proximal limb dissection to the distal limb 
dissection and a negative log2fold FPKM relates to a significant reduction in gene expression.  
In total, between control and TSA treated 14fp cells 7,872 genes showed significant 
differential expression while 1,500 genes showed significant differential expression between 
the proximal and distal sections of the E11.5 limb bud. 
 
Using GOrilla, an online bioinformatics tool which specializes in clustering genes according 
to their associated GO (Gene Ontology) terms to determine which GO terms are enriched 
within a sample, we analysed the biological processes associated with the differentially 
expressed genes in both cell lines and limb bud experiments.  The top 20 GO terms (ranked 
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according to p-value) associated with differentially expressed genes from cell line and limb 
bud experiments are also presented in this section.  The input to GOrilla was a list of 
differentially expressed genes ranked in descending order of log2fold FPKM. 
 
3.4.2 Quality Control of RNA sequencing data  
 
It was important to confirm that changes in the differential expression of genes in these 
experiments were due to either: (a) the addition of TSA to 14fp cells; or, (b) to whether genes 
were being expressed in proximal or distal limb sections; i.e., it was important to confirm that 
the expression of genes in replicate samples were similar to each other and that large variation 
between replicates was not affecting the analysis. Therefore, to check that replicate samples 
had similar gene expression profiles to each other data was plotted on both mds 
(multidimensional scaling) and dendogram graphs (Figure 3.2(A)(B)).  Both of these plots 
show that the replicates for each condition in both sets of experiments cluster closer together 
than they do with other conditions.  For example, in the limb cell experiments replicates of the 
proximal limb dissections cluster closer to each other than they do to the replicates of the distal 
dissections.  This confirms that the major source of variation in these experiments is between 
the different conditions and not between replicates within a condition. 
 
3.4.3. Genome wide FPKM changes for cell line and limb dissection 
experiments 
 
Analysis of the boxplots for both cell lines and limb dissection experiments suggests that the 
global distribution of log10FPKM values show little variation between both treated and 
untreated 14fp cell lines and between proximal and distal limb dissections (the median 
log10FPKM value – depicted as the horizontal line within each boxplot – is similar for each of 
the four samples).  This suggests that for the cell lines there is no observable collective increase 
or decrease in gene expression upon TSA treatment (assuming that TSA treatment causes no 
significant increase or decrease in the amount of RNA produced per cell – this could be 
determined by repeating the experiment with standardized controls (Lovén et al., 2012)).  Also 
for the limb dissections there is no observable collective difference in the expression of all 
genes between proximal and distal sections.  The distribution of log10FPKM values is greater 
in the 14fp cell line experiments than in the limb dissection experiments as seen by the greater 
interquartile range (determined by the distance between the top and bottom of each boxplot) 
on boxplots for both treated and untreated 14fp cells than boxplots for the separate limb regions 
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(Figure 3.3(A)).  The density plots for all samples are similar and show that a large number of 
genes have a positive log10FPKM (as indicated by the peak of the graph), while there are also 









14fp Control Replicate 1 88061533 69502864 
14fp Control Replicate 2 24927241 23648587 
14fp TSA Replicate 1 54252778 43886851 
14fp TSA Replicate 2 67963171 46952553 
Proximal Limb Bud Replicate 1 38861118 31834984 
Proximal Limb Bud Replicate 2 28744255 23551802 
Distal Limb Bud Replicate 1 38830914 31473416 
Distal Limb Bud Replicate 2 40000755 32650196 
 
 
Table 3.1 – The number of reads generated and the number of reads mapped to the mm9 







































Figure 3.2 – Multidimensional scaling (mds) and dendogram plots for both (A) cell line 
experiments and (B) limb dissection experiments (A)(i) TSA and and control samples clearly 
separate along the first dimension of the mds plot.  (ii)  TSA replicates cluster closer 
together than to the control replicates on the dendogram. (B)(i) Proximal and distal limb 
sections clearly separate along the first dimension of the mds plot.  (ii)  Distal section 
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Figure 3.3 – Boxplots (A) and density plots (B) for both cell line and limb dissection 
experiments.  (A)  Boxplots show that the median log10FPKM value (middle line in the 
boxes) is very similar between all samples.  The distribution of log10FPKM values for all 
genes in both proximal and distal limb sections is much narrower than the distributions for 
treated and untreated cells, as indicated by the smaller size of the boxes (and thus a lower 
interquartile range).  (B)  The density plots for all samples show that a large number of 
genes have a positive log10FPKM value (as indicated by the peak), while there are also a 








3.4.4 TSA treatment of 14fp cells affects a variety of cellular processes 
 
Upon analysis of the top 20 genes with significantly upregulated expression (Table 3.2 and 
Figure 3.4) and the top 20 genes with significantly reduced expression (Table 3.3 and Figure 
3.5), it is obvious that the processes other than those affecting the limb bud signaling pathways 
are affected.  The top hit in Table 3.2 is the gene Atp1a3 (8.36944 log2FPKM fold change, 
q=0.00045389) which is known to play a role in sodium and potassium ion transport.    
Analysis of the top GOrilla hits (Table 3.4) shows that the process of “cellular sodium ion 
homeostasis” (q=1.32E-07) is enriched which in addition to Atp1a3 also includes the two other 
genes Tesc (7.18772 log2FPKM fold change, q=0.00265304) and Atp1b2 (7.19875 log2FPKM 
fold change, q=0.000163866) which both appear in Table 3.2.   
 
Unlike the limb experiments, where the GO term “limb morphogenesis” is in the top 20 Gorilla 
hits (Table 3.7), this GO term was not in the top 20 Gorilla hits for the cell line experiments 
(Table 3.4).  This suggests that although signaling pathways involved in patterning the limb 
bud are affected by TSA treatment, the expression of genes involved in other processes (such 
as sodium and potassium ion transport) are altered to a greater extent.  
 
We selected a number of genes known to play a role in embryonic limb development and 
analyzed changes in gene expression.  Most importantly, we observed an increase in the 
expression of the Shh gene (Figure 3.10).  However, this increase was very small with the gene 
failing the Cuffdiff statistical testing procedures using default parameters.  When these 
parameters were altered so that a reduced number of alignments could be included in the 
statistical tests, differential expression of Shh was deemed significant.  Of note, there is also a 
significant upregulation of Fgf8 (q=0.000163866) and a significant downregulation of Grem1 
(-2.37148 log2FPKM fold change, q=0.000163866) which are both involved in Shh signaling 
pathways.  A decrease in Grem1 expression is at odds to the distal limb bud where Shh induces 
Grem1 expression.  As stated previously TSA is an inhibitor of class I and class II HDACs.  
HDACs 1 to 11 are expressed in 14fp cells with HDACs 1, 6, 7, 8, 10 and 11 showing 
significant differential expression.  On the other hand, HDACs 2, 3, 4 and 9 do not show 
significant differential expression.  However, there is substantial expression of all of these 
genes in both treated and untreated cells (Figure 3.6).   
Other investigations (Towers et al., 2008) have analysed the effect of histone deactelyases 
such as TSA when implanted on beads into chick limb buds.  One such study looked at the 
effect of Valpoirc Acid (VPA) on the processes of chondrogenesis in E12 forelimb buds and 
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confirmed that VPA treatment resulted in a significant decrease in both SOX9, SOX5 and 
SOX6 (Paradis and Hales, 2013).  However, we found no statistical difference in the 
differential expression of these genes between TSA treated and untreated 14fp cells. 
One observation from treating 14fp cells with TSA is the large extent of cell death that has 
occurred within 24 hrs.  This correlates with the well-known role of TSA in regulating 
apoptosis.  It was hypothesized, therefore, that TSA treatment may lead to the upregulation of 
several apoptotic markers.  In particular, one study looking at the effect of TSA on pancreatic 
cancer cell lines noticed a significant increase in expression of the apoptosis inducing gene 
Bcl2l11 (Bim) and reduction in expression of the anti-apoptotic genes Bcl2l1 (Bcl-xl) and 
Bcl2l2 (Bcl-w) (Moore et al., 2004).  Indeed, a similar effect was observed on the treatment of 
14fp cells with TSA as Bcl2l11 was significantly induced (2.68475 log2FPKM fold change, 
q=0.000163866) and both Bcl2l1 (-1.70833 log2FPKM fold change, q=0.000163866) and 
Bcl2l2 (-1.04631 log2FPKM fold change, q=0.000722654) were significantly reduced.  TSA 
has also been shown to slow cell growth by restricting progression through the cell cycle at 
the G1 or G2 stage.  For example, components regulating progression through these stages 
such as cyclin D1 and CDK4 were downregulated, while p21waf1 and p53 were upregulated in 
one study looking at the effect of TSA in human breast epithelial cells (Park et al., 2008).  We 
found a significant reduction in gene expression of Cdk4, Cdk6, cyclin D, cyclin E, p53 and 











Table 3.2 - The top 20 genes which show the greatest positive change in log2fold FPKM 
values between untreated and TSA treated 14fp cells. i.e.  the top 20 ranked genes which 
show an increase in expression upon TSA treatment.  The FDR adjusted q-value for each 
gene is provided.  These values were taken from the Cuffdiff output folder “gene 






Gene Locus log2(fold 
change) 
 q value 
Atp1a3 chr7:25763187-25790914 8.36944 0.00045389 
Elavl3 chr9:21819448-21856467 7.51933 0.00566822 
Padi2 chr4:140462274-140513817 7.34784 0.00640266 
Prss16 chr13:22094044-22101610 7.29626 0.00410193 
Nptx1 chr11:119400032-119409134 7.25427 0.00453523 
Atp1b2 chr11:69413251-69419462 7.19875 0.000163866 
Tesc chr5:118477832-118511879 7.18772 0.00265304 
Rassf4 chr6:116583025-116623854 7.09386 0.0137202 
Bex2 chrX:132601103-132602775 7.07583 0.0334972 
Nrxn2 chr19:6418737-6533217 6.99842 0.000163866 
Slc40a1 chr1:45964914-45982439 6.97537 0.0378811 
  Epas1 chr17:87153203-87232750 6.96579 0.000163866 
Pou3f1 chr4:124334888-124337899 6.96488 0.00898437 
Clu chr14:66587319-66600382 6.95934 0.000163866 
Dpysl5 chr5:31014267-31101742 6.83975 0.000163866 
Vgf chr5:137506164-137509221 6.80705 0.000163866 
Cadm3 chr1:175264384-175297826 6.73671 0.00265304 
Lama1 chr17:68046604-68171985 6.73339 0.0080163 
Irf8 chr8:123260275-123280592 6.70344 0.000163866 
Mapk8ip2 chr15:89284341-89292878 6.68748 0.00850558 
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Figure 3.4 – Bar chart displaying the change in FPKM value of the top 20 most positively 
differentially expressed genes from Table 3.2. i.e. the top 20 ranked genes which show an 
increase in expression upon TSA treatment.  FPKM values are displayed as a log scale along 
the vertical axis.  Expression of genes from untreated 14fp cells are highlighted in blue, 
























Table 3.3 - The top 20 genes which show the greatest negative change in log2fold FPKM 
values between untreated and TSA treated 14fp cells. i.e. the top 20 ranked genes which 
show a decrease in expression upon TSA treatment.  The FDR adjusted q-value for each 
gene is provided.  These values were taken from the Cuffdiff output folder “gene 

















change)  q value 
Wisp2 chr2:163646569-163658883 -7.12989 0.000163866 
Fam150a chr1:6349411-6384812 -7.08516 0.00463929 
Tgfb1i1 chr7:135390384-135397226 -6.65208 0.000163866 
Peg12 chr7:69606756-69609396 -6.27441 0.011576 
Calhm2 chr19:47206721-47212784 -5.84305 0.000163866 
Rcbtb2 chr14:73542316-73583861 -5.82715 0.000163866 
Lsp1 chr7:149646774-149701914 -5.75427 0.000163866 
Clcf1 chr19:4214391-4222615 -5.70572 0.00577033 
Wisp1 chr15:66722954-66754761 -5.58081 0.000163866 
Masp1 chr16:23451857-23520663 -5.50122 0.000163866 
Il1rl1 chr1:40496493-40522259 -5.48584 0.000163866 
Anxa8 chr14:34864315-34915940 -5.44822 0.000163866 
Krt7 chr15:101242833-101258237 -5.42591 0.00577033 
Serpinb9b chr13:33119282-33132427 -5.41885 0.00149063 
Clec2d chr6:129130632-129136553 -5.38279 0.000163866 
Efs chr14:55535379-55545625 -5.37985 0.000163866 
Hdac7 chr15:97614795-97674933 -5.29212 0.0420699 
Gm53 chr11:96112973-96125798 -5.28774 0.00536537 
Ptpmt1 chr2:90750869-90758207 -5.24323 0.000163866 






Figure 3.5 – Bar chart displaying the change in FPKM value of the top 20 most negatively 
differentially expressed genes from Table 3.3 i.e. the top 20 ranked genes which show a 
decrease in expression upon TSA treatment.  FPKM values are displayed as a log scale along 
the vertical axis.  Expression of genes from untreated 14fp cells are highlighted in blue, 


























signal transduction 5.39E-10 6.36E-06 
modulation of synaptic transmission 3.10E-09 1.83E-05 
multicellular organismal process 3.57E-09 1.40E-05 
behavior 7.63E-09 2.25E-05 
system process 2.45E-08 5.76E-05 
cellular sodium ion homeostasis 1.32E-07 2.59E-04 
sodium ion homeostasis 2.16E-07 3.64E-04 
regulation of synaptic plasticity 2.28E-07 3.37E-04 
regulation of synapse structure or activity 3.01E-07 3.94E-04 
regulation of neurotransmitter levels 3.81E-07 4.49E-04 
single-organism cellular process 3.97E-07 4.25E-04 
neurological system process 4.36E-07 4.28E-04 
single-organism behavior 6.12E-07 5.55E-04 
G-protein coupled receptor signaling pathway 8.32E-07 7.01E-04 
metal ion transport 8.33E-07 6.55E-04 
single-multicellular organism process 8.60E-07 6.34E-04 
single-organism process 1.12E-06 7.74E-04 
signaling 1.38E-06 9.03E-04 
homophilic cell adhesion via plasma membrane 
adhesion molecules 2.63E-06 1.63E-03 
cell differentiation 2.67E-06 1.57E-03 
 
 
Table 3.4 – Top 20 GOrilla hits for 14fp cell line experiments sorted by p-value, where the 
input dataset was a list of differentially expressed genes ranked in descending order of 
log2fold FPKM values i.e. the differentially expressed gene with the highest positive log2fold 

















Figure 3.6 - Bar chart displaying the change in FPKM values of HDACs 1 to 11 in the 14fp cell 
line experiments.  FPKM values are displayed as a log scale along the vertical axis.  
Expression of genes from untreated 14fp cells are highlighted in blue, while the expression 













3.4.5 Gene expression differences between E11.5 proximal and distal 
limb sections reflect the position of the different signaling 
centers within the developing limb bud. 
 
The top 20 genes with significantly upregulated expression (ranked according to log2FPKM 
fold change values) in the distal limb compared to the proximal limb are set out in Table 3.5 
and highlighted in Figure 3.7.  The top 20 genes with significantly reduced expression (ranked 
according to log2FPKM fold change values) in the distal limb compared to the proximal limb 
are provided in in Table 3.6 and highlighted in Figure 3.8.  The distal limb section includes 
the ZPA where Shh is expressed and, the majority of the AER and underlying mesenchyme 
(the progress zone).  Therefore, genes involved in both the Shh signaling pathway and the AER 
Fgf-Shh feedback loop were expected to have altered expression values between limb bud 
regions.  Indeed, unlike the cell line experiments there is a significant upregulation of Grem1 
(2.5044 log2FPKM fold change, q=0.000902763) and a much greater increase in Shh 
expression (2.88697 log2FPKM fold change, q=0.000902763).  This accords with Shh’s role 
to positively regulate Grem1.  In contrast to cell line experiments which show a decrease in 
Fgf10 there is a significant increase in Fgf10 (1.55067 log2FPKM fold change, 
q=0.000902763).  However, like the cell lines there is a significant increase in Fgf8 (3.24119 
log2FPKM fold change, q=0.000902763).  This is expected as Fgf8 is known to be expressed 
in the AER (Lewandoski et al., 2000).  The gene with greatest significant negative log2FPKM 
fold change was Pax1 (-5.71561 log2FPKM fold change, q=0.000902763).  In previous 
studies, Pax1 was shown to be expressed in anterior posterior regions of the E12 limb bud 
(Timmons et al., 1994).  This matches our results and confirms that genes marking the 
proximal portions of the limb are still active in our dissections.  In addition, the genes Meis1 
(-2.23785 log2FPKM fold change, q= 0.000902763) and Meis2 (-2.49135 log2FPKM fold 
change, q= 0.000902763) which have previously been shown to be expressed in the posterior 
limb (Zeller et al., 2009) showed a significant decrease in expression in our distal dissections 
compared to the proximal dissections.  In contrast, the known distally expressed gene Cyp26b1 
(Yashiro et al., 2004) showed a significant increase in expression in distal dissections (1.28247 
log2FPKM fold change, q= 0.000902763).  This again confirms that the limb bud has been 
accurately dissected as the expression domains of well characterized limb genes match the 
literature. 
 
The Gorilla result from this analysis was as expected with terms such as “limb morphogenesis” 
appearing; however, “male genitalia development”, “neural tube closure” were all listed as top 
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hits (Table 3.7) due to the presence of significantly expressed genes such as Shh and Hox genes 




























Table 3.5 - The top 20 genes which show the greatest positive change in log2fold FPKM 
values in distal over proximal limb regions. i.e. the top 20 ranked genes which show an 
increase in expression in distal regions compared to proximal regions. The FDR adjusted q-
value for each gene is provided.  These values were taken from the Cuffdiff output folder 









Gene  Locus 
log2(fold  
change) q-value 
Evx2 chr2:74493672-74497476 4.53072 0.000902763 
Gja3 chr14:57654496-57676782 4.40322 0.000902763 
Aox3 chr1:58169979-58257296 4.15424 0.000902763 
Hoxd13 chr2:74506366-74509655 4.14145 0.000902763 
5730457N03Rik chr6:52258382-52268372 3.76511 0.000902763 
Evx1 chr6:52258382-52268372 3.43016 0.000902763 
Gpx2 chr12:77893321-77896541 3.41893 0.00170037 
Vwde chr6:13135609-13174965 3.38107 0.000902763 
Fgf8 chr19:45811287-45817374 3.24119 0.000902763 
Sv2b chr7:82259780-82476305 3.20648 0.000902763 
Eomes chr9:118387306-118395250 3.13133 0.000902763 
Hoxa13 chr6:52208851-52210874 2.9647 0.000902763 
Scn11a chr9:119662882-119734574 2.96021 0.000902763 
Tgm3 chr2:129838109-129876135 2.91075 0.0031293 
Shh chr5:28783379-29045749 2.88697 0.000902763 
Nlrp10 chr7:116065366-116073672 2.73749 0.0075471 
Igfbpl1 chr4:45822378-45839699 2.62534 0.000902763 
Hoxd12 chr2:74513086-74515762 2.53079 0.000902763 
Cbln1 chr8:89992751-89996491 2.5122 0.000902763 





Figure 3.7 – Bar chart displaying the change in FPKM value of the top 20 most positively 
differentially expressed genes from Table 3.5. i.e. the top 20 ranked genes which show an 
increase in expression in distal regions compared to proximal regions.  FPKM values are 
displayed as a log scale along the vertical axis.  Expression of genes from proximal limb 
dissections are highlighted in blue, while the expression of genes from distal limb 


























Table 3.6 - The top 20 genes which show the greatest negative change in log2fold FPKM 
values in distal over proximal limb regions. i.e. the top 20 ranked genes which show a 
decrease in expression in distal regions compared to proximal regions   The FDR adjusted 
q-value for each gene is provided.  These values have been taken from the Cuffdiff output 














change)  q value 
Pax1 chr2:147190729-147200784 -5.71561 0.000902763 
Rfx4 chr10:84218792-84369283 -5.18115 0.00381167 
Dcc chr18:71413285-72510723 -5.01257 0.000902763 
Col14a1 chr15:55139304-55352358 -4.98327 0.000902763 
Zcchc5 chrX:104032420-104035982 -4.47706 0.000902763 
Gpr17 chr18:32091160-32118273 -4.38011 0.00381167 
Pkdcc chr17:83614622-83624409 -4.01958 0.000902763 
Calb2 chr8:112666437-112692106 -3.95627 0.000902763 
Tnnt2 chr1:137732962-137748838 -3.83998 0.000902763 
Sox10 chr15:78985342-78994920 -3.81487 0.000902763 
Barx1 chr13:48758404-48761876 -3.7916 0.0153649 
Lmod3 chr6:97188521-97202774 -3.78148 0.0144063 
Foxd3 chr4:99322989-99325362 -3.77032 0.00381167 
Trim55 chr3:19544459-19591599 -3.75539 0.0114033 
Zfp804a chr2:81893814-82100035 -3.73861 0.000902763 
Rxfp2 chr5:150821249-150884761 -3.73358 0.0123733 
Msc chr1:14743428-14746047 -3.73266 0.000902763 
Mybph chr1:136090024-136132008 -3.6845 0.0239337 
Col6a5 chr9:105758399-105862974 -3.64411 0.000902763 
Myh3 chr11:66891801-66915793 -3.59298 0.000902763 
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Figure 3.8 – Bar chart displaying the change in FPKM value of the top 20 most negatively 
differentially expressed genes from Table 3.6. i.e. the top 20 ranked genes which show a 
decrease in expression in distal regions compared to proximal regions.  FPKM values are 
displayed as a log scale along the vertical axis.  Expression of genes from proximal limb 
dissections are highlighted in blue, while the expression of genes from distal limb 






















Table 3.7 – Top 20 GOrilla hits for limb bud experiments sorted by p-value where the input 
dataset was a list of differentially expressed genes ranked in descending order of log2fold 
FPKM values i.e. the differentially expressed gene with the highest positive log2fold FPKM 



















organonitrogen compound metabolic process 3.46E-07 2.58E-03 
male genitalia development 4.92E-06 1.83E-02 
reproductive system development 4.92E-06 1.22E-02 
nitrogen compound metabolic process 1.08E-05 2.01E-02 
pattern specification process 2.41E-05 3.60E-02 
genitalia development 3.72E-05 4.62E-02 
determination of bilateral symmetry 5.71E-05 6.08E-02 
determination of left/right symmetry 5.71E-05 5.32E-02 
cerebral cortex neuron differentiation 6.29E-05 5.21E-02 
tube closure 6.69E-05 4.99E-02 
nucleobase-containing small  
molecule metabolic process 1.23E-04 8.34E-02 
specification of symmetry 1.24E-04 7.73E-02 
neural tube closure 1.43E-04 8.19E-02 
small molecule metabolic process 1.48E-04 7.89E-02 
appendage morphogenesis 1.90E-04 9.47E-02 
limb morphogenesis 1.90E-04 8.88E-02 
organophosphate metabolic process 2.22E-04 9.75E-02 
single-organism metabolic process 2.23E-04 9.23E-02 
alpha-amino acid metabolic process 2.26E-04 8.87E-02 
branching involved in prostate gland morphogenesis 2.47E-04 9.20E-02 
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3.4.6 A subset of genes are differentially expressed in both cell line 
and limb dissection experiments. 
 
In total, 1500 genes showed significant differential expression in the limb bud experiments 
which is much fewer than observed in the cell line experiments where 7,872 genes showed 
significant differential expression.   However, a proportion of these genes overlapped between 
experiments suggesting that the effect of TSA treatment on 14fp cells affected some of the 
same signaling processes that are unevenly distributed across the limb bud.  In total the cell 
line experiments shared 147 differentially expressed genes with a significant positive log2fold 
FPKM with the limb bud experiments.  A total of 272 differentially expressed genes with a 
significant negative log2fold FPKM were found in common (Figure 3.9). 
 
The 147 differentially expressed genes with a significant positive log2fold FPKM between 
both experiments were then filtered according to the log2fold FPKM value from the limb 
dissection experiments.  The 20 most positively differentially expressed genes (ranked 
according to FPKM values from limb bud experiments) are presented in Table 3.8 and the top 
20 most negatively differentially expressed genes (ranked according to FPKM values from 
limb bud experiments) are presented in Table 3.9.  In Table 3.8, Fgf8 has the second highest 
log2fold FPKM value, showing that both TSA treated 14fp cells and the distal limb have an 
enrichment of this gene. Therefore, one of the main effects of TSA treatment is to induce 
expression of genes normally expressed within the AER.  Of note, Pdzd2 (Tsui, 2014) - a 
suspected inhibitor of the Shh signaling pathway - is also significantly upregulated. 
 
Of particular interest is how gene expression of the ETS factors (ETS1, GABP, ETV4 (Pea3) 
and ETV5) (Chapter 1.3.1) are altered in the 14fp cell lines on TSA treatment and how this 
compares to the different compartments of the limb.  Between the proximal and distal limb 
sections, there was no statistical difference in Ets1 and Gabp levels, while there were only 
small deviations to Etv4 and Etv5 (< 1.5 log2fold FPKM).  In the 14fp cells, there was only a 
small deviation of Ets1 expression levels (< 1.5 log2fold FPKM) and no significant change to 
Gabp.  However, there was a substantial drop in Etv4 levels on TSA addition (-1.73994 
log2fold FPKM, q=0.000163866) and an increase in Etv5 (2.20157 log2fold FPKM, q= 
0.000163866).  This is interesting as downregulation of Etv4 on TSA addition correlates with 
the induction of Shh.  As mentioned previously, Silvia Peluso (manuscript in preparation) has 
shown that knock-down of Etv4 (Chapter 3.1.3) in 14fp cells can also induce Shh expression 
and that Etv4 binds to HDAC2.  Therefore, it may be possible that the activation of Shh on 
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TSA treatment is a secondary effect caused by reduction of Etv4 levels.  Decreased levels of 
ETV4 binding to the ZRS in combination with increased H3K27ac also caused by TSA 
treatment would then allow the enhancer to activate Shh expression.  The reduction of Etv4 
levels before Shh expression may explain why it takes 24 hr after TSA treatment before Shh 
is expressed to its maximum instead of this process occuring instantaneously.  A time course 
of Pea3 levels after TSA treatment may shed more light on the order of the events resulting in 
Shh expression.  However, the addition of TSA caused no significant changes to Hdac2 levels, 
thereby confirming that changes to the expression levels of this gene are not resulting in Shh 
expression.  The increase in expression of Etv5, an inhibitor of Shh, may counteract the effect 
of reducing Etv4 and explain why only such a small quantity of Shh is expressed. 
 
In mice, a total of 26 different ETS factors are expressed.  We examined the remainder of these 
in addition to ETS1, GABp, ETV4 and ETV5 to determine if there is a significant variation 
in their gene expression between either proximal and distal limb sections or between 14fp cells 
before and after TSA treatment.  In the limb experiments, there was no significant change in 
any of the other ETS factors except Ets2 (which showed a log2fold FPKM change of less than 
1.5).  However, in the cell lines experiments, in addition to the changes already mentioned, a 
number of other ETS factors showed altered expression profiles.  Elf2, Elf4, Fli1, Erf, Elk3 
and Etv6 all showed a significant reduction in expression on addition of TSA with log2fold 
FPKM changes greater than -1.5. (i.e. ~ a 3-fold decrease or greater).  Etv3 was the only gene 


























































Figure 3.9 – Venn diagrams showing the number of genes with (A) a significant positive 
log2fold FPKM change for the cell line experiments (red circle) and the E11.5 limb bud 
experiments (green circle) and (B) a significant negative log2fold FPKM change for the cell 
line experiments (red circle) and the E11.5 limb bud experiments (green circle).  Areas 
where the circles overlap indicate common genes which show the same pattern of log2fold 









Table 3.8 - Top 20 genes with the greatest positive change in log2fold FPKM values shared 
between both cell line and limb experiments.  In this table genes are ranked according to 
log2fold FPKM values from limb bud experiments. i.e the genes which show an increase in 
expression on TSA treatment and also show an increase in expression in the distal limb 
compared to the proximal limb were compared – the top 20 genes which showed 















change)  q value 
Gja3 chr14:57654496-57676782 4.40322 0.000902763 
Fgf8 chr19:45811287-45817374 3.24119 0.000902763 
Eomes chr9:118387306-118395250 3.13133 0.000902763 
Igfbpl1 chr4:45822378-45839699 2.62534 0.000902763 
Cbln1 chr8:89992751-89996491 2.5122 0.000902763 
Pmaip1 chr18:66618257-66625212 2.4633 0.000902763 
Smpd3 chr8:108776447-108861888 2.38778 0.000902763 
Epha8 chr4:136485333-136512731 2.12861 0.000902763 
Srms chr2:180940267-180947876 2.09892 0.00243874 
Chst8 chr7:35459486-35597730 1.95936 0.000902763 
Pdzd2 chr15:12286808-12522311 1.95711 0.000902763 
Enpp1 chr10:24361216-24431908 1.94541 0.000902763 
Slco4a1 chr2:180195682-180209557 1.86905 0.000902763 
Sgms2 chr3:131021903-131047841 1.84697 0.000902763 
Gldc chr19:30172936-30249908 1.82455 0.000902763 
Lmo7 chr14:102129144-102333910 1.80197 0.000902763 
Gbx2 chr1:91824536-91827751 1.79543 0.0129105 
Dgkk chrX:6356431-6525489 1.79234 0.000902763 
Hey1 chr3:8663358-8667038 1.7818 0.000902763 







Table 3.9 - Top 20 genes with the greatest negative change in log2fold FPKM values shared 
between both cell line and limb experiments.  In this table genes are ranked according to 
log2fold FPKM values changes seen in limb bud experiments. i.e the genes which show a 
decrease in expression on TSA treatment and also show a decrease in expression in the 
distal limb compared to the proximal limb were compared – the top 20 genes which 











change)  q value 
Pkdcc chr17:83614622-83624409 -4.01958 0.000902763 
Tnnt2 chr1:137732962-137748838 -3.83998 0.000902763 
Myl4 chr11:104411976-104448533 -3.3695 0.000902763 
Lox chr18:52676891-52689362 -3.30191 0.000902763 
Osr1 chr12:9581247-9588306 -3.24676 0.000902763 
Matn4 chr2:164215128-164240948 -2.8342 0.000902763 
Rapsn chr2:90875783-90885886 -2.79298 0.000902763 
Tnc chr4:63620818-63708049 -2.6887 0.000902763 
Dkk2 chr3:131748255-131843268 -2.67357 0.000902763 
Col12a1 chr9:79446797-79566485 -2.62952 0.000902763 
Sgcd chr11:46792284-47192804 -2.51521 0.000902763 
4933436C20Rik chr8:94849931-94880019 -2.44038 0.000902763 
Ephx1 chr1:182919686-182947626 -2.43408 0.0158466 
Acta2 chr19:34315580-34329826 -2.4279 0.000902763 
Baalc chr15:38765454-38782810 -2.36165 0.00170037 
Sytl2 chr7:97497208-97558949 -2.34326 0.000902763 
Hic1 chr11:74978066-74983757 -2.32203 0.000902763 
Lrrc32 chr7:105642731-105650340 -2.32061 0.000902763 
Slc24a3 chr2:145068346-145467675 -2.22692 0.000902763 
Hoxb3 chr11:96184439-96209244 -2.22167 0.000902763 
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Figure 3.10 - Bar chart displaying the change in FPKM values of some genes known to play 
a role in limb bud development in (A) cell line experiments and (B) the E11.5 limb bud 
experiment.  FPKM values are displayed as a log scale along the vertical axis. In (A) 
expression of genes from control cells are highlighted in blue, while the expression of genes 
from TSA treated cells are represented as orange bars.  In (B) expression of genes from 
proximal limb dissections are highlighted in blue, while the expression of genes from distal 










3.4.7 88fp cells react similarly to 14fp cells when treated with TSA  
 
To determine if induction of Shh expression upon TSA treatment was a unique feature of the 
14fp cell line or if it could be applied to other limb derived cell lines, we examined the effect 
of TSA treatment on the 88fp cell line.  Firstly increasing concentrations of TSA (1 M, 2 M, 
4M and 8M) were added to the separate flasks of 88fp cells and left for 24 hr (this time 
point was chosen as it is the point of maximum Shh expression on TSA treatment of 14fp 
cells).  Gene expression was tested by quantitative real time PCR using the housekeeping gene 
GAPDH for normalisation (Figure 3.11A).  Similar to the 14fp cells, increasing the 
concentration of TSA above 1 M had no effect on Shh expression.  A 1 M concentration of 
TSA was subsequently chosen to use in further experiments as it yields the maximum Shh 
expression with less cell death than higher concentrations of TSA.  A time course was 
subsequently conducted where Shh expression was monitored at intervals of 3 hr, 6 hr, 16 hr 
and 24 hr after treatment with 1 M TSA.  Like the 14fp cells, there is an incremental increase 
in Shh expression up to 24 hr (Figure 3.11B). 
 
Levels of Pea3 and Gabp were also analysed after 24 hr using different concentrations of 
TSA.  In accordance with 14fp cells, Pea3 decreases upon TSA treatment (Figure 3.11(C)) 
with a significant difference between control and 1 M TSA treated cells (student’s t-test, p = 
0.0152).  A significant increase in Gabp expression was observed with 4 M TSA (student’s 
t-test, p = 0.0351) but not with any other TSA concentration.  However, as only two biological 
replicates were used in this experiment and there are large error bars on the expression bar 





















Figure 3.11 – 88fp cells respond to TSA treatment in a similar manner to 14fp cells (Silvia 
Peluso, manuscript in preparation).  (A-D) RT-qPCR was used to test the expression of Shh, 
Gabpα and Pea3 in 88fp cells under different conditions.  (A) The effect of increasing 
concentrations of TSA (1, 2, 4 and 8 M) on Shh expression were tested by qPCR. (B)  Using 
qPCR the effect of the addition of 1 M TSA on Shh expression was tested at different time 
points (3hr, 6hr, 16hr and 24hr).  (C)(D) The effect of increasing TSA concentrations (1, 2, 4 
and 8 M) on levels of Pea3 (C) and and Gabp (D) were tested by qPCR.  Shh expression 
from the distal limb bud was tested as a comparison for all qPCR experiments.  Gapdh was 













RNA sequencing of control and TSA treated 14fp cells confirms that expression of a large 
number of genes is affected by TSA treatment.  Shh is expressed on addition of TSA, but is 
produced in very small quantities.  This result has been confirmed by both qPCR and 
immunofluorescence (Silvia Peluso, manuscript in preparation).  The other affected genes 
preside within a number of different signaling pathways and are involved in regulating many 
different processes.  However, a number of developmentally important genes expressed within 
either the distal or proximal limb sections are also expressed in the 14fp cells.  It is therefore 
concluded that the 14fp cell line is a good model system to study the signaling pathways 
involved in embryonic limb development.  In addition, the 88fp cell line responds in a similar 
fashion to the 14fp cells with maximum SHH expression obtained using 1 M TSA for 24 hr.  







































The mechanism by which enhancers interact with promoters to regulate gene expression 
remains an ongoing area of research.  As enhancers can interact with genes up to 1 Mb away 
it is widely accepted that under certain circumstances the two sequences can come together by 
the “looping out” of intervening DNA.  The key question is how does an enhancer locate a 
promoter to facilitate such loops?  In some cases, this may occur through a simple diffusion 
process where an enhancer comes into contact with a promoter by chance and binds due to the 
attraction of transcription factors and other proteins at both of these sequences.  In other cases, 
a scanning process has been suggested where the enhancer moves along the DNA only 
stopping when it reaches the promoter (reviewed in (Pennacchio et al., 2013).  In addition, the 
interaction between proteins bound at boundary elements such as CTCF may also bring 
enhancers and promoters into close proximity (Chapter 1.5.1). 
 
In the limb bud, the Sonic hedgehog regulatory domain is guarded by five main CTCF protein 
binding sites which are believed to be of central importance in the construction of a 
Topological Associated Domain (TAD) containing this region.  Two of these binding sites are 
located around the Shh gene while the other three are located within or around the Lmbr1 gene.  
Evidence of this TAD has been shown by Hi-C experiments where the boundaries of the TAD 
are located near these CTCF binding sites.  The binding of CTCF to these binding sites may 
result in the proteins interacting with each other to create a loop-like structure.  Regions within 
the Shh regulatory domain which are inside the loop are thus restricted from interacting with 
regions outside the loop and thus the Shh enhancers are restricted from acting upon genes 
located outside of the TAD.  Of course this is a simplistic view, as several sub-TADs located 
within the Shh regulatory region may appear as smaller loops within the larger looped 
structure. 
 
Recent experiments have looked at the effects of removing CTCF binding sites on the 
structures of TADs (Chapter 1.5.3).  In short, such alterations have shifted the boundaries of 
TADs allowing enhancers to interact with genes with which they had previously been 
restricted.  In humans this can occur naturally resulting in a variety of different diseases 
(Lupiáñez et al., 2015).  It was hypothesised that removing CTCF binding sites situated near 
the boundaries of the TAD containing the Shh regulatory domain may have similar effects.  In 
addition, previous investigations have shown that the Shh containing TAD is highly compact 
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in both Shh expressing and non-expressing tissues (Figure 4.1).  Perhaps, such compaction is 
caused by CTCF protein binding and removal of the binding sites may then relax the structure. 
 
Although the Shh containing TAD maintains a compact structure in a variety of tissues, there 
may be alterations within the TAD that are dependent on the expression status of the Shh gene.  
As mentioned previously (Chapter 1.3.8) one investigation (Amano et al., 2009) noted a 
greater co-localisation between the ZRS and Shh in anterior and posterior portions of the limb 
bud compared to the middle region.  In contrast, a recent collaboration between the Hill and 
Bickmore laboratories showed that the ZRS and Shh co-localise more closely only within the 
ZPA where the gene is expressed (Williamson et al., 2016).  This suggests a mechanism 
whereby the ZRS moves into contact with Shh within the ZPA that then activates the gene. 
 
In collaboration with the Bickmore laboratory a series of ES cell lines have been created each 
with a different deletion of one of the five CTCF binding sites located at the Shh containing 
TAD boundaries (Lettice and Williamson, unpublished).  These deletions were generated 
using the CRISPR/Cas9 system.  Using these cell lines, I have performed a series of 
experiments to analyse the effects of systematically removing different CTCF binding sites on 
the compaction of the Shh locus.  In addition, using the Shh inducible cell lines (Chapter 3), I 
have looked at the co-localisation of the ZRS and Shh under several different conditions that 
activate the gene.  The aim of these experiments was to determine if the ZRS behaves in a 
























Figure 4.1 – Boxplots from 3D-FISH experiments showing the interprobe distance between 
either Shh and Dpp6 or Shh and the ZRS in different embryonic mouse tissues.  The distance 
between Shh and Dpp6 in the genome is roughly equidistant to that between Shh and the 
ZRS (the Shh-Dpp6 region therefore serves as a good control when analysing compaction 
of the Shh-ZRS region).  “A” and “P” refer to anterior and posterior regions of the limb bud.  
All tissue sections are taken from and E11.5 mouse embryo.  Outliers are indicated with 
asterisks.  For each tissue section, the interprobe distance between Shh and Dpp6 is greater 
than that between Shh and the ZRS suggesting that the Shh-Dpp6 region is less compact in 













4.2.1 General Aims 
 
I am interested in how the TAD containing the Shh regulatory domain is affected under 
different conditions.  Firstly, I examined how the conformation of the locus changes between 
Shh expressing and non-expressing 14fp, 88fp and MD cells.  Secondly, in an attempt to 
determine why the Shh locus is so compact, I analysed how the structure of the TAD changes 
when key CTCF binding sites located at the boundaries of the locus are removed. 
 
4.2.2 Experimental Aims 
 
The experimental aims of this section are as follows: 
 
 Perform FISH on 14fp, 88fp and MD cell lines using probes for both Shh and the ZRS 
to examine how the distance between these points changes on the addition of TSA. 
 
 Perform FISH on 14fp cells using probes for both Shh and the ZRS to examine how 
the distance between these points changes when Pea3 is knocked down. 
 
 Perform FISH on 14fp cells using a probe for Shh and a chromosome 5 paint to 
examine if the Shh gene loops out from its chromosome territory on the addition of 
TSA. 
 
 Use custom designed MYtags (fluorescent oligonucleotides) to compare the 
compaction of the genomic region from Shh to the ZRS and the region from Shh to 
Dpp6 in both TSA treated and untreated 14fp cells. 
 
 Use custom designed MYtags to compare the compaction of the region from Shh-ZRS 
and the region from Shh-Dpp6 in both wild type and mutant ES cells which each 







4.3.1 14fp, MD cells and 88fp cells are all hyperdiploid 
 
Before conducting FISH experiments, the ploidy of the 14fp, MD and 88fp cells were 
examined by counting chromosomes in metaphase spreads (Figure 4.2).  Typically, 20 spreads 
or more were captured and analysed for each cell line.  For the 14fp cells, the majority of 
spreads contained between 77 - 83 chromosomes (74 %) and were considered as tetraploid 
(tetraploid mice nuclei should contain exactly 80 chromosomes; however, chromosome 
numbers in this range were considered to be tetraploid due to experimental variation i.e. 
chromosomes lying on top of each other).  The remainder of the spreads contained more than 
40 chromosomes but less than 77 and were considered as simply hyperdiploid.  Similar results 
were obtained with the MD and 88fp cell lines, with slightly greater numbers considered 
hyperdiploid in comparison to tetraploid.  In further experiments where a chromosome 5 paint 
was used (Chapter 4.3.5) in experiments using 14fp cells, four chromosome territories could 
be distinguished in some of the cells thereby confirming that the cells contained 4 copies of 
chromosome 5.  It was important to study the ploidy of each cell line before conducting FISH 
experiments so that the number of FISH probes binding within each nucleus could be 
predicted.  For example, as the majority of the 14fp cells were deemed to be tetraploid this 
suggested that in FISH experiments, four Shh probes and four ZRS probes should be observed 

























Figure 4.2 – Metaphase spreads of 14fp and MD cell lines showing chromosomes labelled 




4.3.2 Shh-ZRS co-localisation does not change in 14fp, 88fp and MD 
cell lines on TSA treatment. 
 
In recent investigations, the ZRS was shown to co-localise more closely to the Shh gene within 
the ZPA of the E11.5 limb bud where SHH is produced (Chapter 4.1).  To determine if the 
ZRS co-localised more closely to Shh in the immortalised limb cell lines (Chapter 3), 3D-FISH 
experiments were performed using probes for both Shh and the ZRS (Table 4.1). 
 
Fosmid probes for both Shh and the ZRS were provided by the Bickmore laboratory and were 
used to perform 3D-FISH experiments in 14fp, 88fp and MD cell lines.  14fp and 88fp cells 
both express Shh on TSA treatment, while MD cells do not and therefore provide a suitable 
control.  Each cell line was treated with either 1 M TSA or DMSO (as a control) for 24 hr 
before fixation.  In 14fp and 88fp cell lines experiments, SHH expression was checked by 
either qPCR or immunofluorescence using a SHH antibody (Figure 4.3).  Immunofluorescence 
of the 14fp cells shows that the majority of the cells contain an increased fluorescent signal 
when treated with TSA.  The antibody used to detect SHH binds to the C-terminal SHH 
peptide, a processed form of the protein which does not leave the cell (unlike the N-terminal 
SHH peptide which can be detected in the extracelluar matrix) (Chapter 1).  Therefore, the 
assumption is that the TSA treated cells are each producing SHH protein and not taking it up 
from the extracellular matrix where it has been produced from other cells. 
 
The distance between the Shh and ZRS probes was measured for each condition in each cell 
line.  Over 100 measurements were recorded for each condition in each experiment (Figures 
4.2 and 4.3).  Mann-Whitney U tests confirmed that there was no statistical difference in the 
distance between the ZRS and Shh after TSA treatment in all three cell lines (p-values > 0.05).  
In a study analysing the chromatin positioning of HoxD enhancers, FISH probes < 200nm 
apart were considered to be co-localised (Williamson et al., 2012).  FISH measurements were 
therefore binned into 200 nm groups and Fisher exact tests performed to determine if there 
was a significant change in the co-localised signals upon TSA treatment.  For the three cell 
lines, p-values > 0.05 were obtained confirming that TSA treatment does not cause a detectable 
change in the co-localisation of Shh and the ZRS.   
 
It should be noted that the expression of Shh on TSA treatment in the 88fp cells is much lower 
than the Shh expression observed in the limb bud controls (Figure 4.4).  Shh expression in the 
14fp cells on TSA treatment is also much lower than limb bud controls (Figures 4.7).  Perhaps 
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the reason why no significant differences were observed in the co-localisation of Shh and the 






Fosmid Start End 
Shh 28754458 28795879 
SBE4 29107140 29147593 
ZRS 29611727 29653695 
 
 



































Figure 4.3 – TSA treatment did not affect co-localisation of Shh and the ZRS in 14fp cells.  
3D-FISH was conducted in duplicate using probes for both Shh and the ZRS.  (A)  SHH 
expression was checked by immunofluorescence for both replicates using a SHH primary 
antibody yielding a green signal when viewed under a fluorescent microscope.  There was 
an observable increase in green signal in TSA treated cells compared to control cells (Nb 
The contrast of these images has been altered so the signal can be viewed more clearly in 
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this document.  However, the same manipulations were conducted on images for both TSA 
treated and control 14fp cells and therefore the difference in green signal between both 
conditions should remain unchanged). (B)  Images from 3D-FISH experiments from one of 
the replicates for both control and TSA treated 14fp cells.  Nuclei are stained with DAPI and 
appear blue.  Both images show a zoomed in image of the red (Shh) and green (ZRS) FISH 
probes.  (C)  The measurements from 3D-FISH data for both control and TSA treated 14fp 
cells were grouped into 200 nm “bins” and plotted as a bar chart.  Signals were considered 
co-localised if they fell into the first bin and were less than or equal to 200 nm apart.  There 
was no significant difference between co-localised signals in the 14fp cells upon TSA 
treatment (as tested by Fisher exact tests) and no significant difference in compaction (as 
tested by Mann-Whiteny U tests – see Figure 4.4(C)).  Over 100 measurements were 
recorded for control and TSA treated cells for both replicates.  Error bars represent the 















Figure 4.4 - TSA treatment did not affect co-localisation of Shh and the ZRS in 88fp and MD 
cell lines.  The measurements from 3D-FISH data for both control and TSA treated 88p and 
MD cells were grouped into 200 nm “bins” and plotted as bar charts.  Signals were 
considered co-localised if they fell into the first bin and were less than or equal to 200 nm 
apart.  (A)(B) There was no significant difference between co-localised signals in the 88fp 
and MD cells upon TSA treatment (as tested by Fisher exact tests). The expression of Shh 
in 88fp TSA treated cells was tested by qPCR (A, upper).  In these graphs error bars 











































































































   



























and MD cells was examined by plotting the distributions of Shh-ZRS distances on boxplots 
and testing the statistical difference between distributions using the Mann-Whitney U test.  
In this plot the measurements for replicate samples are combined with each boxplot 
representing the total number of measurements.  No significant change in compaction 
were observed between the cell lines or between TSA treated and control cells.  Over 100 









































4.3.3 The localisation of probes at the Nuclear Periphery is unaffected 
by TSA treatment  
 
Several investigations have linked the localisation of genes at the nuclear periphery to a 
repression of gene expression (Chapter 1) (Zullo et al., 2012).  It was hypothesised that TSA 
treatment may alter the number of Shh and ZRS probes located at the nuclear periphery, 
perhaps moving them towards the nuclear interior which is associated with an increase in gene 
expression (Therizols et al., 2014).  To investigate this hypothesis, FISH data obtained from 
treating 14fp cells with TSA (as well as the control cells) was used to look at the location of 
both Shh and ZRS probes within the nucleus.  A nuclear erosion script was used which divides 
the nuclear section visualised into 5 regions of equal area (Figure 4.5).  Region 1 incorporates 
the nuclear periphery while region 5 incorporates the nuclear centre.  To determine if the 
difference in the number of probes located in region 1 was significantly different between 
control and TSA treated cells the Fisher exact test was used. There was no significant 
difference between the number of probes located at the nuclear periphery (p-value > 0.05) 
between samples.  This suggests that TSA treatment has no effect on the positioning of the 
Shh locus at the nuclear periphery. 
 
However, one of the caveats of using this nuclear erosion script was that the position of probes 
within the nucleus could only be examined along only two dimensions (i.e. probe position was 
examined along the x and y axes but not along the z axes).  Therefore, in theory some probes 
which appear in region 5 (Figure 4.5) and are considered to be located within the nuclear centre 



















Figure 4.5 – Shh and ZRS probes do not move away from the nuclear periphery upon TSA 
treatment.  A nuclear erosion script was used to analyse the position of Shh and ZRS probes 
from the 14fp cell FISH experiments within the nucleus.  This divided the nucleus into 5 
regions each of equal area.  The first region included the nuclear periphery while the fifth 
was situated at the nuclear centre (regions labelled 1-5).  The number of probes located in 
each region was determined.  There was no significant difference in the number of probes 
located at the nuclear periphery in 14fp control and TSA treated cells as tested by using the 











































4.3.4 Knock down of PEA3 induces SHH expression, but has no effect 
on Shh-ZRS co-localisation 
 
In order to determine if additional experimental methods of inducing Shh expression - other 
than the addition of TSA - had an effect on the co-localisation of the ZRS and Shh 3D-FISH 
was performed on both control 14fp cells and 14fp cells with knocked down levels of Pea3.  
This was achieved by using Pea3 ShRNAi mediated through use of a lentivirus (performed by 
Silvia Peluso).  PEA3 protein (also known as ETV4) was previously shown to bind to the ZRS 
and act as a negative regulator of Shh expression.  In combination with other ETS factors, this 
restricts Shh expression to the ZPA of the E11.5 mouse embryo.  In the 14fp cells, Silvia 
Peluso (manuscript in preparation) showed that knock down of Pea3 induces Shh expression 
(Chapter 3.1.3). 
 
In this experiment, the effect of Pea3 knock down on Shh expression was analysed by 
performing immunofluorescence on both control 14fp cells and cells with knocked down 
levels of PEA3 using a SHH antibody (performed by Silvia Peluso).  Cells with reduced levels 
of PEA3 showed an increase in SHH expression compared to the controls (Figure 4.6(A)) as 
indicated by an increase in the fluorescent signal confirming that reducing PEA3 levels 
increases SHH expression.  However, there was no significant difference in the distance 
between Shh and the ZRS when comparing control cells and cells with reduced levels of PEA3 
(p-value > 0.05).  In addition, there was no significant difference in the proportion of co-
localising signals (p-value > 0.05) between both conditions.  Therefore, it was concluded that 
although knock-down of PEA3 increases SHH expression, it has no effect on the distance 

















Figure 4.6 – Reduced levels of PEA3 increase Shh expression but have no effect on Shh-ZRS 
co-localisation.  3D-FISH was performed on control 14fp cells and 14fp cells with knocked 
down Pea3.  (A, upper) Immunofluorescence was used to check that knock down of Pea3 



























































An increase in green signal was detectable in Pea3 knock down 14fp cells suggesting an 
increase in Shh expression.  (Nb The contrast of these images has been altered so the signal 
can be viewed more clearly in this document.  However, the same manipulations were 
conducted on images for both TSA treated and control 14fp cells and therefore the 
difference in green signal between both conditions should remain unchanged).  (A, lower) 
Images from 3D-FISH experiments from both the Pea3 knock down control and Pea3 knock 
down 14fp cells.  Nuclei are stained with DAPI and appear blue.  Both images show a 
zoomed in image of the red (Shh) and green (ZRS) FISH probes.  (B) The measurements from 
3D-FISH data for both Pea3 knock down control and Pea3 knock down 14fp cells were 
grouped into 200 nm “bins” and plotted as bar charts.  Signals were considered co-localised 
if they fell into the first bin and were less than or equal to 200 nm apart.  There was no 
significant difference between co-localised signals in the Pea3 knock down control and 
Pea3 knock down 14fp cells (as tested by Fisher exact tests).  Over 100 measurements were 



































4.3.5 TSA treatment causes Shh to loop out of its Chromosome 
Territory 
 
3D-FISH experiments on the different cell lines showed that TSA treatment did not have an 
effect on co-localisation of Shh and the ZRS.  One reason for this may be that the cells were 
expressing Shh at a very low level and, differences in co-localisation were too minor to be 
detected by FISH.  Alternatively, the Shh gene may be activated through additional 
mechanisms on addition of TSA. 
 
It was hypothesised that if TSA had no effect on Shh-ZRS co-localisation, it may activate the 
Shh gene by causing it to loop out of its chromosome territory into the contact of transcription 
factories (Chambeyron and Bickmore, 2004).  This was tested by performing FISH on 14fp 
cells using a fosmid probe for the Shh gene and a chromosome 5 paint (Shh is located within 
chromosome 5) on both control and TSA treated samples.  Chromosome paints consist of 
different nucleic acid probes containing fluorophores which can hybridize to specific DNA 
sequences.  In this case, the probes bind to chromosome 5 which can then be visualised using 
a fluorescence microscope. 
 
The experiment was repeated in duplicate with > 50 chromosome territories examined for each 
condition and replicate (Figure 4.7).  Shh expression of TSA treated cells was checked by 
qPCR.  Fisher exact tests were performed on the combined control and TSA distributions.  
There was a significant difference between control and TSA treated samples (p-value = 
0.0364), thereby suggesting that TSA treatment caused an increase in the number of Shh 
probes located outside the chromosome territories rather than inside the territories.  This 
increase in localisation outside of the chromosome territory may result in expression of the 
Shh gene. 
 
To confirm that the looping out of the Shh gene from its chromosome territory is a result of 
Shh expression and not simply an effect of TSA, similar experiments are being repeated with 
MD cells as a control.  If TSA has no effect on Shh looping in MD cells the looping out of the 













































Figure 4.7 – Shh loops out of its chromosome territory upon TSA treatment.  (A)(B) FISH 
experiments were conducted using a chromosome 5 paint (which fluoresces green under 
the fluorescent microscope) and a fosmid probe for Shh (red).  (A)  In the 14fp cell line 
distinct chromosome 5 territories could be visualised (red arrows) with most cells 
containing between three and four of these territories.  (A, inset) A zoomed-in view of one 
of the chromosome 5 territories with the Shh gene positioned outside it.  (B) SHH 
expression was tested for in this experiment by qPCR.  (C)  Bar graphs showing the 
proportion of Shh probe located either inside or outside the chromosome 5 territories in 
control and TSA treated 14fp cells.  There was a significant increase in the proportion of 
probes located outside the chromosome 5 territories upon TSA treatment.  This was 





4.3.6 Analysis of Chromatin Compaction at the Shh locus in 14fp cells  
 
The data presented in Chapter 4.3.1 – 4.3.5 shows that in the immortalised limb cell lines 
(14fp, 88fp and MD cells) there is no change in Shh-ZRS co-localisation upon Shh expression.  
However, like E11.5 limb cells (Figure 4.1), the Shh-ZRS region in the cell lines is highly 
compact with roughly 20 % of probes co-localised (interprobe distance ≤ 200nm) even when 
Shh is not expressed.  To look at compaction of the Shh locus within the 14fp cell line in more 
detail, MYtag technology was utilised where individual nucleic acids of roughly 40-60 bp are 
directly labelled with a fluorescent probe.  Together MYtag libraries (consisting of thousands 
of fluorescently labelled nucleic acid probes) can be used in FISH experiments (instead of 
fosmid probes) to tile areas of the genome and can be visualised under a fluorescent 
microscope.  The purpose of this was to examine the structure of the locus containing Shh and 
the ZRS in comparison to a neighbouring region of similar length (i.e. the region between Shh 
and Dpp6).  It was hoped that using MYtags would help to visualise local 
architectural/structural features within the Shh-ZRS TAD; in particular, those not visualised 
by 3D-FISH.   
 
In these experiments, eight regions of 20 kb were tiled using MYtags between the Shh gene 
and the ZRS (Chr5: 28,783,380 - 29,704,930) with a 100 kb spacing between each region 
(Figure 4.11(B)).  As a control, another region of equal size ranging from Shh to Dpp6 (Chr5: 
27,861,830 - 28,783,380) was tiled using MYtags in a similar fashion. In preliminary 
experiments (with ES cells) the Shh-ZRS MYtags contained an ATTO-488 fluorophore, while 
the Shh-Dpp6 MYtags contained an ATTO-647N fluorophore.  However, these fluoresced 
with only a faint signal under the microscope and it was difficult to discriminate between the 
20 kb MYtag spots.  These libraries were subsequently re-ordered with the Shh-ZRS 
fluorophore replaced by ATTO-594 and the Shh-Dpp6 fluorophore replaced by 6-FAM.  The 
subsequent images obtained were much brighter.  All MYtag experiments were conducted 
using a 2D-FISH protocol as described in the Methods Chapter.   
 
For both control and TSA treated cells, the number of spots observed for the Shh-ZRS region 
(appear as red spots) and the Shh-Dpp6 region (appear as green spots) were counted (Figure 
4.8).  In total, spots for over 100 different sets of Shh-ZRS and Shh-Dpp6 loci for both control 
and treated cells were counted. On examining spot numbers, it became obvious that for any 
given loci one large spot may consist of several smaller spots which cannot be individually 
identified.  In this way, counting the number of spots may not be completely reflective of the 
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relative compaction of a locus.  Therefore, in addition to counting the number of spots the total 
area covered by the spots, per locus was also measured. 
 
In both TSA treated and control 14fp cells, there was a significant difference in the number of 
spots counted for the Shh-ZRS loci compared to the Shh-Dpp6 loci (p-values < 0.0001).  The 
Shh-Dpp6 loci showed consistently more spots than the Shh-ZRS loci suggesting that the latter 
are much more compact (Figure 4.9).  The boxplots for Shh-ZRS and Shh-Dpp6 loci for both 
treated and untreated 14fp cells are almost identical to those obtained in the ES cell 
experiments (Chapter 4.3.8).  This suggests that the extent to which both the Shh-ZRS and 
Shh-Dpp6 loci are compacted is similar across different cell lines.  However, there was no 
significant difference (p-value > 0.05) in the number of spots counted for the Shh-ZRS loci 
between TSA treated and control 14fp cells, thereby suggesting that TSA treatment does not 
alter the compaction of this locus. 
 
Again, when spot area was analysed there was a significant difference between the area of red 
(Shh-ZRS) and green (Shh-Dpp6) spots in both control and TSA treated cells (p-values < 
0.0001).  The area of green spots was greater in both cases suggesting that the Shh-Dpp6 locus 
was less compact.  In contrast, there was no significant difference between the area of red spots 
between control and TSA treated cells (p-value > 0.05).  Therefore, in this case analysis of 
both spot area and spot number suggested that TSA treatment did not alter the compaction of 





















































Figure 4.8 - Images showing the MYtag spots in (A) Control and (B) TSA treated 14fp cells.  
Inset in each image is an enhanced view of MYtags binding at one locus. Red arrows point 























































Figure 4.9 – (A) Boxplots showing the distribution of the number of red and green spots 
counted for control and TSA treated 14fp cells (n>100). (B)(C) The number of red and green 
spots counted for control (B) and TSA treated (C) 14fp cells in MYtag experiments plotted 
as a bar charts.  The number of spots counted per locus (horizontal axis) is plotted against 
the percentage of the total spots counted (vertical axis).  Red bars represent red spots 
counted for the MYtags binding to the region between Shh and Lmbr1, while green bars 













































Figure 4.10 – (A) Boxplots showing the distribution of red and green spot areas counted for 
control and TSA treated 14fp cells (n>100) (B)(C) The area of red and green spots counted 
for control (B) and TSA treated (C) 14fp cells in MYtag experiments plotted as a bar charts.  
The area of spots counted per locus (horizontal axis) is plotted against the percentage of 
the total spots counted (vertical axis).  Red bars represent red spots counted for the MYtags 
binding to the region between Shh and Lmbr1, while green bars represent green spots 





4.3.7 Analysis of Chromatin Compaction at the Shh locus in ES cells 
 
Chapter 4.3.6 showed that the Shh-ZRS region is much more compact than the Shh-Dpp6 
region which is of similar size.  However, what caused this high degree of compaction was 
unknown.  It was hypothesised that the binding of the protein CTCF to specific binding sites 
at the boundaries of the TAD containing Shh may help to create such a compact structure.  To 
test this hypothesis, FISH experiments were conducted (similar to those detailed in Chapter 
4.3.6) with MYtags on ES cells containing specific deletions of CTCF binding sites at the 
boundaries of the Shh containing TAD.   
 
The ES cell mutants were provided by Williamson and Lettice (manuscript in preparation). 
Functional CTCF binding sites were identified by Chip-seq as part of the ENCODE project, 
with the 5 regions used within the Shh regulatory region appearing as peaks in multiple cell 
lines.  The ‘Optimized CRISPR Design tool’ (http://crispr.mit.edu/) was used to design guide 
RNAs which flanked either side of the peaks (regions ranging from 750 bp to 1.4 kb). The 
resultant oligos were cloned into px458, which carries Cas9 from S. pyogenes in addition to 
2A-EGFP, and a cloning backbone for the sgRNA (Addgene). E14Tg2A ES cells were 
electroporated with both the vectors for one CTCF site and allowed to grow for 48 hours before 
being FACS sorted for the GFP contained within the vector. Fluorescent cells were then plated 
at low density until clones became apparent (approximately 10 days). Homozygous clones 
were identified by PCR screening for the presence of the shorter deleted allele and the absence 
of wildtype one and expanded for further analysis.  Each of these cell lines therefore had a 
deletion of a single CTCF binding site located at the boundaries of the Shh locus.  The locations 
of the CTCF deletions are labelled 1-5 on Figure 4.11(B).  For the remainder of this document, 
these mutant cell lines are referred to as ES mutant 1-5. 
 
For each cell line, the number of spots observed for the Shh-ZRS region (appear as red spots) 
and the Shh-Dpp6 region (appear as green spots) were counted.  In total, spots for over 100 
different sets of Shh-ZRS and Shh-Dpp6 loci (70 loci for ES mutant 3) were counted.  As all 
the ES cells were diploid, roughly 50 different nuclei were examined.  In total, a maximum of 
6 red spots in a single locus were observed, while all eight green spots could be observed in a 
single locus in all cell lines.  This suggests that compared to the Shh-Dpp6 region, the Shh-
ZRS region is more compact.   
 
On viewing the boxplots of both spot number and spot area for the Shh-ZRS and Shh-Dpp6 
regions, it is immediately obvious that the Shh-ZRS region is much more compact than the 
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Shh-Dpp6 region in both E14 wild type ES cells and all the mutant cell lines (Figure 4.12).  
Mann-Whitney U tests were used to analyse the distribution of spot numbers between Shh-
ZRS and Shh-Dpp6 regions across all the cell lines.  A p-value of <0.0001 was produced for 
both wild type and mutant lines, thereby confirming that there is a highly significant difference 
between the number of observed spots for the Shh-ZRS locus compared to the number of spots 
observed for the Shh-Dpp6 locus across all cell lines studied. When the Shh-ZRS spot number 
distributions were compared to those of each of the mutants separately, there was no statistical 
difference.  Therefore, when analysing in terms of spot number, there is no notable change in 
compaction of the Shh-ZRS locus in ES cells when CTCF sites binding the locus are removed 
independently.  
 
In contrast to the spot number analysis, there was a significant difference in the total area 
(Figure 4.12(C)) of Shh-ZRS spots in the wild type cells compared to each of the CTCF mutant 
cell lines (p-value < 0.0001) with the wild type cells being less compact.  In this experiment, 
analysis of both spot number and spot area produce conflicting results and, therefore, it cannot 
be confirmed if the CTCF deletions have an effect on compaction.  Perhaps analysing spot 
area is more sensitive than analysing spot number.  Performing chromosome conformation 
capture experiments (3C) on each of the cell lines and comparing the results to these MYtag 
experiments, may help to determine whether analysing spot area or spot number is more 
accurate. 
  
















Figure 4.11 – (A) The heat map obtained from Hi-C showing the topological associated 
domain (TAD) containing the Shh gene in mouse ESCs at 40 kb resolution 
(http://promoter.bx.psu.edu/hi-c/).  Interactions between regions are depicted by a red 
pixel, with a more intense red colour signifying a stronger interaction.  Regions of CTCF 
binding obtained from Encode E14 ChIP data are shown below the heat map 
(https://genome.ucsc.edu/ENCODE/).  (B)  The region spanning from Lmbr1 to Dpp6 
showing the position MYtag clusters bind.  8 MYtag clusters bind between Shh and Lmbr1 
and are labelled with the ATT0-594 fluorophore appearing red under the microscope while 
8 MYtag clusters bind between Shh and Dpp6 and are labelled with the fluorophore 6-FAM 
appearing green under the microscope.  Each cluster is 20 kb in length with roughly 100 kb 
spacing between each cluster.  Regions of CTCF binding obtained from Encode E14 ChIP 
data are shown below the heat map with labels 1 – 5 signifying the position of the CTCF 








Figure 4.12 – (A) Images showing the MYtag spots in the 5 mutant ES cell lines.  Red spots 
are Mytags binding to the region between Shh and Dpp6 while green spots are MYtags 
binding to the region between Shh and Lmbr1.  Red arrows point to the position of the 
MYtags.  (Inset) Enhanced image of MYtags binding at one locus per mutant cell line.  (B) 
Boxplots showing the distribution of the number of red and green spots counted for wild 
type and mutant ES cells (n>70).  (C) Boxplots showing the distribution of calculated spot 








Figure 4.13 – The number of red and green spots counted for E14 wild type and mutant ES 
cells in the MYtag experiments plotted as a bar charts.  The number of spots counted per 
locus (horizontal axis) is plotted against the percentage of the total spots counted (vertical 
axis) for that particular cell line.  Red bars represent red spots counted for the MYtags 
binding to the region between Shh and Lmbr1, while green bars represent green spots 











Figure 4.14 - The area of red and green spots counted for E14 wild type and mutant ES cells 
in the MYtag experiments plotted as a bar charts.  The area of spots counted per locus 
(horizontal axis) is plotted against the percentage of the total spots counted (vertical axis) 
for that particular cell line.  Red bars represent the areas of red spots for the MYtags 
binding to the region between Shh and Lmbr1, while green bars represent the areas of 
green spots for the MYtags binding to the region between Shh and Dpp6. 
 179 
4.4 Discussion  
 
In this chapter, 3D-FISH experiments showed that the distance between the ZRS and Shh is 
unaffected in 14fp, 88fp and MD cells when treated with TSA.  This is also the case when 
PEA3 levels are reduced (an alternative method of inducing Shh expression) in the 14fp cell 
lines.  The distance of these FISH probes from the nuclear periphery is also unaffected upon 
TSA treatment.  These results contrast recent FISH data in which Shh and ZRS signals co-
localise more closely in the ZPA of the E11.5 limb bud where Shh is expressed, compared to 
other regions of the limb where Shh is not expressed (Williamson et al., 2016).  The reason for 
these conflicting results is unclear but it is possible that TSA may activate the gene through 
some alternative mechanism (discussed further in Chapter 5 and Silvia Peluso - manuscript in 
preparation).  It should also be noted that compared to the ZPA of an E11.5 limb bud, the 
expression of Shh in the 14fp cells upon TSA treatment is relatively low.  Although TSA is 
activating the Shh gene in 14fp cells, interactions may be occurring at a low level at any one 
time and, therefore, the co-localization of the ZRS Shh is not detectable by FISH. 
 
An additional method of inducing Shh expression is to increase expression of the protein 
GABP (Chapter 3).  At present experiments are ongoing to determine if increasing levels of 
GABP has an effect on the co-localisation of the Shh gene and the ZRS.  To do this, 14fp 
cells are transfected with a Gabp expression vector (Figure 4.15) capable of producing 
GABP on treatment with doxycycline (dox) (Silvia Peluso - manuscript in preparation) and 
tested for Shh-ZRS co-localisation by 3D-FISH experiments.  Attempts are being made to 
optimise this experiment by FACS sorting only the mCherry positive GABP expressing cells 
before performing FISH.  In this way, the distances between the ZRS and Shh can be examined 
in cells exclusively expressing GABP. 
 
Interestingly, there was a significant increase in the proportion of Shh probes located outside 
the nuclear territory compared to those located inside the territory upon TSA treatment.  This 
accords with published data suggesting that within the ZPA, Shh relocates outside of its 
chromosome territory causing SHH production.  Preliminary FISH data (see Appendix) using 
probes for both Shh and SBE4 in 14fp cells, where SBE4 is located between Shh and the ZRS 
in the locus, also suggests that the distance between Shh and SBE4 is greater than that between 
Shh and the ZRS.  This also agrees with recent findings (Williamson et al., 2016) suggesting 
that in all cells, Shh and the ZRS are held tightly together perhaps forming a loop which moves 
SBE4 further away from both points (Appendices - Figure 1). 
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To analyse compaction of the 14fp cells, directly labelled fluorescent probes called MYtags 
were used to tile the regions spanning from Shh to the ZRS, and then from Shh to the Dpp6, 
where the distance between Shh-ZRS is roughly the same as that between Shh-Dpp6.  The 
Shh-ZRS region was significantly more compact than the Shh-Dpp6 region but, compaction 
of the Shh-ZRS region was unaffected by treatment with TSA.  Again, this confirms that Shh-
ZRS locus maintains a baseline level of compaction regardless of cell type, tissue or the 
expression status of the Shh gene.  It should be noted that when using MYtags a complete 
complement of 8 spots were observed for the Shh-Dpp6 region but only a maximum of 6 spots 
for the Shh-ZRS region.  It was rationalised that the reason for this observation was that the 
Shh-ZRS region was more compact and therefore the spots were lying on top of each other so 
that only a select few could be observed.  Of course, it may be that some of the MYtags did 
not anneal correctly and this is why 6 spots - instead of the full complement of 8 - were 
observed.  To confirm that this is not the case, Fibre-FISH - which involves stretching out 
DNA - could be performed using the MYtags.  If 8 spots are observed for the Shh-ZRS region, 
this would confirm that all MYtags are capable of binding and, the reason only 6 are seen in 
the ES cell and 14fp experiments is due to the compact nature of the chromatin. 
 
MYtags were also used to analyse how compaction of the Shh locus is affected when key 
CTCF binding sites at the boundaries of the TAD containing the locus are deleted.  To carry 
out this examination, ES cells were used each containing deletions of a separate CTCF binding 
site (deletions obtained using the CRISP/Cas9 system).  It was found that in both wild type 
and mutant cell lines, the Shh-ZRS region was always more tightly compact than the region 
between Shh-Dpp6.  However, on analysis of spot number, there was no significant difference 
in compaction of the Shh-ZRS loci between the different cell lines.  In contrast, when spot area 
was analysed wild type cells were shown to be less compact than each of the mutant cell lines.  
The reasons for this are unclear as deletion of CTCF sites were expected to make the locus 
less compact.  To confirm that the locus is becoming more compact on deletion of CTCF sites 
3D-FISH experiments could be conducted on both wild type and CTCF mutant ES cells.  
Measuring the distance between various probes located across the Shh locus in these cell lines 
should confirm whether the mutants are less compact. 
 
However, independent of spot number or spot area analysis, these results confirm recently 
published data that the Shh locus is highly compact even in tissues not expressing Shh.  When 
considering spot number analyses, the reason why deletion of the CTCF binding sites did not 
affect compaction of the Shh locus is unclear. However, deleting one CTCF site at a time still 
 181 
leaves 4 sites intact at the boundaries of the locus in addition to other sites located further away 
which may be enough to maintain the chromatin structure.  It is postulated that if this 
experiment was repeated in ES cells containing double or triple deletions of TAD boundary 
CTCF binding sites, there would be a more pronounced relaxation of the chromatin structure 







Figure 4.15 - The expression vector used to express GABP on dox administration.  Cells 
are selected by growing in medium containing G418 solution.  Those containing the vector 
express the neo gene thereby producing neomycin and are resistant.  The placement of the 
IRES2 site within the vector also allows the production of the Tet-On 3G protein in addition 
to neomycin from the same PSV40 promoter.  In the presence of dox, Tet-On 3G can bind 
to the PTRE3G promoter resulting in the production of mCherry and FLAG tagged GABP 
with both proteins produced separately due to the presence of the intervening P2A self-
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In summary, (when considering spot number analyses) compaction of the Shh regulatory 
region was unaffected in ES cells with single deletions of CTCF binding sites located at the 
boundaries of the TAD containing Shh.  Compaction of the locus was also not affected when 
14fp cells were treated with TSA. 14fp, 88fp and MD cell lines showed no significant changes 
in Shh-ZRS co-localisation upon TSA treatment and, in addition, reducing PEA3 levels or 
increasing GABP levels had no effect on Shh-ZRS co-localisation in 14fp cells.  In contrast, 
TSA treatment caused Shh to loop out of its chromosome territory in 14fp cells which possibly 
















































Chapter 4 details the use of FISH experiments to explore compaction of the Shh locus and co-
localisation of Shh and the ZRS in different cell lines.  Firstly, 3D-FISH experiments using 
fosmid probes confirmed that, at least in the cell lines (14fp, 88fp and MD cell lines), there is 
no difference in the proximity of Shh and the ZRS in both TSA treated cells and untreated 
cells.  Secondly, experiments performed in 14fp and ES cells using MYtags confirmed that 
the region from Shh to the ZRS is much more compact than that between Shh and Dpp6.  
However, these experiments gave little insight into the effect Shh expression has on Shh gene 
interactions within the entire Shh regulatory domain.  To identify these additional changes 
within the locus (if any), we used a combined approach of carbon copy chromosome 
conformation capture (5C) with 3D modelling and circular chromosome conformation capture 
(4C).  3C techniques are commonly used to confirm results from FISH data and vice versa.  
However, although these techniques are usually complementary, there are situations where 
results obtained from such procedures do not correlate.  For example, in one investigation an 
increase in interaction frequency between two 5C restriction fragments was observed for a 
region shown to become less compact in FISH experiments (Williamson et al., 2014).  
Therefore, we were also interested in how the results from both 4C and 5C would compare 
with the previously obtained FISH data and the predicted structural models of the Shh 
regulatory domain. 
 
Chromatin conformation capture techniques have already been used to study the Shh locus in 
several different tissues.  In the limb bud 3C confirmed FISH data that the ZRS and Shh are in 
close proximity in both anterior and posterior portions of the limb (Amano et al., 2009).  5C 
experiments using cells from the embryonic limb, head and body confirmed Hi-C data that the 
Shh regulatory region is contained within a TAD and the structure of this TAD is conserved 
across different tissues (Williamson et al., 2016). 
 
As mentioned previously (Chapter 1), the activity of enhancers within the Shh regulatory 
region has been examined using the sleeping beauty transposon system (Anderson et al., 2014).  
The sleeping beauty transposon carrying LacZ reporter gene inserts randomly into the locus 
allowing the spatiotemporal activity of the various enhancers to be assessed.  This showed that 
the ZRS acted upon regions very close to itself in either direction.  Inserts in the gene desert 
showed increasing LacZ expression the closer they were positioned to Shh.  Therefore, using 
5C we proposed to examine whether the frequency of ZRS contacts increases closer to Shh (in 
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agreement with the Sleeping Beauty system) and whether there are any other substantial 











































5.2 Aims  
 
5.2.1 General Aims 
 
The aim of this section was to perform chromosome conformation experiments on the Shh 
inducible and control cell lines (14fp, 88fp and MD cells) to identify interaction differences.  
The interactions within the TAD containing the Shh gene will be examined to determine the 
changes that may occur in the activation of Shh expression. 
 
5.2.2 Experimental Aims 
 
The experimental aims of this section are as follows: 
 
 Perform 5C on both TSA treated and control (Shh expressing and non-expressing) 
14fp, 88fp and MD cell lines. 
 
 Identify significant interaction differences between the cell lines using in silico 4C 
profiles. 
 
 Identify significant interaction differences between TSA treated and control cells (Shh 
expressing and non-expressing) of the same cell line using in silico 4C profiles. 
 
 Use the Autochrom3D modelling tool to create 3D models of the 5C data.  
 



















5.3.1. 5C quality control and processing 
 
5C experiments were conducted as described in Chapter 2.  Gel pictures showing quality 
control checks at various stages of the protocol are provided in Figure 5.1.  All 5C libraries 
were created by first producing a 3C library by digesting formaldehyde fixed cells with HindIII 
restriction enzyme followed by ligation with T4 DNA ligase.  5C primers (provided by the 
Bickmore laboratory) designed to anneal to the ends of HindIII fragments were annealed, 
ligated and amplified to produce the final 5C library.  In total 365 primers were designed to 
anneal across a region encompassing the entire Shh TAD (Chr5: 28,317,087-30,005,000).   All 
5C libraries were sequenced using in-house Ion Torrent PGM sequencing.  The number of raw 
sequence reads are provided in Table 5.1.   These were processed using an automated pipeline 
provided by the Dostie laboratory which filtered out poor quality reads (Q < 30) and aligned 
remaining reads to the mouse mm9 genome.  The output of this tool was an interaction 
frequency matrix which can be used uploaded onto the my5C website 
(http://my5c.umassmed.edu/welcome/welcome.php) and used to analyse 5C heatmaps. 
 
In addition to primers designed across the Shh regulatory region, primers were also designed 
for a region containing Usp22 gene (Chr11: 60,917,307-61,003,268) which in previous studies 
shows no interaction with the Shh regulatory domain and therefore acts as a good control 
region for 5C experiments (Berlivet et al., 2013).  High quality 5C experiments showed 
interactions within the Usp22 gene which did not interact with the Shh containing TAD.  Poor 
quality experiments showed interactions between the TADS containing the Shh and Usp22 
genes and subsequently discarded. The quality of 5C experiments could also be examined 
using R packages such as HiTC, the output of which is shown in Figure 5.2.  This shows that 
all interactions are maintained within a single chromosome with negligible trans interactions 
across different chromosomes (Figure 5.2(A)).  Also, the interactions of a single point are 
greatest with those closest to it with the interaction frequency decreasing with points which 
are further away (Figure 5.2(B)).   
 
All 5C experiments were normalized by dividing reads counts per primer pair by the total read 
number and multiplying the values by 1000.  This produced a matrix with each value in the 
matrix representing the frequency with which two primers interact (termed the interaction 
frequencies).  These were analysed using my5C.  For initial analysis (example in Figure 5.3) 
primer pair interactions were binned into 30 kb regions producing 57 “bins” spanning the 
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region from Chr5: 28317087 – 30005000.  Interactions were also studied in 10 kb and 50 kb 
bins (Figure 5.5). Unaltered heat maps are included in the Appendices.  In some experiments 
single primer pair interactions produced interaction frequencies with a much greater value 
(>100 fold) than the average interaction frequency.  These were removed from the interaction 
frequency matrices before normalization.  Other studies have removed single interaction 
frequency values in a similar way (Smith et al., 2016).  Pearson coefficients were calculated 
to determine how similar the interaction frequency matrices of each 5C experiment were 
(Table 5.2). These values range from zero to one, with a value of zero suggesting no correlation 
and a value of one suggesting a perfect correlation between two samples.  Replicate 5C 
samples showed a high degree of similarity with Pearson coefficient values > 0.69 (Table 5.2).  
Upon removal of singletons, these values also increased showing an even greater degree of 



























Sample Biological Replicate 1 Biological Replicate 2 
88fp Control 923,410 4,201,036
88fp TSA 1,584,078 3,856,256
14fp Control 3,173,784 2,863,822
14fp TSA 4,604,748 N/A
MD Control 4,181,036 N/A











































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.1 - Agarose gels showing quality checks at various stages of the 4C/5C protocols.  
(A)  Undigested decrosslinked formaldehyde fixed cells appear as a high molecular weight 
band while decrosslinked Hind III digested cells appear as a high molecular weight smear 
(running from around 12 – 4 kb).  (B)  3C libraries appear as a high molecular weight band.  
(C) In 4C the 2nd restriction digest (in this case with enzyme MlucI) results in a low molecular 
weight smear running from around 0.3 – 1 kb.  (D)  Different starting concentrations of 4C 
library (0 – 200 ng) are tested by PCR to assess which concentration produces maximum 
product while at the same time avoiding saturation.  This concentration is used in 
subsequent PCRs.  (E) In the 5C protocol, 3C libraries are tested by PCR using two primers 
on HindIII fragments which only come together on ligation of successfully digested cells.  
The 3C libraries are first serially diluted with PCR conducted on increasingly lower starting 
concentrations.  PCRs run on an agarose gel show a decrease in amplified PCR product with 
an eventual increase in primer dimer.  Using gel densitometry, the intensity of this product 
can be plotted against starting 3C library concentration.  The starting 3C library 












































Figure 5.2 – Quality control checks used to assess the 5C experiments.  (A) A typical 5C 
experiment shows only intra molecular interactions and no trans interactions.  (B)  For a 






Figure 5.3 – A typical heat map obtained from the my5C website (in this case for the TSA 
treated 88fp cell line with interactions binned into 30 kb regions).  Each pixel represents an 
interaction between two regions. Interactions occurring at low frequency appear white, 
while more frequent interactions appear red.  The most frequent interactions appear black.  
A dissecting diagonal line appears in black signifying the high interaction frequency of 
regions located next to each other.  This line highlights the genomic position of the binned 
fragments i.e. bin 0 (beginning Chr5:  28317087) begins at the top left of the heat map while 
bin 56 appears in the bottom right corner (ending Chr5:  30005000).  All cell lines studied 
show 3 large TADs (visible as 3 large red squares).  The first TAD contains the genes En2, 
Cnpy1 and Rbm33, the second TAD contains the genes Shh, Rnf32 and part of Lmbr1, while 
the third TAD contains the remainder of Lmbr1, Nom1 and Mnx1.  Each heat map consists 
of two triangles displaying the same interactions reflected along the diagonal.  Only one of 
these triangles needs to be analysed and subsequent heat maps are depicted as a single 
triangle.  E14 limb ChIP-seq peaks from ENCODE are displayed and labelled as Chapter 4. 
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5.3.2 Optimisation of 5C Procedure 
 
Before sequencing, 3 l of each 5C library was amplified through 26 cycles of PCR and 
analysed using the Agilent Bioanalyser.  However, on several occasions this did not produce 
enough amplified 5C library for sequencing and left a substantial amount of primer dimers 
which may affect sequencing.  Therefore, for certain libraries PCR was conducted using an 
increased starting volume of 5C library from 3 l to 6 l and the number of cycles was 
increased from 26 cycles to 28, 30 and occasionally 32 cycles.  This produced substantially 
more 5C product with less primer dimer for sequencing. 
 
5.3.3 The TAD containing the Shh regulatory domain is conserved 
across the cell lines  
 
5C experiments were conducted using TSA treated and control 14fp, 88fp and MD cell lines.  
The aim of these experiments was to determine how the interactions of the ZRS and the Shh 
gene are altered between Shh expressing and non-expressing cells.  As mentioned in the 
previous chapters, the 14fp and 88fp cell lines express Shh on TSA treatment while the MD 
cells do not and are therefore used as a control.   Each 5C experiment produced a heat map 
with the same general features as Figure 5.3 (when interactions are grouped into 30 kb bins).  
In this heat map, three main TADs are obvious.  The first spans from bin 0 to bin 14 (Chr5:  
28317087 – 28767087); the second from bin 14 to bin 44 (Chr5:28737087 – 29667087); and, 
the third from bin 45 to bin 56 (chr5:29667087 – 30005000).  The first TAD contains the genes 
En2, Cnpy1 and Rbm33; the second TAD contains Shh, Rnf32 and part of the Lmbr1 gene; 
and, the third contains the remainder of Lmbr1, Nom1 and Mnx1.  The position of the TAD 
boundaries correlates closely with CTCF binding sites.  For example, limb E14 CTCF peaks 
located near the Shh gene are very close to the boundary between TADs 1 and 2 and, peaks at 
the Lmbr1 gene are close to the boundary between TADs 2 and 3 (these CTCF binding sites 
are those which have been deleted in MYtag ES cell experiments and the labelling of peaks is 
consistent with Chapter 4).  Interestingly, a smaller region of high interactions is observed 
between bins 43 and 46 (Chr5:29607087 – 29727087) which lies between TADs 2 and 3.  This 
may be a smaller TAD formed by the interactions of CTCF protein bound at sites 3, 4 and 5. 






5.3.4 Shh and the ZRS show high interaction frequencies in Shh 
expressing and non-expressing cells  
 
The interaction between Shh and the ZRS was analysed in both TSA treated and control cells 
(arrows, Figure 5.4).  High interaction frequencies were observed between both regions in all 
cells regardless of Shh expression and thus confirm 3D-FISH data showing the same levels of 
co-localisation between Shh and the ZRS (Chapter 4).  To confirm that such interactions were 
significant, interactions from each 5C experiment were grouped into bins of either 10, 30 or 
50 kb.  The Z-score for each bin was calculated according to the following equation (Baù and 
Marti-Renom, 2011): 
 
Z-score = (averageLog10 - currentEntryLog10 / stdevLog10) 
 
This calculation involves subtracting the log10 interaction frequency value for each interaction 
from the average log10 interaction frequency of the entire dataset and dividing by the standard 
deviation of the log10 interaction frequencies.  Using the Z-scores, the associated p-value of 
each interaction was calculated with the assumption that the data was normally distributed.  
Only interactions with a p-value of < 0.001 were considered significant and are shown in 
Figure 5 for single replicates of both TSA treated and control 14fp, 88fp and MD cell lines.  
Strikingly, at 30 kb resolution the interaction between bins containing Shh and the ZRS are 
significant in each cell line (arrows in Figure 5.5) regardless of Shh expression, thereby 
confirming that both regions are in close contact. 
 
In-silico 4C graphs were plotted from the 5C data using either Shh or the ZRS as the “bait” 
(Figures 5.6 and 5.7).  When Shh was used, the increase in interaction frequency at the ZRS 
was obvious compared to the surrounding sequence.  When the ZRS was used as “bait”, there 
was an obvious enrichment of interactions at Shh with virtually no interactions in the 
interceding regions.  The neural enhancer SBE4, which is located roughly in the middle of the 
sequence separating Shh and the ZRS, was also examined.  The interaction frequency between 
Shh and the ZRS was always greater than the interaction frequency between Shh and SBE4 or 
between the ZRS and SBE4.  This suggests that in the cell lines, Shh and the ZRS are always 
in much closer contact than Shh and SBE4 and, also agrees with a looping model where Shh 
and the ZRS are brought together resulting in the SBE4 being pushed away from this location 
in the loop. 
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These trends were confirmed when the experiments were repeated with an additional 
biological replicate for each cell line and treatment (Figure 7).  However, replicates for TSA 
treated 14fp cells and control MD cells were of poor quality and must be repeated.  These have 
been omitted from this analysis.   
 
5.3.5 In 14fp and 88fp cells TSA treatment reduces the interaction 
frequency of regions located around Lmbr1. 
 
To assess the differences between Shh expressing and non-expressing cells for each of the cell 
lines, normalised interaction matrices for control cells were subtracted from normalised 
interaction matrices from TSA treated cells (Figure 5.8).  For the 14fp and 88fp cell lines, TSA 
treatment resulted in decrease in interaction frequency within TAD2 of regions included in 
bins 39 to 44 (chr5:29487087 – 29667087) (when interactions are grouped into 30 kb bins).  
This region includes the genes Rnf32 and Lmbr1.  An increase in interaction frequency of 
regions included in bins 14 to 38 (chr5:  28737087 – 29487087) was observed upon TSA 





Figure 5.4 - Heat maps from 5C experiments for TSA treated and control (A) 88fp cells (B) 
14fp cells and (C) MD cells.  The intensity of interactions represents the frequency of 
interactions and ranges from white to red to black with increasing frequencies.  All heat 
maps show interactions binned into 30 kb regions. Purple arrows identify the interaction 
between bins containing Shh and the ZRS.  E14 limb ChIP-seq peaks from ENCODE are 






Figure 5.5 – The interactions for each 5C experiment were grouped into bins of either 10, 
30 or 50 kb and the Z-scores for each bin calculated as described in Chapter 5.3.3.  Using 
the Z-scores the p-value for each interaction was calculated assuming the data was 
normally distributed.  For the binned interaction data above, only significant interactions 
are displayed.  The normalized interaction frequency heat maps for each experiment 
showing all interactions are also displayed.  Purple arrows point to the interaction between 





Figure 5.6 – In silico 4C profiles obtained from the 5C heat maps using either Shh or the ZRS 
as the bait sequence for (A) 88fp cells (B) 14fp cells and (C) MD cells.  Interactions of control 
cells are depicted as red lines while interactions of TSA treated cells are depicted as blue 
lines. The bait sequence is highlighted in yellow in each graph while other regions of 
interest are highlighted in green.  These profiles are obtained from the 1st biological 







Figure 5.7 – In silico 4C profiles obtained from the 5C heat maps using either Shh or the ZRS 
as the bait sequence for (A) 88fp cells (B) 14fp cells and (C) MD cells.  Interactions of control 
cells are depicted as red lines while interactions of TSA treated cells are depicted as blue 
lines. The bait sequence is highlighted in yellow in each graph while other regions of 
interest are highlighted in green.   These profiles are obtained from the 2nd biological 
replicate for each cell line.  TSA treated 14fp cells and control MD cells produced poor 
















































Figure 5.8 – Heat maps showing the difference in interaction frequencies in control and TSA 
treated (A) 88fp (B) 14fp and (C) MD cell lines.  Enrichment of TSA interactions appear as 
red pixels while enriched interactions within control cells appear in blue.  More intense 
colors depict greater interaction frequencies.  All heat maps show interactions between 
binned into 30 kb regions.  E14 limb ChIP-seq peaks from ENCODE are displayed. Each heat 





5.3.6 Modelling of 5C data 
 
Working with our collaborators in the Semple laboratory, (PhD student Ben Moore) the 
normalised and binned (30 kb bins) interaction frequency matrix obtained from the my5C 
website was used to create a model of the 5C data (Figure 5.9).  The “pairwise” file from my5C 
was converted to a format suitable for inserting into the online modelling tool Autochrom3D 
(Peng et al., 2013) (R script provided in Appendices (Moore, B)).  10 simulations (Figure 5.10) 
were created for both TSA treated and control 14fp, 88fp and MD cell lines (using biological 
replicate 1 for each) and the distances between Shh and the ZRS compared by Mann-Whitney 
U tests.  Within these models, Shh lies across two beads and so the distances between both of 
these beads and the bead containing the ZRS were analysed.  For both 14fp and 88fp cells, 
there was no significant difference in the distance between the ZRS and Shh when measuring 
from either of the Shh beads (p > 0.05).  These results agree with 3D-FISH data (Chapter 4) 
where TSA treatment does not affect the distance between Shh and ZRS fosmid probes (Figure 
5.11(A)(B)).  However, there was a significant difference in the distance between Shh and the 
ZRS in MD cells when measuring from either of the Shh beads (p < 0.0001) (Figure 5.11 
(A)(B)).  This contrasts 3D-FISH data where no significant change is observed in Shh and 
ZRS fosmid probe distances on TSA treatment.   
 
Another output from Autochrom3D was the radius of gyration (ROG) for each simulation 
which can serve as an indicator for compaction (all radius of gyration values calculated as 
described by (Peng et al., 2013)).  Small ROG values indicate a compact structure while larger 
values suggest a decompact structure.  In this investigation, the ROG was calculated for each 
simulation and Mann-Whitney U tests used to determine if there was a significant difference 
in values between cell lines (Figure 5.11(C)).  Interestingly, for each cell line there was a 
significant increase in the ROG upon TSA treatment, suggesting a decrease in compaction.  
This contrasts the MYtag FISH experiments where no significant difference in compaction 










Figure 5.9 – 5C models of TSA treated and control 88fp, 14fp and MD cells by the online 
modelling tool Autochrom3D.  Shh is located across 2 beads and is highlighted in red, while 
the ZRS is highlighted in green.  The distance from either of the Shh beads to the ZRS is 


































Figure 5.10 – Simulations were repeated 10 times each for TSA treated and control 88fp, 






Figure 5.11 – The distance between (A) the first Shh bead and the ZRS and (B) the second 
Shh bead and the ZRS in TSA treated and control 14fp, 88fp and MD cells was determined 
for each of the 10 simulations and plotted as a boxplot.  Significant differences in the 
distance between these points was determined by Mann-Whitney U tests (* = p ≤0.05, **** 
= p ≤ 0.0001).  (C) Relative compaction of each simulation was determined as a function of 
the radius of gyration (m) with measurements for each of the simulations plotted as 
mentioned above.  For each cell there was a significant decrease in compaction upon TSA 










5.3.7 Preliminary 4C data suggests a specific interaction at the Shh 
gene of TSA treated 14fp cells 
 
4C (also referred to as 3C-seq) was conducted according to the procedure published by the 
Soler laboratory and detailed in the Methods (Peng et al., 2013, Stadhouders et al., 2013).  The 
aim of these experiments was to study ZRS and Shh interactions within the Shh regulatory 
domain using a technique with a higher resolution than 5C. (i.e. It is not always possible to 
design primers to the ends of each restriction fragment used in 5C experiments.  As a result, 
4C experiments are normally of a higher resolution). 
 
The bait sequence used was the 1.7 kb HindIII fragment containing the ZRS.  Cells were fixed 
in 2 % formaldehyde and the primary digestion conducted using Hind III.  After the first 
ligation, 3C libraries were digested with MlucI followed by an another ligation to produce 4C 
libraries.  PCR primers were designed within the bait sequence before the restriction sites and 
thereby amplify a region of known sequence before progressing into unknown sequence.  This 
procedure was repeated with 14fp cells treated with TSA for both 24 hr and 18 hr and for 
DMSO treated control cells as well.  After amplification and purification 4C libraries were 
sequenced using the in-house Ion Proton™ (Ion Torrent) system.  To our knowledge this is 
the first time Ion Torrent technology has been used to sequence 4C libraires.  The number of 
reads obtained for each 4C sample are given in Table 5.3. 
4C analysis was conducted in collaboration with the Semple laboratory and this analysis has 
also been described in the thesis provided by PhD student Ben Moore (unpublished).  In brief, 
reads containing the end of the bait sequence reading through the second restriction site into 
the unknown sequence were isolated and filtered so that only those with high quality score (Q 
> 30) were maintained.  These were aligned to the mm9 genome and the BAM files used as 
an input for the r3Cseq package which was used to normalise the data and identify significant 
cis and trans interactions.  
The results from 4C experiments are provided in Figure 5.12.  In 14fp cells treated with TSA 
for 18 hr, there was a significant interaction at the Shh gene (FDR q-value < 5 x 10-10) which 
was not observed in the control cells.  This interaction is also observed in 14fp cells treated 
for 24 hr (FDR q-value < 5 x 10-10).  However, in control cells, the adjacent 3’ HindIII fragment 
shows a significant interaction (FDR q-value < 5 x 10-5) which is not observed in the treated 
cells.  Cells treated for 18hr, and to a lesser extent those treated for 24 hr, showed a decreased 
number of significant interactions across the locus.  We rationalize that TSA treatment may 
 206 
cause a reduction in the ZRS interactions across the Shh regulatory region with the enhancer 
now highly specific for the Shh gene, a mechanism which may lead to SHH production. 
As this technique involved the use of Ion Torrent sequencing instead of Illumina sequencing 
which is commonly used in other publications, we asked our collaborators to assess the quality 
of our data.  Both sequence duplication levels and the percentage of cis interactions were 
analysed.  Sequence duplication levels ranged from 62.8 % to 84.4 % and therefore fall below 
the 95 % expected as described by Soler laboratory.  There was also a significant reduction in 
cis interactions below the expected 50 %, ranging from 7 – 20 % across the three samples.  
However, as expected the highest number of bait specific interactions occurred along 
chromosome 5 (in cis), with other chromosomes (in trans) showing less bait specific 
interactions.  Both analyses suggest a low signal-to-noise ratio within the data where non-
specific interactions have also been examined.  This may be because 4C libraries were 
sequenced from the side of the second restriction digest site and not from the primary 
restriction site as described in the protocol.  This was conducted because the HindIII fragment 
used for 4C is extremely AT rich and suitable PCR primers could only be designed at this 
specific site.  Sequencing from this end of the library is likely to have increased background 
noise.  Repeat experiments are currently ongoing with biological replicates, performing both 
Ion Torrent and Illumina sequencing to examine how the output from both procedures compare 




















Figure 5.12 – Figures provided by Ben Moore (PhD Student, Semple laboratory).  (A) 
Differences in ZRS interactions at the Shh gene upon TSA treatment (18 hr) in 14fp cells.  
Lmbr1 (containing the ZRS) is depicted by the large pink rectangle and Shh as the small pink 
rectangle.  Significant interactions between the ZRS and other chromatin regions are shown 




within a 200 kb region containing the Shh gene.  The width of each bar represents the size 
of a HindIII restriction fragment. (B) Significant interactions of the ZRS with other 
chromatin regions in 14fp cells treated with TSA for 18 hr and 24 hr as well as untreated 
control cells. Significant interactions between the ZRS and other chromatin regions are 
shown as red (control cells) and purple (TSA treated cells) arches.  Expression of Shh in TSA 













































5.4 Discussion  
5C experiments were conducted on TSA treated and control 14fp, 88fp and MD cell lines.  In 
these experiments, the Shh gene was contained within a topological associated domain (TAD), 
the boundaries of which remained constant across all cell lines.  These boundary regions 
correlate with five E14 ChIP-seq CTCF protein binding peaks (Figure 5.3), thereby suggesting 
a role of CTCF in establishing the TAD (the role of the CTCF protein binding to these sites to 
create a compact region is discussed in Chapter 4).  Some studies have used polymer based 
models to study chromatin structure where proteins such as CTCF bind to a designated binding 
site and make contact with another CTCF protein to create a loop (Brackley et al., 2016).  
These models are then compared to chromatin conformation capture data to determine their 
validity.  In some cases, interactions from the model replicate interactions from the 
experimental data to a high degree of accuracy thereby confirming the importance of CTCF in 
establishing the chromatin structure.  Recently collaborative work has begun with the 
Marenduzzo laboratory to determine if some of these CTCF polymer models can replicate 
interactions seen in our 5C data.  
A significant interaction was detected between Shh and the ZRS in each cell line regardless of 
Shh expression.  This agrees with the recently published 5C data showing that the Shh gene 
and ZRS are always in close proximity in different tissues (Williamson et al., 2016).  However, 
chromatin models using the online software Autochrom3D suggested that in each cell line the 
chromatin became less compact on TSA treatment (there was a significant increase in the 
radius of gyration upon TSA treatment in each cell line).  This is at odds with previous FISH 
data using MYtags which suggested that TSA does not affect compaction of this region.  
However, previous investigations have shown that TSA treatment in other cell lines causes a 
reversible decompaction of chromatin (Tóth et al., 2004).  In this investigation the decrease in 
chromatin compaction upon TSA treatment depicted by the models may be a result of the 
parameters selected for modelling.  Going forward it may be beneficial to use an additional 
modelling program and compare the results to those obtained using Autochrom3D. 
 
Replicate experiments need to be repeated for the 4C experiments before concrete conclusions 
can be deduced.  However, it is interesting that in both 14fp cells treated for either 18 hr and 
24 hr with TSA, there is a decrease in significant interactions across the Shh regulatory region 
compared to the control untreated cells.  It would be intriguing if one of the effects of TSA 
was to increase the specificity of the ZRS for the Shh gene, resulting in a decrease in non-
specific interactions across the locus.  However, as stated, more experiments need to be 
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conducted to confirm this hypothesis. On comparison of both 4C and 5C experiments, it is 
obvious that the ZRS contacts regions close to, or at, the Shh gene in both expressing and non-
expressing cells.  4C experiments in Shh expressing cells do show a specific interaction at the 
ZRS which is not significant in non-expressing cells (Figure 5.12). This interaction is not 
obvious from 5C experiments.  4C experiments also show interactions between the ZRS and 
regions passed the Shh gene and into the adjacent TAD, in all cells regardless of Shh 
expression.  These significant ZRS interactions were not detected by 5C.  To resolve the 
differences between 5C and 4C, all 4C experiments must be completed in duplicate.  If the 
discrepancies still remain FISH experiments could be conducted to determine if specific ZRS 














5.5 Conclusions  
 
In summary, 5C experiments show that there is a significant interaction between the ZRS and 
Shh gene in both Shh expressing and non-expressing cells suggesting that both regions are 
always in close contact.  Modelling of the 5C data using the software Autochrom3D suggests 
that on the addition of TSA the Shh locus becomes less compact.  This contrasts with FISH 
data (Chapter 4) which shows Shh-ZRS co-localisation is unaffected by the addition of TSA 
Preliminary 4C data suggests that interactions the ZRS makes within the Shh regulatory region 










































6.1 14fp Cells - a model system to study Shh limb bud 
expression 
 
In this investigation 14fp cells were used – cells derived from the posterior portion of an E11.5 
limb bud (which incorporates the ZPA where Shh is expressed) – to study the mechanism of 
Shh expression within the limb.  Preliminary PCR experiments (Silvia Peluso, manuscript in 
preparation) showed that the 14fp cells retained expression of some genes expressed within 
the posterior limb such as Hand2 and Gremlin but Shh expression was not maintained (Chapter 
3.1).  However, the addition of trichostatin A (TSA), an inhibitor of class I and II HDACs, to 
these cells resulted in the production of SHH with maximum expression obtained 24 hr after 
addition of TSA.  Furthermore, upon TSA treatment the Shh gene appeared to be activated by 
the limb bud specific enhancer the ZRS (zone of polarizing activity regulatory sequence).  In 
untreated cells the ZRS contained the histone marks H3K4me1 but not H3K27ac.  In other 
investigations enhancers displaying such modifications have been described as poised.  
However, on addition of TSA there was an accumulation of H3K27ac at the ZRS in addition 
to the H3K4me1 already present (Silvia Peluso, manuscript in preparation) – enhancers with 
such histone marks are considered active (Creyghton et al., 2010).  Therefore, it seems that in 
14fp cells addition of TSA changes the activity of the ZRS from a poised to active state which 
subsequently activates the Shh gene. 
 
In order to examine how closely the cultured 14fp cells resemble the cells within an E11.5 
limb bud and, to determine the effects of TSA on gene expression within 14fp cells, RNA 
sequencing experiments were conducted on the following samples:  TSA treated and untreated 
14fp cells; and, cells dissected from the proximal and distal regions of an E11.5 limb bud.  
Although there were obvious differences in the expression of many genes, 14fp cells 
maintained the expression of some key developmental genes critical to patterning the E11.5 
limb bud.  For example, the ETS factors - ETS1, GABPα, ETV4 and ETV5 - were all present 
in the untreated 14fp cells.  These are extremely important in restricting Shh expression to the 
ZPA.  Gremlin and Hand2 were also expressed and showed a reduction in expression upon 
TSA treatment - confirming PCR experiments.  Most importantly Shh was absent in the 
untreated cell line but was induced upon TSA treatment.  Although Shh expression is low, 
immunofluorescence and qPCR experiments have confirmed that Shh is induced upon TSA 
treatment (Chapters 4 -5 and Silvia Peluso, manuscript in preparation). 
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The addition of TSA and other HDAC inhibitors to cultured cell lines has previously been 
reported to have wide ranging effects on genes expressed in many different pathways.  In 
cancer cell lines, TSA affects cell cycle progression and therefore slows growth rate and 
increases apoptosis.  In the 14fp cells, addition of TSA also altered the expression of cell cycle 
components such as Cdk4 and Cdk6 and genes involved in apoptotic pathways such as Bcl2l11 
and Bcl2l1.  Therefore, for the 14fp cells it was clear that TSA addition affected multiple 
signaling pathways and was not specific to regulating the expression of genes involved in limb 
development.  For this reason, induction of Shh expression by both increasing GABPα and 
reducing PEA3 levels was also examined in this investigation (discussed later).  
 
6.2 Model of TSA induced Shh expression in 14fp 
cells 
 
The mechanism by which TSA induces Shh expression has not yet been fully elucidated.  
However, several experiments have identified key steps in this process.  Silvia Peluso 
(manuscript in preparation) has shown that knock down of Pea3 or an increase in GABPα 
levels can induce Shh expression in 14fp cells.  Indeed, in this investigation knock down of 
Pea3 was used to induce Shh expression in FISH experiments (Chapter 4).  Co-
immunoprecipitation experiments also identified PEA3 as a binding partner for HDAC2 and 
GABPα as a binding partner for P300 (a histone acetyltransferase).  Within the ZRS there are 
five binding sites for ETS1/GABPα and two binding sites for ETV4(PEA3)/ETV5 (Lettice et 
al., 2012) and ChIP experiments have shown that PEA3, HDAC2, GABPα and P300 are 
enriched at the ZRS (Silvia Peluso, manuscript in preparation) in 14fp cells.  Therefore, in a 
non-induced state I propose that the ZRS binds PEA3 which recruits HDAC2 and GABPα 
which recruits P300. 
 
As mentioned previously, TSA is a histone deacetylase inhibitor and, therefore, on addition of 
TSA to 14fp cells, HDAC2 is inhibited.  It is hypothesized that this could have two possible 
consequences: either HDAC2 inhibition causes loss of PEA3 binding to the ZRS resulting in 
an increase in the ratio of positive: negative ETS regulators and an increase in Shh expression; 
or, HDAC2 inhibition disrupts binding between HDAC2 and PEA3.  In the latter event, PEA3 
remains bound to the ZRS without HDAC2.  In other cell lines PEA3 can be acetylated by 
P300 and act as a positive regulator of gene expression (Guo et al., 2011).  Therefore, in 14fp 
cells a loss of binding between PEA3 and HDAC2 could allow PEA3 to be acetylated by P300 
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thereby shifting the function of PEA3 from a negative regulator of Shh expression to a positive 
regulator.  Human PEA3 has been shown to interact with MED25, a component of the mediator 
complex which is involved in transcriptional regulation (Verger et al., 2013).  To identify 
whether a similar interaction between these two proteins occurs in the mouse limb bud, ChIP-
seq with a MED25 antibody in TSA treated and control 14fp cells could be attempted. 
 
ChIP experiments (Silvia Peluso manuscript in preparation) in 14fp cells confirm a reduction 
in PEA3 levels at the ZRS on TSA addition.  This result argues in favor of the first mechanism 
in which HDAC2 inhibition prevents binding of PEA3 to the ZRS.  However, the RNA 
sequencing experiments (Chapter 3) showed that TSA reduced Pea3 expression levels, so it is 
also possible that the reduction of PEA3 bound to the ZRS on TSA treatment is due to the 
reduced levels of available PEA3 protein.  A combination of all these mechanisms may be 
occurring upon TSA addition, leading to Shh expression. 
 
The PRC2 complex is involved in repressing gene expression with studies in humans (Boyer 
et al., 2006) showing that the PRC2 components EZH2/EED interact with HDAC2 at these 
repressed sites (van der Vlag and Otte, 1999).  It would be interesting to determine if 
EZH2/EED binds to HDAC2 in the 14fp cell line before and after TSA treatment.  It is 
hypothesized that in the absence of TSA, HDAC2 binds to EZH2/EED with the PRC2 complex 
repressing Shh expression.  Upon TSA treatment, inhibition of HDAC2 prevents the 
association of EZH2/EED with the ZRS, thereby relieving PRC2 induced Shh gene repression.  
In prostate cancer cell lines, the addition of TSA inhibited EZH2 regulated gene repression 
(Varambally et al., 2002).  Therefore, in the 14fp cells, this hypothesis could be tested by 
performing ChIP-seq experiments using antibodies against EED and EZH2 in TSA treated and 
control 14fp cells. 
 
6.3 Compaction of the Shh regulatory region is 
unaffected by Shh expression 
 
To study compaction of the Shh locus 3D-FISH was conducted on TSA treated and control 
14fp, 88fp and MD cell lines.  The 14fp and 88fp cells both express Shh on TSA treatment 
while Shh expression is not detected in MD cells – the MD cells therefore act as a suitable 
control cell line.  In FISH experiments, no significant difference was observed in the 
percentage of co-localised Shh and ZRS probes across all cell lines independent of whether 
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Shh was being expressed or not.  This was a surprise, as recent publications have shown that 
there is a significant increase in co-localisation between the ZRS and Shh in the ZPA of the 
mouse E11.5 limb bud where Shh is expressed (Williamson et al., 2016).  This suggests a 
mechanism in which the ZRS moves into contact with the Shh gene to regulate Shh expression 
of cells within the ZPA.  However, in the 14fp cell line the expression of Shh upon TSA 
treatment is low compared to Shh expression within an E11.5 limb bud (see qPCR control 
experiments – Chapters 4 and 5).  It is possible that the effect of TSA addition to the cell lines 
cannot be detected by FISH experiments.  Alternatively, the mechanism of Shh induction in 
the 14fp and 88fp cell lines is different to that of cells in the ZPA (Chapter 6.2).  To study 
compaction of the Shh locus in more detail, fluorescently labelled MYtags were used with one 
library used to tile the region between Shh and the ZRS and another to tile the region between 
Shh and Dpp6.  The Shh-ZRS region was much more compact than the Shh-Dpp6 region but 
no significant difference in compaction was observed between the Shh-ZRS regions in TSA 
treated and control 14fp cells (compaction was determined by counting MYtag spot number 
and by spot area).  
 
Together these observations suggest that compaction of the Shh locus within the cell lines does 
not change on addition of TSA.  This is interesting as previous investigations in other cell lines 
have shown that TSA can cause reversible decompaction of large chromatin regions (Tóth et 
al., 2004).  The fact that compaction of this locus is unaffected by TSA treatment suggests that 
there are intrinsic mechanisms that cause compaction and these forces are unaffected by the 
addition of TSA.  It was hypothesized that the binding of the protein CTCF to sites located 
near both the Shh gene and the ZRS may hold the locus in a tightly compact position.  Bound 
CTCF proteins would interact with each other bringing the ZRS into contact with Shh.  To test 
this hypothesis Laura Lettice and Iain Williamson designed and constructed ES cells using the 
CRISPR/Cas9 system, which singly deleted each of the CTCF binding sites located next to 
Shh or the ZRS.  In total five mutant lines were created, each with a different CTCF binding 
site mutation.  Laura and Iain have since gone on to use these cell lines for other experiments 
(manuscript in preparation).  In this investigation, the two MYtag libraries were used to assess 
compaction in both wild type (WT) ES cells and the CTCF binding site mutants.  Like the 
14fp cells, the Shh-Dpp6 region was much less compact than the Shh-ZRS region in the WT 
and mutant cells.  There was no significant difference in the number of spots for the Shh-ZRS 
region between WT and mutant cells, suggesting that compaction of the locus does not change 
when single CTCF binding sites are removed.  However, on analysis of spot area there was in 
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increase in compaction of the Shh-ZRS region in the mutants compared to wild type cells.  The 
reason for the contrasting results between both analyses is unclear. 
 
The fact that no change in compaction was observed when analyzing spot number for the Shh-
ZRS region in the ES cell mutants was surprising as I believe that CTCF binding is integral 
for maintaining the region in a compact state.  Using MYtags to tile the Shh locus in 14fp cells 
and ES cells is an innovative and a potentially very informative tool to look at compaction but 
in this investigation there were a number of caveats.  Firstly, although all MYtag spots were 
observed for the Shh-Dpp6 library, only a maximum of 6 spots (out of a possible 8 spots) were 
observed for the Shh-ZRS library at any one time.  Therefore, it was unclear whether the 
compact nature of the chromatin always prevented the final two spots from being visible or 
whether the MYtags were not fully annealing in the FISH experiments.   In order to confirm 
that the latter scenario is not occurring, the MYtag libraries need to be tested on decondensed 
chromatin which should show all 8 spots for the Shh-ZRS region if all MYtags are binding 
properly.  Also, all MYtag experiments were conducted using a 2D-FISH protocol as it was 
found that the intensity of the fluorescent spots was greater when cells were treated in this way 
compared to 3D-FISH experiments.  However, this meant images could not be taken through 
three dimensions (i.e. images through separate z-stacks were not possible) which may mean 
the spot number analysis may be less accurate.  Probably the biggest limitation was that using 
only one MYtag library to tile a region meant that no positional information was provided in 
these experiments i.e. for the the Shh-Dpp6 region 8 spots were sometimes visible for a single 
locus but the exact position at which each spot was bound to the DNA was unknown.  
Originally we had planned to hybridize fosmid probes for the Shh gene and the ZRS along 
with MYtags in the same FISH experiment; however, this has yet to be optimized.  FISH 
experiments using fosmid probes on the ES mutants are currently being conducted (Iain 
Williamson and Laura Lettice, manuscript in preparation). 
 
6.4 Interactions within the Shh regulatory region 
 
To look at interactions within the Shh regulatory region upon Shh expression, 5C was 
conducted in 14fp and 88fp cell lines while MD cells were used as a control.  In all cell lines, 
regardless of Shh expression, an increased interaction frequency was observed for the Shh gene 
with the ZRS.  This suggests that within the cells Shh and the ZRS are in close proximity even 
when the gene is not being expressed.  Heat maps for all the cell lines confirmed that Shh is 
contained within a topological associated domain (TAD) which also contains the genes Rnf32 
and part of Lmbr1.  4C provided an additional way of analyzing ZRS interactions at a higher 
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resolution with preliminary experiments suggesting that there were less significant interactions 
across the locus on TSA treatment.  Further experiments need to be conducted to confirm this 
result. 
 
6.5 Future Work 
 
In the immediate future replicates for the 5C experiments, TSA treated 14fp cells; and control 
MD cells are needed before publication.  Also, replicates are needed for the 14fp cell 4C 
experiments.  4C should also be conducted on the MD cell line which would act as a suitable 
control.  Towards the end of this investigation, both 5C and FISH experiments were planned 
using the Shhgfpcre mouse (https://www.jax.org/strain/005622).  This mouse expresses 
enhanced green fluorescent protein (EGFP) in all regions where Shh is also expressed.  Initial 
experiments had begun where the green fluorescent cells from an E11.5 limb bud (visible in 
the ZPA) were separated from the non-fluorescent cells by fluorescent associated cell sorting 
(FACs).  In these experiments, cells were first fixed in formaldehyde before FACs and then 
lysed and stored at -80 °C until needed.  The plan was to combine all GFP positive nuclei into 
one sample and then perform 5C.  As a control, the GFP negative nuclei could also be 
combined and used for 5C.  The aim of these experiments was to determine if there were 
significant interaction differences between cells both within and outside the ZPA in E11.5 
limb buds.  FISH experiments on both GFP positive and negative cells could also be used to 
identify the distance between the ZRS and Shh gene in both Shh expressing and non-expressing 
limb tissue.  However, as mentioned previously the recent paper by Williamson and Lettice 
(Williamson et al., 2016) performed FISH experiments on both anterior and posterior 
(containing the ZPA) limb sections and these showed that the ZRS and Shh gene co-localise 
more closely in the posterior region.  Therefore, the major question being examined by the 
Shhgfpcre mouse FISH experiments has largely been answered.   
 
A number of future FISH experiments are also planned using the MYtags.  Firstly, it would be 
interesting to look at chromatin compaction using mouse tissue.  Compaction of the Shh locus 
in the E11.5 limb bud could be compared to other expressing tissue such as the lungs, brain 
and gut, as well non-expressing tissue such as the mandible and heart.  Also, it would be 
interesting to perform MYtag FISH experiments on E11.5 limb bud sections to examine how 
compaction changes in either: an anterior to posterior orientation or, proximal to distal 
orientation i.e. from regions containing the ZPA where Shh is expressed to regions not 
expressing Shh. 
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Lastly, to provide confirmation that the ZRS activates the Shh gene in 14fp cells when treated 
with TSA, experiments could be conducted using CRISPr to delete the ZRS.  14fp cells with 
a ZRS deletion would not be expected to induce Shh expression.   The compaction of the Shh 





















Figure 6.1 – Possible mechanisms of TSA induced Shh expression in 14fp cells.  In untreated 
cells, the Shh gene and the ZRS are in close proximity, while other enhancers such as SBE4 
are located further away from the gene.  The ZRS contains the protein PEA3 bound to 
HDAC2.  On addition of TSA there are two possibilities.  Firstly, as TSA is an HDAC inhibitor 
it binds directly to HDAC2 and therefore prevents the binding of negative regulator PEA3 
to the ZRS.  As a result, there is a shift in the ratio of positive:negative regulators bound to 
the ZRS resulting in Shh expression.  Alternatively, TSA treatment inhibits HDAC2 and it is 
no longer bound at the ZRS but PEA3 binding is unaffected and it remains bound without 
HDAC2.  In this scenario it is possible that the PEA3 protein is itself acetylated by histone 
acetyltransferases such as P300, thereby changing its role from a negative regulator of Shh 
expression to a positive regulator.  In humans MED25 can bind to PEA3.  If this occurs in 
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Figure 1 – Preliminary 3D-FISH data shows Shh-ZRS probes are more tightly compact than 
than Shh-SBE4 probes in 14fp cells suggesting that the Shh regulatory region is contained 
within a loop (p-value < 0.0001, Mann-Whitney U test).  Over 100 measurements were 






























# read in pairwise output from my5c 
pw <- read.table("~/Desktop/mddmsoformodelling.txt", skip=5, sep="\t", header=F) 
 
# parse start and end co-ordinates from fragment IDs 
s1 <- as.numeric(gsub(".*?:(\\d+)-.*", "\\1", pw[,1])) 
e1 <- as.numeric(gsub(".*-(\\d+)$", "\\1", pw[,1])) 
s2 <- as.numeric(gsub(".*?:(\\d+)-.*", "\\1", pw[,3])) 
e2 <- as.numeric(gsub(".*-(\\d+)$", "\\1", pw[,3])) 
 
# average start and ends to get midpoint 
out <- data.frame(chr1="chr5", p1=as.integer(rowMeans(cbind(s1, e1))), 
                  chr2="chr5", p2=as.integer(rowMeans(cbind(s2, e2))), 
                  interaction=pw[,2]) 
 
# remove NAs 
out <- out[complete.cases(out),] 
 
# remove control region (if present) 
out <- out[out$p1 < 60e6 & out$p2 < 60e6,] 
 
# write to tab-delimited file 
write.table(out, "~/Desktop/mddsmofinal112.txt", sep="\t", 
            row.names=F, col.names=F, quote=F) 
 
 
Figure 2 – R script used to convert pairwise file output from my5C into an input format for 



























Figure 3 – Unprocessed heat maps of the first biological replicate for TSA treated and 











Figure 4 – Unprocessed heat maps of the second biological replicate for TSA treated and 
control 14fp, 88fp and MD cell lines.  TSA treated 14fp cells and control MD cells were of 


























AFFER, M., CHESI, M., CHEN, W. D., KEATS, J. J., DEMCHENKO, Y. N., TAMIZHMANI, K., 
GARBITT, V. M., RIGGS, D. L., BRENTS, L. A., ROSCHKE, A. V., VAN WIER, S., 
FONSECA, R., BERGSAGEL, P. L. & KUEHL, W. M. 2014. Promiscuous MYC locus 
rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC 
expression in multiple myeloma. Leukemia, 28, 1725-35. 
AHITUV, N., ZHU, Y., VISEL, A., HOLT, A., AFZAL, V., PENNACCHIO, L. A. & RUBIN, E. M. 2007. 
Deletion of ultraconserved elements yields viable mice. PLoS Biol, 5, e234. 
AHN, K., MISHINA, Y., HANKS, M. C., BEHRINGER, R. R. & CRENSHAW, E. B. 2001. BMPR-IA 
signaling is required for the formation of the apical ectodermal ridge and dorsal-
ventral patterning of the limb. Development, 128, 4449-61. 
AMANAI, K. & JIANG, J. 2001. Distinct roles of Central missing and Dispatched in sending the 
Hedgehog signal. Development, 128, 5119-27. 
AMANO, T., SAGAI, T., TANABE, H., MIZUSHINA, Y., NAKAZAWA, H. & SHIROISHI, T. 2009. 
Chromosomal dynamics at the Shh locus: limb bud-specific differential regulation of 
competence and active transcription. Dev Cell, 16, 47-57. 
AMENDOLA, M. & VAN STEENSEL, B. 2015. Nuclear lamins are not required for lamina-
associated domain organization in mouse embryonic stem cells. EMBO Rep, 16, 
610-7. 
ANDERSON, E., DEVENNEY, P. S., HILL, R. E. & LETTICE, L. A. 2014. Mapping the Shh long-
range regulatory domain. Development, 141, 3934-43. 
ANDERSON, E., PELUSO, S., LETTICE, L. A. & HILL, R. E. 2012. Human limb abnormalities 
caused by disruption of hedgehog signaling. Trends Genet, 28, 364-73. 
ANDREY, G., MONTAVON, T., MASCREZ, B., GONZALEZ, F., NOORDERMEER, D., LELEU, M., 
TRONO, D., SPITZ, F. & DUBOULE, D. 2013. A switch between topological domains 
underlies HoxD genes collinearity in mouse limbs. Science, 340, 1234167. 
ARNOLD, C. D., GERLACH, D., STELZER, C., BORYŃ, Ł., RATH, M. & STARK, A. 2013. Genome-
wide quantitative enhancer activity maps identified by STARR-seq. Science, 339, 
1074-7. 
ARNOSTI, D. N. & KULKARNI, M. M. 2005. Transcriptional enhancers: Intelligent 
enhanceosomes or flexible billboards? J Cell Biochem, 94, 890-8. 
AUSIÓ, J. 2015. The shades of gray of the chromatin fiber: recent literature provides new 
insights into the structure of chromatin. Bioessays, 37, 46-51. 
BALCIUNAS, D., DAVIDSON, A. E., SIVASUBBU, S., HERMANSON, S. B., WELLE, Z. & EKKER, S. 
C. 2004. Enhancer trapping in zebrafish using the Sleeping Beauty transposon. BMC 
Genomics, 5, 62. 
BARROW, J. R., THOMAS, K. R., BOUSSADIA-ZAHUI, O., MOORE, R., KEMLER, R., CAPECCHI, 
M. R. & MCMAHON, A. P. 2003. Ectodermal Wnt3/beta-catenin signaling is required 
for the establishment and maintenance of the apical ectodermal ridge. Genes Dev, 
17, 394-409. 
BAÙ, D. & MARTI-RENOM, M. A. 2011. Structure determination of genomic domains by 
satisfaction of spatial restraints. Chromosome Res, 19, 25-35. 
BEJERANO, G., PHEASANT, M., MAKUNIN, I., STEPHEN, S., KENT, W. J., MATTICK, J. S. & 
HAUSSLER, D. 2004. Ultraconserved elements in the human genome. Science, 304, 
1321-5. 
BELL, A. C., WEST, A. G. & FELSENFELD, G. 1999. The protein CTCF is required for the 
enhancer blocking activity of vertebrate insulators. Cell, 98, 387-96. 
BENKO, S., FANTES, J. A., AMIEL, J., KLEINJAN, D. J., THOMAS, S., RAMSAY, J., JAMSHIDI, N., 
ESSAFI, A., HEANEY, S., GORDON, C. T., MCBRIDE, D., GOLZIO, C., FISHER, M., 
PERRY, P., ABADIE, V., AYUSO, C., HOLDER-ESPINASSE, M., KILPATRICK, N., LEES, M. 
M., PICARD, A., TEMPLE, I. K., THOMAS, P., VAZQUEZ, M. P., VEKEMANS, M., ROEST 
 229 
CROLLIUS, H., HASTIE, N. D., MUNNICH, A., ETCHEVERS, H. C., PELET, A., FARLIE, P. 
G., FITZPATRICK, D. R. & LYONNET, S. 2009. Highly conserved non-coding elements 
on either side of SOX9 associated with Pierre Robin sequence. Nat Genet, 41, 359-
64. 
BERLIVET, S., PAQUETTE, D., DUMOUCHEL, A., LANGLAIS, D., DOSTIE, J. & KMITA, M. 2013. 
Clustering of tissue-specific sub-TADs accompanies the regulation of HoxA genes in 
developing limbs. PLoS Genet, 9, e1004018. 
BHATIA, S., BENGANI, H., FISH, M., BROWN, A., DIVIZIA, M. T., DE MARCO, R., DAMANTE, 
G., GRAINGER, R., VAN HEYNINGEN, V. & KLEINJAN, D. A. 2013. Disruption of 
autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer 
causes aniridia. Am J Hum Genet, 93, 1126-34. 
BIEN-WILLNER, G. A., STANKIEWICZ, P. & LUPSKI, J. R. 2007. SOX9cre1, a cis-acting 
regulatory element located 1.1 Mb upstream of SOX9, mediates its enhancement 
through the SHH pathway. Hum Mol Genet, 16, 1143-56. 
BITGOOD, M. J. & MCMAHON, A. P. 1995. Hedgehog and Bmp genes are coexpressed at 
many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol, 172, 126-
38. 
BLOW, M. J., MCCULLEY, D. J., LI, Z., ZHANG, T., AKIYAMA, J. A., HOLT, A., PLAJZER-FRICK, I., 
SHOUKRY, M., WRIGHT, C., CHEN, F., AFZAL, V., BRISTOW, J., REN, B., BLACK, B. L., 
RUBIN, E. M., VISEL, A. & PENNACCHIO, L. A. 2010. ChIP-Seq identification of weakly 
conserved heart enhancers. Nat Genet, 42, 806-10. 
BOYER, L. A., PLATH, K., ZEITLINGER, J., BRAMBRINK, T., MEDEIROS, L. A., LEE, T. I., LEVINE, 
S. S., WERNIG, M., TAJONAR, A., RAY, M. K., BELL, G. W., OTTE, A. P., VIDAL, M., 
GIFFORD, D. K., YOUNG, R. A. & JAENISCH, R. 2006. Polycomb complexes repress 
developmental regulators in murine embryonic stem cells. Nature, 441, 349-53. 
BOYLE, S., GILCHRIST, S., BRIDGER, J. M., MAHY, N. L., ELLIS, J. A. & BICKMORE, W. A. 2001. 
The spatial organization of human chromosomes within the nuclei of normal and 
emerin-mutant cells. Hum Mol Genet, 10, 211-9. 
BRACKLEY, C. A., BROWN, J. M., WAITHE, D., BABBS, C., DAVIES, J., HUGHES, J. R., BUCKLE, 
V. J. & MARENDUZZO, D. 2016. Predicting the three-dimensional folding of cis-
regulatory regions in mammalian genomes using bioinformatic data and polymer 
models. Genome Biol, 17, 59. 
BRISCOE, J. & THÉROND, P. P. 2013. The mechanisms of Hedgehog signalling and its roles in 
development and disease. Nat Rev Mol Cell Biol, 14, 416-29. 
BUENROSTRO, J. D., GIRESI, P. G., ZABA, L. C., CHANG, H. Y. & GREENLEAF, W. J. 2013. 
Transposition of native chromatin for fast and sensitive epigenomic profiling of 
open chromatin, DNA-binding proteins and nucleosome position. Nat Methods, 10, 
1213-8. 
BUGLINO, J. A. & RESH, M. D. 2008. Hhat is a palmitoylacyltransferase with specificity for N-
palmitoylation of Sonic Hedgehog. J Biol Chem, 283, 22076-88. 
BURKE, R., NELLEN, D., BELLOTTO, M., HAFEN, E., SENTI, K. A., DICKSON, B. J. & BASLER, K. 
1999. Dispatched, a novel sterol-sensing domain protein dedicated to the release of 
cholesterol-modified hedgehog from signaling cells. Cell, 99, 803-15. 
CAO, K., CAPELL, B. C., ERDOS, M. R., DJABALI, K. & COLLINS, F. S. 2007. A lamin A protein 
isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with 
mitosis in progeria and normal cells. Proc Natl Acad Sci U S A, 104, 4949-54. 
CAPELL, B. C., ERDOS, M. R., MADIGAN, J. P., FIORDALISI, J. J., VARGA, R., CONNEELY, K. N., 
GORDON, L. B., DER, C. J., COX, A. D. & COLLINS, F. S. 2005. Inhibiting farnesylation 
of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford 
progeria syndrome. Proc Natl Acad Sci U S A, 102, 12879-84. 
 230 
CAPRA, J. A., ERWIN, G. D., MCKINSEY, G., RUBENSTEIN, J. L. & POLLARD, K. S. 2013. Many 
human accelerated regions are developmental enhancers. Philos Trans R Soc Lond B 
Biol Sci, 368, 20130025. 
CARTER, A. J. & WAGNER, G. P. 2002. Evolution of functionally conserved enhancers can be 
accelerated in large populations: a population-genetic model. Proc Biol Sci, 269, 
953-60. 
CHAMBEYRON, S. & BICKMORE, W. A. 2004. Chromatin decondensation and nuclear 
reorganization of the HoxB locus upon induction of transcription. Genes Dev, 18, 
1119-30. 
CHAMOUN, Z., MANN, R. K., NELLEN, D., VON KESSLER, D. P., BELLOTTO, M., BEACHY, P. A. 
& BASLER, K. 2001. Skinny hedgehog, an acyltransferase required for palmitoylation 
and activity of the hedgehog signal. Science, 293, 2080-4. 
CHOUDHRY, Z., RIKANI, A. A., CHOUDHRY, A. M., TARIQ, S., ZAKARIA, F., ASGHAR, M. W., 
SARFRAZ, M. K., HAIDER, K., SHAFIQ, A. A. & MOBASSARAH, N. J. 2014. Sonic 
hedgehog signalling pathway: a complex network. Ann Neurosci, 21, 28-31. 
COHEN, M., BRISCOE, J. & BLASSBERG, R. 2013. Morphogen interpretation: the 
transcriptional logic of neural tube patterning. Curr Opin Genet Dev, 23, 423-8. 
COTNEY, J., LENG, J., YIN, J., REILLY, S. K., DEMARE, L. E., EMERA, D., AYOUB, A. E., RAKIC, P. 
& NOONAN, J. P. 2013. The evolution of lineage-specific regulatory activities in the 
human embryonic limb. Cell, 154, 185-96. 
CREANGA, A., GLENN, T. D., MANN, R. K., SAUNDERS, A. M., TALBOT, W. S. & BEACHY, P. A. 
2012. Scube/You activity mediates release of dually lipid-modified Hedgehog signal 
in soluble form. Genes Dev, 26, 1312-25. 
CREMER, M., KÜPPER, K., WAGLER, B., WIZELMAN, L., VON HASE, J., WEILAND, Y., KREJA, L., 
DIEBOLD, J., SPEICHER, M. R. & CREMER, T. 2003. Inheritance of gene density-
related higher order chromatin arrangements in normal and tumor cell nuclei. J Cell 
Biol, 162, 809-20. 
CRETEKOS, C. J., RASWEILER, J. J. & BEHRINGER, R. R. 2001. Comparative studies on limb 
morphogenesis in mice and bats: a functional genetic approach towards a 
molecular understanding of diversity in organ formation. Reprod Fertil Dev, 13, 691-
5. 
CRETEKOS, C. J., WANG, Y., GREEN, E. D., MARTIN, J. F., RASWEILER, J. J. & BEHRINGER, R. R. 
2008. Regulatory divergence modifies limb length between mammals. Genes Dev, 
22, 141-51. 
CREYGHTON, M. P., CHENG, A. W., WELSTEAD, G. G., KOOISTRA, T., CAREY, B. W., STEINE, E. 
J., HANNA, J., LODATO, M. A., FRAMPTON, G. M., SHARP, P. A., BOYER, L. A., 
YOUNG, R. A. & JAENISCH, R. 2010. Histone H3K27ac separates active from poised 
enhancers and predicts developmental state. Proc Natl Acad Sci U S A, 107, 21931-
6. 
CRICK, F. 1970. Diffusion in embryogenesis. Nature, 225, 420-2. 
CUI, K. & ZHAO, K. 2012. Genome-wide approaches to determining nucleosome occupancy 
in metazoans using MNase-Seq. Methods Mol Biol, 833, 413-9. 
DE WIT, E. & DE LAAT, W. 2012. A decade of 3C technologies: insights into nuclear 
organization. Genes Dev, 26, 11-24. 
DEKKER, J., RIPPE, K., DEKKER, M. & KLECKNER, N. 2002. Capturing chromosome 
conformation. Science, 295, 1306-11. 
DERTI, A., ROTH, F. P., CHURCH, G. M. & WU, C. T. 2006. Mammalian ultraconserved 
elements are strongly depleted among segmental duplications and copy number 
variants. Nat Genet, 38, 1216-20. 
DITTMER, T. A. & MISTELI, T. 2011. The lamin protein family. Genome Biol, 12, 222. 
 231 
DIXON, J. R., SELVARAJ, S., YUE, F., KIM, A., LI, Y., SHEN, Y., HU, M., LIU, J. S. & REN, B. 2012. 
Topological domains in mammalian genomes identified by analysis of chromatin 
interactions. Nature, 485, 376-80. 
DOSTIE, J., RICHMOND, T. A., ARNAOUT, R. A., SELZER, R. R., LEE, W. L., HONAN, T. A., 
RUBIO, E. D., KRUMM, A., LAMB, J., NUSBAUM, C., GREEN, R. D. & DEKKER, J. 2006. 
Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution 
for mapping interactions between genomic elements. Genome Res, 16, 1299-309. 
DOUGLAS, A. T. & HILL, R. D. 2014. Variation in vertebrate cis-regulatory elements in 
evolution and disease. Transcription, 5, e28848. 
DRAKE, J. A., BIRD, C., NEMESH, J., THOMAS, D. J., NEWTON-CHEH, C., REYMOND, A., 
EXCOFFIER, L., ATTAR, H., ANTONARAKIS, S. E., DERMITZAKIS, E. T. & HIRSCHHORN, 
J. N. 2006. Conserved noncoding sequences are selectively constrained and not 
mutation cold spots. Nat Genet, 38, 223-7. 
DUAN, Z., ANDRONESCU, M., SCHUTZ, K., LEE, C., SHENDURE, J., FIELDS, S., NOBLE, W. S. & 
ANTHONY BLAU, C. 2012. A genome-wide 3C-method for characterizing the three-
dimensional architectures of genomes. Methods, 58, 277-88. 
DUDLEY, A. T., ROS, M. A. & TABIN, C. J. 2002. A re-examination of proximodistal patterning 
during vertebrate limb development. Nature, 418, 539-44. 
ECHELARD, Y., EPSTEIN, D. J., ST-JACQUES, B., SHEN, L., MOHLER, J., MCMAHON, J. A. & 
MCMAHON, A. P. 1993. Sonic hedgehog, a member of a family of putative signaling 
molecules, is implicated in the regulation of CNS polarity. Cell, 75, 1417-30. 
EUGSTER, C., PANÁKOVÁ, D., MAHMOUD, A. & EATON, S. 2007. Lipoprotein-heparan sulfate 
interactions in the Hh pathway. Dev Cell, 13, 57-71. 
FACTOR, D. C., CORRADIN, O., ZENTNER, G. E., SAIAKHOVA, A., SONG, L., CHENOWETH, J. 
G., MCKAY, R. D., CRAWFORD, G. E., SCACHERI, P. C. & TESAR, P. J. 2014. 
Epigenomic comparison reveals activation of "seed" enhancers during transition 
from naive to primed pluripotency. Cell Stem Cell, 14, 854-63. 
FALLON, J. F., LÓPEZ, A., ROS, M. A., SAVAGE, M. P., OLWIN, B. B. & SIMANDL, B. K. 1994. 
FGF-2: apical ectodermal ridge growth signal for chick limb development. Science, 
264, 104-7. 
FARIN, H. F., LÜDTKE, T. H., SCHMIDT, M. K., PLACZKO, S., SCHUSTER-GOSSLER, K., PETRY, 
M., CHRISTOFFELS, V. M. & KISPERT, A. 2013. Tbx2 terminates shh/fgf signaling in 
the developing mouse limb bud by direct repression of gremlin1. PLoS Genet, 9, 
e1003467. 
FISHER, S., GRICE, E. A., VINTON, R. M., BESSLING, S. L. & MCCALLION, A. S. 2006. 
Conservation of RET regulatory function from human to zebrafish without sequence 
similarity. Science, 312, 276-9. 
FLAVAHAN, W. A., DRIER, Y., LIAU, B. B., GILLESPIE, S. M., VENTEICHER, A. S., STEMMER-
RACHAMIMOV, A. O., SUVÀ, M. L. & BERNSTEIN, B. E. 2016. Insulator dysfunction 
and oncogene activation in IDH mutant gliomas. Nature, 529, 110-4. 
FLÖTTMANN, R., WAGNER, J., KOBUS, K., CURRY, C. J., SAVARIRAYAN, R., NISHIMURA, G., 
YASUI, N., SPRANGER, J., VAN ESCH, H., LYONS, M. J., DUPONT, B. R., DWIVEDI, A., 
KLOPOCKI, E., HORN, D., MUNDLOS, S. & SPIELMANN, M. 2015. Microdeletions on 
6p22.3 are associated with mesomelic dysplasia Savarirayan type. J Med Genet, 52, 
476-83. 
FUDENBERG, G., IMAKAEV, M., LU, C., GOLOBORODKO, A., ABDENNUR, N. & MIRNY, L. A. 
2016. Formation of Chromosomal Domains by Loop Extrusion. Cell Rep, 15, 2038-
49. 
 232 
GALLET, A., RODRIGUEZ, R., RUEL, L. & THEROND, P. P. 2003. Cholesterol modification of 
hedgehog is required for trafficking and movement, revealing an asymmetric 
cellular response to hedgehog. Dev Cell, 4, 191-204. 
GALLET, A., RUEL, L., STACCINI-LAVENANT, L. & THÉROND, P. P. 2006. Cholesterol 
modification is necessary for controlled planar long-range activity of Hedgehog in 
Drosophila epithelia. Development, 133, 407-18. 
GIORGIO, E., ROBYR, D., SPIELMANN, M., FERRERO, E., DI GREGORIO, E., IMPERIALE, D., 
VAULA, G., STAMOULIS, G., SANTONI, F., ATZORI, C., GASPARINI, L., FERRERA, D., 
CANALE, C., GUIPPONI, M., PENNACCHIO, L. A., ANTONARAKIS, S. E., BRUSSINO, A. 
& BRUSCO, A. 2015. A large genomic deletion leads to enhancer adoption by the 
lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating 
leukodystrophy (ADLD). Hum Mol Genet, 24, 3143-54. 
GIRESI, P. G., KIM, J., MCDANIELL, R. M., IYER, V. R. & LIEB, J. D. 2007. FAIRE (Formaldehyde-
Assisted Isolation of Regulatory Elements) isolates active regulatory elements from 
human chromatin. Genome Res, 17, 877-85. 
GIRISHA, K. M., BIDCHOL, A. M., KAMATH, P. S., SHAH, K. H., MORTIER, G. R., MUNDLOS, S. 
& SHAH, H. 2014. A novel mutation (g.106737G>T) in zone of polarizing activity 
regulatory sequence (ZRS) causes variable limb phenotypes in Werner mesomelia. 
Am J Med Genet A, 164A, 898-906. 
GLASSFORD, W. J. & REBEIZ, M. 2013. Assessing constraints on the path of regulatory 
sequence evolution. Philos Trans R Soc Lond B Biol Sci, 368, 20130026. 
GUELEN, L., PAGIE, L., BRASSET, E., MEULEMAN, W., FAZA, M. B., TALHOUT, W., EUSSEN, B. 
H., DE KLEIN, A., WESSELS, L., DE LAAT, W. & VAN STEENSEL, B. 2008. Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions. Nature, 453, 948-51. 
GUO, B., PANAGIOTAKI, N., WARWOOD, S. & SHARROCKS, A. D. 2011. Dynamic modification 
of the ETS transcription factor PEA3 by sumoylation and p300-mediated 
acetylation. Nucleic Acids Res, 39, 6403-13. 
GUO, H., DAI, L., HUANG, Y., LIAO, Q. & BAI, Y. 2013. A large novel deletion downstream of 
PAX6 gene in a Chinese family with ocular coloboma. PLoS One, 8, e83073. 
GUO, Y., XU, Q., CANZIO, D., SHOU, J., LI, J., GORKIN, D. U., JUNG, I., WU, H., ZHAI, Y., TANG, 
Y., LU, Y., WU, Y., JIA, Z., LI, W., ZHANG, M. Q., REN, B., KRAINER, A. R., MANIATIS, T. 
& WU, Q. 2015. CRISPR Inversion of CTCF Sites Alters Genome Topology and 
Enhancer/Promoter Function. Cell, 162, 900-10. 
HAGÈGE, H., KLOUS, P., BRAEM, C., SPLINTER, E., DEKKER, J., CATHALA, G., DE LAAT, W. & 
FORNÉ, T. 2007. Quantitative analysis of chromosome conformation capture assays 
(3C-qPCR). Nat Protoc, 2, 1722-33. 
HARE, E. E., PETERSON, B. K. & EISEN, M. B. 2008a. A careful look at binding site 
reorganization in the even-skipped enhancers of Drosophila and sepsids. PLoS 
Genet, 4, e1000268. 
HARE, E. E., PETERSON, B. K., IYER, V. N., MEIER, R. & EISEN, M. B. 2008b. Sepsid even-
skipped enhancers are functionally conserved in Drosophila despite lack of 
sequence conservation. PLoS Genet, 4, e1000106. 
HARFE, B. D., SCHERZ, P. J., NISSIM, S., TIAN, H., MCMAHON, A. P. & TABIN, C. J. 2004. 
Evidence for an expansion-based temporal Shh gradient in specifying vertebrate 
digit identities. Cell, 118, 517-28. 
HARO, E., DELGADO, I., JUNCO, M., YAMADA, Y., MANSOURI, A., OBERG, K. C. & ROS, M. A. 
2014. Sp6 and Sp8 transcription factors control AER formation and dorsal-ventral 
patterning in limb development. PLoS Genet, 10, e1004468. 
HEBROK, M. 2003. Hedgehog signaling in pancreas development. Mech Dev, 120, 45-57. 
 233 
HEYN, H., VIDAL, E., FERREIRA, H. J., VIZOSO, M., SAYOLS, S., GOMEZ, A., MORAN, S., 
BOQUE-SASTRE, R., GUIL, S., MARTINEZ-CARDUS, A., LIN, C. Y., ROYO, R., SANCHEZ-
MUT, J. V., MARTINEZ, R., GUT, M., TORRENTS, D., OROZCO, M., GUT, I., YOUNG, R. 
A. & ESTELLER, M. 2016. Epigenomic analysis detects aberrant super-enhancer DNA 
methylation in human cancer. Genome Biol, 17, 11. 
HNISZ, D., ABRAHAM, B. J., LEE, T. I., LAU, A., SAINT-ANDRÉ, V., SIGOVA, A. A., HOKE, H. A. & 
YOUNG, R. A. 2013. Super-enhancers in the control of cell identity and disease. Cell, 
155, 934-47. 
HNISZ, D., WEINTRAUB, A. S., DAY, D. S., VALTON, A. L., BAK, R. O., LI, C. H., GOLDMANN, J., 
LAJOIE, B. R., FAN, Z. P., SIGOVA, A. A., REDDY, J., BORGES-RIVERA, D., LEE, T. I., 
JAENISCH, R., PORTEUS, M. H., DEKKER, J. & YOUNG, R. A. 2016. Activation of proto-
oncogenes by disruption of chromosome neighborhoods. Science, 351, 1454-8. 
HYON, C., CHANTOT-BASTARAUD, S., HARBUZ, R., BHOURI, R., PERROT, N., PEYCELON, M., 
SIBONY, M., ROJO, S., PIGUEL, X., BILAN, F., GILBERT-DUSSARDIER, B., KITZIS, A., 
MCELREAVEY, K., SIFFROI, J. P. & BASHAMBOO, A. 2015. Refining the regulatory 
region upstream of SOX9 associated with 46,XX testicular disorders of Sex 
Development (DSD). Am J Med Genet A, 167A, 1851-8. 
IANAKIEV, P., VAN BAREN MJ, DALY, M. J., TOLEDO, S. P., CAVALCANTI, M. G., NETO, J. C., 
SILVEIRA, E. L., FREIRE-MAIA, A., HEUTINK, P., KILPATRICK, M. W. & TSIPOURAS, P. 
2001. Acheiropodia is caused by a genomic deletion in C7orf2, the human 
orthologue of the Lmbr1 gene. Am J Hum Genet, 68, 38-45. 
IBORRA, F. J., POMBO, A., JACKSON, D. A. & COOK, P. R. 1996. Active RNA polymerases are 
localized within discrete transcription "factories' in human nuclei. J Cell Sci, 109 ( Pt 
6), 1427-36. 
INGHAM, P. & VICENTE, C. 2014. An interview with Phil Ingham. Development, 141, 2363-5. 
JAT, P. S., NOBLE, M. D., ATALIOTIS, P., TANAKA, Y., YANNOUTSOS, N., LARSEN, L. & 
KIOUSSIS, D. 1991. Direct derivation of conditionally immortal cell lines from an H-
2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A, 88, 5096-100. 
JEONG, Y., EL-JAICK, K., ROESSLER, E., MUENKE, M. & EPSTEIN, D. J. 2006. A functional 
screen for sonic hedgehog regulatory elements across a 1 Mb interval identifies 
long-range ventral forebrain enhancers. Development, 133, 761-72. 
KAGEY, M. H., NEWMAN, J. J., BILODEAU, S., ZHAN, Y., ORLANDO, D. A., VAN BERKUM, N. L., 
EBMEIER, C. C., GOOSSENS, J., RAHL, P. B., LEVINE, S. S., TAATJES, D. J., DEKKER, J. & 
YOUNG, R. A. 2010. Mediator and cohesin connect gene expression and chromatin 
architecture. Nature, 467, 430-5. 
KATZMAN, S., KERN, A. D., BEJERANO, G., FEWELL, G., FULTON, L., WILSON, R. K., SALAMA, 
S. R. & HAUSSLER, D. 2007. Human genome ultraconserved elements are 
ultraselected. Science, 317, 915. 
KENGAKU, M., CAPDEVILA, J., RODRIGUEZ-ESTEBAN, C., DE LA PEÑA, J., JOHNSON, R. L., 
IZPISÚA BELMONTE, J. C. & TABIN, C. J. 1998. Distinct WNT pathways regulating 
AER formation and dorsoventral polarity in the chick limb bud. Science, 280, 1274-
7. 
KOKUBU, C., HORIE, K., ABE, K., IKEDA, R., MIZUNO, S., UNO, Y., OGIWARA, S., OHTSUKA, 
M., ISOTANI, A., OKABE, M., IMAI, K. & TAKEDA, J. 2009. A transposon-based 
chromosomal engineering method to survey a large cis-regulatory landscape in 
mice. Nat Genet, 41, 946-52. 
KOZHEMYAKINA, E., IONESCU, A. & LASSAR, A. B. 2014. GATA6 is a crucial regulator of Shh 
in the limb bud. PLoS Genet, 10, e1004072. 
 234 
KRAUSS, S., CONCORDET, J. P. & INGHAM, P. W. 1993. A functionally conserved homolog of 
the Drosophila segment polarity gene hh is expressed in tissues with polarizing 
activity in zebrafish embryos. Cell, 75, 1431-44. 
KUBBEN, N., ADRIAENS, M., MEULEMAN, W., VONCKEN, J. W., VAN STEENSEL, B. & MISTELI, 
T. 2012. Mapping of lamin A- and progerin-interacting genome regions. 
Chromosoma, 121, 447-64. 
KUGLER, M. C., JOYNER, A. L., LOOMIS, C. A. & MUNGER, J. S. 2015. Sonic hedgehog 
signaling in the lung. From development to disease. Am J Respir Cell Mol Biol, 52, 1-
13. 
KURTH, I., KLOPOCKI, E., STRICKER, S., VAN OOSTERWIJK, J., VANEK, S., ALTMANN, J., 
SANTOS, H. G., VAN HARSSEL, J. J., DE RAVEL, T., WILKIE, A. O., GAL, A. & 
MUNDLOS, S. 2009. Duplications of noncoding elements 5' of SOX9 are associated 
with brachydactyly-anonychia. Nat Genet, 41, 862-3. 
LANGMORE, J. P. & PAULSON, J. R. 1983. Low angle x-ray diffraction studies of chromatin 
structure in vivo and in isolated nuclei and metaphase chromosomes. J Cell Biol, 96, 
1120-31. 
LEE, J. D. & TREISMAN, J. E. 2001. Sightless has homology to transmembrane 
acyltransferases and is required to generate active Hedgehog protein. Curr Biol, 11, 
1147-52. 
LEE, J. J., EKKER, S. C., VON KESSLER, D. P., PORTER, J. A., SUN, B. I. & BEACHY, P. A. 1994. 
Autoproteolysis in hedgehog protein biogenesis. Science, 266, 1528-37. 
LEE, T. I., JENNER, R. G., BOYER, L. A., GUENTHER, M. G., LEVINE, S. S., KUMAR, R. M., 
CHEVALIER, B., JOHNSTONE, S. E., COLE, M. F., ISONO, K., KOSEKI, H., FUCHIKAMI, 
T., ABE, K., MURRAY, H. L., ZUCKER, J. P., YUAN, B., BELL, G. W., HERBOLSHEIMER, 
E., HANNETT, N. M., SUN, K., ODOM, D. T., OTTE, A. P., VOLKERT, T. L., BARTEL, D. 
P., MELTON, D. A., GIFFORD, D. K., JAENISCH, R. & YOUNG, R. A. 2006. Control of 
developmental regulators by Polycomb in human embryonic stem cells. Cell, 125, 
301-13. 
LETTICE, L. A., HILL, A. E., DEVENNEY, P. S. & HILL, R. E. 2008. Point mutations in a distant 
sonic hedgehog cis-regulator generate a variable regulatory output responsible for 
preaxial polydactyly. Hum Mol Genet, 17, 978-85. 
LETTICE, L. A., WILLIAMSON, I., WILTSHIRE, J. H., PELUSO, S., DEVENNEY, P. S., HILL, A. E., 
ESSAFI, A., HAGMAN, J., MORT, R., GRIMES, G., DEANGELIS, C. L. & HILL, R. E. 2012. 
Opposing functions of the ETS factor family define Shh spatial expression in limb 
buds and underlie polydactyly. Dev Cell, 22, 459-67. 
LEVSKY, J. M. & SINGER, R. H. 2003. Fluorescence in situ hybridization: past, present and 
future. J Cell Sci, 116, 2833-8. 
LEWANDOSKI, M., SUN, X. & MARTIN, G. R. 2000. Fgf8 signalling from the AER is essential 
for normal limb development. Nat Genet, 26, 460-3. 
LITINGTUNG, Y., LEI, L., WESTPHAL, H. & CHIANG, C. 1998. Sonic hedgehog is essential to 
foregut development. Nat Genet, 20, 58-61. 
LOGAN, C., HORNBRUCH, A., CAMPBELL, I. & LUMSDEN, A. 1997. The role of Engrailed in 
establishing the dorsoventral axis of the chick limb. Development, 124, 2317-24. 
LOHAN, S., SPIELMANN, M., DOELKEN, S. C., FLÖTTMANN, R., MUHAMMAD, F., BAIG, S. M., 
WAJID, M., HÜLSEMANN, W., HABENICHT, R., KJAER, K. W., PATIL, S. J., GIRISHA, K. 
M., ABARCA-BARRIGA, H. H., MUNDLOS, S. & KLOPOCKI, E. 2014. Microduplications 
encompassing the Sonic hedgehog limb enhancer ZRS are associated with Haas-
type polysyndactyly and Laurin-Sandrow syndrome. Clin Genet, 86, 318-25. 
 235 
LOVÉN, J., HOKE, H. A., LIN, C. Y., LAU, A., ORLANDO, D. A., VAKOC, C. R., BRADNER, J. E., 
LEE, T. I. & YOUNG, R. A. 2013. Selective inhibition of tumor oncogenes by 
disruption of super-enhancers. Cell, 153, 320-34. 
LOVÉN, J., ORLANDO, D. A., SIGOVA, A. A., LIN, C. Y., RAHL, P. B., BURGE, C. B., LEVENS, D. 
L., LEE, T. I. & YOUNG, R. A. 2012. Revisiting global gene expression analysis. Cell, 
151, 476-82. 
LUPIÁÑEZ, D. G., KRAFT, K., HEINRICH, V., KRAWITZ, P., BRANCATI, F., KLOPOCKI, E., HORN, 
D., KAYSERILI, H., OPITZ, J. M., LAXOVA, R., SANTOS-SIMARRO, F., GILBERT-
DUSSARDIER, B., WITTLER, L., BORSCHIWER, M., HAAS, S. A., OSTERWALDER, M., 
FRANKE, M., TIMMERMANN, B., HECHT, J., SPIELMANN, M., VISEL, A. & MUNDLOS, 
S. 2015. Disruptions of topological chromatin domains cause pathogenic rewiring of 
gene-enhancer interactions. Cell, 161, 1012-25. 
MAESHIMA, K., HIHARA, S. & ELTSOV, M. 2010. Chromatin structure: does the 30-nm fibre 
exist in vivo? Curr Opin Cell Biol, 22, 291-7. 
MAESHIMA, K., IDE, S., HIBINO, K. & SASAI, M. 2016. Liquid-like behavior of chromatin. Curr 
Opin Genet Dev, 37, 36-45. 
MAESHIMA, K., IMAI, R., TAMURA, S. & NOZAKI, T. 2014. Chromatin as dynamic 10-nm 
fibers. Chromosoma, 123, 225-37. 
MARIANI, F. V., AHN, C. P. & MARTIN, G. R. 2008. Genetic evidence that FGFs have an 
instructive role in limb proximal-distal patterning. Nature, 453, 401-5. 
MARINIĆ, M., AKTAS, T., RUF, S. & SPITZ, F. 2013. An integrated holo-enhancer unit defines 
tissue and gene specificity of the Fgf8 regulatory landscape. Dev Cell, 24, 530-42. 
MARSDEN, M. P. & LAEMMLI, U. K. 1979. Metaphase chromosome structure: evidence for a 
radial loop model. Cell, 17, 849-58. 
MARTIN, P. 1990. Tissue patterning in the developing mouse limb. Int J Dev Biol, 34, 323-36. 
MATTOUT, A., PIKE, B. L., TOWBIN, B. D., BANK, E. M., GONZALEZ-SANDOVAL, A., STADLER, 
M. B., MEISTER, P., GRUENBAUM, Y. & GASSER, S. M. 2011. An EDMD mutation in 
C. elegans lamin blocks muscle-specific gene relocation and compromises muscle 
integrity. Curr Biol, 21, 1603-14. 
MERCADER, N., LEONARDO, E., PIEDRA, M. E., MARTÍNEZ-A, C., ROS, M. A. & TORRES, M. 
2000. Opposing RA and FGF signals control proximodistal vertebrate limb 
development through regulation of Meis genes. Development, 127, 3961-70. 
MERIDETH, M. A., GORDON, L. B., CLAUSS, S., SACHDEV, V., SMITH, A. C., PERRY, M. B., 
BREWER, C. C., ZALEWSKI, C., KIM, H. J., SOLOMON, B., BROOKS, B. P., GERBER, L. 
H., TURNER, M. L., DOMINGO, D. L., HART, T. C., GRAF, J., REYNOLDS, J. C., 
GROPMAN, A., YANOVSKI, J. A., GERHARD-HERMAN, M., COLLINS, F. S., NABEL, E. 
G., CANNON, R. O., GAHL, W. A. & INTRONE, W. J. 2008. Phenotype and course of 
Hutchinson-Gilford progeria syndrome. N Engl J Med, 358, 592-604. 
MICCHELLI, C. A., THE, I., SELVA, E., MOGILA, V. & PERRIMON, N. 2002. Rasp, a putative 
transmembrane acyltransferase, is required for Hedgehog signaling. Development, 
129, 843-51. 
MICHAUD, J. L., LAPOINTE, F. & LE DOUARIN, N. M. 1997. The dorsoventral polarity of the 
presumptive limb is determined by signals produced by the somites and by the 
lateral somatopleure. Development, 124, 1453-63. 
MIELE, A., GHELDOF, N., TABUCHI, T. M., DOSTIE, J. & DEKKER, J. 2006. Mapping chromatin 
interactions by chromosome conformation capture. Curr Protoc Mol Biol, Chapter 
21, Unit 21.11. 
MILLER, L. A., WERT, S. E. & WHITSETT, J. A. 2001. Immunolocalization of sonic hedgehog 
(Shh) in developing mouse lung. J Histochem Cytochem, 49, 1593-604. 
 236 
MITCHELL, J. A. & FRASER, P. 2008. Transcription factories are nuclear subcompartments 
that remain in the absence of transcription. Genes Dev, 22, 20-5. 
MONTAVON, T., SOSHNIKOVA, N., MASCREZ, B., JOYE, E., THEVENET, L., SPLINTER, E., DE 
LAAT, W., SPITZ, F. & DUBOULE, D. 2011. A regulatory archipelago controls Hox 
genes transcription in digits. Cell, 147, 1132-45. 
MOORE, P. S., BARBI, S., DONADELLI, M., COSTANZO, C., BASSI, C., PALMIERI, M. & SCARPA, 
A. 2004. Gene expression profiling after treatment with the histone deacetylase 
inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic 
genes in pancreatic adenocarcinoma cells. Biochim Biophys Acta, 1693, 167-76. 
MOREY, C., DA SILVA, N. R., PERRY, P. & BICKMORE, W. A. 2007. Nuclear reorganisation and 
chromatin decondensation are conserved, but distinct, mechanisms linked to Hox 
gene activation. Development, 134, 909-19. 
NANNI, L., MING, J. E., BOCIAN, M., STEINHAUS, K., BIANCHI, D. W., DIE-SMULDERS, C., 
GIANNOTTI, A., IMAIZUMI, K., JONES, K. L., CAMPO, M. D., MARTIN, R. A., 
MEINECKE, P., PIERPONT, M. E., ROBIN, N. H., YOUNG, I. D., ROESSLER, E. & 
MUENKE, M. 1999. The mutational spectrum of the sonic hedgehog gene in 
holoprosencephaly: SHH mutations cause a significant proportion of autosomal 
dominant holoprosencephaly. Hum Mol Genet, 8, 2479-88. 
NARENDRA, V., ROCHA, P. P., AN, D., RAVIRAM, R., SKOK, J. A., MAZZONI, E. O. & REINBERG, 
D. 2015. CTCF establishes discrete functional chromatin domains at the Hox clusters 
during differentiation. Science, 347, 1017-21. 
NISHIMOTO, S. & LOGAN, M. P. 2016. Subdivision of the lateral plate mesoderm and 
specification of the forelimb and hindlimb forming domains. Semin Cell Dev Biol, 49, 
102-8. 
NISHIMOTO, S., WILDE, S. M., WOOD, S. & LOGAN, M. P. 2015. RA Acts in a Coherent Feed-
Forward Mechanism with Tbx5 to Control Limb Bud Induction and Initiation. Cell 
Rep, 12, 879-91. 
NISHINO, Y., ELTSOV, M., JOTI, Y., ITO, K., TAKATA, H., TAKAHASHI, Y., HIHARA, S., 
FRANGAKIS, A. S., IMAMOTO, N., ISHIKAWA, T. & MAESHIMA, K. 2012. Human 
mitotic chromosomes consist predominantly of irregularly folded nucleosome 
fibres without a 30-nm chromatin structure. EMBO J, 31, 1644-53. 
NISWANDER, L., JEFFREY, S., MARTIN, G. R. & TICKLE, C. 1994. A positive feedback loop 
coordinates growth and patterning in the vertebrate limb. Nature, 371, 609-12. 
NISWANDER, L., TICKLE, C., VOGEL, A., BOOTH, I. & MARTIN, G. R. 1993. FGF-4 replaces the 
apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell, 75, 
579-87. 
NORBNOP, P., SRICHOMTHONG, C., SUPHAPEETIPORN, K. & SHOTELERSUK, V. 2014. ZRS 
406A>G mutation in patients with tibial hypoplasia, polydactyly and triphalangeal 
first fingers. J Hum Genet, 59, 467-70. 
NORTHCOTT, P. A., LEE, C., ZICHNER, T., STÜTZ, A. M., ERKEK, S., KAWAUCHI, D., SHIH, D. J., 
HOVESTADT, V., ZAPATKA, M., STURM, D., JONES, D. T., KOOL, M., REMKE, M., 
CAVALLI, F. M., ZUYDERDUYN, S., BADER, G. D., VANDENBERG, S., ESPARZA, L. A., 
RYZHOVA, M., WANG, W., WITTMANN, A., STARK, S., SIEBER, L., SEKER-CIN, H., 
LINKE, L., KRATOCHWIL, F., JÄGER, N., BUCHHALTER, I., IMBUSCH, C. D., ZIPPRICH, 
G., RAEDER, B., SCHMIDT, S., DIESSL, N., WOLF, S., WIEMANN, S., BRORS, B., 
LAWERENZ, C., EILS, J., WARNATZ, H. J., RISCH, T., YASPO, M. L., WEBER, U. D., 
BARTHOLOMAE, C. C., VON KALLE, C., TURÁNYI, E., HAUSER, P., SANDEN, E., 
DARABI, A., SIESJÖ, P., STERBA, J., ZITTERBART, K., SUMERAUER, D., VAN SLUIS, P., 
VERSTEEG, R., VOLCKMANN, R., KOSTER, J., SCHUHMANN, M. U., EBINGER, M., 
GRIMES, H. L., ROBINSON, G. W., GAJJAR, A., MYNAREK, M., VON HOFF, K., 
 237 
RUTKOWSKI, S., PIETSCH, T., SCHEURLEN, W., FELSBERG, J., REIFENBERGER, G., 
KULOZIK, A. E., VON DEIMLING, A., WITT, O., EILS, R., GILBERTSON, R. J., 
KORSHUNOV, A., TAYLOR, M. D., LICHTER, P., KORBEL, J. O., WECHSLER-REYA, R. J. 
& PFISTER, S. M. 2014. Enhancer hijacking activates GFI1 family oncogenes in 
medulloblastoma. Nature, 511, 428-34. 
NÜSSLEIN-VOLHARD, C. & WIESCHAUS, E. 1980. Mutations affecting segment number and 
polarity in Drosophila. Nature, 287, 795-801. 
O'KANE, C. J. & GEHRING, W. J. 1987. Detection in situ of genomic regulatory elements in 
Drosophila. Proc Natl Acad Sci U S A, 84, 9123-7. 
OHLIG, S., FARSHI, P., PICKHINKE, U., VAN DEN BOOM, J., HÖING, S., JAKUSCHEV, S., 
HOFFMANN, D., DREIER, R., SCHÖLER, H. R., DIERKER, T., BORDYCH, C. & GROBE, K. 
2011. Sonic hedgehog shedding results in functional activation of the solubilized 
protein. Dev Cell, 20, 764-74. 
OLINS, A. L. & OLINS, D. E. 1974. Spheroid chromatin units (v bodies). Science, 183, 330-2. 
OSBORNE, C. S., CHAKALOVA, L., BROWN, K. E., CARTER, D., HORTON, A., DEBRAND, E., 
GOYENECHEA, B., MITCHELL, J. A., LOPES, S., REIK, W. & FRASER, P. 2004. Active 
genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet, 
36, 1065-71. 
PAIVA, K. B., SILVA-VALENZUELA, M., MASSIRONI, S. M., KO, G. M., SIQUEIRA, F. M. & 
NUNES, F. D. 2010. Differential Shh, Bmp and Wnt gene expressions during 
craniofacial development in mice. Acta Histochem, 112, 508-17. 
PALM, W., SWIERCZYNSKA, M. M., KUMARI, V., EHRHART-BORNSTEIN, M., BORNSTEIN, S. R. 
& EATON, S. 2013. Secretion and signaling activities of lipoprotein-associated 
hedgehog and non-sterol-modified hedgehog in flies and mammals. PLoS Biol, 11, 
e1001505. 
PAN, A., CHANG, L., NGUYEN, A. & JAMES, A. W. 2013. A review of hedgehog signaling in 
cranial bone development. Front Physiol, 4, 61. 
PANÁKOVÁ, D., SPRONG, H., MAROIS, E., THIELE, C. & EATON, S. 2005. Lipoprotein particles 
are required for Hedgehog and Wingless signalling. Nature, 435, 58-65. 
PARADIS, F. H. & HALES, B. F. 2013. Exposure to valproic acid inhibits chondrogenesis and 
osteogenesis in mid-organogenesis mouse limbs. Toxicol Sci, 131, 234-41. 
PARK, H., LEE, Y. J., KIM, T. H., LEE, J., YOON, S., CHOI, W. S., MYUNG, C. S. & KIM, H. S. 
2008. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of 
apoptosis in H-ras-transformed breast epithelial cells. Int J Mol Med, 22, 605-11. 
PARKER, S. C., STITZEL, M. L., TAYLOR, D. L., OROZCO, J. M., ERDOS, M. R., AKIYAMA, J. A., 
VAN BUEREN, K. L., CHINES, P. S., NARISU, N., BLACK, B. L., VISEL, A., PENNACCHIO, 
L. A., COLLINS, F. S., PROGRAM, N. C. S., AUTHORS, N. I. O. H. I. S. C. C. S. P. & 
AUTHORS, N. C. S. P. 2013. Chromatin stretch enhancer states drive cell-specific 
gene regulation and harbor human disease risk variants. Proc Natl Acad Sci U S A, 
110, 17921-6. 
PENG, C., FU, L. Y., DONG, P. F., DENG, Z. L., LI, J. X., WANG, X. T. & ZHANG, H. Y. 2013. The 
sequencing bias relaxed characteristics of Hi-C derived data and implications for 
chromatin 3D modeling. Nucleic Acids Res, 41, e183. 
PENNACCHIO, L. A., AHITUV, N., MOSES, A. M., PRABHAKAR, S., NOBREGA, M. A., SHOUKRY, 
M., MINOVITSKY, S., DUBCHAK, I., HOLT, A., LEWIS, K. D., PLAJZER-FRICK, I., 
AKIYAMA, J., DE VAL, S., AFZAL, V., BLACK, B. L., COURONNE, O., EISEN, M. B., VISEL, 
A. & RUBIN, E. M. 2006. In vivo enhancer analysis of human conserved non-coding 
sequences. Nature, 444, 499-502. 
PENNACCHIO, L. A., BICKMORE, W., DEAN, A., NOBREGA, M. A. & BEJERANO, G. 2013. 
Enhancers: five essential questions. Nat Rev Genet, 14, 288-95. 
 238 
PENNISI, E. 2003. Human genome. A low number wins the GeneSweep Pool. Science, 300, 
1484. 
PEPINSKY, R. B., ZENG, C., WEN, D., RAYHORN, P., BAKER, D. P., WILLIAMS, K. P., BIXLER, S. 
A., AMBROSE, C. M., GARBER, E. A., MIATKOWSKI, K., TAYLOR, F. R., WANG, E. A. & 
GALDES, A. 1998. Identification of a palmitic acid-modified form of human Sonic 
hedgehog. J Biol Chem, 273, 14037-45. 
PERIC-HUPKES, D., MEULEMAN, W., PAGIE, L., BRUGGEMAN, S. W., SOLOVEI, I., BRUGMAN, 
W., GRÄF, S., FLICEK, P., KERKHOVEN, R. M., VAN LOHUIZEN, M., REINDERS, M., 
WESSELS, L. & VAN STEENSEL, B. 2010. Molecular maps of the reorganization of 
genome-nuclear lamina interactions during differentiation. Mol Cell, 38, 603-13. 
PETIT, F., JOURDAIN, A. S., HOLDER-ESPINASSE, M., KEREN, B., ANDRIEUX, J., DUTERQUE-
COQUILLAUD, M., PORCHET, N., MANOUVRIER-HANU, S. & ESCANDE, F. 2016. The 
disruption of a novel limb cis-regulatory element of SHH is associated with 
autosomal dominant preaxial polydactyly-hypertrichosis. Eur J Hum Genet, 24, 37-
43. 
PHILLIPS-CREMINS, J. E., SAURIA, M. E., SANYAL, A., GERASIMOVA, T. I., LAJOIE, B. R., BELL, 
J. S., ONG, C. T., HOOKWAY, T. A., GUO, C., SUN, Y., BLAND, M. J., WAGSTAFF, W., 
DALTON, S., MCDEVITT, T. C., SEN, R., DEKKER, J., TAYLOR, J. & CORCES, V. G. 2013. 
Architectural protein subclasses shape 3D organization of genomes during lineage 
commitment. Cell, 153, 1281-95. 
PLESSY, C., DICKMEIS, T., CHALMEL, F. & STRÄHLE, U. 2005. Enhancer sequence 
conservation between vertebrates is favoured in developmental regulator genes. 
Trends Genet, 21, 207-10. 
PORTER, J. A., YOUNG, K. E. & BEACHY, P. A. 1996. Cholesterol modification of hedgehog 
signaling proteins in animal development. Science, 274, 255-9. 
PRICE, C. M. 1993. Fluorescence in situ hybridization. Blood Rev, 7, 127-34. 
RADA-IGLESIAS, A., BAJPAI, R., SWIGUT, T., BRUGMANN, S. A., FLYNN, R. A. & WYSOCKA, J. 
2011. A unique chromatin signature uncovers early developmental enhancers in 
humans. Nature, 470, 279-83. 
RAMALHO-SANTOS, M., MELTON, D. A. & MCMAHON, A. P. 2000. Hedgehog signals 
regulate multiple aspects of gastrointestinal development. Development, 127, 
2763-72. 
RAZIN, S. V., GAVRILOV, A. A., VASSETZKY, Y. S. & ULIANOV, S. V. 2016. Topologically 
associating domains: gene warehouses adapted to serve transcriptional regulation. 
Transcription, 0. 
RIDDLE, R. D., ENSINI, M., NELSON, C., TSUCHIDA, T., JESSELL, T. M. & TABIN, C. 1995. 
Induction of the LIM homeobox gene Lmx1 by WNT7a establishes dorsoventral 
pattern in the vertebrate limb. Cell, 83, 631-40. 
RIDDLE, R. D., JOHNSON, R. L., LAUFER, E. & TABIN, C. 1993. Sonic hedgehog mediates the 
polarizing activity of the ZPA. Cell, 75, 1401-16. 
RUBIN, L. & SAUNDERS, J. W. 1972. Ectodermal-mesodermal interactions in the growth of 
limb buds in the chick embryo: constancy and temporal limits of the ectodermal 
induction. Dev Biol, 28, 94-112. 
RUBINSTEIN, M. & DE SOUZA, F. S. 2013. Evolution of transcriptional enhancers and animal 
diversity. Philos Trans R Soc Lond B Biol Sci, 368, 20130017. 
SAGAI, T., AMANO, T., TAMURA, M., MIZUSHINA, Y., SUMIYAMA, K. & SHIROISHI, T. 2009. A 
cluster of three long-range enhancers directs regional Shh expression in the 
epithelial linings. Development, 136, 1665-74. 
SANBORN, A. L., RAO, S. S., HUANG, S. C., DURAND, N. C., HUNTLEY, M. H., JEWETT, A. I., 
BOCHKOV, I. D., CHINNAPPAN, D., CUTKOSKY, A., LI, J., GEETING, K. P., GNIRKE, A., 
 239 
MELNIKOV, A., MCKENNA, D., STAMENOVA, E. K., LANDER, E. S. & AIDEN, E. L. 2015. 
Chromatin extrusion explains key features of loop and domain formation in wild-
type and engineered genomes. Proc Natl Acad Sci U S A, 112, E6456-65. 
SCHALCH, T., DUDA, S., SARGENT, D. F. & RICHMOND, T. J. 2005. X-ray structure of a 
tetranucleosome and its implications for the chromatin fibre. Nature, 436, 138-41. 
SCHERZ, P. J., HARFE, B. D., MCMAHON, A. P. & TABIN, C. J. 2004. The limb bud Shh-Fgf 
feedback loop is terminated by expansion of former ZPA cells. Science, 305, 396-9. 
SCHNEIDER, I. & SHUBIN, N. H. 2013. The origin of the tetrapod limb: from expeditions to 
enhancers. Trends Genet, 29, 419-26. 
SEDAT, J. & MANUELIDIS, L. 1978. A direct approach to the structure of eukaryotic 
chromosomes. Cold Spring Harb Symp Quant Biol, 42 Pt 1, 331-50. 
SEXTON, T., KURUKUTI, S., MITCHELL, J. A., UMLAUF, D., NAGANO, T. & FRASER, P. 2012. 
Sensitive detection of chromatin coassociations using enhanced chromosome 
conformation capture on chip. Nat Protoc, 7, 1335-50. 
SHETH, R., GRÉGOIRE, D., DUMOUCHEL, A., SCOTTI, M., PHAM, J. M., NEMEC, S., BASTIDA, 
M. F., ROS, M. A. & KMITA, M. 2013. Decoupling the function of Hox and Shh in 
developing limb reveals multiple inputs of Hox genes on limb growth. Development, 
140, 2130-8. 
SHEVELYOV, Y. Y., LAVROV, S. A., MIKHAYLOVA, L. M., NURMINSKY, I. D., KULATHINAL, R. J., 
EGOROVA, K. S., ROZOVSKY, Y. M. & NURMINSKY, D. I. 2009. The B-type lamin is 
required for somatic repression of testis-specific gene clusters. Proc Natl Acad Sci U 
S A, 106, 3282-7. 
SIMONIS, M., KLOUS, P., HOMMINGA, I., GALJAARD, R. J., RIJKERS, E. J., GROSVELD, F., 
MEIJERINK, J. P. & DE LAAT, W. 2009. High-resolution identification of balanced and 
complex chromosomal rearrangements by 4C technology. Nat Methods, 6, 837-42. 
SIMONIS, M., KLOUS, P., SPLINTER, E., MOSHKIN, Y., WILLEMSEN, R., DE WIT, E., VAN 
STEENSEL, B. & DE LAAT, W. 2006. Nuclear organization of active and inactive 
chromatin domains uncovered by chromosome conformation capture-on-chip (4C). 
Nat Genet, 38, 1348-54. 
SMITH, E. M., LAJOIE, B. R., JAIN, G. & DEKKER, J. 2016. Invariant TAD Boundaries Constrain 
Cell-Type-Specific Looping Interactions between Promoters and Distal Elements 
around the CFTR Locus. Am J Hum Genet, 98, 185-201. 
SMITH, J. C. 1980. The time required for positional signalling in the chick wing bud. J 
Embryol Exp Morphol, 60, 321-8. 
SMITH, J. C., TICKLE, C. & WOLPERT, L. 1978. Attenuation of positional signalling in the chick 
limb by high doses of gamma-radiation. Nature, 272, 612-3. 
SONG, L. & CRAWFORD, G. E. 2010. DNase-seq: a high-resolution technique for mapping 
active gene regulatory elements across the genome from mammalian cells. Cold 
Spring Harb Protoc, 2010, pdb.prot5384. 
SOSHNIKOVA, N., ZECHNER, D., HUELSKEN, J., MISHINA, Y., BEHRINGER, R. R., TAKETO, M. 
M., CRENSHAW, E. B. & BIRCHMEIER, W. 2003. Genetic interaction between 
Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the 
dorsal-ventral axis in the limb. Genes Dev, 17, 1963-8. 
SPLINTER, E., HEATH, H., KOOREN, J., PALSTRA, R. J., KLOUS, P., GROSVELD, F., GALJART, N. 
& DE LAAT, W. 2006. CTCF mediates long-range chromatin looping and local histone 
modification in the beta-globin locus. Genes Dev, 20, 2349-54. 
STADHOUDERS, R., KOLOVOS, P., BROUWER, R., ZUIN, J., VAN DEN HEUVEL, A., KOCKX, C., 
PALSTRA, R. J., WENDT, K. S., GROSVELD, F., VAN IJCKEN, W. & SOLER, E. 2013. 
Multiplexed chromosome conformation capture sequencing for rapid genome-scale 
 240 
high-resolution detection of long-range chromatin interactions. Nat Protoc, 8, 509-
24. 
SUMMERBELL, D. 1974. A quantitative analysis of the effect of excision of the AER from the 
chick limb-bud. J Embryol Exp Morphol, 32, 651-60. 
SUMMERBELL, D., LEWIS, J. H. & WOLPERT, L. 1973. Positional information in chick limb 
morphogenesis. Nature, 244, 492-6. 
SWANSON, C. I., SCHWIMMER, D. B. & BAROLO, S. 2011. Rapid evolutionary rewiring of a 
structurally constrained eye enhancer. Curr Biol, 21, 1186-96. 
TABIN, C. & WOLPERT, L. 2007. Rethinking the proximodistal axis of the vertebrate limb in 
the molecular era. Genes Dev, 21, 1433-42. 
TANAKA, Y., OKADA, Y. & HIROKAWA, N. 2005. FGF-induced vesicular release of Sonic 
hedgehog and retinoic acid in leftward nodal flow is critical for left-right 
determination. Nature, 435, 172-7. 
TE WELSCHER, P., FERNANDEZ-TERAN, M., ROS, M. A. & ZELLER, R. 2002. Mutual genetic 
antagonism involving GLI3 and dHAND prepatterns the vertebrate limb bud 
mesenchyme prior to SHH signaling. Genes Dev, 16, 421-6. 
THANOS, D. & MANIATIS, T. 1995. Virus induction of human IFN beta gene expression 
requires the assembly of an enhanceosome. Cell, 83, 1091-100. 
THERIZOLS, P., ILLINGWORTH, R. S., COURILLEAU, C., BOYLE, S., WOOD, A. J. & BICKMORE, 
W. A. 2014. Chromatin decondensation is sufficient to alter nuclear organization in 
embryonic stem cells. Science, 346, 1238-42. 
THONGJUEA, S., STADHOUDERS, R., GROSVELD, F. G., SOLER, E. & LENHARD, B. 2013. 
r3Cseq: an R/Bioconductor package for the discovery of long-range genomic 
interactions from chromosome conformation capture and next-generation 
sequencing data. Nucleic Acids Res, 41, e132. 
TIMMONS, P. M., WALLIN, J., RIGBY, P. W. & BALLING, R. 1994. Expression and function of 
Pax 1 during development of the pectoral girdle. Development, 120, 2773-85. 
TOWERS, M., MAHOOD, R., YIN, Y. & TICKLE, C. 2008. Integration of growth and 
specification in chick wing digit-patterning. Nature, 452, 882-6. 
TREMETHICK, D. J. 2007. Higher-order structures of chromatin: the elusive 30 nm fiber. Cell, 
128, 651-4. 
TSUI, M. G. 2014. PDZD2, a candidate for brachydactyly type A1, encodes a 
secreted protein that negatively modulates hedgehog signaling Ph.D. THESIS, The University 
of Hong Kong. 
TUKACHINSKY, H., KUZMICKAS, R. P., JAO, C. Y., LIU, J. & SALIC, A. 2012. Dispatched and 
scube mediate the efficient secretion of the cholesterol-modified hedgehog ligand. 
Cell Rep, 2, 308-20. 
TÓTH, K. F., KNOCH, T. A., WACHSMUTH, M., FRANK-STÖHR, M., STÖHR, M., BACHER, C. P., 
MÜLLER, G. & RIPPE, K. 2004. Trichostatin A-induced histone acetylation causes 
decondensation of interphase chromatin. J Cell Sci, 117, 4277-87. 
VALTON, A. L. & DEKKER, J. 2016. TAD disruption as oncogenic driver. Curr Opin Genet Dev, 
36, 34-40. 
VAN DE WERKEN, H. J., DE VREE, P. J., SPLINTER, E., HOLWERDA, S. J., KLOUS, P., DE WIT, E. 
& DE LAAT, W. 2012. 4C technology: protocols and data analysis. Methods Enzymol, 
513, 89-112. 
VAN DER VLAG, J. & OTTE, A. P. 1999. Transcriptional repression mediated by the human 
polycomb-group protein EED involves histone deacetylation. Nat Genet, 23, 474-8. 
VANDERMEER, J. E., LOZANO, R., SUN, M., XUE, Y., DAENTL, D., JABS, E. W., WILCOX, W. R. 
& AHITUV, N. 2014. A novel ZRS mutation leads to preaxial polydactyly type 2 in a 
 241 
heterozygous form and Werner mesomelic syndrome in a homozygous form. Hum 
Mutat, 35, 945-8. 
VARAMBALLY, S., DHANASEKARAN, S. M., ZHOU, M., BARRETTE, T. R., KUMAR-SINHA, C., 
SANDA, M. G., GHOSH, D., PIENTA, K. J., SEWALT, R. G., OTTE, A. P., RUBIN, M. A. & 
CHINNAIYAN, A. M. 2002. The polycomb group protein EZH2 is involved in 
progression of prostate cancer. Nature, 419, 624-9. 
VERGER, A., BAERT, J. L., VERREMAN, K., DEWITTE, F., FERREIRA, E., LENS, Z., DE LAUNOIT, 
Y., VILLERET, V. & MONTÉ, D. 2013. The Mediator complex subunit MED25 is 
targeted by the N-terminal transactivation domain of the PEA3 group members. 
Nucleic Acids Res, 41, 4847-59. 
VERHEYDEN, J. M. & SUN, X. 2008. An Fgf/Gremlin inhibitory feedback loop triggers 
termination of limb bud outgrowth. Nature, 454, 638-41. 
VIETRI RUDAN, M., BARRINGTON, C., HENDERSON, S., ERNST, C., ODOM, D. T., TANAY, A. & 
HADJUR, S. 2015. Comparative Hi-C reveals that CTCF underlies evolution of 
chromosomal domain architecture. Cell Rep, 10, 1297-309. 
VISEL, A., BLOW, M. J., LI, Z., ZHANG, T., AKIYAMA, J. A., HOLT, A., PLAJZER-FRICK, I., 
SHOUKRY, M., WRIGHT, C., CHEN, F., AFZAL, V., REN, B., RUBIN, E. M. & 
PENNACCHIO, L. A. 2009. ChIP-seq accurately predicts tissue-specific activity of 
enhancers. Nature, 457, 854-8. 
VISEL, A., PRABHAKAR, S., AKIYAMA, J. A., SHOUKRY, M., LEWIS, K. D., HOLT, A., PLAJZER-
FRICK, I., AFZAL, V., RUBIN, E. M. & PENNACCHIO, L. A. 2008. Ultraconservation 
identifies a small subset of extremely constrained developmental enhancers. Nat 
Genet, 40, 158-60. 
WADE, C., BRINAS, I., WELFARE, M., WICKING, C. & FARLIE, P. G. 2012. Twist2 contributes to 
termination of limb bud outgrowth and patterning through direct regulation of 
Grem1. Dev Biol, 370, 145-53. 
WAGNER, G. P. & CHIU, C. H. 2001. The tetrapod limb: a hypothesis on its origin. J Exp Zool, 
291, 226-40. 
WHYTE, W. A., ORLANDO, D. A., HNISZ, D., ABRAHAM, B. J., LIN, C. Y., KAGEY, M. H., RAHL, 
P. B., LEE, T. I. & YOUNG, R. A. 2013. Master transcription factors and mediator 
establish super-enhancers at key cell identity genes. Cell, 153, 307-19. 
WIECZOREK, D., PAWLIK, B., LI, Y., AKARSU, N. A., CALIEBE, A., MAY, K. J., SCHWEIGER, B., 
VARGAS, F. R., BALCI, S., GILLESSEN-KAESBACH, G. & WOLLNIK, B. 2010. A specific 
mutation in the distant sonic hedgehog (SHH) cis-regulator (ZRS) causes Werner 
mesomelic syndrome (WMS) while complete ZRS duplications underlie Haas type 
polysyndactyly and preaxial polydactyly (PPD) with or without triphalangeal thumb. 
Hum Mutat, 31, 81-9. 
WILLIAMSON, I. 2012. Differential chromatin topology and 
transcription factor enhancer binding 
regulate spatiotemporal gene expression in 
limb development. PhD by Research, University of Edinburgh. 
WILLIAMSON, I., BERLIVET, S., ESKELAND, R., BOYLE, S., ILLINGWORTH, R. S., PAQUETTE, D., 
DOSTIE, J. & BICKMORE, W. A. 2014. Spatial genome organization: contrasting 
views from chromosome conformation capture and fluorescence in situ 
hybridization. Genes Dev, 28, 2778-91. 
 242 
WILLIAMSON, I., ESKELAND, R., LETTICE, L. A., HILL, A. E., BOYLE, S., GRIMES, G. R., HILL, R. 
E. & BICKMORE, W. A. 2012. Anterior-posterior differences in HoxD chromatin 
topology in limb development. Development, 139, 3157-67. 
WILLIAMSON, I., LETTICE, L. A., HILL, R. E. & BICKMORE, W. A. 2016. Shh and ZRS enhancer 
co-localisation is specific to the zone of polarizing activity. Development. 
WILSON, K. L. & FOISNER, R. 2010. Lamin-binding Proteins. Cold Spring Harb Perspect Biol, 
2, a000554. 
WOLPERT, L. 1969. Positional information and the spatial pattern of cellular differentiation. 
J Theor Biol, 25, 1-47. 
WORMAN, H. J. & BONNE, G. 2007. "Laminopathies": a wide spectrum of human diseases. 
Exp Cell Res, 313, 2121-33. 
XIAO, B., JI, X., XING, Y., CHEN, Y. W. & TAO, J. 2013. A rare case of 46, XX SRY-negative male 
with approximately 74-kb duplication in a region upstream of SOX9. Eur J Med 
Genet, 56, 695-8. 
XU, M. & COOK, P. R. 2008. Similar active genes cluster in specialized transcription factories. 
J Cell Biol, 181, 615-23. 
YAMAGISHI, C., YAMAGISHI, H., MAEDA, J., TSUCHIHASHI, T., IVEY, K., HU, T. & SRIVASTAVA, 
D. 2006. Sonic hedgehog is essential for first pharyngeal arch development. Pediatr 
Res, 59, 349-54. 
YANG, Y. & NISWANDER, L. 1995. Interaction between the signaling molecules WNT7a and 
SHH during vertebrate limb development: dorsal signals regulate anteroposterior 
patterning. Cell, 80, 939-47. 
YAO, B., WANG, Q., LIU, C. F., BHATTARAM, P., LI, W., MEAD, T. J., CRISH, J. F. & LEFEBVRE, 
V. 2015. The SOX9 upstream region prone to chromosomal aberrations causing 
campomelic dysplasia contains multiple cartilage enhancers. Nucleic Acids Res, 43, 
5394-408. 
YARDIMCI, G. G. & NOBLE, W. S. 2015. Predictive model of 3D domain formation via CTCF-
mediated extrusion. Proc Natl Acad Sci U S A, 112, 14404-5. 
YASHIRO, K., ZHAO, X., UEHARA, M., YAMASHITA, K., NISHIJIMA, M., NISHINO, J., SAIJOH, Y., 
SAKAI, Y. & HAMADA, H. 2004. Regulation of retinoic acid distribution is required 
for proximodistal patterning and outgrowth of the developing mouse limb. Dev Cell, 
6, 411-22. 
ZELLER, R., LÓPEZ-RÍOS, J. & ZUNIGA, A. 2009. Vertebrate limb bud development: moving 
towards integrative analysis of organogenesis. Nat Rev Genet, 10, 845-58. 
ZENTNER, G. E., TESAR, P. J. & SCACHERI, P. C. 2011. Epigenetic signatures distinguish 
multiple classes of enhancers with distinct cellular functions. Genome Res, 21, 
1273-83. 
ZHAO, W., DAI, F., BONAFEDE, A., SCHAFER, S., JUNG, M., YUSUF, F., GAMEL, A. J., WANG, J. 
& BRAND-SABERI, B. 2009. Histone deacetylase inhibitor, trichostatin A, affects 
gene expression patterns during morphogenesis of chicken limb buds in vivo. Cells 
Tissues Organs, 190, 121-34. 
ZHAO, Z., TAVOOSIDANA, G., SJÖLINDER, M., GÖNDÖR, A., MARIANO, P., WANG, S., 
KANDURI, C., LEZCANO, M., SANDHU, K. S., SINGH, U., PANT, V., TIWARI, V., 
KURUKUTI, S. & OHLSSON, R. 2006. Circular chromosome conformation capture 
(4C) uncovers extensive networks of epigenetically regulated intra- and 
interchromosomal interactions. Nat Genet, 38, 1341-7. 
ZORN, C., CREMER, C., CREMER, T. & ZIMMER, J. 1979. Unscheduled DNA synthesis after 
partial UV irradiation of the cell nucleus. Distribution in interphase and metaphase. 
Exp Cell Res, 124, 111-9. 
 243 
ZULLO, J. M., DEMARCO, I. A., PIQUÉ-REGI, R., GAFFNEY, D. J., EPSTEIN, C. B., SPOONER, C. 
J., LUPERCHIO, T. R., BERNSTEIN, B. E., PRITCHARD, J. K., REDDY, K. L. & SINGH, H. 
2012. DNA sequence-dependent compartmentalization and silencing of chromatin 
at the nuclear lamina. Cell, 149, 1474-87. 
ZÚÑIGA, A., HARAMIS, A. P., MCMAHON, A. P. & ZELLER, R. 1999. Signal relay by BMP 

























































DOUGLAS, A. T. & HILL, R. D. 2014. Variation in vertebrate cis-regulatory elements in 
evolution and disease. Transcription, 5, e28848. 
Paper 2 
Douglas, Adam, Peluso, Silvia, Lettice, Laura A, and Hill, Robert E (Aug 2016) Cis‐
Regulatory Mutations in Human Disease. In: eLS. John Wiley & Sons Ltd, Chichester. 
http://www.els.net [doi: 10.1002/9780470015902.a0024920] 
Paper 3 
MORT, R. L., FORD, M. J., SAKAUE-SAWANO, A., LINDSTROM, N. O., CASADIO, A., DOUGLAS, 
A. T., KEIGHREN, M. A., HOHENSTEIN, P., MIYAWAKI, A. & JACKSON, I. J. 2014. Fucci2a: a 
bicistronic cell cycle reporter that allows Cre mediated tissue specific expression in mice. Cell 
Cycle, 13, 2681-96. 
 
 
 
 
 
